data_1vsq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1vsq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.507 ' HB ' ' HG2' ' A' ' 105' ' ' ARG . 76.6 p . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 121.106 0.479 . . . . 0.45000000000000001 111.038 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.606 ' O ' ' HD2' ' A' ' 105' ' ' ARG . 47.0 mt -71.24 136.2 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.736 -1.95 . . . . 0.39000000000000001 105.736 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.98 144.42 36.76 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 115.292 -0.867 . . . . 0.37 110.744 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.531 HD12 HG23 ' A' ' 101' ' ' THR . 45.3 mt -126.27 130.14 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.825 0.85 . . . . 0.32000000000000001 109.053 177.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.29 129.28 74.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.035 -1.839 . . . . 0.33000000000000002 106.035 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 mt -109.11 132.24 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.445 -0.576 . . . . 0.26000000000000001 109.445 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.55 133.01 6.17 Favored Glycine 0 N--CA 1.463 0.476 0 C-N-CA 120.271 -0.966 . . . . 0.25 111.849 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 14' ' ' ALA . 14.4 t . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 107.422 -1.325 . . . . 1.05 107.422 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 114.981 0.752 . . . . 0.33000000000000002 114.981 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -121.95 25.66 9.01 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 114.486 1.291 . . . . 0.90000000000000002 114.486 -174.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.92 -27.27 43.73 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 115.277 1.584 . . . . 0.25 115.277 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.499 ' N ' HG22 ' A' ' 9' ' ' THR . . . -54.7 -46.48 74.15 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.827 0.74 . . . . 0.27000000000000002 112.799 -176.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -59.79 -40.39 88.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.593 -0.443 . . . . 0.44 111.224 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.31 -35.22 73.53 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.105 1.15 . . . . 0.40999999999999998 114.105 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.05 -39.99 95.3 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.139 -1.43 . . . . 0.27000000000000002 107.139 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.13 -43.47 91.81 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.149 -0.685 . . . . 0.35999999999999999 109.149 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HG2' ' HZ2' ' A' ' 19' ' ' LYS . 24.7 mttm -61.56 -39.18 90.2 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.242 0.544 . . . . 0.46999999999999997 111.234 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.96 -47.64 79.64 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 115.048 -0.978 . . . . 0.37 108.609 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.71 86.11 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 119.754 -0.778 . . . . 0.39000000000000001 111.465 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.96 -23.34 65.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.103 -0.499 . . . . 2.5 110.692 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.47 -32.01 69.39 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 105.703 -1.962 . . . . 3.0600000000000001 105.703 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.8 mt -84.74 -38.38 19.74 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 113.817 1.043 . . . . 1.1899999999999999 113.817 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -109.6 -12.03 14.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 119.025 2.972 . . . . 1.1699999999999999 119.025 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.98 165.07 31.38 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 105.457 -3.057 . . . . 0.52000000000000002 105.457 -175.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -58.82 138.97 56.96 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 122.41 1.1 . . . . 0.57999999999999996 112.611 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -105.91 146.75 29.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.264 -1.789 . . . . 0.45000000000000001 113.038 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -106.46 157.34 17.72 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.497 -1.229 . . . . 0.54000000000000004 107.816 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.25 41.22 20.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.096 1.147 . . . . 0.44 114.096 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.8 t -131.09 134.53 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.381 -0.97 . . . . 0.39000000000000001 108.381 177.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.66 18.93 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 109.899 -1.28 . . . . 0.37 109.899 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.22 157.76 36.4 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 118.203 1.001 . . . . 0.42999999999999999 108.921 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.84 159.15 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.453 -0.794 . . . . 0.38 110.29 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -113.46 162.85 15.63 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.757 -0.656 . . . . 0.41999999999999998 109.592 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 36' ' ' PHE . 1.9 t80 -134.19 117.5 16.57 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.886 -1.524 . . . . 0.45000000000000001 106.886 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.6 t -108.11 145.44 31.45 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 113.92 -1.491 . . . . 0.51000000000000001 110.848 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -57.06 136.08 74.54 Favored 'Trans proline' 0 C--N 1.352 0.752 0 N-CA-C 107.929 -1.604 . . . . 0.53000000000000003 107.929 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.55 -25.75 16.55 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.065 -1.214 . . . . 0.57999999999999996 110.065 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.34 157.66 21.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.373 0.606 . . . . 0.54000000000000004 110.009 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -125.08 179.29 5.11 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.343 -0.984 . . . . 2.5099999999999998 108.343 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.19 72.97 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 113.003 0.742 . . . . 0.5 113.003 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.86 -36.45 84.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.84 0.828 . . . . 2.8300000000000001 112.164 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.5 m -63.92 -47.58 79.99 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 106.01 -1.848 . . . . 0.56000000000000005 106.01 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.71 -37.48 86.7 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.108 0.781 . . . . 0.46999999999999997 113.108 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.1 mt -58.59 -43.15 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.587 -0.894 . . . . 0.52000000000000002 108.587 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -62.58 -42.73 99.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.966 -0.694 . . . . 0.59999999999999998 110.875 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -61.58 -44.34 97.21 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 119.347 -0.941 . . . . 0.48999999999999999 111.34 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -61.02 -45.65 93.96 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 120.015 -0.674 . . . . 0.41999999999999998 109.595 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -60.15 -40.04 88.44 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 113.158 0.799 . . . . 0.53000000000000003 113.158 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.58 -35.64 81.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.449 0.643 . . . . 0.54000000000000004 110.135 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.17 -43.61 70.47 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 119.578 -0.849 . . . . 0.45000000000000001 110.205 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.73 -37.92 80.28 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.281 -0.418 . . . . 0.45000000000000001 112.041 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.31 -26.36 29.07 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.699 0.629 . . . . 0.55000000000000004 112.699 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -95.49 -4.75 44.35 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.224 0.824 . . . . 0.55000000000000004 113.224 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 69.8 mt -105.85 157.54 17.4 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 113.313 0.857 . . . . 0.46000000000000002 113.313 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -89.34 107.94 19.35 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 102.541 -3.133 . . . . 0.46999999999999997 102.541 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.9 p -106.98 15.38 25.39 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 124.097 0.873 . . . . 0.44 111.05 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.3 p -64.03 -34.27 77.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 115.553 1.686 . . . . 0.5 115.553 -177.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.77 -9.39 43.79 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.274 0.559 . . . . 0.5 112.271 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.71 172.22 13.03 Favored Glycine 0 C--O 1.242 0.598 0 C-N-CA 119.486 -1.34 . . . . 0.40000000000000002 113.406 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.3 t -139.47 130.17 32.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 N-CA-C 109.273 -0.639 . . . . 0.37 109.273 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.581 ' HG ' HD22 ' A' ' 65' ' ' LEU . 27.8 tp -115.86 113.37 23.26 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.549 1.781 . . . . 0.29999999999999999 108.446 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.68 122.19 33.23 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 106.507 -1.664 . . . . 0.35999999999999999 106.507 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.581 HD22 ' HG ' ' A' ' 63' ' ' LEU . 83.0 mt -109.55 115.25 29.56 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 104.519 -2.4 . . . . 0.23999999999999999 104.519 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.405 HG21 ' HA ' ' A' ' 91' ' ' ALA . 25.4 m -119.93 163.31 17.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 113.221 0.823 . . . . 0.25 113.221 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 14.3 p-10 -64.94 -54.05 36.8 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 118.031 2.604 . . . . 0.27000000000000002 118.031 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -142.23 151.41 42.09 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 122.541 1.163 . . . . 1.05 112.693 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -66.32 134.47 52.67 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.178 -1.374 . . . . 0.48999999999999999 107.857 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.72 -8.14 70.59 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 121.281 3.272 . . . . 0.38 121.281 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.23 174.9 55.24 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 119.341 -1.409 . . . . 0.34000000000000002 110.065 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.18 -47.77 98.5 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 122.089 -0.653 . . . . 1.75 112.057 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -53.5 -41.56 72.46 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 118.293 -0.671 . . . . 0.32000000000000001 110.604 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -67.28 -48.26 68.2 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 123.506 0.504 . . . . 0.39000000000000001 109.865 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -60.1 -42.71 95.24 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.945 1.091 . . . . 2.2799999999999998 113.945 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.6 85.57 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.388 -0.925 . . . . 0.42999999999999999 111.675 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.83 89.97 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.7 -0.852 . . . . 0.38 108.7 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.3 m -58.72 -39.82 81.96 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.423 0.527 . . . . 1.8500000000000001 112.423 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 79' ' ' ARG . 33.8 mtt180 -67.31 -29.55 69.15 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 112.957 0.725 . . . . 3.98 112.957 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.404 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 76.5 mt -77.15 -42.18 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.755 0.65 . . . . 0.46000000000000002 112.755 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 87' ' ' TYR . 2.6 m -80.15 -16.72 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 115.456 1.65 . . . . 0.45000000000000001 115.456 -175.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -29.31 -55.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 1 N-CA-C 122.123 4.12 . . . . 1.29 122.123 -177.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.55 39.4 3.97 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 116.387 -2.125 . . . . 0.58999999999999997 109.525 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -112.33 133.55 54.37 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 114.505 -1.225 . . . . 0.5 109.745 -179.401 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.23 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 106.732 -1.581 . . . . 0.52000000000000002 106.732 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.67 15.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 115.395 1.628 . . . . 0.47999999999999998 115.395 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.485 ' HB3' ' HB ' ' A' ' 81' ' ' VAL . 6.1 m-85 -127.47 130.92 50.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.538 -2.023 . . . . 0.42999999999999999 105.538 175.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.59 154.67 41.76 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.29 -0.564 . . . . 0.39000000000000001 110.311 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 t -121.69 128.48 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 106.315 -1.735 . . . . 0.34000000000000002 106.315 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 63' ' ' LEU . 34.3 mt -124.16 119.51 56.87 Favored 'Isoleucine or valine' 0 C--O 1.256 1.405 0 N-CA-C 108.258 -1.016 . . . . 0.31 108.258 177.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.405 ' HA ' HG21 ' A' ' 66' ' ' VAL . . . -84.4 163.29 19.6 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 114.674 -1.148 . . . . 0.27000000000000002 112.388 176.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.71 24.62 55.53 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 114.821 0.688 . . . . 0.20999999999999999 114.821 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.82 132.73 6.61 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 N-CA-C 113.483 0.92 . . . . 0.17000000000000001 113.483 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.577 ' HB3' ' HB3' ' B' ' 94' ' ' ASN . 50.9 p30 -141.88 169.61 17.28 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.65 -1.241 . . . . 0.26000000000000001 107.65 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.431 HG21 HD13 ' A' ' 95' ' ' ILE . 50.4 mm -60.22 -43.37 93.47 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 114.522 1.304 . . . . 1.0900000000000001 114.522 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.55 -42.94 55.52 Favored 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 117.584 -1.144 . . . . 0.34000000000000002 110.343 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 39.8 ttm -61.56 -48.93 78.75 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 120.348 -0.541 . . . . 0.28999999999999998 109.704 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.44 -48.05 83.43 Favored 'General case' 0 C--O 1.201 -1.487 0 N-CA-C 112.784 0.661 . . . . 0.29999999999999999 112.784 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.51 -49.8 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 112.729 0.641 . . . . 1.1100000000000001 112.729 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -63.67 -40.51 97.01 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.253 -0.579 . . . . 2.04 111.671 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.531 HG23 HD12 ' A' ' 5' ' ' ILE . 53.3 m -66.24 -46.09 78.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.34999999999999998 110.89 -178.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.5 -37.84 88.93 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 123.537 0.523 . . . . 0.40000000000000002 110.571 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 69.8 mtp -66.12 -45.74 80.0 Favored 'General case' 0 C--O 1.243 0.717 0 O-C-N 121.353 -0.842 . . . . 2.1299999999999999 112.099 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.86 75.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.179 0.807 . . . . 1.1000000000000001 113.179 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 15.7 ttp180 -52.6 -32.63 42.43 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 113.4 0.889 . . . . 0.42999999999999999 113.4 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -73.6 -19.6 60.83 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 114.001 1.111 . . . . 2.1899999999999999 114.001 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -90.67 18.24 6.64 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.204 1.002 . . . . 2.2000000000000002 109.49 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.6 t70 46.69 58.55 16.73 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 117.248 2.314 . . . . 0.52000000000000002 117.248 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -74.13 168.5 24.66 Favored 'Trans proline' 0 C--O 1.206 -1.1 0 C-N-CA 120.455 0.77 . . . . 0.48999999999999999 110.659 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.511 ' HG ' ' CG ' ' A' ' 113' ' ' GLU . 54.4 p -77.05 162.74 27.27 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.613 -1.625 . . . . 0.5 106.613 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -55.95 -51.55 67.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 112.373 0.509 . . . . 0.44 112.373 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.51 -37.73 76.21 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 112.924 0.712 . . . . 0.51000000000000001 112.924 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.511 ' CG ' ' HG ' ' A' ' 110' ' ' SER . 88.7 mt-10 -62.8 -46.87 85.94 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.416 -0.356 . . . . 0.54000000000000004 110.156 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.418 ' HA ' HD12 ' A' ' 114' ' ' LEU . 15.0 tp -64.26 -45.97 85.78 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 121.087 -0.245 . . . . 0.40999999999999998 111.235 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.91 -48.3 81.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.583 -0.447 . . . . 0.39000000000000001 110.478 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.83 -44.31 94.1 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.202 0.525 . . . . 0.46999999999999997 112.338 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.34 -42.93 99.79 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 122.071 -0.393 . . . . 1.1299999999999999 111.009 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.06 94.48 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 119.748 -0.781 . . . . 0.34999999999999998 112.096 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.65 -46.26 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.83 -0.433 . . . . 0.40000000000000002 109.83 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -63.65 -45.29 90.84 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.678 0.992 . . . . 0.52000000000000002 113.678 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.2 p -71.42 -32.35 68.29 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 120.607 -0.437 . . . . 1.1200000000000001 111.867 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.41 -45.58 95.63 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.362 -1.495 . . . . 0.32000000000000001 109.362 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.43 -42.01 65.53 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 112.588 0.588 . . . . 0.47999999999999998 112.588 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.52 -20.32 62.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 119.609 -0.836 . . . . 2.3999999999999999 111.899 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.61 -16.69 76.03 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 124.203 0.939 . . . . 0.38 113.559 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.462 HG13 ' CE ' ' B' ' 97' ' ' MET . 93.6 t -88.97 112.98 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 106.193 -1.78 . . . . 0.40000000000000002 106.193 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -156.43 136.92 13.11 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.387 -0.968 . . . . 3.29 108.387 -173.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.65 146.67 23.98 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 122.043 0.925 . . . . 1.1399999999999999 109.996 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 tp -66.84 -56.86 8.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.314 -0.857 . . . . 1.22 111.407 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.5 mttt 62.97 178.54 0.15 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.655 0.741 . . . . 3.2000000000000002 110.518 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.13 146.74 53.15 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.345 -0.983 . . . . 1.48 108.345 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.53 147.66 38.02 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.484 -0.76 . . . . 5.1299999999999999 109.529 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -64.66 148.64 90.36 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.305 2.003 . . . . 3.1400000000000001 112.415 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.014 -0.993 . . . . 4.0199999999999996 109.17 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' THR . . . . . 0.49 ' HB ' ' HG2' ' B' ' 105' ' ' ARG . 77.3 p . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.166 0.508 . . . . 0.38 111.01 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.617 ' O ' ' HD2' ' B' ' 105' ' ' ARG . 47.1 mt -71.25 136.18 26.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 105.791 -1.929 . . . . 0.40999999999999998 105.791 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.99 144.43 36.73 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.387 -0.824 . . . . 0.34999999999999998 110.795 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 44.6 mt -126.23 130.25 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.764 0.826 . . . . 0.28000000000000003 108.981 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 86.4 t -124.42 129.27 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.004 -1.85 . . . . 0.34999999999999998 106.004 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.559 HG23 ' HB2' ' B' ' 14' ' ' ALA . 35.7 mt -109.06 132.27 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 109.548 -0.538 . . . . 0.28999999999999998 109.548 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.52 133.04 6.19 Favored Glycine 0 N--CA 1.462 0.384 0 C-N-CA 120.326 -0.94 . . . . 0.33000000000000002 111.885 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.497 HG22 ' N ' ' B' ' 14' ' ' ALA . 15.0 t . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 107.363 -1.347 . . . . 1.0600000000000001 107.363 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 114.863 0.705 . . . . 0.42999999999999999 114.863 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -123.57 25.67 8.1 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 114.44 1.274 . . . . 0.90000000000000002 114.44 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.03 -27.17 43.15 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 115.216 1.562 . . . . 0.31 115.216 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.559 ' HB2' HG23 ' B' ' 7' ' ' ILE . . . -54.74 -46.44 74.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.887 0.767 . . . . 0.28999999999999998 112.834 -176.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.79 -40.35 88.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.958 -0.464 . . . . 0.39000000000000001 111.265 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.19 -35.46 73.97 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.056 1.132 . . . . 0.37 114.056 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.02 -39.95 95.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.09 -1.448 . . . . 0.20999999999999999 107.09 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' LEU . . . . . 0.502 HD11 HG11 ' B' ' 31' ' ' VAL . 18.6 tp -65.21 -43.39 91.68 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 109.192 -0.67 . . . . 0.27000000000000002 109.192 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -61.62 -39.11 90.1 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 121.242 0.544 . . . . 0.39000000000000001 111.266 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.9 -47.64 79.77 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-N 115.056 -0.975 . . . . 0.23999999999999999 108.59 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.7 86.26 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.681 -0.808 . . . . 0.23999999999999999 111.49 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.98 -23.21 65.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.014 -0.539 . . . . 2.54 110.755 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.66 -31.87 68.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.689 -1.967 . . . . 3.1000000000000001 105.689 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 45.6 mt -84.75 -38.3 19.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.837 1.051 . . . . 1.1100000000000001 113.837 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 91.3 mt -109.66 -11.98 14.69 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 119.046 2.98 . . . . 1.0900000000000001 119.046 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.83 165.08 31.57 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 105.521 -3.032 . . . . 0.35999999999999999 105.521 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.69 138.99 56.72 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.338 1.066 . . . . 0.41999999999999998 112.687 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -106.06 146.7 29.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.272 -1.785 . . . . 0.29999999999999999 112.963 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -106.37 157.34 17.69 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 114.434 -1.257 . . . . 0.39000000000000001 107.794 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.13 41.3 20.68 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.085 1.142 . . . . 0.34000000000000002 114.085 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.502 HG11 HD11 ' B' ' 18' ' ' LEU . 93.7 t -131.08 134.62 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.31 -0.996 . . . . 0.29999999999999999 108.31 177.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.73 18.91 Favored Glycine 0 N--CA 1.469 0.886 0 N-CA-C 109.82 -1.312 . . . . 0.32000000000000001 109.82 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.26 157.69 36.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.167 0.983 . . . . 0.41999999999999998 108.953 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.79 159.1 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.577 -0.738 . . . . 0.42999999999999999 110.306 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.36 162.78 15.66 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.713 -0.676 . . . . 0.46999999999999997 109.617 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' B' ' 36' ' ' PHE . 2.3 t80 -134.16 117.56 16.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.888 -1.523 . . . . 0.56999999999999995 106.888 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.454 HG12 ' HD2' ' B' ' 38' ' ' PRO . 95.0 t -108.1 145.42 31.42 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.943 -1.481 . . . . 0.60999999999999999 110.855 -176.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.454 ' HD2' HG12 ' B' ' 37' ' ' VAL . 58.6 Cg_exo -57.01 136.14 74.96 Favored 'Trans proline' 0 C--N 1.352 0.719 0 N-CA-C 107.949 -1.597 . . . . 0.64000000000000001 107.949 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.48 -25.78 16.61 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.126 -1.19 . . . . 0.69999999999999996 110.126 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.27 157.66 21.48 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.336 0.588 . . . . 0.65000000000000002 110.031 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' B' ' 41' ' ' ASN . 29.5 p-10 -125.06 179.31 5.1 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.372 -0.973 . . . . 2.6699999999999999 108.372 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.13 73.0 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 112.972 0.73 . . . . 0.63 112.972 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.77 -36.58 84.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.934 0.873 . . . . 2.8199999999999998 112.163 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 89.4 m -63.9 -47.53 80.25 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 105.987 -1.857 . . . . 0.65000000000000002 105.987 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.411 HD12 ' HB3' ' B' ' 72' ' ' SER . 36.5 mt -62.74 -37.68 87.52 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 112.979 0.733 . . . . 0.56999999999999995 112.979 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.47 -43.14 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.635 -0.876 . . . . 0.62 108.635 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -62.66 -42.72 99.77 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 119.984 -0.686 . . . . 0.66000000000000003 110.825 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.52 -44.42 97.1 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 119.346 -0.942 . . . . 0.55000000000000004 111.47 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -60.89 -45.72 93.5 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 119.986 -0.686 . . . . 0.47999999999999998 109.637 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -60.09 -40.14 88.55 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 113.131 0.789 . . . . 0.58999999999999997 113.131 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.5 -35.61 81.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.434 0.635 . . . . 0.55000000000000004 110.17 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.11 -43.83 70.23 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 119.572 -0.851 . . . . 0.46000000000000002 110.141 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' B' ' 53' ' ' LEU . 91.0 mt -59.55 -38.0 79.92 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.261 -0.427 . . . . 0.46999999999999997 112.048 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.27 -26.32 28.39 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.744 0.646 . . . . 0.52000000000000002 112.744 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -95.57 -4.73 44.13 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 113.126 0.787 . . . . 0.5 113.126 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 69.4 mt -105.77 157.43 17.45 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.396 0.888 . . . . 0.40999999999999998 113.396 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -89.34 107.99 19.38 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 102.557 -3.127 . . . . 0.41999999999999998 102.557 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 72.9 p -107.09 15.4 25.26 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 124.153 0.908 . . . . 0.46000000000000002 111.064 -177.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 73.0 p -63.95 -34.29 77.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 115.595 1.702 . . . . 0.48999999999999999 115.595 -177.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.87 -9.35 43.61 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.267 0.556 . . . . 0.47999999999999998 112.202 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.74 172.19 13.02 Favored Glycine 0 C--O 1.242 0.642 0 C-N-CA 119.484 -1.341 . . . . 0.44 113.383 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.41 130.25 32.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 109.259 -0.645 . . . . 0.41999999999999998 109.259 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.55 ' HG ' HD23 ' B' ' 65' ' ' LEU . 27.9 tp -115.84 113.42 23.34 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.497 1.748 . . . . 0.35999999999999999 108.411 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.78 122.17 33.29 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.491 -1.67 . . . . 0.42999999999999999 106.491 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.55 HD23 ' HG ' ' B' ' 63' ' ' LEU . 83.2 mt -109.52 115.27 29.61 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 104.531 -2.396 . . . . 0.28000000000000003 104.531 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 26.0 m -120.01 163.4 17.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 113.186 0.81 . . . . 0.35999999999999999 113.186 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' B' ' 67' ' ' ASP . 14.8 p-10 -64.9 -54.07 36.53 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 118.069 2.618 . . . . 0.39000000000000001 118.069 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 45.3 p -142.23 151.4 42.06 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.533 1.158 . . . . 1.0900000000000001 112.692 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' TRP . . . . . . . . . . . . . 32.8 t-105 -66.27 134.45 52.67 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.153 -1.385 . . . . 0.64000000000000001 107.818 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.73 -8.14 70.6 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 121.218 3.247 . . . . 0.52000000000000002 121.218 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.2 174.92 55.25 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 119.282 -1.437 . . . . 0.48999999999999999 110.109 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' SER . . . . . 0.411 ' HB3' HD12 ' B' ' 45' ' ' LEU . 0.6 OUTLIER -57.15 -47.84 98.4 Favored Pre-proline 0 C--N 1.329 -0.291 0 O-C-N 122.017 -0.696 . . . . 1.78 112.01 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -53.44 -41.6 71.92 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 118.391 -0.606 . . . . 0.45000000000000001 110.619 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -67.2 -48.37 68.1 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 123.458 0.474 . . . . 0.53000000000000003 109.845 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -60.05 -42.71 95.08 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.972 1.101 . . . . 2.4199999999999999 113.972 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.46 85.71 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.242 -0.983 . . . . 0.55000000000000004 111.721 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.05 -38.83 90.25 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 108.618 -0.882 . . . . 0.48999999999999999 108.618 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 70.5 m -58.65 -39.89 81.88 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.416 0.524 . . . . 1.8700000000000001 112.416 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -67.2 -29.58 69.28 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 113.042 0.756 . . . . 4.0899999999999999 113.042 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 76.1 mt -77.2 -42.15 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.697 0.629 . . . . 0.56000000000000005 112.697 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' B' ' 87' ' ' TYR . 2.6 m -80.03 -16.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.901 0 N-CA-C 115.465 1.654 . . . . 0.56000000000000005 115.465 -175.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -29.4 -55.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.352 1 N-CA-C 122.096 4.11 . . . . 1.3 122.096 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.49 39.3 3.99 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 116.394 -2.122 . . . . 0.71999999999999997 109.601 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.37 133.55 54.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.442 -1.254 . . . . 0.60999999999999999 109.748 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.25 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 106.707 -1.59 . . . . 0.63 106.707 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.68 15.24 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 115.406 1.632 . . . . 0.56999999999999995 115.406 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' TYR . . . . . 0.476 ' HB3' ' HB ' ' B' ' 81' ' ' VAL . 6.1 m-85 -127.45 130.89 50.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 105.506 -2.035 . . . . 0.51000000000000001 105.506 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . 0.404 ' HG2' HG13 ' B' ' 115' ' ' VAL . 6.7 tp10 -146.6 154.66 41.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.228 -0.589 . . . . 0.48999999999999999 110.357 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.77 128.47 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 106.235 -1.765 . . . . 0.46000000000000002 106.235 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 34.2 mt -124.14 119.52 56.93 Favored 'Isoleucine or valine' 0 C--O 1.255 1.378 0 N-CA-C 108.245 -1.02 . . . . 0.38 108.245 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.46 163.21 19.59 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 114.738 -1.119 . . . . 0.38 112.314 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.89 24.49 55.33 Favored Glycine 0 CA--C 1.499 -0.911 0 N-CA-C 114.817 0.687 . . . . 0.28999999999999998 114.817 176.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.85 132.85 6.69 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 N-CA-C 113.461 0.911 . . . . 0.23999999999999999 113.461 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' ASN . . . . . 0.577 ' HB3' ' HB3' ' A' ' 94' ' ' ASN . 51.2 p30 -141.98 169.48 17.52 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.688 -1.227 . . . . 0.22 107.688 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 51.3 mm -60.2 -43.37 93.54 Favored Pre-proline 0 C--O 1.24 0.588 0 N-CA-C 114.491 1.293 . . . . 1.04 114.491 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.55 -42.85 56.53 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 117.575 -1.15 . . . . 0.25 110.34 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' MET . . . . . 0.462 ' CE ' HG13 ' A' ' 126' ' ' VAL . 39.9 ttm -61.72 -48.85 78.86 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 120.377 -0.529 . . . . 0.28000000000000003 109.633 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' B' ' 98' ' ' LEU . 14.3 tp -60.46 -48.01 83.62 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 112.822 0.675 . . . . 0.20000000000000001 112.822 -177.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.52 -49.9 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 112.715 0.635 . . . . 1.0700000000000001 112.715 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -63.52 -40.59 97.43 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 120.235 -0.586 . . . . 2.0099999999999998 111.696 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' THR . . . . . . . . . . . . . 53.5 m -66.23 -46.12 78.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.731 -0.668 . . . . 0.28999999999999998 110.892 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . 0.406 HD12 ' HG ' ' B' ' 98' ' ' LEU . 97.6 mt -64.47 -37.79 88.76 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 123.607 0.567 . . . . 0.28999999999999998 110.563 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' MET . . . . . . . . . . . . . 72.6 mtp -66.1 -45.81 79.84 Favored 'General case' 0 C--O 1.242 0.695 0 O-C-N 121.264 -0.897 . . . . 2.2200000000000002 112.132 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.81 75.62 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.3 0.852 . . . . 1.0700000000000001 113.3 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 1.44 ' NE ' ' HE ' ' B' ' 105' ' ' ARG . 15.8 ttp180 -52.56 -32.69 42.16 Favored 'General case' 0 C--O 1.21 -1.013 0 N-CA-C 113.4 0.889 . . . . 0.37 113.4 -178.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.57 -19.59 60.85 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 114.1 1.148 . . . . 2.1299999999999999 114.1 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -90.62 18.15 6.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 122.159 0.981 . . . . 2.27 109.476 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 12.7 t70 46.79 58.47 16.88 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 117.269 2.322 . . . . 0.47999999999999998 117.269 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -74.09 168.43 24.82 Favored 'Trans proline' 0 C--O 1.206 -1.109 0 C-N-CA 120.55 0.833 . . . . 0.47999999999999998 110.604 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' SER . . . . . 0.484 ' HG ' ' CG ' ' B' ' 113' ' ' GLU . 54.3 p -77.0 162.78 27.28 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.706 -1.59 . . . . 0.55000000000000004 106.706 175.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -55.94 -51.48 67.5 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 112.445 0.535 . . . . 0.5 112.445 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -58.67 -37.67 76.51 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 112.897 0.703 . . . . 0.59999999999999998 112.897 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . 0.484 ' CG ' ' HG ' ' B' ' 110' ' ' SER . 88.7 mt-10 -62.84 -46.77 86.37 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 116.417 -0.356 . . . . 0.56999999999999995 110.141 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 15.1 tp -64.41 -45.86 85.77 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 121.019 -0.272 . . . . 0.44 111.191 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.404 HG13 ' HG2' ' B' ' 88' ' ' GLU . 63.5 t -56.88 -48.32 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 O-C-N 121.891 -0.506 . . . . 0.46000000000000002 110.52 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.25 94.3 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.133 0.492 . . . . 0.51000000000000001 112.326 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 tp -62.4 -42.8 99.71 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 122.125 -0.359 . . . . 1.1299999999999999 110.989 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.29 -45.1 94.51 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 119.798 -0.761 . . . . 0.35999999999999999 112.059 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.61 -46.26 89.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.803 -0.443 . . . . 0.45000000000000001 109.803 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -63.71 -45.22 90.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 113.717 1.006 . . . . 0.52000000000000002 113.717 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 34.6 p -71.44 -32.28 68.16 Favored 'General case' 0 C--O 1.216 -0.681 0 C-N-CA 120.585 -0.446 . . . . 1.1100000000000001 111.987 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.38 -45.74 95.31 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.332 -1.507 . . . . 0.31 109.332 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.21 -42.15 66.11 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 112.622 0.601 . . . . 0.48999999999999999 112.622 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.43 -20.27 62.92 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 119.578 -0.849 . . . . 2.4199999999999999 111.964 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.78 -16.6 76.3 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 124.246 0.966 . . . . 0.31 113.511 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 93.7 t -88.99 113.07 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 106.171 -1.789 . . . . 0.34000000000000002 106.171 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -156.45 136.84 13.03 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.409 -0.96 . . . . 3.3900000000000001 108.409 -173.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.6 146.71 23.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.031 0.92 . . . . 1.1000000000000001 109.986 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 tp -66.94 -57.09 7.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.337 -0.847 . . . . 1.1200000000000001 111.37 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 63.01 178.65 0.15 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.646 0.736 . . . . 3.2000000000000002 110.595 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.03 146.61 53.36 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.353 -0.98 . . . . 1.4299999999999999 108.353 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.33 147.94 38.5 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.444 -0.785 . . . . 5.2800000000000002 109.476 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -64.76 148.7 90.21 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.415 2.076 . . . . 3.3199999999999998 112.368 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.011 -0.995 . . . . 4.1900000000000004 109.12 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 159' ' ' ASN . . . . . 0.75 ' ND2' ' HZ2' ' C' ' 259' ' ' LYS . 1.8 t-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 108.992 -0.744 . . . . 6.8399999999999999 108.992 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 160' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -85.87 25.5 1.1 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.59 -0.893 . . . . 3.8900000000000001 108.59 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 161' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -118.63 -141.88 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.583 -0.895 . . . . 2.21 108.583 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 162' ' ' MET . . . . . 0.556 ' SD ' ' CG2' ' C' ' 240' ' ' VAL . 0.3 OUTLIER -61.63 156.19 20.55 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.764 -1.21 . . . . 2.48 110.562 -178.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 163' ' ' VAL . . . . . . . . . . . . . 94.9 t -113.11 117.68 56.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.06 -0.719 . . . . 1.24 109.06 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 164' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.73 103.39 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.49 -0.929 . . . . 1.0900000000000001 108.49 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.59 -35.33 80.7 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.211 -1.555 . . . . 0.46999999999999997 109.211 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 tp -172.04 147.97 2.18 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.771 -1.172 . . . . 1.0800000000000001 111.209 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 167' ' ' ALA . . . . . . . . . . . . . . . -117.69 104.39 10.96 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.048 -0.723 . . . . 1.0700000000000001 109.048 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 168' ' ' ARG . . . . . 0.522 ' NH1' ' CG1' ' C' ' 178' ' ' VAL . 44.4 ttp180 -106.37 126.09 51.81 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.972 0.891 . . . . 3.7000000000000002 110.835 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 169' ' ' ILE . . . . . . . . . . . . . 82.3 mt -95.5 129.21 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 109.222 -0.659 . . . . 1.05 109.222 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 170' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -165.95 117.04 1.04 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.812 -0.755 . . . . 0.48999999999999999 110.327 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 171' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.97 -9.94 11.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.429 -0.794 . . . . 2.3300000000000001 109.759 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 172' ' ' ARG . . . . . . . . . . . . . 12.4 mtt180 -101.71 -5.16 25.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 3.5299999999999998 110.47 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 173' ' ' LEU . . . . . . . . . . . . . 14.5 mt 59.0 -100.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.141 -0.974 . . . . 2.0099999999999998 109.917 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 174' ' ' ILE . . . . . . . . . . . . . 77.7 mt -97.71 121.3 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.026 -1.046 . . . . 1.23 108.285 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 175' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -143.19 127.57 17.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.131 -0.98 . . . . 0.76000000000000001 109.426 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 176' ' ' GLY . . . . . . . . . . . . . . . 60.33 -152.63 37.16 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.833 -1.307 . . . . 0.58999999999999997 109.833 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 177' ' ' GLN . . . . . 0.746 ' H ' ' NE2' ' C' ' 177' ' ' GLN . 0.1 OUTLIER -89.36 12.21 16.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.573 -0.957 . . . . 3.5299999999999998 109.332 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . 0.522 ' CG1' ' NH1' ' C' ' 168' ' ' ARG . 48.1 t -61.54 -42.83 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 1.1499999999999999 108.953 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 179' ' ' ALA . . . . . 0.502 ' O ' ' OG1' ' C' ' 183' ' ' THR . . . -73.16 -36.38 66.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.929 -1.107 . . . . 1.1599999999999999 110.187 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 180' ' ' THR . . . . . . . . . . . . . 21.5 m -66.34 -54.42 24.82 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.697 -0.801 . . . . 1.25 109.79 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 181' ' ' ARG . . . . . 0.539 ' NH2' ' CG2' ' C' ' 308' ' ' THR . 55.1 ttt-85 -64.7 -43.62 92.88 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.013 -0.675 . . . . 3.7400000000000002 110.608 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 182' ' ' TRP . . . . . 0.468 ' CH2' ' ND2' ' C' ' 264' ' ' ASN . 19.5 m95 -65.82 -32.2 73.6 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.034 -1.041 . . . . 1.01 109.591 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 183' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' C' ' 179' ' ' ALA . 71.9 m -65.29 -47.1 77.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.946 -1.096 . . . . 1.2 110.252 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -69.66 -42.93 73.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 2.6099999999999999 110.806 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 185' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -68.32 -39.61 81.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.95 -1.094 . . . . 2.52 109.569 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 186' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' C' ' 182' ' ' TRP . 72.6 p -81.42 -1.26 45.03 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.282 -0.886 . . . . 1.1399999999999999 109.685 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 187' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 52.14 48.42 22.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.055 -1.028 . . . . 2.6200000000000001 108.604 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 188' ' ' VAL . . . . . 0.44 HG11 ' H ' ' C' ' 190' ' ' ARG . 47.8 t -105.05 133.46 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.164 -0.96 . . . . 1.99 110.122 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 189' ' ' SER . . . . . . . . . . . . . 27.8 p -109.75 -6.33 15.32 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.761 -0.829 . . . . 1.8899999999999999 108.761 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 190' ' ' ARG . . . . . 0.44 ' H ' HG11 ' C' ' 188' ' ' VAL . 29.4 mtt-85 -135.92 142.83 44.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.555 -0.716 . . . . 4.0499999999999998 110.441 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 191' ' ' ILE . . . . . . . . . . . . . 87.6 mt -133.38 127.61 54.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.173 -1.047 . . . . 1.1399999999999999 108.173 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 192' ' ' ILE . . . . . . . . . . . . . 97.1 mt -115.66 128.68 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.257 -0.902 . . . . 1.1299999999999999 109.665 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 193' ' ' VAL . . . . . . . . . . . . . 53.3 t -99.7 128.88 51.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.825 -0.806 . . . . 1.3799999999999999 108.825 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 194' ' ' VAL . . . . . . . . . . . . . 43.0 t -112.51 103.57 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.535 -0.728 . . . . 1.1200000000000001 109.479 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 195' ' ' SER . . . . . . . . . . . . . 38.0 t -167.25 125.61 1.31 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.342 -0.943 . . . . 1.9099999999999999 109.31 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 196' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.01 -34.88 66.65 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.574 -0.704 . . . . 0.97999999999999998 109.984 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 197' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -65.55 -45.49 83.21 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.147 -0.971 . . . . 2.3199999999999998 109.959 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 198' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.11 -43.21 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.102 -0.998 . . . . 1.3400000000000001 109.028 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.6 -26.5 55.72 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.79 -0.764 . . . . 1.24 109.168 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 200' ' ' ALA . . . . . . . . . . . . . . . -84.9 -5.38 59.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.028 -1.045 . . . . 1.3 109.882 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 201' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -102.75 95.38 6.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.9 -1.125 . . . . 1.1499999999999999 109.554 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 202' ' ' THR . . . . . . . . . . . . . 24.7 p -66.22 -33.21 75.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.407 -0.808 . . . . 2.1600000000000001 110.631 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 203' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.33 -47.49 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.851 -1.156 . . . . 1.3799999999999999 109.598 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 204' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -63.69 -42.24 98.04 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.349 -0.94 . . . . 3.6000000000000001 109.576 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 205' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -58.01 -42.42 85.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 2.27 109.482 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 206' ' ' THR . . . . . . . . . . . . . 73.2 m -60.63 -48.71 80.55 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.088 -1.045 . . . . 1.4099999999999999 109.564 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 207' ' ' LEU . . . . . . . . . . . . . 30.6 mt -62.62 -44.45 96.26 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.934 -1.107 . . . . 1.3700000000000001 110.736 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.5 -41.45 98.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.718 -1.239 . . . . 1.3400000000000001 110.055 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 209' ' ' THR . . . . . . . . . . . . . 35.8 p -67.89 -31.83 71.89 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.371 -0.831 . . . . 1.3999999999999999 110.28 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 210' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -80.37 -17.54 51.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.782 -1.199 . . . . 2.7400000000000002 110.857 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 17.5 m -107.69 17.65 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.952 -1.092 . . . . 1.4399999999999999 108.639 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.29 123.42 82.48 Favored Pre-proline 0 N--CA 1.483 1.221 0 N-CA-C 107.82 -1.178 . . . . 1.27 107.82 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 213' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -44.31 144.48 2.95 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.037 1.825 . . . . 1.25 112.731 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 214' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -56.52 134.85 66.98 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.196 1.931 . . . . 1.47 112.028 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 215' ' ' GLY . . . . . . . . . . . . . . . 79.91 -8.52 50.03 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.922 -1.271 . . . . 0.87 109.922 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 216' ' ' VAL . . . . . . . . . . . . . 58.6 t -114.8 136.78 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -1.076 . . . . 1.5600000000000001 108.8 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.87 135.77 45.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.438 -0.789 . . . . 1.99 109.836 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 218' ' ' ALA . . . . . . . . . . . . . . . -110.17 131.37 55.12 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.315 -0.994 . . . . 1.1299999999999999 108.315 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -120.97 153.51 37.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.401 -0.812 . . . . 0.77000000000000002 109.808 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 54.8 t -126.35 117.83 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.624 0.726 . . . . 1.24 109.07 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 31.7 m -141.01 165.14 19.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.412 -0.805 . . . . 1.1699999999999999 109.622 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 222' ' ' ASP . . . . . 0.709 ' OD1' ' N ' ' C' ' 225' ' ' LYS . 6.8 p30 -94.18 167.23 11.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.479 -0.763 . . . . 1.3400000000000001 109.305 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.46 -44.82 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.151 -0.968 . . . . 1.1599999999999999 110.455 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 224' ' ' ALA . . . . . 0.474 ' O ' HG23 ' C' ' 227' ' ' ILE . . . -62.72 -44.73 95.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.934 -1.104 . . . . 1.3 109.398 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 225' ' ' LYS . . . . . 0.709 ' N ' ' OD1' ' C' ' 222' ' ' ASP . 45.7 tttm -68.14 -35.35 77.95 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.775 -1.203 . . . . 2.5800000000000001 109.674 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 226' ' ' MET . . . . . . . . . . . . . 10.3 tpt -62.08 -40.4 95.71 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.934 -1.104 . . . . 1.54 111.191 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 227' ' ' ILE . . . . . 0.53 HG23 ' N ' ' C' ' 228' ' ' ARG . 17.4 tt -60.9 -34.56 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.611 -0.885 . . . . 1.3400000000000001 108.611 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 228' ' ' ARG . . . . . 0.53 ' N ' HG23 ' C' ' 227' ' ' ILE . 0.4 OUTLIER -74.47 -38.86 62.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.722 -0.611 . . . . 4.6600000000000001 110.948 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 70.3 t -62.18 -41.73 92.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.864 -1.162 . . . . 1.1799999999999999 107.864 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 230' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' C' ' 230' ' ' TYR . 36.7 t80 -67.04 -32.13 73.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.102 -0.999 . . . . 1.0700000000000001 109.927 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 231' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.76 6.73 2.34 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.119 -0.988 . . . . 0.98999999999999999 110.104 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 232' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -110.18 117.78 50.87 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.246 -0.909 . . . . 1.0600000000000001 109.435 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 233' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -65.73 1.51 2.19 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.646 1.564 . . . . 1.3300000000000001 111.98 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 234' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.36 -24.76 65.33 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 2.1899999999999999 108.807 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 235' ' ' TYR . . . . . 0.482 ' O ' ' HB2' ' C' ' 238' ' ' GLU . 81.1 m-85 -105.49 15.71 26.66 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.594 -0.842 . . . . 1.75 109.003 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 236' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' C' ' 238' ' ' GLU . . . -54.81 135.62 47.44 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.076 -1.64 . . . . 1.23 109.65 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.78 -33.41 1.9 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.288 -1.525 . . . . 0.67000000000000004 109.288 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 238' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' C' ' 235' ' ' TYR . 4.0 mm-40 -54.25 138.93 37.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.805 -1.409 . . . . 2.48 109.437 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 239' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -99.1 116.33 31.08 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.463 -0.939 . . . . 3.46 108.463 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 240' ' ' VAL . . . . . 0.556 ' CG2' ' SD ' ' C' ' 162' ' ' MET . 26.3 t -121.85 148.78 25.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.876 0.846 . . . . 1.29 110.448 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 241' ' ' MET . . . . . . . . . . . . . 13.8 ttm -102.9 134.95 45.47 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.925 -1.139 . . . . 2.25 107.925 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 242' ' ' LEU . . . . . . . . . . . . . 61.2 mt -102.04 127.28 49.0 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.689 -0.804 . . . . 1.1100000000000001 109.877 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 243' ' ' LEU . . . . . . . . . . . . . 97.6 mt -109.5 126.08 53.15 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.981 0.896 . . . . 1.29 109.045 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 244' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -127.0 162.03 26.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.771 0.796 . . . . 0.33000000000000002 109.275 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 245' ' ' THR . . . . . . . . . . . . . 70.2 p -109.48 -19.47 13.23 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.958 -0.756 . . . . 1.1000000000000001 108.958 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 246' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' C' ' 246' ' ' ASN . 17.3 p30 -151.08 141.85 14.91 Favored Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 120.003 -0.679 . . . . 1.5700000000000001 109.872 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 247' ' ' PRO . . . . . 0.424 ' HG3' ' CE2' ' C' ' 291' ' ' PHE . 7.3 Cg_endo -60.85 -14.63 33.4 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.683 2.255 . . . . 0.93000000000000005 112.1 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 248' ' ' THR . . . . . . . . . . . . . 95.7 m -64.99 -42.66 94.31 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.151 0.976 . . . . 1.3 108.624 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 249' ' ' ASP . . . . . 0.44 ' O ' HD11 ' C' ' 253' ' ' LEU . 97.8 m-20 -67.48 -23.4 65.48 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.54 -0.725 . . . . 0.53000000000000003 109.801 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 250' ' ' VAL . . . . . . . . . . . . . 98.3 t -73.62 -43.77 54.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.672 -1.267 . . . . 1.1000000000000001 109.848 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 251' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.41 -35.02 77.92 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.426 -0.953 . . . . 1.51 108.426 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 252' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -62.48 -44.09 97.23 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.723 -0.791 . . . . 3.73 110.156 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 253' ' ' LEU . . . . . 0.44 HD11 ' O ' ' C' ' 249' ' ' ASP . 1.2 mp -64.07 -40.42 96.22 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 117.999 -1.48 . . . . 1.72 108.876 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 254' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.7 -44.61 97.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 120.835 -1.165 . . . . 1.1599999999999999 108.948 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 255' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.23 -30.97 69.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.018 -1.052 . . . . 2.4700000000000002 109.917 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 256' ' ' GLY . . . . . . . . . . . . . . . -74.28 2.8 43.16 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.498 -1.441 . . . . 0.57999999999999996 109.498 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 257' ' ' GLY . . . . . . . . . . . . . . . 94.37 15.79 45.94 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.627 -1.389 . . . . 0.53000000000000003 109.627 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 258' ' ' VAL . . . . . . . . . . . . . 96.7 t -77.66 139.72 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.034 -1.469 . . . . 1.1599999999999999 107.034 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 259' ' ' LYS . . . . . 0.75 ' HZ2' ' ND2' ' C' ' 159' ' ' ASN . 17.9 tttt -99.01 123.93 43.64 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.089 -1.007 . . . . 3.6600000000000001 110.811 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 260' ' ' ILE . . . . . . . . . . . . . 98.1 mt -129.99 125.67 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.43 -0.794 . . . . 1.1000000000000001 109.147 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 65.9 p -89.51 -31.44 17.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.776 -1.202 . . . . 1.24 110.238 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 262' ' ' SER . . . . . . . . . . . . . 15.8 m -159.06 153.51 24.15 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.176 -0.953 . . . . 1.01 110.092 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 263' ' ' VAL . . . . . . . . . . . . . 50.9 t -122.74 134.61 65.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.538 -0.912 . . . . 1.1299999999999999 108.538 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 264' ' ' ASN . . . . . 0.468 ' ND2' ' CH2' ' C' ' 182' ' ' TRP . 33.7 t30 -108.57 128.08 54.51 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.517 0.675 . . . . 1.9399999999999999 110.607 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 265' ' ' VAL . . . . . 0.421 HG22 ' SD ' ' C' ' 314' ' ' MET . 3.2 t -90.64 108.43 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 120.058 -0.657 . . . . 1.1399999999999999 109.68 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 266' ' ' GLY . . . . . . . . . . . . . . . -80.75 -53.94 3.84 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.153 -1.179 . . . . 0.40999999999999998 110.153 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . -172.57 152.93 17.73 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.646 -1.74 . . . . 0.42999999999999999 111.476 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 268' ' ' MET . . . . . . . . . . . . . 97.0 mtp -143.1 118.08 10.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.481 -1.011 . . . . 1.1200000000000001 110.443 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.34 128.21 21.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.371 -0.831 . . . . 1.21 109.523 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 270' ' ' PHE . . . . . 0.536 ' CG ' ' N ' ' C' ' 271' ' ' ARG . 13.3 t80 -69.5 161.8 28.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 1.0700000000000001 109.618 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 271' ' ' ARG . . . . . 0.536 ' N ' ' CG ' ' C' ' 270' ' ' PHE . 32.7 ttm180 -160.66 158.67 29.24 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.27 -0.972 . . . . 3.77 109.676 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 272' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -66.48 138.25 57.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.081 -1.012 . . . . 3.6299999999999999 110.459 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 273' ' ' GLY . . . . . . . . . . . . . . . 95.52 -12.32 67.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.818 -1.713 . . . . 0.91000000000000003 108.818 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 274' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -101.81 163.37 12.29 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.484 -1.01 . . . . 2.1299999999999999 109.388 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 275' ' ' THR . . . . . . . . . . . . . 20.8 m -109.95 135.83 50.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.674 -0.862 . . . . 1.27 108.674 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 276' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -82.02 119.21 23.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.246 -0.909 . . . . 3.2400000000000002 110.176 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 277' ' ' VAL . . . . . 0.435 HG22 ' N ' ' C' ' 278' ' ' ASN . 27.5 m -99.22 -28.18 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.81 -0.756 . . . . 1.3100000000000001 109.612 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 278' ' ' ASN . . . . . 0.464 HD21 HG13 ' C' ' 303' ' ' VAL . 10.2 t-20 -135.99 -177.16 4.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.658 0.742 . . . . 1.52 109.761 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . 0.414 ' N ' ' OD1' ' C' ' 278' ' ' ASN . 39.5 m-20 -56.93 -29.88 63.5 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.791 -0.568 . . . . 2.73 110.787 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . -148.06 27.01 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.829 -1.169 . . . . 1.25 109.538 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 281' ' ' VAL . . . . . . . . . . . . . 60.8 t -118.99 121.98 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.825 0.822 . . . . 1.23 109.678 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 282' ' ' SER . . . . . . . . . . . . . 29.0 m -118.64 147.61 43.58 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.447 0.642 . . . . 1.21 110.02 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 283' ' ' VAL . . . . . 0.43 HG22 HG11 ' C' ' 277' ' ' VAL . 16.7 m -135.26 142.84 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.446 1.117 . . . . 1.27 110.539 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 284' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' C' ' 287' ' ' ASP . 44.1 p-10 -110.61 171.67 7.33 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 106.923 -1.51 . . . . 0.77000000000000002 106.923 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 285' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.18 -24.21 40.12 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.833 -1.167 . . . . 2.3399999999999999 109.587 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 286' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -79.59 -43.46 22.89 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.233 -0.917 . . . . 2.48 110.026 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 287' ' ' ASP . . . . . 0.57 ' N ' ' OD1' ' C' ' 284' ' ' ASP . 93.3 m-20 -64.25 -42.08 96.67 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.237 -0.915 . . . . 0.64000000000000001 109.096 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 288' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.48 -45.77 97.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.387 -0.821 . . . . 1.29 109.518 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 289' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -57.44 -39.6 76.6 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.216 -0.928 . . . . 2.52 110.262 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.37 -41.01 85.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.82 -1.175 . . . . 1.1299999999999999 109.9 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 291' ' ' PHE . . . . . 0.449 ' CE2' ' HE3' ' C' ' 314' ' ' MET . 40.0 m-85 -63.93 -39.02 93.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.56999999999999995 109.73 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 292' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -64.08 -39.5 94.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.149 -0.969 . . . . 2.5499999999999998 110.226 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 293' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -65.78 -41.54 91.86 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.943 -1.098 . . . . 2.3300000000000001 109.635 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 294' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.18 -43.22 99.32 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.871 -1.143 . . . . 1.1799999999999999 108.867 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 295' ' ' ASN . . . . . 0.529 HD21 ' HG3' ' C' ' 315' ' ' MET . 40.3 t-20 -64.01 -40.01 95.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 2.02 109.953 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.66 -21.38 65.67 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.815 -1.178 . . . . 1.26 109.242 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 297' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -90.13 8.85 30.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.769 -1.207 . . . . 2.9700000000000002 109.91 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.44 11.43 82.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.903 -1.279 . . . . 0.63 109.903 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 299' ' ' ILE . . . . . 0.419 HD12 HG23 ' C' ' 299' ' ' ILE . 97.8 mt -84.71 134.56 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.974 -1.309 . . . . 1.1399999999999999 109.151 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 300' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -82.0 141.66 33.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.869 . . . . 2.2999999999999998 110.615 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 301' ' ' LEU . . . . . . . . . . . . . 66.9 mt -123.08 111.27 16.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.269 -0.641 . . . . 1.1899999999999999 109.269 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 302' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.57 139.87 49.69 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.9 . . . . 2.2599999999999998 110.289 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 303' ' ' VAL . . . . . 0.611 ' CG2' ' SD ' ' C' ' 314' ' ' MET . 51.8 t -111.99 124.77 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.673 -0.862 . . . . 1.1299999999999999 108.673 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 304' ' ' ARG . . . . . 0.42 ' HE ' ' CG ' ' C' ' 264' ' ' ASN . 33.4 ptt180 -164.93 137.87 4.64 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.505 -0.878 . . . . 3.1800000000000002 110.343 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 305' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -80.82 -45.42 16.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 3.6099999999999999 109.817 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 306' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.33 154.01 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.106 -0.996 . . . . 1.24 108.737 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 307' ' ' SER . . . . . . . . . . . . . 83.5 p -64.55 -16.29 62.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.983 -1.073 . . . . 1.8100000000000001 109.516 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 308' ' ' THR . . . . . 0.539 ' CG2' ' NH2' ' C' ' 181' ' ' ARG . 44.5 p -86.14 -9.07 57.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.047 -1.033 . . . . 1.3600000000000001 110.005 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 309' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -92.49 152.69 42.35 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.025 -1.047 . . . . 0.81000000000000005 109.936 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 310' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -55.37 139.15 81.42 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.968 1.779 . . . . 1.21 111.755 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 311' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -84.24 132.82 34.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 3.6099999999999999 109.823 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 312' ' ' LEU . . . . . . . . . . . . . 80.2 mt -117.51 154.74 30.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.103 -0.998 . . . . 1.3100000000000001 108.309 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 313' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -91.26 130.49 37.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.076 -1.015 . . . . 2.77 109.827 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 314' ' ' MET . . . . . 0.611 ' SD ' ' CG2' ' C' ' 303' ' ' VAL . 8.2 tpt -56.39 -44.17 79.97 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.67 -0.644 . . . . 1.54 109.63 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 315' ' ' MET . . . . . 0.529 ' HG3' HD21 ' C' ' 295' ' ' ASN . 95.9 mmm -61.18 -40.39 93.73 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.299 -0.876 . . . . 2.1499999999999999 110.22 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 316' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.9 -44.0 97.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.319 -0.863 . . . . 0.81999999999999995 109.81 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 317' ' ' LEU . . . . . . . . . . . . . 92.8 mt -66.49 -41.98 88.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.877 . . . . 1.3100000000000001 110.036 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 318' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.26 -24.49 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.311 -0.868 . . . . 1.3500000000000001 109.957 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 319' ' ' SER . . . . . 0.475 ' O ' ' C ' ' C' ' 323' ' ' LYS . 0.9 OUTLIER -72.72 -31.56 65.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.084 -1.01 . . . . 2.02 109.518 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 320' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -84.19 -2.45 56.9 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.78 -1.168 . . . . 2.5099999999999998 109.167 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 321' ' ' ILE . . . . . . . . . . . . . 93.2 mt -113.76 -58.74 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.914 -1.143 . . . . 1.72 107.914 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 322' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' C' ' 323' ' ' LYS . 12.3 t0 -95.01 85.11 4.26 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.16 -1.792 . . . . 2.2599999999999998 106.16 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 323' ' ' LYS . . . . . 1.166 ' HA ' ' NZ ' ' C' ' 323' ' ' LYS . 0.0 OUTLIER . . . . . 1 C--O 1.524 15.537 0 CA-C-O 126.309 2.957 . . . . 6.29 109.465 -177.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.507 ' HB ' ' HG2' ' A' ' 105' ' ' ARG . 76.6 p . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 121.106 0.479 . . . . 0.45000000000000001 111.038 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.606 ' O ' ' HD2' ' A' ' 105' ' ' ARG . 47.0 mt -71.24 136.2 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.736 -1.95 . . . . 0.39000000000000001 105.736 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.98 144.42 36.76 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 115.292 -0.867 . . . . 0.37 110.744 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.531 HD12 HG23 ' A' ' 101' ' ' THR . 45.3 mt -126.27 130.14 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.825 0.85 . . . . 0.32000000000000001 109.053 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.29 129.28 74.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.035 -1.839 . . . . 0.33000000000000002 106.035 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 mt -109.11 131.73 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.445 -0.576 . . . . 0.26000000000000001 109.445 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.75 135.83 7.43 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.791 -1.324 . . . . 0.25 109.791 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.025 -1.28 . . . . 1.05 109.592 179.941 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.553 0 N-CA-C 110.02 -1.232 . . . . 0.33000000000000002 110.02 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -130.69 32.1 4.43 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.233 -1.157 . . . . 0.90000000000000002 110.447 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.51 -27.27 58.68 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 115.277 1.584 . . . . 0.25 115.277 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.7 -46.48 74.15 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.827 0.74 . . . . 0.27000000000000002 112.799 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -59.79 -40.39 88.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.593 -0.443 . . . . 0.44 111.224 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.31 -35.22 73.53 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.105 1.15 . . . . 0.40999999999999998 114.105 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.05 -39.99 95.3 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.139 -1.43 . . . . 0.27000000000000002 107.139 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.13 -43.47 91.81 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.149 -0.685 . . . . 0.35999999999999999 109.149 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HG2' ' HZ2' ' A' ' 19' ' ' LYS . 24.7 mttm -61.56 -39.18 90.2 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.242 0.544 . . . . 0.46999999999999997 111.234 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.96 -47.64 79.64 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 115.048 -0.978 . . . . 0.37 108.609 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.71 86.11 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 119.754 -0.778 . . . . 0.39000000000000001 111.465 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.96 -23.34 65.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.103 -0.499 . . . . 2.5 110.692 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.47 -32.01 69.39 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 105.703 -1.962 . . . . 3.0600000000000001 105.703 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.8 mt -84.74 -38.38 19.74 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 113.817 1.043 . . . . 1.1899999999999999 113.817 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -109.6 -12.03 14.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 119.025 2.972 . . . . 1.1699999999999999 119.025 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.98 165.07 31.38 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 105.457 -3.057 . . . . 0.52000000000000002 105.457 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -58.82 138.97 56.96 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 122.41 1.1 . . . . 0.57999999999999996 112.611 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -105.91 146.75 29.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.264 -1.789 . . . . 0.45000000000000001 113.038 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -106.46 157.34 17.72 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.497 -1.229 . . . . 0.54000000000000004 107.816 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.25 41.22 20.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.096 1.147 . . . . 0.44 114.096 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.8 t -131.09 134.53 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.381 -0.97 . . . . 0.39000000000000001 108.381 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.66 18.93 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 109.899 -1.28 . . . . 0.37 109.899 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.22 157.76 36.4 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 118.203 1.001 . . . . 0.42999999999999999 108.921 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.84 159.15 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.453 -0.794 . . . . 0.38 110.29 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -113.46 162.85 15.63 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.757 -0.656 . . . . 0.41999999999999998 109.592 173.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 36' ' ' PHE . 1.9 t80 -134.19 117.5 16.57 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.886 -1.524 . . . . 0.45000000000000001 106.886 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.6 t -108.11 145.44 31.45 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 113.92 -1.491 . . . . 0.51000000000000001 110.848 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -57.06 136.08 74.54 Favored 'Trans proline' 0 C--N 1.352 0.752 0 N-CA-C 107.929 -1.604 . . . . 0.53000000000000003 107.929 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.55 -25.75 16.55 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.065 -1.214 . . . . 0.57999999999999996 110.065 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.34 157.66 21.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.373 0.606 . . . . 0.54000000000000004 110.009 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -125.08 179.29 5.11 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.343 -0.984 . . . . 2.5099999999999998 108.343 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.19 72.97 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 113.003 0.742 . . . . 0.5 113.003 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.86 -36.45 84.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.84 0.828 . . . . 2.8300000000000001 112.164 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.5 m -63.92 -47.58 79.99 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 106.01 -1.848 . . . . 0.56000000000000005 106.01 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.71 -37.48 86.7 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.108 0.781 . . . . 0.46999999999999997 113.108 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.1 mt -58.59 -43.15 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.587 -0.894 . . . . 0.52000000000000002 108.587 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -62.58 -42.73 99.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.966 -0.694 . . . . 0.59999999999999998 110.875 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -61.58 -44.34 97.21 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 119.347 -0.941 . . . . 0.48999999999999999 111.34 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -61.02 -45.65 93.96 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 120.015 -0.674 . . . . 0.41999999999999998 109.595 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -60.15 -40.04 88.44 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 113.158 0.799 . . . . 0.53000000000000003 113.158 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.58 -35.64 81.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.449 0.643 . . . . 0.54000000000000004 110.135 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.17 -43.61 70.47 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 119.578 -0.849 . . . . 0.45000000000000001 110.205 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.73 -37.92 80.28 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.281 -0.418 . . . . 0.45000000000000001 112.041 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.31 -26.36 29.07 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.699 0.629 . . . . 0.55000000000000004 112.699 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -95.49 -4.75 44.35 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.224 0.824 . . . . 0.55000000000000004 113.224 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 69.8 mt -105.85 157.54 17.4 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 113.313 0.857 . . . . 0.46000000000000002 113.313 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -89.34 107.94 19.35 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 102.541 -3.133 . . . . 0.46999999999999997 102.541 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.9 p -106.98 15.38 25.39 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 124.097 0.873 . . . . 0.44 111.05 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.3 p -64.03 -34.27 77.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 115.553 1.686 . . . . 0.5 115.553 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.77 -9.39 43.79 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.274 0.559 . . . . 0.5 112.271 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.71 172.22 13.03 Favored Glycine 0 C--O 1.242 0.598 0 C-N-CA 119.486 -1.34 . . . . 0.40000000000000002 113.406 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.3 t -139.47 130.17 32.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 N-CA-C 109.273 -0.639 . . . . 0.37 109.273 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.581 ' HG ' HD22 ' A' ' 65' ' ' LEU . 27.8 tp -115.86 113.37 23.26 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.549 1.781 . . . . 0.29999999999999999 108.446 177.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.68 122.19 33.23 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 106.507 -1.664 . . . . 0.35999999999999999 106.507 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.581 HD22 ' HG ' ' A' ' 63' ' ' LEU . 83.0 mt -109.55 115.25 29.56 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 104.519 -2.4 . . . . 0.23999999999999999 104.519 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.405 HG21 ' HA ' ' A' ' 91' ' ' ALA . 25.4 m -119.93 163.31 17.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 113.221 0.823 . . . . 0.25 113.221 -176.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 14.3 p-10 -64.94 -54.05 36.8 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 118.031 2.604 . . . . 0.27000000000000002 118.031 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -142.23 151.41 42.09 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 122.541 1.163 . . . . 1.05 112.693 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -66.32 134.47 52.67 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.178 -1.374 . . . . 0.48999999999999999 107.857 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.72 -8.14 70.59 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 121.281 3.272 . . . . 0.38 121.281 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.23 174.9 55.24 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 119.341 -1.409 . . . . 0.34000000000000002 110.065 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.18 -47.77 98.5 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 122.089 -0.653 . . . . 1.75 112.057 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -53.5 -41.56 72.46 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 118.293 -0.671 . . . . 0.32000000000000001 110.604 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -67.28 -48.26 68.2 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 123.506 0.504 . . . . 0.39000000000000001 109.865 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -60.1 -42.71 95.24 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.945 1.091 . . . . 2.2799999999999998 113.945 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.6 85.57 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.388 -0.925 . . . . 0.42999999999999999 111.675 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.83 89.97 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.7 -0.852 . . . . 0.38 108.7 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.3 m -58.72 -39.82 81.96 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.423 0.527 . . . . 1.8500000000000001 112.423 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 79' ' ' ARG . 33.8 mtt180 -67.31 -29.55 69.15 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 112.957 0.725 . . . . 3.98 112.957 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.404 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 76.5 mt -77.15 -42.18 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.755 0.65 . . . . 0.46000000000000002 112.755 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 87' ' ' TYR . 2.6 m -80.15 -16.72 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 115.456 1.65 . . . . 0.45000000000000001 115.456 -175.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -29.31 -55.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 1 N-CA-C 122.123 4.12 . . . . 1.29 122.123 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.55 39.4 3.97 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 116.387 -2.125 . . . . 0.58999999999999997 109.525 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -112.33 133.55 54.37 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 114.505 -1.225 . . . . 0.5 109.745 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.23 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 106.732 -1.581 . . . . 0.52000000000000002 106.732 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.67 15.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 115.395 1.628 . . . . 0.47999999999999998 115.395 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.485 ' HB3' ' HB ' ' A' ' 81' ' ' VAL . 6.1 m-85 -127.47 130.92 50.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.538 -2.023 . . . . 0.42999999999999999 105.538 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.59 154.67 41.76 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.29 -0.564 . . . . 0.39000000000000001 110.311 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 t -121.69 128.48 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 106.315 -1.735 . . . . 0.34000000000000002 106.315 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 63' ' ' LEU . 34.3 mt -124.16 119.51 56.87 Favored 'Isoleucine or valine' 0 C--O 1.256 1.405 0 N-CA-C 108.258 -1.016 . . . . 0.31 108.258 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.405 ' HA ' HG21 ' A' ' 66' ' ' VAL . . . -84.4 163.29 19.6 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 114.674 -1.148 . . . . 0.27000000000000002 112.388 176.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.71 24.62 55.53 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 114.821 0.688 . . . . 0.20999999999999999 114.821 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.82 132.73 6.61 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 N-CA-C 113.483 0.92 . . . . 0.17000000000000001 113.483 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.577 ' HB3' ' HB3' ' B' ' 94' ' ' ASN . 50.9 p30 -141.88 169.61 17.28 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.65 -1.241 . . . . 0.26000000000000001 107.65 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.431 HG21 HD13 ' A' ' 95' ' ' ILE . 50.4 mm -60.22 -43.37 93.47 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 114.522 1.304 . . . . 1.0900000000000001 114.522 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.55 -42.94 55.52 Favored 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 117.584 -1.144 . . . . 0.34000000000000002 110.343 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 39.8 ttm -61.56 -48.93 78.75 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 120.348 -0.541 . . . . 0.28999999999999998 109.704 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.44 -48.05 83.43 Favored 'General case' 0 C--O 1.201 -1.487 0 N-CA-C 112.784 0.661 . . . . 0.29999999999999999 112.784 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.51 -49.8 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 112.729 0.641 . . . . 1.1100000000000001 112.729 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -63.67 -40.51 97.01 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.253 -0.579 . . . . 2.04 111.671 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.531 HG23 HD12 ' A' ' 5' ' ' ILE . 53.3 m -66.24 -46.09 78.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.34999999999999998 110.89 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.5 -37.84 88.93 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 123.537 0.523 . . . . 0.40000000000000002 110.571 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 69.8 mtp -66.12 -45.74 80.0 Favored 'General case' 0 C--O 1.243 0.717 0 O-C-N 121.353 -0.842 . . . . 2.1299999999999999 112.099 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.86 75.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.179 0.807 . . . . 1.1000000000000001 113.179 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 15.7 ttp180 -52.6 -32.63 42.43 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 113.4 0.889 . . . . 0.42999999999999999 113.4 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -73.6 -19.6 60.83 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 114.001 1.111 . . . . 2.1899999999999999 114.001 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -90.67 18.24 6.64 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.204 1.002 . . . . 2.2000000000000002 109.49 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.6 t70 46.69 58.55 16.73 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 117.248 2.314 . . . . 0.52000000000000002 117.248 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -74.13 168.5 24.66 Favored 'Trans proline' 0 C--O 1.206 -1.1 0 C-N-CA 120.455 0.77 . . . . 0.48999999999999999 110.659 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.511 ' HG ' ' CG ' ' A' ' 113' ' ' GLU . 54.4 p -77.05 162.74 27.27 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.613 -1.625 . . . . 0.5 106.613 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -55.95 -51.55 67.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 112.373 0.509 . . . . 0.44 112.373 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.51 -37.73 76.21 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 112.924 0.712 . . . . 0.51000000000000001 112.924 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.511 ' CG ' ' HG ' ' A' ' 110' ' ' SER . 88.7 mt-10 -62.8 -46.87 85.94 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.416 -0.356 . . . . 0.54000000000000004 110.156 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.418 ' HA ' HD12 ' A' ' 114' ' ' LEU . 15.0 tp -64.26 -45.97 85.78 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 121.087 -0.245 . . . . 0.40999999999999998 111.235 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.91 -48.3 81.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.583 -0.447 . . . . 0.39000000000000001 110.478 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.83 -44.31 94.1 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.202 0.525 . . . . 0.46999999999999997 112.338 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.34 -42.93 99.79 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 122.071 -0.393 . . . . 1.1299999999999999 111.009 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.06 94.48 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 119.748 -0.781 . . . . 0.34999999999999998 112.096 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.65 -46.26 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.83 -0.433 . . . . 0.40000000000000002 109.83 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -63.65 -45.29 90.84 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.678 0.992 . . . . 0.52000000000000002 113.678 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.2 p -71.42 -32.35 68.29 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 120.607 -0.437 . . . . 1.1200000000000001 111.867 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.41 -45.58 95.63 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.362 -1.495 . . . . 0.32000000000000001 109.362 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.43 -42.01 65.53 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 112.588 0.588 . . . . 0.47999999999999998 112.588 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.52 -20.32 62.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 119.609 -0.836 . . . . 2.3999999999999999 111.899 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.61 -16.69 76.03 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 124.203 0.939 . . . . 0.38 113.559 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.462 HG13 ' CE ' ' B' ' 97' ' ' MET . 93.6 t -88.97 112.98 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 106.193 -1.78 . . . . 0.40000000000000002 106.193 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -156.43 136.92 13.11 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.387 -0.968 . . . . 3.29 108.387 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.65 146.67 23.98 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 122.043 0.925 . . . . 1.1399999999999999 109.996 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 tp -66.84 -56.53 9.97 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.314 -0.857 . . . . 1.22 111.407 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 62.48 178.69 0.14 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.653 0.739 . . . . 3.2000000000000002 110.403 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.18 146.25 53.57 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.691 -0.855 . . . . 1.48 108.691 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.416 ' H ' ' HG2' ' A' ' 132' ' ' LYS . 0.8 OUTLIER -113.01 145.21 32.61 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.581 -0.699 . . . . 5.1299999999999999 109.317 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -64.24 146.97 91.09 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.513 2.142 . . . . 3.1400000000000001 112.472 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 118.043 -0.979 . . . . 4.0199999999999996 109.095 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' THR . . . . . 0.49 ' HB ' ' HG2' ' B' ' 105' ' ' ARG . 77.3 p . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.166 0.508 . . . . 0.38 111.01 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.617 ' O ' ' HD2' ' B' ' 105' ' ' ARG . 47.1 mt -71.25 136.18 26.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 105.791 -1.929 . . . . 0.40999999999999998 105.791 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.99 144.43 36.73 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.387 -0.824 . . . . 0.34999999999999998 110.795 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 44.6 mt -126.23 130.25 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.764 0.826 . . . . 0.28000000000000003 108.981 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 86.4 t -124.42 129.27 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.004 -1.85 . . . . 0.34999999999999998 106.004 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.559 HG23 ' HB2' ' B' ' 14' ' ' ALA . 35.7 mt -109.06 131.71 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 109.548 -0.538 . . . . 0.28999999999999998 109.548 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.79 135.71 7.35 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.817 -1.313 . . . . 0.33000000000000002 109.817 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.497 1.896 0 O-C-N 121.083 -1.245 . . . . 1.0600000000000001 109.77 -179.863 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 110.93 -0.868 . . . . 0.42999999999999999 110.93 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -131.25 32.04 4.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.469 -1.018 . . . . 0.90000000000000002 110.628 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.5 -27.17 58.66 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 115.216 1.562 . . . . 0.31 115.216 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.559 ' HB2' HG23 ' B' ' 7' ' ' ILE . . . -54.74 -46.44 74.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.887 0.767 . . . . 0.28999999999999998 112.834 -176.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.79 -40.35 88.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.958 -0.464 . . . . 0.39000000000000001 111.265 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.19 -35.46 73.97 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.056 1.132 . . . . 0.37 114.056 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.02 -39.95 95.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.09 -1.448 . . . . 0.20999999999999999 107.09 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' LEU . . . . . 0.502 HD11 HG11 ' B' ' 31' ' ' VAL . 18.6 tp -65.21 -43.39 91.68 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 109.192 -0.67 . . . . 0.27000000000000002 109.192 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -61.62 -39.11 90.1 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 121.242 0.544 . . . . 0.39000000000000001 111.266 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.9 -47.64 79.77 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-N 115.056 -0.975 . . . . 0.23999999999999999 108.59 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.7 86.26 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.681 -0.808 . . . . 0.23999999999999999 111.49 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.98 -23.21 65.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.014 -0.539 . . . . 2.54 110.755 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.66 -31.87 68.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.689 -1.967 . . . . 3.1000000000000001 105.689 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 45.6 mt -84.75 -38.3 19.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.837 1.051 . . . . 1.1100000000000001 113.837 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 91.3 mt -109.66 -11.98 14.69 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 119.046 2.98 . . . . 1.0900000000000001 119.046 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.83 165.08 31.57 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 105.521 -3.032 . . . . 0.35999999999999999 105.521 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.69 138.99 56.72 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.338 1.066 . . . . 0.41999999999999998 112.687 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -106.06 146.7 29.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.272 -1.785 . . . . 0.29999999999999999 112.963 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -106.37 157.34 17.69 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 114.434 -1.257 . . . . 0.39000000000000001 107.794 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.13 41.3 20.68 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.085 1.142 . . . . 0.34000000000000002 114.085 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.502 HG11 HD11 ' B' ' 18' ' ' LEU . 93.7 t -131.08 134.62 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.31 -0.996 . . . . 0.29999999999999999 108.31 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.73 18.91 Favored Glycine 0 N--CA 1.469 0.886 0 N-CA-C 109.82 -1.312 . . . . 0.32000000000000001 109.82 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.26 157.69 36.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.167 0.983 . . . . 0.41999999999999998 108.953 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.79 159.1 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.577 -0.738 . . . . 0.42999999999999999 110.306 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.36 162.78 15.66 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.713 -0.676 . . . . 0.46999999999999997 109.617 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' B' ' 36' ' ' PHE . 2.3 t80 -134.16 117.56 16.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.888 -1.523 . . . . 0.56999999999999995 106.888 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.454 HG12 ' HD2' ' B' ' 38' ' ' PRO . 95.0 t -108.1 145.42 31.42 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.943 -1.481 . . . . 0.60999999999999999 110.855 -176.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.454 ' HD2' HG12 ' B' ' 37' ' ' VAL . 58.6 Cg_exo -57.01 136.14 74.96 Favored 'Trans proline' 0 C--N 1.352 0.719 0 N-CA-C 107.949 -1.597 . . . . 0.64000000000000001 107.949 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.48 -25.78 16.61 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.126 -1.19 . . . . 0.69999999999999996 110.126 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.27 157.66 21.48 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.336 0.588 . . . . 0.65000000000000002 110.031 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' B' ' 41' ' ' ASN . 29.5 p-10 -125.06 179.31 5.1 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.372 -0.973 . . . . 2.6699999999999999 108.372 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.13 73.0 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 112.972 0.73 . . . . 0.63 112.972 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.77 -36.58 84.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.934 0.873 . . . . 2.8199999999999998 112.163 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 89.4 m -63.9 -47.53 80.25 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 105.987 -1.857 . . . . 0.65000000000000002 105.987 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.411 HD12 ' HB3' ' B' ' 72' ' ' SER . 36.5 mt -62.74 -37.68 87.52 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 112.979 0.733 . . . . 0.56999999999999995 112.979 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.47 -43.14 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.635 -0.876 . . . . 0.62 108.635 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -62.66 -42.72 99.77 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 119.984 -0.686 . . . . 0.66000000000000003 110.825 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.52 -44.42 97.1 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 119.346 -0.942 . . . . 0.55000000000000004 111.47 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -60.89 -45.72 93.5 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 119.986 -0.686 . . . . 0.47999999999999998 109.637 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -60.09 -40.14 88.55 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 113.131 0.789 . . . . 0.58999999999999997 113.131 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.5 -35.61 81.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.434 0.635 . . . . 0.55000000000000004 110.17 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.11 -43.83 70.23 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 119.572 -0.851 . . . . 0.46000000000000002 110.141 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' B' ' 53' ' ' LEU . 91.0 mt -59.55 -38.0 79.92 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.261 -0.427 . . . . 0.46999999999999997 112.048 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.27 -26.32 28.39 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.744 0.646 . . . . 0.52000000000000002 112.744 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -95.57 -4.73 44.13 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 113.126 0.787 . . . . 0.5 113.126 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 69.4 mt -105.77 157.43 17.45 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.396 0.888 . . . . 0.40999999999999998 113.396 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -89.34 107.99 19.38 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 102.557 -3.127 . . . . 0.41999999999999998 102.557 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 72.9 p -107.09 15.4 25.26 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 124.153 0.908 . . . . 0.46000000000000002 111.064 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 73.0 p -63.95 -34.29 77.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 115.595 1.702 . . . . 0.48999999999999999 115.595 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.87 -9.35 43.61 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.267 0.556 . . . . 0.47999999999999998 112.202 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.74 172.19 13.02 Favored Glycine 0 C--O 1.242 0.642 0 C-N-CA 119.484 -1.341 . . . . 0.44 113.383 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.41 130.25 32.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 109.259 -0.645 . . . . 0.41999999999999998 109.259 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.55 ' HG ' HD23 ' B' ' 65' ' ' LEU . 27.9 tp -115.84 113.42 23.34 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.497 1.748 . . . . 0.35999999999999999 108.411 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.78 122.17 33.29 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.491 -1.67 . . . . 0.42999999999999999 106.491 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.55 HD23 ' HG ' ' B' ' 63' ' ' LEU . 83.2 mt -109.52 115.27 29.61 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 104.531 -2.396 . . . . 0.28000000000000003 104.531 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 26.0 m -120.01 163.4 17.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 113.186 0.81 . . . . 0.35999999999999999 113.186 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' B' ' 67' ' ' ASP . 14.8 p-10 -64.9 -54.07 36.53 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 118.069 2.618 . . . . 0.39000000000000001 118.069 -177.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 45.3 p -142.23 151.4 42.06 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.533 1.158 . . . . 1.0900000000000001 112.692 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' TRP . . . . . . . . . . . . . 32.8 t-105 -66.27 134.45 52.67 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.153 -1.385 . . . . 0.64000000000000001 107.818 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.73 -8.14 70.6 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 121.218 3.247 . . . . 0.52000000000000002 121.218 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.2 174.92 55.25 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 119.282 -1.437 . . . . 0.48999999999999999 110.109 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' SER . . . . . 0.411 ' HB3' HD12 ' B' ' 45' ' ' LEU . 0.6 OUTLIER -57.15 -47.84 98.4 Favored Pre-proline 0 C--N 1.329 -0.291 0 O-C-N 122.017 -0.696 . . . . 1.78 112.01 179.536 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -53.44 -41.6 71.92 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 118.391 -0.606 . . . . 0.45000000000000001 110.619 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -67.2 -48.37 68.1 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 123.458 0.474 . . . . 0.53000000000000003 109.845 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -60.05 -42.71 95.08 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.972 1.101 . . . . 2.4199999999999999 113.972 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.46 85.71 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.242 -0.983 . . . . 0.55000000000000004 111.721 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.05 -38.83 90.25 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 108.618 -0.882 . . . . 0.48999999999999999 108.618 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 70.5 m -58.65 -39.89 81.88 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.416 0.524 . . . . 1.8700000000000001 112.416 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -67.2 -29.58 69.28 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 113.042 0.756 . . . . 4.0899999999999999 113.042 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 76.1 mt -77.2 -42.15 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.697 0.629 . . . . 0.56000000000000005 112.697 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' B' ' 87' ' ' TYR . 2.6 m -80.03 -16.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.901 0 N-CA-C 115.465 1.654 . . . . 0.56000000000000005 115.465 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -29.4 -55.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.352 1 N-CA-C 122.096 4.11 . . . . 1.3 122.096 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.49 39.3 3.99 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 116.394 -2.122 . . . . 0.71999999999999997 109.601 178.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.37 133.55 54.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.442 -1.254 . . . . 0.60999999999999999 109.748 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.25 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 106.707 -1.59 . . . . 0.63 106.707 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.68 15.24 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 115.406 1.632 . . . . 0.56999999999999995 115.406 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' TYR . . . . . 0.476 ' HB3' ' HB ' ' B' ' 81' ' ' VAL . 6.1 m-85 -127.45 130.89 50.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 105.506 -2.035 . . . . 0.51000000000000001 105.506 175.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . 0.404 ' HG2' HG13 ' B' ' 115' ' ' VAL . 6.7 tp10 -146.6 154.66 41.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.228 -0.589 . . . . 0.48999999999999999 110.357 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.77 128.47 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 106.235 -1.765 . . . . 0.46000000000000002 106.235 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 34.2 mt -124.14 119.52 56.93 Favored 'Isoleucine or valine' 0 C--O 1.255 1.378 0 N-CA-C 108.245 -1.02 . . . . 0.38 108.245 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.46 163.21 19.59 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 114.738 -1.119 . . . . 0.38 112.314 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.89 24.49 55.33 Favored Glycine 0 CA--C 1.499 -0.911 0 N-CA-C 114.817 0.687 . . . . 0.28999999999999998 114.817 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.85 132.85 6.69 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 N-CA-C 113.461 0.911 . . . . 0.23999999999999999 113.461 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' ASN . . . . . 0.577 ' HB3' ' HB3' ' A' ' 94' ' ' ASN . 51.2 p30 -141.98 169.48 17.52 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.688 -1.227 . . . . 0.22 107.688 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 51.3 mm -60.2 -43.37 93.54 Favored Pre-proline 0 C--O 1.24 0.588 0 N-CA-C 114.491 1.293 . . . . 1.04 114.491 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.55 -42.85 56.53 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 117.575 -1.15 . . . . 0.25 110.34 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' MET . . . . . 0.462 ' CE ' HG13 ' A' ' 126' ' ' VAL . 39.9 ttm -61.72 -48.85 78.86 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 120.377 -0.529 . . . . 0.28000000000000003 109.633 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' B' ' 98' ' ' LEU . 14.3 tp -60.46 -48.01 83.62 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 112.822 0.675 . . . . 0.20000000000000001 112.822 -177.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.52 -49.9 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 112.715 0.635 . . . . 1.0700000000000001 112.715 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -63.52 -40.59 97.43 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 120.235 -0.586 . . . . 2.0099999999999998 111.696 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' THR . . . . . . . . . . . . . 53.5 m -66.23 -46.12 78.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.731 -0.668 . . . . 0.28999999999999998 110.892 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . 0.406 HD12 ' HG ' ' B' ' 98' ' ' LEU . 97.6 mt -64.47 -37.79 88.76 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 123.607 0.567 . . . . 0.28999999999999998 110.563 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' MET . . . . . . . . . . . . . 72.6 mtp -66.1 -45.81 79.84 Favored 'General case' 0 C--O 1.242 0.695 0 O-C-N 121.264 -0.897 . . . . 2.2200000000000002 112.132 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.81 75.62 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.3 0.852 . . . . 1.0700000000000001 113.3 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 1.44 ' NE ' ' HE ' ' B' ' 105' ' ' ARG . 15.8 ttp180 -52.56 -32.69 42.16 Favored 'General case' 0 C--O 1.21 -1.013 0 N-CA-C 113.4 0.889 . . . . 0.37 113.4 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.57 -19.59 60.85 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 114.1 1.148 . . . . 2.1299999999999999 114.1 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -90.62 18.15 6.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 122.159 0.981 . . . . 2.27 109.476 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 12.7 t70 46.79 58.47 16.88 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 117.269 2.322 . . . . 0.47999999999999998 117.269 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -74.09 168.43 24.82 Favored 'Trans proline' 0 C--O 1.206 -1.109 0 C-N-CA 120.55 0.833 . . . . 0.47999999999999998 110.604 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' SER . . . . . 0.484 ' HG ' ' CG ' ' B' ' 113' ' ' GLU . 54.3 p -77.0 162.78 27.28 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.706 -1.59 . . . . 0.55000000000000004 106.706 175.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -55.94 -51.48 67.5 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 112.445 0.535 . . . . 0.5 112.445 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -58.67 -37.67 76.51 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 112.897 0.703 . . . . 0.59999999999999998 112.897 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . 0.484 ' CG ' ' HG ' ' B' ' 110' ' ' SER . 88.7 mt-10 -62.84 -46.77 86.37 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 116.417 -0.356 . . . . 0.56999999999999995 110.141 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 15.1 tp -64.41 -45.86 85.77 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 121.019 -0.272 . . . . 0.44 111.191 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.404 HG13 ' HG2' ' B' ' 88' ' ' GLU . 63.5 t -56.88 -48.32 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 O-C-N 121.891 -0.506 . . . . 0.46000000000000002 110.52 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.25 94.3 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.133 0.492 . . . . 0.51000000000000001 112.326 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 tp -62.4 -42.8 99.71 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 122.125 -0.359 . . . . 1.1299999999999999 110.989 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.29 -45.1 94.51 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 119.798 -0.761 . . . . 0.35999999999999999 112.059 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.61 -46.26 89.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.803 -0.443 . . . . 0.45000000000000001 109.803 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -63.71 -45.22 90.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 113.717 1.006 . . . . 0.52000000000000002 113.717 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 34.6 p -71.44 -32.28 68.16 Favored 'General case' 0 C--O 1.216 -0.681 0 C-N-CA 120.585 -0.446 . . . . 1.1100000000000001 111.987 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.38 -45.74 95.31 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.332 -1.507 . . . . 0.31 109.332 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.21 -42.15 66.11 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 112.622 0.601 . . . . 0.48999999999999999 112.622 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.43 -20.27 62.92 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 119.578 -0.849 . . . . 2.4199999999999999 111.964 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.78 -16.6 76.3 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 124.246 0.966 . . . . 0.31 113.511 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 93.7 t -88.99 113.07 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 106.171 -1.789 . . . . 0.34000000000000002 106.171 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -156.45 136.84 13.03 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.409 -0.96 . . . . 3.3900000000000001 108.409 -173.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.6 146.71 23.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.031 0.92 . . . . 1.1000000000000001 109.986 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 tp -66.94 -56.78 8.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.337 -0.847 . . . . 1.1200000000000001 111.37 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 62.63 178.8 0.14 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.612 0.72 . . . . 3.2000000000000002 110.401 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.97 146.22 53.78 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.719 -0.845 . . . . 1.4299999999999999 108.719 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . 0.419 ' H ' ' HG2' ' B' ' 132' ' ' LYS . 0.8 OUTLIER -112.87 145.23 32.61 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.513 -0.742 . . . . 5.2800000000000002 109.219 -179.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -64.41 146.97 90.57 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.474 2.116 . . . . 3.3199999999999998 112.42 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.988 -1.006 . . . . 4.1900000000000004 109.133 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 159' ' ' ASN . . . . . 0.75 ' ND2' ' HZ2' ' C' ' 259' ' ' LYS . 1.8 t-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 108.992 -0.744 . . . . 6.8399999999999999 108.992 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 160' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -85.87 25.5 1.1 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.59 -0.893 . . . . 3.8900000000000001 108.59 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 161' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -118.63 -141.88 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.583 -0.895 . . . . 2.21 108.583 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 162' ' ' MET . . . . . 0.556 ' SD ' ' CG2' ' C' ' 240' ' ' VAL . 0.3 OUTLIER -61.63 156.19 20.55 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.764 -1.21 . . . . 2.48 110.562 -178.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 163' ' ' VAL . . . . . . . . . . . . . 94.9 t -113.11 117.68 56.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.06 -0.719 . . . . 1.24 109.06 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 164' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.73 103.39 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.49 -0.929 . . . . 1.0900000000000001 108.49 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.59 -35.33 80.7 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.211 -1.555 . . . . 0.46999999999999997 109.211 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 tp -172.04 147.97 2.18 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.771 -1.172 . . . . 1.0800000000000001 111.209 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 167' ' ' ALA . . . . . . . . . . . . . . . -117.69 104.39 10.96 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.048 -0.723 . . . . 1.0700000000000001 109.048 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 168' ' ' ARG . . . . . 0.522 ' NH1' ' CG1' ' C' ' 178' ' ' VAL . 44.4 ttp180 -106.37 126.09 51.81 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.972 0.891 . . . . 3.7000000000000002 110.835 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 169' ' ' ILE . . . . . . . . . . . . . 82.3 mt -95.5 129.21 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 109.222 -0.659 . . . . 1.05 109.222 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 170' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -165.95 117.04 1.04 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.812 -0.755 . . . . 0.48999999999999999 110.327 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 171' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.97 -9.94 11.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.429 -0.794 . . . . 2.3300000000000001 109.759 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 172' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' C' ' 174' ' ' ILE . 12.4 mtt180 -101.71 -6.49 23.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 3.5299999999999998 110.47 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 173' ' ' LEU . . . . . . . . . . . . . 13.7 mt 59.1 -89.16 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.44 -0.948 . . . . 2.0099999999999998 108.44 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 174' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' C' ' 172' ' ' ARG . 70.8 mt -109.98 116.77 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.069 -1.02 . . . . 1.23 110.227 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 175' ' ' HIS . . . . . 0.465 ' O ' ' CG ' ' C' ' 175' ' ' HIS . 10.0 p80 -139.35 117.61 11.95 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.947 -1.095 . . . . 0.76000000000000001 109.033 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.55 -152.74 45.05 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 110.066 -1.214 . . . . 0.58999999999999997 110.066 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 177' ' ' GLN . . . . . 0.746 ' H ' ' NE2' ' C' ' 177' ' ' GLN . 0.1 OUTLIER -91.15 12.21 20.76 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.744 -0.856 . . . . 3.5299999999999998 109.332 -178.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . 0.522 ' CG1' ' NH1' ' C' ' 168' ' ' ARG . 48.1 t -61.54 -42.83 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 1.1499999999999999 108.953 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 179' ' ' ALA . . . . . 0.502 ' O ' ' OG1' ' C' ' 183' ' ' THR . . . -73.16 -36.38 66.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.929 -1.107 . . . . 1.1599999999999999 110.187 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 180' ' ' THR . . . . . . . . . . . . . 21.5 m -66.34 -54.42 24.82 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.697 -0.801 . . . . 1.25 109.79 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 181' ' ' ARG . . . . . 0.539 ' NH2' ' CG2' ' C' ' 308' ' ' THR . 55.1 ttt-85 -64.7 -43.62 92.88 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.013 -0.675 . . . . 3.7400000000000002 110.608 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 182' ' ' TRP . . . . . 0.468 ' CH2' ' ND2' ' C' ' 264' ' ' ASN . 19.5 m95 -65.82 -32.2 73.6 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.034 -1.041 . . . . 1.01 109.591 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 183' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' C' ' 179' ' ' ALA . 71.9 m -65.29 -47.1 77.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.946 -1.096 . . . . 1.2 110.252 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -69.66 -42.93 73.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 2.6099999999999999 110.806 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 185' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -68.32 -39.61 81.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.95 -1.094 . . . . 2.52 109.569 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 186' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' C' ' 182' ' ' TRP . 72.6 p -81.42 -1.26 45.03 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.282 -0.886 . . . . 1.1399999999999999 109.685 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 187' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 52.14 48.42 22.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.055 -1.028 . . . . 2.6200000000000001 108.604 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 188' ' ' VAL . . . . . 0.44 HG11 ' H ' ' C' ' 190' ' ' ARG . 47.8 t -105.05 133.46 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.164 -0.96 . . . . 1.99 110.122 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 189' ' ' SER . . . . . . . . . . . . . 27.8 p -109.75 -6.33 15.32 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.761 -0.829 . . . . 1.8899999999999999 108.761 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 190' ' ' ARG . . . . . 0.44 ' H ' HG11 ' C' ' 188' ' ' VAL . 29.4 mtt-85 -135.92 142.83 44.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.555 -0.716 . . . . 4.0499999999999998 110.441 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 191' ' ' ILE . . . . . . . . . . . . . 87.6 mt -133.38 127.61 54.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.173 -1.047 . . . . 1.1399999999999999 108.173 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 192' ' ' ILE . . . . . . . . . . . . . 97.1 mt -115.66 128.68 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.257 -0.902 . . . . 1.1299999999999999 109.665 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 193' ' ' VAL . . . . . . . . . . . . . 53.3 t -99.7 128.88 51.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.825 -0.806 . . . . 1.3799999999999999 108.825 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 194' ' ' VAL . . . . . . . . . . . . . 43.0 t -112.51 103.57 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.535 -0.728 . . . . 1.1200000000000001 109.479 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 195' ' ' SER . . . . . . . . . . . . . 38.0 t -167.25 125.61 1.31 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.342 -0.943 . . . . 1.9099999999999999 109.31 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 196' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.01 -34.88 66.65 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.574 -0.704 . . . . 0.97999999999999998 109.984 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 197' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -65.55 -45.49 83.21 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.147 -0.971 . . . . 2.3199999999999998 109.959 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 198' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.11 -43.21 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.102 -0.998 . . . . 1.3400000000000001 109.028 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.6 -26.5 55.72 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.79 -0.764 . . . . 1.24 109.168 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 200' ' ' ALA . . . . . . . . . . . . . . . -84.9 -5.38 59.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.028 -1.045 . . . . 1.3 109.882 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 201' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -102.75 95.38 6.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.9 -1.125 . . . . 1.1499999999999999 109.554 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 202' ' ' THR . . . . . . . . . . . . . 24.7 p -66.22 -33.21 75.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.407 -0.808 . . . . 2.1600000000000001 110.631 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 203' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.33 -47.49 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.851 -1.156 . . . . 1.3799999999999999 109.598 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 204' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -63.69 -42.24 98.04 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.349 -0.94 . . . . 3.6000000000000001 109.576 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 205' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -58.01 -42.42 85.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 2.27 109.482 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 206' ' ' THR . . . . . . . . . . . . . 73.2 m -60.63 -48.71 80.55 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.088 -1.045 . . . . 1.4099999999999999 109.564 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 207' ' ' LEU . . . . . . . . . . . . . 30.6 mt -62.62 -44.45 96.26 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.934 -1.107 . . . . 1.3700000000000001 110.736 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.5 -41.45 98.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.718 -1.239 . . . . 1.3400000000000001 110.055 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 209' ' ' THR . . . . . . . . . . . . . 35.8 p -67.89 -31.83 71.89 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.371 -0.831 . . . . 1.3999999999999999 110.28 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 210' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -80.37 -17.54 51.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.782 -1.199 . . . . 2.7400000000000002 110.857 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 17.5 m -107.69 17.65 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.952 -1.092 . . . . 1.4399999999999999 108.639 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.29 123.42 82.48 Favored Pre-proline 0 N--CA 1.483 1.221 0 N-CA-C 107.82 -1.178 . . . . 1.27 107.82 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 213' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -44.31 144.48 2.95 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.037 1.825 . . . . 1.25 112.731 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 214' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -56.52 134.85 66.98 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.196 1.931 . . . . 1.47 112.028 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 215' ' ' GLY . . . . . . . . . . . . . . . 79.91 -8.52 50.03 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.922 -1.271 . . . . 0.87 109.922 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 216' ' ' VAL . . . . . . . . . . . . . 58.6 t -114.8 136.78 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -1.076 . . . . 1.5600000000000001 108.8 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.87 135.77 45.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.438 -0.789 . . . . 1.99 109.836 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 218' ' ' ALA . . . . . . . . . . . . . . . -110.17 131.37 55.12 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.315 -0.994 . . . . 1.1299999999999999 108.315 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -120.97 153.51 37.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.401 -0.812 . . . . 1.0 109.808 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 54.8 t -126.35 117.83 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.624 0.726 . . . . 1.24 109.07 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 31.7 m -141.01 165.14 19.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.412 -0.805 . . . . 1.1699999999999999 109.622 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 222' ' ' ASP . . . . . 0.709 ' OD1' ' N ' ' C' ' 225' ' ' LYS . 6.8 p30 -94.18 167.23 11.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.479 -0.763 . . . . 1.3400000000000001 109.305 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.46 -44.82 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.151 -0.968 . . . . 1.1599999999999999 110.455 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 224' ' ' ALA . . . . . 0.474 ' O ' HG23 ' C' ' 227' ' ' ILE . . . -62.72 -44.73 95.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.934 -1.104 . . . . 1.3 109.398 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 225' ' ' LYS . . . . . 0.709 ' N ' ' OD1' ' C' ' 222' ' ' ASP . 45.7 tttm -68.14 -35.35 77.95 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.775 -1.203 . . . . 2.5800000000000001 109.674 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 226' ' ' MET . . . . . . . . . . . . . 10.3 tpt -62.08 -40.4 95.71 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.934 -1.104 . . . . 1.54 111.191 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 227' ' ' ILE . . . . . 0.53 HG23 ' N ' ' C' ' 228' ' ' ARG . 17.4 tt -60.9 -34.56 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.611 -0.885 . . . . 1.3400000000000001 108.611 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 228' ' ' ARG . . . . . 0.53 ' N ' HG23 ' C' ' 227' ' ' ILE . 0.4 OUTLIER -74.47 -38.86 62.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.722 -0.611 . . . . 4.6600000000000001 110.948 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 70.3 t -62.18 -41.73 92.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.864 -1.162 . . . . 1.1799999999999999 107.864 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 230' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' C' ' 230' ' ' TYR . 36.7 t80 -67.04 -32.13 73.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.102 -0.999 . . . . 1.0700000000000001 109.927 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 231' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.76 6.73 2.34 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.119 -0.988 . . . . 0.98999999999999999 110.104 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 232' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -110.18 117.78 50.87 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.246 -0.909 . . . . 1.0600000000000001 109.435 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 233' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -65.73 1.51 2.19 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.646 1.564 . . . . 1.3300000000000001 111.98 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 234' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.36 -24.76 65.33 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 2.1899999999999999 108.807 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 235' ' ' TYR . . . . . 0.482 ' O ' ' HB2' ' C' ' 238' ' ' GLU . 81.1 m-85 -105.49 15.71 26.66 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.594 -0.842 . . . . 1.75 109.003 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 236' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' C' ' 238' ' ' GLU . . . -54.81 135.62 47.44 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.076 -1.64 . . . . 1.23 109.65 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.78 -33.41 1.9 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.288 -1.525 . . . . 0.67000000000000004 109.288 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 238' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' C' ' 235' ' ' TYR . 4.0 mm-40 -54.25 138.93 37.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.805 -1.409 . . . . 2.48 109.437 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 239' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -99.1 116.33 31.08 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.463 -0.939 . . . . 3.46 108.463 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 240' ' ' VAL . . . . . 0.556 ' CG2' ' SD ' ' C' ' 162' ' ' MET . 26.3 t -121.85 148.78 25.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.876 0.846 . . . . 1.29 110.448 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 241' ' ' MET . . . . . . . . . . . . . 13.8 ttm -102.9 134.95 45.47 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.925 -1.139 . . . . 2.25 107.925 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 242' ' ' LEU . . . . . . . . . . . . . 61.2 mt -102.04 127.28 49.0 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.689 -0.804 . . . . 1.1100000000000001 109.877 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 243' ' ' LEU . . . . . . . . . . . . . 97.6 mt -109.5 126.08 53.15 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.981 0.896 . . . . 1.29 109.045 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 244' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -127.0 162.03 26.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.771 0.796 . . . . 0.33000000000000002 109.275 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 245' ' ' THR . . . . . . . . . . . . . 70.2 p -109.48 -19.47 13.23 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.958 -0.756 . . . . 1.1000000000000001 108.958 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 246' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' C' ' 246' ' ' ASN . 17.3 p30 -151.08 141.85 14.91 Favored Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 120.003 -0.679 . . . . 1.5700000000000001 109.872 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 247' ' ' PRO . . . . . 0.424 ' HG3' ' CE2' ' C' ' 291' ' ' PHE . 7.3 Cg_endo -60.85 -14.63 33.4 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.683 2.255 . . . . 0.93000000000000005 112.1 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 248' ' ' THR . . . . . . . . . . . . . 95.7 m -64.99 -42.66 94.31 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.151 0.976 . . . . 1.3 108.624 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 249' ' ' ASP . . . . . 0.44 ' O ' HD11 ' C' ' 253' ' ' LEU . 97.8 m-20 -67.48 -23.4 65.48 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.54 -0.725 . . . . 0.53000000000000003 109.801 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 250' ' ' VAL . . . . . . . . . . . . . 98.3 t -73.62 -43.77 54.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.672 -1.267 . . . . 1.1000000000000001 109.848 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 251' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.41 -35.02 77.92 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.426 -0.953 . . . . 1.51 108.426 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 252' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -62.48 -44.09 97.23 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.723 -0.791 . . . . 3.73 110.156 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 253' ' ' LEU . . . . . 0.44 HD11 ' O ' ' C' ' 249' ' ' ASP . 1.2 mp -64.07 -40.42 96.22 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 117.999 -1.48 . . . . 1.72 108.876 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 254' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.7 -44.61 97.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 120.835 -1.165 . . . . 1.1599999999999999 108.948 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 255' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.23 -30.97 69.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.018 -1.052 . . . . 2.4700000000000002 109.917 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 256' ' ' GLY . . . . . . . . . . . . . . . -74.28 2.8 43.16 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.498 -1.441 . . . . 0.57999999999999996 109.498 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 257' ' ' GLY . . . . . . . . . . . . . . . 94.37 15.79 45.94 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.627 -1.389 . . . . 0.53000000000000003 109.627 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 258' ' ' VAL . . . . . . . . . . . . . 96.7 t -77.66 139.72 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.034 -1.469 . . . . 1.1599999999999999 107.034 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 259' ' ' LYS . . . . . 0.75 ' HZ2' ' ND2' ' C' ' 159' ' ' ASN . 17.9 tttt -99.01 123.93 43.64 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.089 -1.007 . . . . 3.6600000000000001 110.811 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 260' ' ' ILE . . . . . . . . . . . . . 98.1 mt -129.99 125.67 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.43 -0.794 . . . . 1.1000000000000001 109.147 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 65.9 p -89.51 -31.44 17.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.776 -1.202 . . . . 1.24 110.238 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 262' ' ' SER . . . . . . . . . . . . . 15.8 m -159.06 153.51 24.15 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.176 -0.953 . . . . 1.01 110.092 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 263' ' ' VAL . . . . . . . . . . . . . 50.9 t -122.74 134.61 65.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.538 -0.912 . . . . 1.1299999999999999 108.538 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 264' ' ' ASN . . . . . 0.468 ' ND2' ' CH2' ' C' ' 182' ' ' TRP . 33.7 t30 -108.57 128.08 54.51 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.517 0.675 . . . . 1.9399999999999999 110.607 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 265' ' ' VAL . . . . . 0.421 HG22 ' SD ' ' C' ' 314' ' ' MET . 3.2 t -90.64 108.43 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 120.058 -0.657 . . . . 1.1399999999999999 109.68 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 266' ' ' GLY . . . . . . . . . . . . . . . -80.75 -53.94 3.84 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.153 -1.179 . . . . 0.40999999999999998 110.153 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . -172.57 152.93 17.73 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.646 -1.74 . . . . 0.42999999999999999 111.476 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 268' ' ' MET . . . . . . . . . . . . . 97.0 mtp -143.1 118.08 10.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.481 -1.011 . . . . 1.1200000000000001 110.443 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.34 128.21 21.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.371 -0.831 . . . . 1.21 109.523 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 270' ' ' PHE . . . . . 0.536 ' CG ' ' N ' ' C' ' 271' ' ' ARG . 13.3 t80 -69.5 161.8 28.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 1.0700000000000001 109.618 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 271' ' ' ARG . . . . . 0.536 ' N ' ' CG ' ' C' ' 270' ' ' PHE . 32.7 ttm180 -160.66 158.67 29.24 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.27 -0.972 . . . . 3.77 109.676 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 272' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -66.48 138.25 57.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.081 -1.012 . . . . 3.6299999999999999 110.459 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 273' ' ' GLY . . . . . . . . . . . . . . . 95.52 -12.32 67.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.818 -1.713 . . . . 0.91000000000000003 108.818 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 274' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -101.81 163.37 12.29 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.484 -1.01 . . . . 2.1299999999999999 109.388 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 275' ' ' THR . . . . . . . . . . . . . 20.8 m -109.95 135.83 50.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.674 -0.862 . . . . 1.27 108.674 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 276' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -82.02 119.21 23.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.246 -0.909 . . . . 3.2400000000000002 110.176 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 277' ' ' VAL . . . . . 0.435 HG22 ' N ' ' C' ' 278' ' ' ASN . 27.5 m -99.22 -28.18 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.81 -0.756 . . . . 1.3100000000000001 109.612 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 278' ' ' ASN . . . . . 0.464 HD21 HG13 ' C' ' 303' ' ' VAL . 10.2 t-20 -135.99 -177.16 4.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.658 0.742 . . . . 1.52 109.761 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . 0.414 ' N ' ' OD1' ' C' ' 278' ' ' ASN . 39.5 m-20 -56.93 -29.88 63.5 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.791 -0.568 . . . . 2.73 110.787 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . -148.06 27.01 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.829 -1.169 . . . . 1.25 109.538 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 281' ' ' VAL . . . . . . . . . . . . . 60.8 t -118.99 121.98 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.825 0.822 . . . . 1.23 109.678 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 282' ' ' SER . . . . . . . . . . . . . 29.0 m -118.64 147.61 43.58 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.447 0.642 . . . . 1.21 110.02 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 283' ' ' VAL . . . . . 0.43 HG22 HG11 ' C' ' 277' ' ' VAL . 16.7 m -135.26 142.84 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.446 1.117 . . . . 1.27 110.539 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 284' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' C' ' 287' ' ' ASP . 44.1 p-10 -110.61 171.67 7.33 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 106.923 -1.51 . . . . 0.77000000000000002 106.923 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 285' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.18 -24.21 40.12 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.833 -1.167 . . . . 2.3399999999999999 109.587 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 286' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -79.59 -43.46 22.89 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.233 -0.917 . . . . 2.48 110.026 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 287' ' ' ASP . . . . . 0.57 ' N ' ' OD1' ' C' ' 284' ' ' ASP . 93.3 m-20 -64.25 -42.08 96.67 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.237 -0.915 . . . . 0.64000000000000001 109.096 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 288' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.48 -45.77 97.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.387 -0.821 . . . . 1.29 109.518 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 289' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -57.44 -39.6 76.6 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.216 -0.928 . . . . 2.52 110.262 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.37 -41.01 85.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.82 -1.175 . . . . 1.1299999999999999 109.9 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 291' ' ' PHE . . . . . 0.449 ' CE2' ' HE3' ' C' ' 314' ' ' MET . 40.0 m-85 -63.93 -39.02 93.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.56999999999999995 109.73 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 292' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -64.08 -39.5 94.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.149 -0.969 . . . . 2.5499999999999998 110.226 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 293' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -65.78 -41.54 91.86 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.943 -1.098 . . . . 2.3300000000000001 109.635 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 294' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.18 -43.22 99.32 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.871 -1.143 . . . . 1.1799999999999999 108.867 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 295' ' ' ASN . . . . . 0.529 HD21 ' HG3' ' C' ' 315' ' ' MET . 40.3 t-20 -64.01 -40.01 95.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 2.02 109.953 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.66 -21.38 65.67 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.815 -1.178 . . . . 1.26 109.242 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 297' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -90.13 8.85 30.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.769 -1.207 . . . . 2.9700000000000002 109.91 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.44 11.43 82.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.903 -1.279 . . . . 0.63 109.903 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 299' ' ' ILE . . . . . 0.419 HD12 HG23 ' C' ' 299' ' ' ILE . 97.8 mt -84.71 134.56 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.974 -1.309 . . . . 1.1399999999999999 109.151 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 300' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -82.0 141.66 33.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.869 . . . . 2.2999999999999998 110.615 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 301' ' ' LEU . . . . . . . . . . . . . 66.9 mt -123.08 111.27 16.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.269 -0.641 . . . . 1.1899999999999999 109.269 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 302' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.57 139.87 49.69 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.9 . . . . 2.2599999999999998 110.289 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 303' ' ' VAL . . . . . 0.611 ' CG2' ' SD ' ' C' ' 314' ' ' MET . 51.8 t -111.99 124.77 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.673 -0.862 . . . . 1.1299999999999999 108.673 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 304' ' ' ARG . . . . . 0.42 ' HE ' ' CG ' ' C' ' 264' ' ' ASN . 33.4 ptt180 -164.93 137.87 4.64 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.505 -0.878 . . . . 3.1800000000000002 110.343 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 305' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -80.82 -45.42 16.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 3.6099999999999999 109.817 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 306' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.33 154.01 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.106 -0.996 . . . . 1.24 108.737 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 307' ' ' SER . . . . . . . . . . . . . 83.5 p -64.55 -16.29 62.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.983 -1.073 . . . . 1.8100000000000001 109.516 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 308' ' ' THR . . . . . 0.539 ' CG2' ' NH2' ' C' ' 181' ' ' ARG . 44.5 p -86.14 -9.07 57.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.047 -1.033 . . . . 1.3600000000000001 110.005 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 309' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -92.49 152.69 42.35 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.025 -1.047 . . . . 0.81000000000000005 109.936 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 310' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -55.37 139.15 81.42 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.968 1.779 . . . . 1.21 111.755 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 311' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -84.24 132.82 34.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 3.6099999999999999 109.823 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 312' ' ' LEU . . . . . . . . . . . . . 80.2 mt -117.51 154.74 30.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.103 -0.998 . . . . 1.3100000000000001 108.309 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 313' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -91.26 130.49 37.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.076 -1.015 . . . . 2.77 109.827 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 314' ' ' MET . . . . . 0.611 ' SD ' ' CG2' ' C' ' 303' ' ' VAL . 8.2 tpt -56.39 -44.17 79.97 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.67 -0.644 . . . . 1.54 109.63 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 315' ' ' MET . . . . . 0.529 ' HG3' HD21 ' C' ' 295' ' ' ASN . 95.9 mmm -61.18 -40.39 93.73 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.299 -0.876 . . . . 2.1499999999999999 110.22 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 316' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.9 -44.0 97.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.319 -0.863 . . . . 0.81999999999999995 109.81 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 317' ' ' LEU . . . . . . . . . . . . . 92.8 mt -66.49 -41.98 88.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.877 . . . . 1.3100000000000001 110.036 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 318' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.26 -24.49 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.311 -0.868 . . . . 1.3500000000000001 109.957 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 319' ' ' SER . . . . . 0.475 ' O ' ' C ' ' C' ' 323' ' ' LYS . 0.9 OUTLIER -72.72 -31.56 65.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.084 -1.01 . . . . 2.02 109.518 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 320' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -84.19 -2.45 56.9 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.78 -1.168 . . . . 2.5099999999999998 109.167 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 321' ' ' ILE . . . . . . . . . . . . . 93.2 mt -113.76 -58.74 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.914 -1.143 . . . . 1.72 107.914 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 322' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' C' ' 323' ' ' LYS . 12.3 t0 -95.01 85.11 4.26 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.16 -1.792 . . . . 2.2599999999999998 106.16 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 323' ' ' LYS . . . . . 1.166 ' HA ' ' NZ ' ' C' ' 323' ' ' LYS . 0.0 OUTLIER . . . . . 1 C--O 1.524 15.537 0 CA-C-O 126.309 2.957 . . . . 6.29 109.465 -177.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.507 ' HB ' ' HG2' ' A' ' 105' ' ' ARG . 76.6 p . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 121.106 0.479 . . . . 0.45000000000000001 111.038 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.606 ' O ' ' HD2' ' A' ' 105' ' ' ARG . 47.0 mt -71.24 136.2 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.736 -1.95 . . . . 0.39000000000000001 105.736 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.98 144.42 36.76 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 115.292 -0.867 . . . . 0.37 110.744 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.531 HD12 HG23 ' A' ' 101' ' ' THR . 45.3 mt -126.27 130.14 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.825 0.85 . . . . 0.32000000000000001 109.053 177.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.29 129.28 74.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.035 -1.839 . . . . 0.33000000000000002 106.035 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 mt -109.11 132.24 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.445 -0.576 . . . . 0.26000000000000001 109.445 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.55 133.01 6.17 Favored Glycine 0 N--CA 1.463 0.476 0 C-N-CA 120.271 -0.966 . . . . 0.25 111.849 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 14' ' ' ALA . 14.4 t -141.61 163.83 31.87 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 107.422 -1.325 . . . . 1.05 107.422 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' NEP . . . . . 0.585 ' ND1' ' OD2' ' A' ' 67' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 73.28 -147.27 38.96 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 116.57 -2.728 . . . . 0.33000000000000002 114.981 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -121.95 25.66 9.01 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 114.486 1.291 . . . . 0.90000000000000002 114.486 -174.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.92 -27.27 43.73 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 115.277 1.584 . . . . 0.25 115.277 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.499 ' N ' HG22 ' A' ' 9' ' ' THR . . . -54.7 -46.48 74.15 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.827 0.74 . . . . 0.27000000000000002 112.799 -176.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -59.79 -40.39 88.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.593 -0.443 . . . . 0.44 111.224 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.31 -35.22 73.53 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.105 1.15 . . . . 0.40999999999999998 114.105 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.05 -39.99 95.3 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.139 -1.43 . . . . 0.27000000000000002 107.139 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.13 -43.47 91.81 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.149 -0.685 . . . . 0.35999999999999999 109.149 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HG2' ' HZ2' ' A' ' 19' ' ' LYS . 24.7 mttm -61.56 -39.18 90.2 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.242 0.544 . . . . 0.46999999999999997 111.234 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.96 -47.64 79.64 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 115.048 -0.978 . . . . 0.37 108.609 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.71 86.11 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 119.754 -0.778 . . . . 0.39000000000000001 111.465 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.96 -23.34 65.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.103 -0.499 . . . . 2.5 110.692 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.47 -32.01 69.39 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 105.703 -1.962 . . . . 3.0600000000000001 105.703 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.8 mt -84.74 -38.38 19.74 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 113.817 1.043 . . . . 1.1899999999999999 113.817 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -109.6 -12.03 14.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 119.025 2.972 . . . . 1.1699999999999999 119.025 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.98 165.07 31.38 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 105.457 -3.057 . . . . 0.52000000000000002 105.457 -175.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -58.82 138.97 56.96 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 122.41 1.1 . . . . 0.57999999999999996 112.611 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -105.91 146.75 29.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.264 -1.789 . . . . 0.45000000000000001 113.038 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -106.46 157.34 17.72 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.497 -1.229 . . . . 0.54000000000000004 107.816 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.25 41.22 20.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.096 1.147 . . . . 0.44 114.096 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.8 t -131.09 134.53 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.381 -0.97 . . . . 0.39000000000000001 108.381 177.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.66 18.93 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 109.899 -1.28 . . . . 0.37 109.899 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.22 157.76 36.4 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 118.203 1.001 . . . . 0.42999999999999999 108.921 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.84 159.15 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.453 -0.794 . . . . 0.38 110.29 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -113.46 162.85 15.63 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.757 -0.656 . . . . 0.41999999999999998 109.592 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 36' ' ' PHE . 1.9 t80 -134.19 117.5 16.57 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.886 -1.524 . . . . 0.45000000000000001 106.886 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.6 t -108.11 145.44 31.45 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 113.92 -1.491 . . . . 0.51000000000000001 110.848 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -57.06 136.08 74.54 Favored 'Trans proline' 0 C--N 1.352 0.752 0 N-CA-C 107.929 -1.604 . . . . 0.53000000000000003 107.929 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.55 -25.75 16.55 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.065 -1.214 . . . . 0.57999999999999996 110.065 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.34 157.66 21.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.373 0.606 . . . . 0.54000000000000004 110.009 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -125.08 179.29 5.11 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.343 -0.984 . . . . 2.5099999999999998 108.343 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.19 72.97 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 113.003 0.742 . . . . 0.5 113.003 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.86 -36.45 84.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.84 0.828 . . . . 2.8300000000000001 112.164 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.5 m -63.92 -47.58 79.99 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 106.01 -1.848 . . . . 0.56000000000000005 106.01 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.71 -37.48 86.7 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.108 0.781 . . . . 0.46999999999999997 113.108 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.1 mt -58.59 -43.15 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.587 -0.894 . . . . 0.52000000000000002 108.587 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -62.58 -42.73 99.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.966 -0.694 . . . . 0.59999999999999998 110.875 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -61.58 -44.34 97.21 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 119.347 -0.941 . . . . 0.48999999999999999 111.34 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -61.02 -45.65 93.96 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 120.015 -0.674 . . . . 0.41999999999999998 109.595 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -60.15 -40.04 88.44 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 113.158 0.799 . . . . 0.53000000000000003 113.158 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.58 -35.64 81.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.449 0.643 . . . . 0.54000000000000004 110.135 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.17 -43.61 70.47 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 119.578 -0.849 . . . . 0.45000000000000001 110.205 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.73 -37.92 80.28 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.281 -0.418 . . . . 0.45000000000000001 112.041 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.31 -26.36 29.07 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.699 0.629 . . . . 0.55000000000000004 112.699 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -95.49 -4.75 44.35 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.224 0.824 . . . . 0.55000000000000004 113.224 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 69.8 mt -105.85 157.54 17.4 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 113.313 0.857 . . . . 0.46000000000000002 113.313 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -89.34 107.94 19.35 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 102.541 -3.133 . . . . 0.46999999999999997 102.541 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.9 p -106.98 15.38 25.39 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 124.097 0.873 . . . . 0.44 111.05 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.3 p -64.03 -34.27 77.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 115.553 1.686 . . . . 0.5 115.553 -177.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.77 -9.39 43.79 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.274 0.559 . . . . 0.5 112.271 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.71 172.22 13.03 Favored Glycine 0 C--O 1.242 0.598 0 C-N-CA 119.486 -1.34 . . . . 0.40000000000000002 113.406 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.3 t -139.47 130.17 32.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 N-CA-C 109.273 -0.639 . . . . 0.37 109.273 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.581 ' HG ' HD22 ' A' ' 65' ' ' LEU . 27.8 tp -115.86 113.37 23.26 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.549 1.781 . . . . 0.29999999999999999 108.446 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.68 122.19 33.23 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 106.507 -1.664 . . . . 0.35999999999999999 106.507 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.581 HD22 ' HG ' ' A' ' 63' ' ' LEU . 83.0 mt -109.55 115.25 29.56 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 104.519 -2.4 . . . . 0.23999999999999999 104.519 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.405 HG21 ' HA ' ' A' ' 91' ' ' ALA . 25.4 m -119.93 163.31 17.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 113.221 0.823 . . . . 0.25 113.221 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.585 ' OD2' ' ND1' ' A' ' 10' ' ' NEP . 14.3 p-10 -64.94 -54.05 36.8 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 118.031 2.604 . . . . 0.27000000000000002 118.031 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -142.23 151.41 42.09 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 122.541 1.163 . . . . 1.05 112.693 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -66.32 134.47 52.67 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.178 -1.374 . . . . 0.48999999999999999 107.857 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.72 -8.14 70.59 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 121.281 3.272 . . . . 0.38 121.281 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.23 174.9 55.24 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 119.341 -1.409 . . . . 0.34000000000000002 110.065 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.18 -47.77 98.5 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 122.089 -0.653 . . . . 1.75 112.057 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -53.5 -41.56 72.46 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 118.293 -0.671 . . . . 0.32000000000000001 110.604 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -67.28 -48.26 68.2 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 123.506 0.504 . . . . 0.39000000000000001 109.865 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -60.1 -42.71 95.24 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.945 1.091 . . . . 2.2799999999999998 113.945 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.6 85.57 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.388 -0.925 . . . . 0.42999999999999999 111.675 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.83 89.97 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.7 -0.852 . . . . 0.38 108.7 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.3 m -58.72 -39.82 81.96 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.423 0.527 . . . . 1.8500000000000001 112.423 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 79' ' ' ARG . 33.8 mtt180 -67.31 -29.55 69.15 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 112.957 0.725 . . . . 3.98 112.957 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.404 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 76.5 mt -77.15 -42.18 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.755 0.65 . . . . 0.46000000000000002 112.755 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 87' ' ' TYR . 2.6 m -80.15 -16.72 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 115.456 1.65 . . . . 0.45000000000000001 115.456 -175.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -29.31 -55.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 1 N-CA-C 122.123 4.12 . . . . 1.29 122.123 -177.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.55 39.4 3.97 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 116.387 -2.125 . . . . 0.58999999999999997 109.525 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -112.33 133.55 54.37 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 114.505 -1.225 . . . . 0.5 109.745 -179.401 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.23 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 106.732 -1.581 . . . . 0.52000000000000002 106.732 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.67 15.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 115.395 1.628 . . . . 0.47999999999999998 115.395 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.485 ' HB3' ' HB ' ' A' ' 81' ' ' VAL . 6.1 m-85 -127.47 130.92 50.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.538 -2.023 . . . . 0.42999999999999999 105.538 175.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.59 154.67 41.76 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.29 -0.564 . . . . 0.39000000000000001 110.311 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 t -121.69 128.48 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 106.315 -1.735 . . . . 0.34000000000000002 106.315 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 63' ' ' LEU . 34.3 mt -124.16 119.51 56.87 Favored 'Isoleucine or valine' 0 C--O 1.256 1.405 0 N-CA-C 108.258 -1.016 . . . . 0.31 108.258 177.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.405 ' HA ' HG21 ' A' ' 66' ' ' VAL . . . -84.4 163.29 19.6 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 114.674 -1.148 . . . . 0.27000000000000002 112.388 176.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.71 24.62 55.53 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 114.821 0.688 . . . . 0.20999999999999999 114.821 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.82 132.73 6.61 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 N-CA-C 113.483 0.92 . . . . 0.17000000000000001 113.483 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.577 ' HB3' ' HB3' ' B' ' 94' ' ' ASN . 50.9 p30 -141.88 169.61 17.28 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.65 -1.241 . . . . 0.26000000000000001 107.65 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.431 HG21 HD13 ' A' ' 95' ' ' ILE . 50.4 mm -60.22 -43.37 93.47 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 114.522 1.304 . . . . 1.0900000000000001 114.522 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.55 -42.94 55.52 Favored 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 117.584 -1.144 . . . . 0.34000000000000002 110.343 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 39.8 ttm -61.56 -48.93 78.75 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 120.348 -0.541 . . . . 0.28999999999999998 109.704 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.44 -48.05 83.43 Favored 'General case' 0 C--O 1.201 -1.487 0 N-CA-C 112.784 0.661 . . . . 0.29999999999999999 112.784 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.51 -49.8 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 112.729 0.641 . . . . 1.1100000000000001 112.729 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -63.67 -40.51 97.01 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.253 -0.579 . . . . 2.04 111.671 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.531 HG23 HD12 ' A' ' 5' ' ' ILE . 53.3 m -66.24 -46.09 78.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.34999999999999998 110.89 -178.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.5 -37.84 88.93 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 123.537 0.523 . . . . 0.40000000000000002 110.571 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 69.8 mtp -66.12 -45.74 80.0 Favored 'General case' 0 C--O 1.243 0.717 0 O-C-N 121.353 -0.842 . . . . 2.1299999999999999 112.099 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.86 75.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.179 0.807 . . . . 1.1000000000000001 113.179 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 15.7 ttp180 -52.6 -32.63 42.43 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 113.4 0.889 . . . . 0.42999999999999999 113.4 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -73.6 -19.6 60.83 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 114.001 1.111 . . . . 2.1899999999999999 114.001 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -90.67 18.24 6.64 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.204 1.002 . . . . 2.2000000000000002 109.49 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.6 t70 46.69 58.55 16.73 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 117.248 2.314 . . . . 0.52000000000000002 117.248 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -74.13 168.5 24.66 Favored 'Trans proline' 0 C--O 1.206 -1.1 0 C-N-CA 120.455 0.77 . . . . 0.48999999999999999 110.659 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.511 ' HG ' ' CG ' ' A' ' 113' ' ' GLU . 54.4 p -77.05 162.74 27.27 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.613 -1.625 . . . . 0.5 106.613 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -55.95 -51.55 67.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 112.373 0.509 . . . . 0.44 112.373 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.51 -37.73 76.21 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 112.924 0.712 . . . . 0.51000000000000001 112.924 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.511 ' CG ' ' HG ' ' A' ' 110' ' ' SER . 88.7 mt-10 -62.8 -46.87 85.94 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.416 -0.356 . . . . 0.54000000000000004 110.156 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.418 ' HA ' HD12 ' A' ' 114' ' ' LEU . 15.0 tp -64.26 -45.97 85.78 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 121.087 -0.245 . . . . 0.40999999999999998 111.235 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.91 -48.3 81.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.583 -0.447 . . . . 0.39000000000000001 110.478 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.83 -44.31 94.1 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.202 0.525 . . . . 0.46999999999999997 112.338 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.34 -42.93 99.79 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 122.071 -0.393 . . . . 1.1299999999999999 111.009 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.06 94.48 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 119.748 -0.781 . . . . 0.34999999999999998 112.096 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.65 -46.26 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.83 -0.433 . . . . 0.40000000000000002 109.83 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -63.65 -45.29 90.84 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.678 0.992 . . . . 0.52000000000000002 113.678 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.2 p -71.42 -32.35 68.29 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 120.607 -0.437 . . . . 1.1200000000000001 111.867 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.41 -45.58 95.63 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.362 -1.495 . . . . 0.32000000000000001 109.362 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.43 -42.01 65.53 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 112.588 0.588 . . . . 0.47999999999999998 112.588 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.52 -20.32 62.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 119.609 -0.836 . . . . 2.3999999999999999 111.899 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.61 -16.69 76.03 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 124.203 0.939 . . . . 0.38 113.559 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.462 HG13 ' CE ' ' B' ' 97' ' ' MET . 93.6 t -88.97 112.98 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 106.193 -1.78 . . . . 0.40000000000000002 106.193 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -156.43 136.92 13.11 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.387 -0.968 . . . . 3.29 108.387 -173.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.65 146.67 23.98 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 122.043 0.925 . . . . 1.1399999999999999 109.996 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 tp -66.84 -56.86 8.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.314 -0.857 . . . . 1.22 111.407 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.5 mttt 62.97 178.54 0.15 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.655 0.741 . . . . 3.2000000000000002 110.518 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.13 146.74 53.15 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.345 -0.983 . . . . 1.48 108.345 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.53 147.66 38.02 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.484 -0.76 . . . . 5.1299999999999999 109.529 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -64.66 148.64 90.36 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.305 2.003 . . . . 3.1400000000000001 112.415 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.014 -0.993 . . . . 4.0199999999999996 109.17 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' THR . . . . . 0.49 ' HB ' ' HG2' ' B' ' 105' ' ' ARG . 77.3 p . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.166 0.508 . . . . 0.38 111.01 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.617 ' O ' ' HD2' ' B' ' 105' ' ' ARG . 47.1 mt -71.25 136.18 26.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 105.791 -1.929 . . . . 0.40999999999999998 105.791 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.99 144.43 36.73 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.387 -0.824 . . . . 0.34999999999999998 110.795 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 44.6 mt -126.23 130.25 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.764 0.826 . . . . 0.28000000000000003 108.981 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 86.4 t -124.42 129.27 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.004 -1.85 . . . . 0.34999999999999998 106.004 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.559 HG23 ' HB2' ' B' ' 14' ' ' ALA . 35.7 mt -109.06 132.27 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 109.548 -0.538 . . . . 0.28999999999999998 109.548 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.52 133.04 6.19 Favored Glycine 0 N--CA 1.462 0.384 0 C-N-CA 120.326 -0.94 . . . . 0.33000000000000002 111.885 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.497 HG22 ' N ' ' B' ' 14' ' ' ALA . 15.0 t -145.94 160.12 42.28 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.363 -1.347 . . . . 1.0600000000000001 107.363 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' NEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.48 -141.86 26.25 Favored Glycine 0 C--N 1.315 -0.623 0 C-N-CA 116.756 -2.64 . . . . 0.42999999999999999 114.863 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -123.57 25.67 8.1 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 114.44 1.274 . . . . 0.90000000000000002 114.44 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.03 -27.17 43.15 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 115.216 1.562 . . . . 0.31 115.216 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.559 ' HB2' HG23 ' B' ' 7' ' ' ILE . . . -54.74 -46.44 74.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.887 0.767 . . . . 0.28999999999999998 112.834 -176.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.79 -40.35 88.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.958 -0.464 . . . . 0.39000000000000001 111.265 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.19 -35.46 73.97 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.056 1.132 . . . . 0.37 114.056 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.02 -39.95 95.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.09 -1.448 . . . . 0.20999999999999999 107.09 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' LEU . . . . . 0.502 HD11 HG11 ' B' ' 31' ' ' VAL . 18.6 tp -65.21 -43.39 91.68 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 109.192 -0.67 . . . . 0.27000000000000002 109.192 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -61.62 -39.11 90.1 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 121.242 0.544 . . . . 0.39000000000000001 111.266 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.9 -47.64 79.77 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-N 115.056 -0.975 . . . . 0.23999999999999999 108.59 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.7 86.26 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.681 -0.808 . . . . 0.23999999999999999 111.49 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.98 -23.21 65.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.014 -0.539 . . . . 2.54 110.755 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.66 -31.87 68.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.689 -1.967 . . . . 3.1000000000000001 105.689 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 45.6 mt -84.75 -38.3 19.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.837 1.051 . . . . 1.1100000000000001 113.837 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 91.3 mt -109.66 -11.98 14.69 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 119.046 2.98 . . . . 1.0900000000000001 119.046 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.83 165.08 31.57 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 105.521 -3.032 . . . . 0.35999999999999999 105.521 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.69 138.99 56.72 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.338 1.066 . . . . 0.41999999999999998 112.687 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -106.06 146.7 29.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.272 -1.785 . . . . 0.29999999999999999 112.963 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -106.37 157.34 17.69 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 114.434 -1.257 . . . . 0.39000000000000001 107.794 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.13 41.3 20.68 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.085 1.142 . . . . 0.34000000000000002 114.085 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.502 HG11 HD11 ' B' ' 18' ' ' LEU . 93.7 t -131.08 134.62 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.31 -0.996 . . . . 0.29999999999999999 108.31 177.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.73 18.91 Favored Glycine 0 N--CA 1.469 0.886 0 N-CA-C 109.82 -1.312 . . . . 0.32000000000000001 109.82 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.26 157.69 36.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.167 0.983 . . . . 0.41999999999999998 108.953 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.79 159.1 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.577 -0.738 . . . . 0.42999999999999999 110.306 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.36 162.78 15.66 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.713 -0.676 . . . . 0.46999999999999997 109.617 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' B' ' 36' ' ' PHE . 2.3 t80 -134.16 117.56 16.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.888 -1.523 . . . . 0.56999999999999995 106.888 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.454 HG12 ' HD2' ' B' ' 38' ' ' PRO . 95.0 t -108.1 145.42 31.42 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.943 -1.481 . . . . 0.60999999999999999 110.855 -176.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.454 ' HD2' HG12 ' B' ' 37' ' ' VAL . 58.6 Cg_exo -57.01 136.14 74.96 Favored 'Trans proline' 0 C--N 1.352 0.719 0 N-CA-C 107.949 -1.597 . . . . 0.64000000000000001 107.949 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.48 -25.78 16.61 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.126 -1.19 . . . . 0.69999999999999996 110.126 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.27 157.66 21.48 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.336 0.588 . . . . 0.65000000000000002 110.031 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' B' ' 41' ' ' ASN . 29.5 p-10 -125.06 179.31 5.1 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.372 -0.973 . . . . 2.6699999999999999 108.372 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.13 73.0 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 112.972 0.73 . . . . 0.63 112.972 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.77 -36.58 84.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.934 0.873 . . . . 2.8199999999999998 112.163 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 89.4 m -63.9 -47.53 80.25 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 105.987 -1.857 . . . . 0.65000000000000002 105.987 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.411 HD12 ' HB3' ' B' ' 72' ' ' SER . 36.5 mt -62.74 -37.68 87.52 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 112.979 0.733 . . . . 0.56999999999999995 112.979 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.47 -43.14 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.635 -0.876 . . . . 0.62 108.635 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -62.66 -42.72 99.77 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 119.984 -0.686 . . . . 0.66000000000000003 110.825 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.52 -44.42 97.1 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 119.346 -0.942 . . . . 0.55000000000000004 111.47 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -60.89 -45.72 93.5 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 119.986 -0.686 . . . . 0.47999999999999998 109.637 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -60.09 -40.14 88.55 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 113.131 0.789 . . . . 0.58999999999999997 113.131 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.5 -35.61 81.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.434 0.635 . . . . 0.55000000000000004 110.17 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.11 -43.83 70.23 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 119.572 -0.851 . . . . 0.46000000000000002 110.141 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' B' ' 53' ' ' LEU . 91.0 mt -59.55 -38.0 79.92 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.261 -0.427 . . . . 0.46999999999999997 112.048 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.27 -26.32 28.39 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.744 0.646 . . . . 0.52000000000000002 112.744 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -95.57 -4.73 44.13 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 113.126 0.787 . . . . 0.5 113.126 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 69.4 mt -105.77 157.43 17.45 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.396 0.888 . . . . 0.40999999999999998 113.396 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -89.34 107.99 19.38 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 102.557 -3.127 . . . . 0.41999999999999998 102.557 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 72.9 p -107.09 15.4 25.26 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 124.153 0.908 . . . . 0.46000000000000002 111.064 -177.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 73.0 p -63.95 -34.29 77.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 115.595 1.702 . . . . 0.48999999999999999 115.595 -177.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.87 -9.35 43.61 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.267 0.556 . . . . 0.47999999999999998 112.202 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.74 172.19 13.02 Favored Glycine 0 C--O 1.242 0.642 0 C-N-CA 119.484 -1.341 . . . . 0.44 113.383 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.41 130.25 32.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 109.259 -0.645 . . . . 0.41999999999999998 109.259 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.55 ' HG ' HD23 ' B' ' 65' ' ' LEU . 27.9 tp -115.84 113.42 23.34 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.497 1.748 . . . . 0.35999999999999999 108.411 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.78 122.17 33.29 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.491 -1.67 . . . . 0.42999999999999999 106.491 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.55 HD23 ' HG ' ' B' ' 63' ' ' LEU . 83.2 mt -109.52 115.27 29.61 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 104.531 -2.396 . . . . 0.28000000000000003 104.531 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 26.0 m -120.01 163.4 17.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 113.186 0.81 . . . . 0.35999999999999999 113.186 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' B' ' 67' ' ' ASP . 14.8 p-10 -64.9 -54.07 36.53 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 118.069 2.618 . . . . 0.39000000000000001 118.069 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 45.3 p -142.23 151.4 42.06 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.533 1.158 . . . . 1.0900000000000001 112.692 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' TRP . . . . . . . . . . . . . 32.8 t-105 -66.27 134.45 52.67 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.153 -1.385 . . . . 0.64000000000000001 107.818 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.73 -8.14 70.6 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 121.218 3.247 . . . . 0.52000000000000002 121.218 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.2 174.92 55.25 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 119.282 -1.437 . . . . 0.48999999999999999 110.109 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.411 ' HB3' HD12 ' B' ' 45' ' ' LEU . 0.6 OUTLIER -57.15 -47.84 98.4 Favored Pre-proline 0 C--N 1.329 -0.291 0 O-C-N 122.017 -0.696 . . . . 1.78 112.01 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -53.44 -41.6 71.92 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 118.391 -0.606 . . . . 0.45000000000000001 110.619 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -67.2 -48.37 68.1 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 123.458 0.474 . . . . 0.53000000000000003 109.845 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -60.05 -42.71 95.08 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.972 1.101 . . . . 2.4199999999999999 113.972 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.46 85.71 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.242 -0.983 . . . . 0.55000000000000004 111.721 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.05 -38.83 90.25 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 108.618 -0.882 . . . . 0.48999999999999999 108.618 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 70.5 m -58.65 -39.89 81.88 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.416 0.524 . . . . 1.8700000000000001 112.416 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -67.2 -29.58 69.28 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 113.042 0.756 . . . . 4.0899999999999999 113.042 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 76.1 mt -77.2 -42.15 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.697 0.629 . . . . 0.56000000000000005 112.697 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' B' ' 87' ' ' TYR . 2.6 m -80.03 -16.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.901 0 N-CA-C 115.465 1.654 . . . . 0.56000000000000005 115.465 -175.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -29.4 -55.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.352 1 N-CA-C 122.096 4.11 . . . . 1.3 122.096 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.49 39.3 3.99 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 116.394 -2.122 . . . . 0.71999999999999997 109.601 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.37 133.55 54.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.442 -1.254 . . . . 0.60999999999999999 109.748 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.25 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 106.707 -1.59 . . . . 0.63 106.707 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.68 15.24 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 115.406 1.632 . . . . 0.56999999999999995 115.406 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' TYR . . . . . 0.476 ' HB3' ' HB ' ' B' ' 81' ' ' VAL . 6.1 m-85 -127.45 130.89 50.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 105.506 -2.035 . . . . 0.51000000000000001 105.506 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . 0.404 ' HG2' HG13 ' B' ' 115' ' ' VAL . 6.7 tp10 -146.6 154.66 41.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.228 -0.589 . . . . 0.48999999999999999 110.357 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.77 128.47 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 106.235 -1.765 . . . . 0.46000000000000002 106.235 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 34.2 mt -124.14 119.52 56.93 Favored 'Isoleucine or valine' 0 C--O 1.255 1.378 0 N-CA-C 108.245 -1.02 . . . . 0.38 108.245 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.46 163.21 19.59 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 114.738 -1.119 . . . . 0.38 112.314 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.89 24.49 55.33 Favored Glycine 0 CA--C 1.499 -0.911 0 N-CA-C 114.817 0.687 . . . . 0.28999999999999998 114.817 176.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.85 132.85 6.69 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 N-CA-C 113.461 0.911 . . . . 0.23999999999999999 113.461 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' ASN . . . . . 0.577 ' HB3' ' HB3' ' A' ' 94' ' ' ASN . 51.2 p30 -141.98 169.48 17.52 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.688 -1.227 . . . . 0.22 107.688 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 51.3 mm -60.2 -43.37 93.54 Favored Pre-proline 0 C--O 1.24 0.588 0 N-CA-C 114.491 1.293 . . . . 1.04 114.491 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.55 -42.85 56.53 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 117.575 -1.15 . . . . 0.25 110.34 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' MET . . . . . 0.462 ' CE ' HG13 ' A' ' 126' ' ' VAL . 39.9 ttm -61.72 -48.85 78.86 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 120.377 -0.529 . . . . 0.28000000000000003 109.633 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' B' ' 98' ' ' LEU . 14.3 tp -60.46 -48.01 83.62 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 112.822 0.675 . . . . 0.20000000000000001 112.822 -177.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.52 -49.9 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 112.715 0.635 . . . . 1.0700000000000001 112.715 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -63.52 -40.59 97.43 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 120.235 -0.586 . . . . 2.0099999999999998 111.696 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' THR . . . . . . . . . . . . . 53.5 m -66.23 -46.12 78.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.731 -0.668 . . . . 0.28999999999999998 110.892 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.406 HD12 ' HG ' ' B' ' 98' ' ' LEU . 97.6 mt -64.47 -37.79 88.76 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 123.607 0.567 . . . . 0.28999999999999998 110.563 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' MET . . . . . . . . . . . . . 72.6 mtp -66.1 -45.81 79.84 Favored 'General case' 0 C--O 1.242 0.695 0 O-C-N 121.264 -0.897 . . . . 2.2200000000000002 112.132 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.81 75.62 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.3 0.852 . . . . 1.0700000000000001 113.3 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 1.44 ' NE ' ' HE ' ' B' ' 105' ' ' ARG . 15.8 ttp180 -52.56 -32.69 42.16 Favored 'General case' 0 C--O 1.21 -1.013 0 N-CA-C 113.4 0.889 . . . . 0.37 113.4 -178.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.57 -19.59 60.85 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 114.1 1.148 . . . . 2.1299999999999999 114.1 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -90.62 18.15 6.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 122.159 0.981 . . . . 2.27 109.476 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 12.7 t70 46.79 58.47 16.88 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 117.269 2.322 . . . . 0.47999999999999998 117.269 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -74.09 168.43 24.82 Favored 'Trans proline' 0 C--O 1.206 -1.109 0 C-N-CA 120.55 0.833 . . . . 0.47999999999999998 110.604 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' SER . . . . . 0.484 ' HG ' ' CG ' ' B' ' 113' ' ' GLU . 54.3 p -77.0 162.78 27.28 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.706 -1.59 . . . . 0.55000000000000004 106.706 175.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -55.94 -51.48 67.5 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 112.445 0.535 . . . . 0.5 112.445 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -58.67 -37.67 76.51 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 112.897 0.703 . . . . 0.59999999999999998 112.897 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . 0.484 ' CG ' ' HG ' ' B' ' 110' ' ' SER . 88.7 mt-10 -62.84 -46.77 86.37 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 116.417 -0.356 . . . . 0.56999999999999995 110.141 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 15.1 tp -64.41 -45.86 85.77 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 121.019 -0.272 . . . . 0.44 111.191 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.404 HG13 ' HG2' ' B' ' 88' ' ' GLU . 63.5 t -56.88 -48.32 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 O-C-N 121.891 -0.506 . . . . 0.46000000000000002 110.52 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.25 94.3 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.133 0.492 . . . . 0.51000000000000001 112.326 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 tp -62.4 -42.8 99.71 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 122.125 -0.359 . . . . 1.1299999999999999 110.989 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.29 -45.1 94.51 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 119.798 -0.761 . . . . 0.35999999999999999 112.059 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.61 -46.26 89.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.803 -0.443 . . . . 0.45000000000000001 109.803 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -63.71 -45.22 90.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 113.717 1.006 . . . . 0.52000000000000002 113.717 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 34.6 p -71.44 -32.28 68.16 Favored 'General case' 0 C--O 1.216 -0.681 0 C-N-CA 120.585 -0.446 . . . . 1.1100000000000001 111.987 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.38 -45.74 95.31 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.332 -1.507 . . . . 0.31 109.332 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.21 -42.15 66.11 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 112.622 0.601 . . . . 0.48999999999999999 112.622 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.43 -20.27 62.92 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 119.578 -0.849 . . . . 2.4199999999999999 111.964 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.78 -16.6 76.3 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 124.246 0.966 . . . . 0.31 113.511 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 93.7 t -88.99 113.07 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 106.171 -1.789 . . . . 0.34000000000000002 106.171 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -156.45 136.84 13.03 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.409 -0.96 . . . . 3.3900000000000001 108.409 -173.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.6 146.71 23.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.031 0.92 . . . . 1.1000000000000001 109.986 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 tp -66.94 -57.09 7.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.337 -0.847 . . . . 1.1200000000000001 111.37 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 63.01 178.65 0.15 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.646 0.736 . . . . 3.2000000000000002 110.595 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.03 146.61 53.36 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.353 -0.98 . . . . 1.4299999999999999 108.353 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.33 147.94 38.5 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.444 -0.785 . . . . 5.2800000000000002 109.476 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -64.76 148.7 90.21 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.415 2.076 . . . . 3.3199999999999998 112.368 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.011 -0.995 . . . . 4.1900000000000004 109.12 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 159' ' ' ASN . . . . . 0.75 ' ND2' ' HZ2' ' C' ' 259' ' ' LYS . 1.8 t-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 108.992 -0.744 . . . . 6.8399999999999999 108.992 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 160' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -85.87 25.5 1.1 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.59 -0.893 . . . . 3.8900000000000001 108.59 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 161' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -118.63 -141.88 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.583 -0.895 . . . . 2.21 108.583 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 162' ' ' MET . . . . . 0.556 ' SD ' ' CG2' ' C' ' 240' ' ' VAL . 0.3 OUTLIER -61.63 156.19 20.55 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.764 -1.21 . . . . 2.48 110.562 -178.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 163' ' ' VAL . . . . . . . . . . . . . 94.9 t -113.11 117.68 56.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.06 -0.719 . . . . 1.24 109.06 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 164' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.73 103.39 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.49 -0.929 . . . . 1.0900000000000001 108.49 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.59 -35.33 80.7 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.211 -1.555 . . . . 0.46999999999999997 109.211 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 tp -172.04 147.97 2.18 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.771 -1.172 . . . . 1.0800000000000001 111.209 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 167' ' ' ALA . . . . . . . . . . . . . . . -117.69 104.39 10.96 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.048 -0.723 . . . . 1.0700000000000001 109.048 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 168' ' ' ARG . . . . . 0.522 ' NH1' ' CG1' ' C' ' 178' ' ' VAL . 44.4 ttp180 -106.37 126.09 51.81 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.972 0.891 . . . . 3.7000000000000002 110.835 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 169' ' ' ILE . . . . . . . . . . . . . 82.3 mt -95.5 129.21 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 109.222 -0.659 . . . . 1.05 109.222 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 170' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -165.95 117.04 1.04 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.812 -0.755 . . . . 0.48999999999999999 110.327 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 171' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.97 -9.94 11.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.429 -0.794 . . . . 2.3300000000000001 109.759 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 172' ' ' ARG . . . . . . . . . . . . . 12.4 mtt180 -101.71 -5.16 25.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 3.5299999999999998 110.47 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 173' ' ' LEU . . . . . . . . . . . . . 14.5 mt 59.0 -100.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.141 -0.974 . . . . 2.0099999999999998 109.917 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 174' ' ' ILE . . . . . . . . . . . . . 77.7 mt -97.71 121.3 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.026 -1.046 . . . . 1.23 108.285 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 175' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -143.19 127.57 17.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.131 -0.98 . . . . 0.76000000000000001 109.426 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 176' ' ' GLY . . . . . . . . . . . . . . . 60.33 -152.63 37.16 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.833 -1.307 . . . . 0.58999999999999997 109.833 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 177' ' ' GLN . . . . . 0.746 ' H ' ' NE2' ' C' ' 177' ' ' GLN . 0.1 OUTLIER -89.36 12.21 16.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.573 -0.957 . . . . 3.5299999999999998 109.332 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . 0.522 ' CG1' ' NH1' ' C' ' 168' ' ' ARG . 48.1 t -61.54 -42.83 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 1.1499999999999999 108.953 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 179' ' ' ALA . . . . . 0.502 ' O ' ' OG1' ' C' ' 183' ' ' THR . . . -73.16 -36.38 66.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.929 -1.107 . . . . 1.1599999999999999 110.187 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 180' ' ' THR . . . . . . . . . . . . . 21.5 m -66.34 -54.42 24.82 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.697 -0.801 . . . . 1.25 109.79 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 181' ' ' ARG . . . . . 0.539 ' NH2' ' CG2' ' C' ' 308' ' ' THR . 55.1 ttt-85 -64.7 -43.62 92.88 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.013 -0.675 . . . . 3.7400000000000002 110.608 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 182' ' ' TRP . . . . . 0.468 ' CH2' ' ND2' ' C' ' 264' ' ' ASN . 19.5 m95 -65.82 -32.2 73.6 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.034 -1.041 . . . . 1.01 109.591 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 183' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' C' ' 179' ' ' ALA . 71.9 m -65.29 -47.1 77.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.946 -1.096 . . . . 1.2 110.252 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -69.66 -42.93 73.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 2.6099999999999999 110.806 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 185' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -68.32 -39.61 81.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.95 -1.094 . . . . 2.52 109.569 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 186' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' C' ' 182' ' ' TRP . 72.6 p -81.42 -1.26 45.03 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.282 -0.886 . . . . 1.1399999999999999 109.685 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 187' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 52.14 48.42 22.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.055 -1.028 . . . . 2.6200000000000001 108.604 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 188' ' ' VAL . . . . . 0.44 HG11 ' H ' ' C' ' 190' ' ' ARG . 47.8 t -105.05 133.46 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.164 -0.96 . . . . 1.99 110.122 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 189' ' ' SER . . . . . . . . . . . . . 27.8 p -109.75 -6.33 15.32 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.761 -0.829 . . . . 1.8899999999999999 108.761 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 190' ' ' ARG . . . . . 0.44 ' H ' HG11 ' C' ' 188' ' ' VAL . 29.4 mtt-85 -135.92 142.83 44.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.555 -0.716 . . . . 4.0499999999999998 110.441 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 191' ' ' ILE . . . . . . . . . . . . . 87.6 mt -133.38 127.61 54.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.173 -1.047 . . . . 1.1399999999999999 108.173 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 192' ' ' ILE . . . . . . . . . . . . . 97.1 mt -115.66 128.68 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.257 -0.902 . . . . 1.1299999999999999 109.665 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 193' ' ' VAL . . . . . . . . . . . . . 53.3 t -99.7 128.88 51.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.825 -0.806 . . . . 1.3799999999999999 108.825 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 194' ' ' VAL . . . . . . . . . . . . . 43.0 t -112.51 103.57 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.535 -0.728 . . . . 1.1200000000000001 109.479 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 195' ' ' SER . . . . . . . . . . . . . 38.0 t -167.25 125.61 1.31 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.342 -0.943 . . . . 1.9099999999999999 109.31 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 196' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.01 -34.88 66.65 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.574 -0.704 . . . . 0.97999999999999998 109.984 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 197' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -65.55 -45.49 83.21 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.147 -0.971 . . . . 2.3199999999999998 109.959 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 198' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.11 -43.21 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.102 -0.998 . . . . 1.3400000000000001 109.028 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.6 -26.5 55.72 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.79 -0.764 . . . . 1.24 109.168 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 200' ' ' ALA . . . . . . . . . . . . . . . -84.9 -5.38 59.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.028 -1.045 . . . . 1.3 109.882 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 201' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -102.75 95.38 6.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.9 -1.125 . . . . 1.1499999999999999 109.554 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 202' ' ' THR . . . . . . . . . . . . . 24.7 p -66.22 -33.21 75.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.407 -0.808 . . . . 2.1600000000000001 110.631 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 203' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.33 -47.49 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.851 -1.156 . . . . 1.3799999999999999 109.598 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 204' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -63.69 -42.24 98.04 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.349 -0.94 . . . . 3.6000000000000001 109.576 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 205' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -58.01 -42.42 85.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 2.27 109.482 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 206' ' ' THR . . . . . . . . . . . . . 73.2 m -60.63 -48.71 80.55 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.088 -1.045 . . . . 1.4099999999999999 109.564 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 207' ' ' LEU . . . . . . . . . . . . . 30.6 mt -62.62 -44.45 96.26 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.934 -1.107 . . . . 1.3700000000000001 110.736 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.5 -41.45 98.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.718 -1.239 . . . . 1.3400000000000001 110.055 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 209' ' ' THR . . . . . . . . . . . . . 35.8 p -67.89 -31.83 71.89 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.371 -0.831 . . . . 1.3999999999999999 110.28 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 210' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -80.37 -17.54 51.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.782 -1.199 . . . . 2.7400000000000002 110.857 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 17.5 m -107.69 17.65 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.952 -1.092 . . . . 1.4399999999999999 108.639 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.29 123.42 82.48 Favored Pre-proline 0 N--CA 1.483 1.221 0 N-CA-C 107.82 -1.178 . . . . 1.27 107.82 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 213' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -44.31 144.48 2.95 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.037 1.825 . . . . 1.25 112.731 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 214' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -56.52 134.85 66.98 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.196 1.931 . . . . 1.47 112.028 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 215' ' ' GLY . . . . . . . . . . . . . . . 79.91 -8.52 50.03 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.922 -1.271 . . . . 0.87 109.922 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 216' ' ' VAL . . . . . . . . . . . . . 58.6 t -114.8 136.78 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -1.076 . . . . 1.5600000000000001 108.8 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.87 135.77 45.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.438 -0.789 . . . . 1.99 109.836 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 218' ' ' ALA . . . . . . . . . . . . . . . -110.17 131.37 55.12 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.315 -0.994 . . . . 1.1299999999999999 108.315 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -120.97 153.51 37.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.401 -0.812 . . . . 0.77000000000000002 109.808 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 54.8 t -126.35 117.83 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.624 0.726 . . . . 1.24 109.07 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 31.7 m -141.01 165.14 19.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.412 -0.805 . . . . 1.1699999999999999 109.622 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 222' ' ' ASP . . . . . 0.709 ' OD1' ' N ' ' C' ' 225' ' ' LYS . 6.8 p30 -94.18 167.23 11.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.479 -0.763 . . . . 1.3400000000000001 109.305 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.46 -44.82 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.151 -0.968 . . . . 1.1599999999999999 110.455 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 224' ' ' ALA . . . . . 0.474 ' O ' HG23 ' C' ' 227' ' ' ILE . . . -62.72 -44.73 95.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.934 -1.104 . . . . 1.3 109.398 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 225' ' ' LYS . . . . . 0.709 ' N ' ' OD1' ' C' ' 222' ' ' ASP . 45.7 tttm -68.14 -35.35 77.95 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.775 -1.203 . . . . 2.5800000000000001 109.674 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 226' ' ' MET . . . . . . . . . . . . . 10.3 tpt -62.08 -40.4 95.71 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.934 -1.104 . . . . 1.54 111.191 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . 0.53 HG23 ' N ' ' C' ' 228' ' ' ARG . 17.4 tt -60.9 -34.56 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.611 -0.885 . . . . 1.3400000000000001 108.611 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . 0.53 ' N ' HG23 ' C' ' 227' ' ' ILE . 0.4 OUTLIER -74.47 -38.86 62.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.722 -0.611 . . . . 4.6600000000000001 110.948 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 70.3 t -62.18 -41.73 92.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.864 -1.162 . . . . 1.1799999999999999 107.864 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 230' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' C' ' 230' ' ' TYR . 36.7 t80 -67.04 -32.13 73.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.102 -0.999 . . . . 1.0700000000000001 109.927 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 231' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.76 6.73 2.34 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.119 -0.988 . . . . 0.98999999999999999 110.104 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 232' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -110.18 117.78 50.87 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.246 -0.909 . . . . 1.0600000000000001 109.435 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 233' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -65.73 1.51 2.19 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.646 1.564 . . . . 1.3300000000000001 111.98 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 234' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.36 -24.76 65.33 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 2.1899999999999999 108.807 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 235' ' ' TYR . . . . . 0.482 ' O ' ' HB2' ' C' ' 238' ' ' GLU . 81.1 m-85 -105.49 15.71 26.66 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.594 -0.842 . . . . 1.75 109.003 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 236' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' C' ' 238' ' ' GLU . . . -54.81 135.62 47.44 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.076 -1.64 . . . . 1.23 109.65 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.78 -33.41 1.9 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.288 -1.525 . . . . 0.67000000000000004 109.288 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 238' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' C' ' 235' ' ' TYR . 4.0 mm-40 -54.25 138.93 37.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.805 -1.409 . . . . 2.48 109.437 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 239' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -99.1 116.33 31.08 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.463 -0.939 . . . . 3.46 108.463 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . 0.556 ' CG2' ' SD ' ' C' ' 162' ' ' MET . 26.3 t -121.85 148.78 25.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.876 0.846 . . . . 1.29 110.448 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 241' ' ' MET . . . . . . . . . . . . . 13.8 ttm -102.9 134.95 45.47 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.925 -1.139 . . . . 2.25 107.925 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 242' ' ' LEU . . . . . . . . . . . . . 61.2 mt -102.04 127.28 49.0 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.689 -0.804 . . . . 1.1100000000000001 109.877 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 243' ' ' LEU . . . . . . . . . . . . . 97.6 mt -109.5 126.08 53.15 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.981 0.896 . . . . 1.29 109.045 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 244' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -127.0 162.03 26.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.771 0.796 . . . . 0.33000000000000002 109.275 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 245' ' ' THR . . . . . . . . . . . . . 70.2 p -109.48 -19.47 13.23 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.958 -0.756 . . . . 1.1000000000000001 108.958 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 246' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' C' ' 246' ' ' ASN . 17.3 p30 -151.08 141.85 14.91 Favored Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 120.003 -0.679 . . . . 1.5700000000000001 109.872 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 247' ' ' PRO . . . . . 0.424 ' HG3' ' CE2' ' C' ' 291' ' ' PHE . 7.3 Cg_endo -60.85 -14.63 33.4 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.683 2.255 . . . . 0.93000000000000005 112.1 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 248' ' ' THR . . . . . . . . . . . . . 95.7 m -64.99 -42.66 94.31 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.151 0.976 . . . . 1.3 108.624 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 249' ' ' ASP . . . . . 0.44 ' O ' HD11 ' C' ' 253' ' ' LEU . 97.8 m-20 -67.48 -23.4 65.48 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.54 -0.725 . . . . 0.53000000000000003 109.801 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 250' ' ' VAL . . . . . . . . . . . . . 98.3 t -73.62 -43.77 54.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.672 -1.267 . . . . 1.1000000000000001 109.848 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 251' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.41 -35.02 77.92 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.426 -0.953 . . . . 1.51 108.426 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 252' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -62.48 -44.09 97.23 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.723 -0.791 . . . . 3.73 110.156 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 253' ' ' LEU . . . . . 0.44 HD11 ' O ' ' C' ' 249' ' ' ASP . 1.2 mp -64.07 -40.42 96.22 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 117.999 -1.48 . . . . 1.72 108.876 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 254' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.7 -44.61 97.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 120.835 -1.165 . . . . 1.1599999999999999 108.948 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 255' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.23 -30.97 69.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.018 -1.052 . . . . 2.4700000000000002 109.917 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 256' ' ' GLY . . . . . . . . . . . . . . . -74.28 2.8 43.16 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.498 -1.441 . . . . 0.57999999999999996 109.498 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 257' ' ' GLY . . . . . . . . . . . . . . . 94.37 15.79 45.94 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.627 -1.389 . . . . 0.53000000000000003 109.627 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 258' ' ' VAL . . . . . . . . . . . . . 96.7 t -77.66 139.72 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.034 -1.469 . . . . 1.1599999999999999 107.034 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 259' ' ' LYS . . . . . 0.75 ' HZ2' ' ND2' ' C' ' 159' ' ' ASN . 17.9 tttt -99.01 123.93 43.64 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.089 -1.007 . . . . 3.6600000000000001 110.811 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 260' ' ' ILE . . . . . . . . . . . . . 98.1 mt -129.99 125.67 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.43 -0.794 . . . . 1.1000000000000001 109.147 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 65.9 p -89.51 -31.44 17.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.776 -1.202 . . . . 1.24 110.238 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 262' ' ' SER . . . . . . . . . . . . . 15.8 m -159.06 153.51 24.15 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.176 -0.953 . . . . 1.01 110.092 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 263' ' ' VAL . . . . . . . . . . . . . 50.9 t -122.74 134.61 65.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.538 -0.912 . . . . 1.1299999999999999 108.538 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 264' ' ' ASN . . . . . 0.468 ' ND2' ' CH2' ' C' ' 182' ' ' TRP . 33.7 t30 -108.57 128.08 54.51 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.517 0.675 . . . . 1.9399999999999999 110.607 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 265' ' ' VAL . . . . . 0.421 HG22 ' SD ' ' C' ' 314' ' ' MET . 3.2 t -90.64 108.43 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 120.058 -0.657 . . . . 1.1399999999999999 109.68 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 266' ' ' GLY . . . . . . . . . . . . . . . -80.75 -53.94 3.84 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.153 -1.179 . . . . 0.40999999999999998 110.153 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . -172.57 152.93 17.73 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.646 -1.74 . . . . 0.42999999999999999 111.476 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 268' ' ' MET . . . . . . . . . . . . . 97.0 mtp -143.1 118.08 10.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.481 -1.011 . . . . 1.1200000000000001 110.443 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.34 128.21 21.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.371 -0.831 . . . . 1.21 109.523 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 270' ' ' PHE . . . . . 0.536 ' CG ' ' N ' ' C' ' 271' ' ' ARG . 13.3 t80 -69.5 161.8 28.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 1.0700000000000001 109.618 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 271' ' ' ARG . . . . . 0.536 ' N ' ' CG ' ' C' ' 270' ' ' PHE . 32.7 ttm180 -160.66 158.67 29.24 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.27 -0.972 . . . . 3.77 109.676 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 272' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -66.48 138.25 57.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.081 -1.012 . . . . 3.6299999999999999 110.459 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 273' ' ' GLY . . . . . . . . . . . . . . . 95.52 -12.32 67.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.818 -1.713 . . . . 0.91000000000000003 108.818 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 274' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -101.81 163.37 12.29 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.484 -1.01 . . . . 2.1299999999999999 109.388 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 275' ' ' THR . . . . . . . . . . . . . 20.8 m -109.95 135.83 50.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.674 -0.862 . . . . 1.27 108.674 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 276' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -82.02 119.21 23.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.246 -0.909 . . . . 3.2400000000000002 110.176 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 277' ' ' VAL . . . . . 0.435 HG22 ' N ' ' C' ' 278' ' ' ASN . 27.5 m -99.22 -28.18 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.81 -0.756 . . . . 1.3100000000000001 109.612 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 278' ' ' ASN . . . . . 0.464 HD21 HG13 ' C' ' 303' ' ' VAL . 10.2 t-20 -135.99 -177.16 4.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.658 0.742 . . . . 1.52 109.761 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . 0.414 ' N ' ' OD1' ' C' ' 278' ' ' ASN . 39.5 m-20 -56.93 -29.88 63.5 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.791 -0.568 . . . . 2.73 110.787 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . -148.06 27.01 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.829 -1.169 . . . . 1.25 109.538 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 281' ' ' VAL . . . . . . . . . . . . . 60.8 t -118.99 121.98 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.825 0.822 . . . . 1.23 109.678 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 282' ' ' SER . . . . . . . . . . . . . 29.0 m -118.64 147.61 43.58 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.447 0.642 . . . . 1.21 110.02 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 283' ' ' VAL . . . . . 0.43 HG22 HG11 ' C' ' 277' ' ' VAL . 16.7 m -135.26 142.84 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.446 1.117 . . . . 1.27 110.539 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 284' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' C' ' 287' ' ' ASP . 44.1 p-10 -110.61 171.67 7.33 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 106.923 -1.51 . . . . 0.77000000000000002 106.923 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 285' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.18 -24.21 40.12 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.833 -1.167 . . . . 2.3399999999999999 109.587 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 286' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -79.59 -43.46 22.89 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.233 -0.917 . . . . 2.48 110.026 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 287' ' ' ASP . . . . . 0.57 ' N ' ' OD1' ' C' ' 284' ' ' ASP . 93.3 m-20 -64.25 -42.08 96.67 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.237 -0.915 . . . . 0.64000000000000001 109.096 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 288' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.48 -45.77 97.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.387 -0.821 . . . . 1.29 109.518 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 289' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -57.44 -39.6 76.6 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.216 -0.928 . . . . 2.52 110.262 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.37 -41.01 85.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.82 -1.175 . . . . 1.1299999999999999 109.9 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 291' ' ' PHE . . . . . 0.449 ' CE2' ' HE3' ' C' ' 314' ' ' MET . 40.0 m-85 -63.93 -39.02 93.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.56999999999999995 109.73 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 292' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -64.08 -39.5 94.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.149 -0.969 . . . . 2.5499999999999998 110.226 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 293' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -65.78 -41.54 91.86 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.943 -1.098 . . . . 2.3300000000000001 109.635 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 294' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.18 -43.22 99.32 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.871 -1.143 . . . . 1.1799999999999999 108.867 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 295' ' ' ASN . . . . . 0.529 HD21 ' HG3' ' C' ' 315' ' ' MET . 40.3 t-20 -64.01 -40.01 95.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 2.02 109.953 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.66 -21.38 65.67 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.815 -1.178 . . . . 1.26 109.242 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 297' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -90.13 8.85 30.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.769 -1.207 . . . . 2.9700000000000002 109.91 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.44 11.43 82.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.903 -1.279 . . . . 0.63 109.903 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 299' ' ' ILE . . . . . 0.419 HD12 HG23 ' C' ' 299' ' ' ILE . 97.8 mt -84.71 134.56 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.974 -1.309 . . . . 1.1399999999999999 109.151 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 300' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -82.0 141.66 33.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.869 . . . . 2.2999999999999998 110.615 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 301' ' ' LEU . . . . . . . . . . . . . 66.9 mt -123.08 111.27 16.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.269 -0.641 . . . . 1.1899999999999999 109.269 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 302' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.57 139.87 49.69 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.9 . . . . 2.2599999999999998 110.289 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 303' ' ' VAL . . . . . 0.611 ' CG2' ' SD ' ' C' ' 314' ' ' MET . 51.8 t -111.99 124.77 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.673 -0.862 . . . . 1.1299999999999999 108.673 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 304' ' ' ARG . . . . . 0.42 ' HE ' ' CG ' ' C' ' 264' ' ' ASN . 33.4 ptt180 -164.93 137.87 4.64 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.505 -0.878 . . . . 3.1800000000000002 110.343 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 305' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -80.82 -45.42 16.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 3.6099999999999999 109.817 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 306' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.33 154.01 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.106 -0.996 . . . . 1.24 108.737 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 307' ' ' SER . . . . . . . . . . . . . 83.5 p -64.55 -16.29 62.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.983 -1.073 . . . . 1.8100000000000001 109.516 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 308' ' ' THR . . . . . 0.539 ' CG2' ' NH2' ' C' ' 181' ' ' ARG . 44.5 p -86.14 -9.07 57.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.047 -1.033 . . . . 1.3600000000000001 110.005 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 309' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -92.49 152.69 42.35 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.025 -1.047 . . . . 0.81000000000000005 109.936 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 310' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -55.37 139.15 81.42 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.968 1.779 . . . . 1.21 111.755 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 311' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -84.24 132.82 34.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 3.6099999999999999 109.823 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 312' ' ' LEU . . . . . . . . . . . . . 80.2 mt -117.51 154.74 30.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.103 -0.998 . . . . 1.3100000000000001 108.309 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 313' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -91.26 130.49 37.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.076 -1.015 . . . . 2.77 109.827 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 314' ' ' MET . . . . . 0.611 ' SD ' ' CG2' ' C' ' 303' ' ' VAL . 8.2 tpt -56.39 -44.17 79.97 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.67 -0.644 . . . . 1.54 109.63 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 315' ' ' MET . . . . . 0.529 ' HG3' HD21 ' C' ' 295' ' ' ASN . 95.9 mmm -61.18 -40.39 93.73 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.299 -0.876 . . . . 2.1499999999999999 110.22 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 316' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.9 -44.0 97.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.319 -0.863 . . . . 0.81999999999999995 109.81 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 317' ' ' LEU . . . . . . . . . . . . . 92.8 mt -66.49 -41.98 88.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.877 . . . . 1.3100000000000001 110.036 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 318' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.26 -24.49 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.311 -0.868 . . . . 1.3500000000000001 109.957 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 319' ' ' SER . . . . . 0.475 ' O ' ' C ' ' C' ' 323' ' ' LYS . 0.9 OUTLIER -72.72 -31.56 65.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.084 -1.01 . . . . 2.02 109.518 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 320' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -84.19 -2.45 56.9 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.78 -1.168 . . . . 2.5099999999999998 109.167 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 321' ' ' ILE . . . . . . . . . . . . . 93.2 mt -113.76 -58.74 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.914 -1.143 . . . . 1.72 107.914 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 322' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' C' ' 323' ' ' LYS . 12.3 t0 -95.01 85.11 4.26 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.16 -1.792 . . . . 2.2599999999999998 106.16 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 323' ' ' LYS . . . . . 1.166 ' HA ' ' NZ ' ' C' ' 323' ' ' LYS . 0.0 OUTLIER . . . . . 1 C--O 1.524 15.537 0 CA-C-O 126.309 2.957 . . . . 6.29 109.465 -177.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.507 ' HB ' ' HG2' ' A' ' 105' ' ' ARG . 76.6 p . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 121.106 0.479 . . . . 0.45000000000000001 111.038 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.606 ' O ' ' HD2' ' A' ' 105' ' ' ARG . 47.0 mt -71.24 136.2 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.736 -1.95 . . . . 0.39000000000000001 105.736 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.98 144.42 36.76 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 115.292 -0.867 . . . . 0.37 110.744 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.531 HD12 HG23 ' A' ' 101' ' ' THR . 45.3 mt -126.27 130.14 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.825 0.85 . . . . 0.32000000000000001 109.053 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.29 129.28 74.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.035 -1.839 . . . . 0.33000000000000002 106.035 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 mt -109.11 131.73 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.445 -0.576 . . . . 0.26000000000000001 109.445 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.75 135.83 7.43 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.791 -1.324 . . . . 0.25 109.791 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.2 t -151.78 164.71 36.44 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.025 -1.28 . . . . 1.05 109.592 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' NEP . . . . . 0.562 ' ND1' ' OD2' ' A' ' 67' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.89 -140.3 15.77 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.02 -1.232 . . . . 0.33000000000000002 110.02 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -130.69 32.1 4.43 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.233 -1.157 . . . . 0.90000000000000002 110.447 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.51 -27.27 58.68 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 115.277 1.584 . . . . 0.25 115.277 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.7 -46.48 74.15 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.827 0.74 . . . . 0.27000000000000002 112.799 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -59.79 -40.39 88.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.593 -0.443 . . . . 0.44 111.224 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.31 -35.22 73.53 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.105 1.15 . . . . 0.40999999999999998 114.105 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.05 -39.99 95.3 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.139 -1.43 . . . . 0.27000000000000002 107.139 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.13 -43.47 91.81 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.149 -0.685 . . . . 0.35999999999999999 109.149 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HG2' ' HZ2' ' A' ' 19' ' ' LYS . 24.7 mttm -61.56 -39.18 90.2 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.242 0.544 . . . . 0.46999999999999997 111.234 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.96 -47.64 79.64 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 115.048 -0.978 . . . . 0.37 108.609 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.71 86.11 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 119.754 -0.778 . . . . 0.39000000000000001 111.465 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.96 -23.34 65.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.103 -0.499 . . . . 2.5 110.692 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.47 -32.01 69.39 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 105.703 -1.962 . . . . 3.0600000000000001 105.703 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.469 HD23 ' CD2' ' B' ' 10' ' ' NEP . 45.8 mt -84.74 -38.38 19.74 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 113.817 1.043 . . . . 1.1899999999999999 113.817 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -109.6 -12.03 14.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 119.025 2.972 . . . . 1.1699999999999999 119.025 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.98 165.07 31.38 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 105.457 -3.057 . . . . 0.52000000000000002 105.457 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -58.82 138.97 56.96 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 122.41 1.1 . . . . 0.57999999999999996 112.611 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -105.91 146.75 29.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.264 -1.789 . . . . 0.45000000000000001 113.038 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -106.46 157.34 17.72 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.497 -1.229 . . . . 0.54000000000000004 107.816 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.25 41.22 20.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.096 1.147 . . . . 0.44 114.096 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.8 t -131.09 134.53 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.381 -0.97 . . . . 0.39000000000000001 108.381 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.66 18.93 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 109.899 -1.28 . . . . 0.37 109.899 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.22 157.76 36.4 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 118.203 1.001 . . . . 0.42999999999999999 108.921 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.84 159.15 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.453 -0.794 . . . . 0.38 110.29 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -113.46 162.85 15.63 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.757 -0.656 . . . . 0.41999999999999998 109.592 173.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 36' ' ' PHE . 1.9 t80 -134.19 117.5 16.57 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.886 -1.524 . . . . 0.45000000000000001 106.886 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.6 t -108.11 145.44 31.45 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 113.92 -1.491 . . . . 0.51000000000000001 110.848 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -57.06 136.08 74.54 Favored 'Trans proline' 0 C--N 1.352 0.752 0 N-CA-C 107.929 -1.604 . . . . 0.53000000000000003 107.929 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.55 -25.75 16.55 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.065 -1.214 . . . . 0.57999999999999996 110.065 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.34 157.66 21.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.373 0.606 . . . . 0.54000000000000004 110.009 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -125.08 179.29 5.11 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.343 -0.984 . . . . 2.5099999999999998 108.343 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.19 72.97 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 113.003 0.742 . . . . 0.5 113.003 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.86 -36.45 84.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.84 0.828 . . . . 2.8300000000000001 112.164 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.5 m -63.92 -47.58 79.99 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 106.01 -1.848 . . . . 0.56000000000000005 106.01 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.71 -37.48 86.7 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.108 0.781 . . . . 0.46999999999999997 113.108 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.1 mt -58.59 -43.15 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.587 -0.894 . . . . 0.52000000000000002 108.587 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -62.58 -42.73 99.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.966 -0.694 . . . . 0.59999999999999998 110.875 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -61.58 -44.34 97.21 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 119.347 -0.941 . . . . 0.48999999999999999 111.34 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -61.02 -45.65 93.96 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 120.015 -0.674 . . . . 0.41999999999999998 109.595 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -60.15 -40.04 88.44 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 113.158 0.799 . . . . 0.53000000000000003 113.158 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.58 -35.64 81.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.449 0.643 . . . . 0.54000000000000004 110.135 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.17 -43.61 70.47 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 119.578 -0.849 . . . . 0.45000000000000001 110.205 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.73 -37.92 80.28 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.281 -0.418 . . . . 0.45000000000000001 112.041 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.31 -26.36 29.07 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.699 0.629 . . . . 0.55000000000000004 112.699 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -95.49 -4.75 44.35 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.224 0.824 . . . . 0.55000000000000004 113.224 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 69.8 mt -105.85 157.54 17.4 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 113.313 0.857 . . . . 0.46000000000000002 113.313 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -89.34 107.94 19.35 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 102.541 -3.133 . . . . 0.46999999999999997 102.541 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.9 p -106.98 15.38 25.39 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 124.097 0.873 . . . . 0.44 111.05 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.3 p -64.03 -34.27 77.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 115.553 1.686 . . . . 0.5 115.553 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.77 -9.39 43.79 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.274 0.559 . . . . 0.5 112.271 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.71 172.22 13.03 Favored Glycine 0 C--O 1.242 0.598 0 C-N-CA 119.486 -1.34 . . . . 0.40000000000000002 113.406 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.3 t -139.47 130.17 32.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 N-CA-C 109.273 -0.639 . . . . 0.37 109.273 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.581 ' HG ' HD22 ' A' ' 65' ' ' LEU . 27.8 tp -115.86 113.37 23.26 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.549 1.781 . . . . 0.29999999999999999 108.446 177.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.68 122.19 33.23 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 106.507 -1.664 . . . . 0.35999999999999999 106.507 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.581 HD22 ' HG ' ' A' ' 63' ' ' LEU . 83.0 mt -109.55 115.25 29.56 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 104.519 -2.4 . . . . 0.23999999999999999 104.519 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.405 HG21 ' HA ' ' A' ' 91' ' ' ALA . 25.4 m -119.93 163.31 17.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 113.221 0.823 . . . . 0.25 113.221 -176.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.562 ' OD2' ' ND1' ' A' ' 10' ' ' NEP . 14.3 p-10 -64.94 -54.05 36.8 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 118.031 2.604 . . . . 0.27000000000000002 118.031 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -142.23 151.41 42.09 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 122.541 1.163 . . . . 1.05 112.693 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -66.32 134.47 52.67 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.178 -1.374 . . . . 0.48999999999999999 107.857 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.72 -8.14 70.59 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 121.281 3.272 . . . . 0.38 121.281 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.23 174.9 55.24 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 119.341 -1.409 . . . . 0.34000000000000002 110.065 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.18 -47.77 98.5 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 122.089 -0.653 . . . . 1.75 112.057 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.402 ' HD2' ' NE2' ' A' ' 10' ' ' NEP . 83.3 Cg_exo -53.5 -41.56 72.46 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 118.293 -0.671 . . . . 0.32000000000000001 110.604 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -67.28 -48.26 68.2 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 123.506 0.504 . . . . 0.39000000000000001 109.865 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -60.1 -42.71 95.24 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.945 1.091 . . . . 2.2799999999999998 113.945 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.6 85.57 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.388 -0.925 . . . . 0.42999999999999999 111.675 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.83 89.97 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.7 -0.852 . . . . 0.38 108.7 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.3 m -58.72 -39.82 81.96 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.423 0.527 . . . . 1.8500000000000001 112.423 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 79' ' ' ARG . 33.8 mtt180 -67.31 -29.55 69.15 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 112.957 0.725 . . . . 3.98 112.957 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.404 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 76.5 mt -77.15 -42.18 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.755 0.65 . . . . 0.46000000000000002 112.755 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 87' ' ' TYR . 2.6 m -80.15 -16.72 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 115.456 1.65 . . . . 0.45000000000000001 115.456 -175.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -29.31 -55.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 1 N-CA-C 122.123 4.12 . . . . 1.29 122.123 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.55 39.4 3.97 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 116.387 -2.125 . . . . 0.58999999999999997 109.525 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -112.33 133.55 54.37 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 114.505 -1.225 . . . . 0.5 109.745 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.23 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 106.732 -1.581 . . . . 0.52000000000000002 106.732 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.67 15.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 115.395 1.628 . . . . 0.47999999999999998 115.395 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.485 ' HB3' ' HB ' ' A' ' 81' ' ' VAL . 6.1 m-85 -127.47 130.92 50.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.538 -2.023 . . . . 0.42999999999999999 105.538 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.59 154.67 41.76 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.29 -0.564 . . . . 0.39000000000000001 110.311 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 t -121.69 128.48 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 106.315 -1.735 . . . . 0.34000000000000002 106.315 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 63' ' ' LEU . 34.3 mt -124.16 119.51 56.87 Favored 'Isoleucine or valine' 0 C--O 1.256 1.405 0 N-CA-C 108.258 -1.016 . . . . 0.31 108.258 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.405 ' HA ' HG21 ' A' ' 66' ' ' VAL . . . -84.4 163.29 19.6 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 114.674 -1.148 . . . . 0.27000000000000002 112.388 176.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.71 24.62 55.53 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 114.821 0.688 . . . . 0.20999999999999999 114.821 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.82 132.73 6.61 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 N-CA-C 113.483 0.92 . . . . 0.17000000000000001 113.483 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.577 ' HB3' ' HB3' ' B' ' 94' ' ' ASN . 50.9 p30 -141.88 169.61 17.28 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.65 -1.241 . . . . 0.26000000000000001 107.65 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.431 HG21 HD13 ' A' ' 95' ' ' ILE . 50.4 mm -60.22 -43.37 93.47 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 114.522 1.304 . . . . 1.0900000000000001 114.522 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.55 -42.94 55.52 Favored 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 117.584 -1.144 . . . . 0.34000000000000002 110.343 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 39.8 ttm -61.56 -48.93 78.75 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 120.348 -0.541 . . . . 0.28999999999999998 109.704 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.44 -48.05 83.43 Favored 'General case' 0 C--O 1.201 -1.487 0 N-CA-C 112.784 0.661 . . . . 0.29999999999999999 112.784 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.51 -49.8 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 112.729 0.641 . . . . 1.1100000000000001 112.729 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -63.67 -40.51 97.01 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.253 -0.579 . . . . 2.04 111.671 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.531 HG23 HD12 ' A' ' 5' ' ' ILE . 53.3 m -66.24 -46.09 78.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.34999999999999998 110.89 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.5 -37.84 88.93 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 123.537 0.523 . . . . 0.40000000000000002 110.571 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 69.8 mtp -66.12 -45.74 80.0 Favored 'General case' 0 C--O 1.243 0.717 0 O-C-N 121.353 -0.842 . . . . 2.1299999999999999 112.099 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.86 75.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.179 0.807 . . . . 1.1000000000000001 113.179 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 15.7 ttp180 -52.6 -32.63 42.43 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 113.4 0.889 . . . . 0.42999999999999999 113.4 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -73.6 -19.6 60.83 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 114.001 1.111 . . . . 2.1899999999999999 114.001 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -90.67 18.24 6.64 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.204 1.002 . . . . 2.2000000000000002 109.49 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.6 t70 46.69 58.55 16.73 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 117.248 2.314 . . . . 0.52000000000000002 117.248 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -74.13 168.5 24.66 Favored 'Trans proline' 0 C--O 1.206 -1.1 0 C-N-CA 120.455 0.77 . . . . 0.48999999999999999 110.659 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.511 ' HG ' ' CG ' ' A' ' 113' ' ' GLU . 54.4 p -77.05 162.74 27.27 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.613 -1.625 . . . . 0.5 106.613 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -55.95 -51.55 67.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 112.373 0.509 . . . . 0.44 112.373 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.51 -37.73 76.21 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 112.924 0.712 . . . . 0.51000000000000001 112.924 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.511 ' CG ' ' HG ' ' A' ' 110' ' ' SER . 88.7 mt-10 -62.8 -46.87 85.94 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.416 -0.356 . . . . 0.54000000000000004 110.156 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.418 ' HA ' HD12 ' A' ' 114' ' ' LEU . 15.0 tp -64.26 -45.97 85.78 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 121.087 -0.245 . . . . 0.40999999999999998 111.235 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.91 -48.3 81.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.583 -0.447 . . . . 0.39000000000000001 110.478 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.83 -44.31 94.1 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.202 0.525 . . . . 0.46999999999999997 112.338 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.34 -42.93 99.79 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 122.071 -0.393 . . . . 1.1299999999999999 111.009 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.06 94.48 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 119.748 -0.781 . . . . 0.34999999999999998 112.096 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.65 -46.26 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.83 -0.433 . . . . 0.40000000000000002 109.83 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -63.65 -45.29 90.84 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.678 0.992 . . . . 0.52000000000000002 113.678 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.2 p -71.42 -32.35 68.29 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 120.607 -0.437 . . . . 1.1200000000000001 111.867 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.41 -45.58 95.63 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.362 -1.495 . . . . 0.32000000000000001 109.362 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.43 -42.01 65.53 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 112.588 0.588 . . . . 0.47999999999999998 112.588 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.52 -20.32 62.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 119.609 -0.836 . . . . 2.3999999999999999 111.899 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.61 -16.69 76.03 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 124.203 0.939 . . . . 0.38 113.559 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.462 HG13 ' CE ' ' B' ' 97' ' ' MET . 93.6 t -88.97 112.98 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 106.193 -1.78 . . . . 0.40000000000000002 106.193 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -156.43 136.92 13.11 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.387 -0.968 . . . . 3.29 108.387 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.65 146.67 23.98 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 122.043 0.925 . . . . 1.1399999999999999 109.996 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 tp -66.84 -56.53 9.97 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.314 -0.857 . . . . 1.22 111.407 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 62.48 178.69 0.14 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.653 0.739 . . . . 3.2000000000000002 110.403 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.18 146.25 53.57 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.691 -0.855 . . . . 1.48 108.691 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.416 ' H ' ' HG2' ' A' ' 132' ' ' LYS . 0.8 OUTLIER -113.01 145.21 32.61 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.581 -0.699 . . . . 5.1299999999999999 109.317 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -64.24 146.97 91.09 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.513 2.142 . . . . 3.1400000000000001 112.472 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 118.043 -0.979 . . . . 4.0199999999999996 109.095 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' THR . . . . . 0.49 ' HB ' ' HG2' ' B' ' 105' ' ' ARG . 77.3 p . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.166 0.508 . . . . 0.38 111.01 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.617 ' O ' ' HD2' ' B' ' 105' ' ' ARG . 47.1 mt -71.25 136.18 26.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 105.791 -1.929 . . . . 0.40999999999999998 105.791 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.99 144.43 36.73 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.387 -0.824 . . . . 0.34999999999999998 110.795 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 44.6 mt -126.23 130.25 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.764 0.826 . . . . 0.28000000000000003 108.981 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 86.4 t -124.42 129.27 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.004 -1.85 . . . . 0.34999999999999998 106.004 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.559 HG23 ' HB2' ' B' ' 14' ' ' ALA . 35.7 mt -109.06 131.71 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 109.548 -0.538 . . . . 0.28999999999999998 109.548 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.79 135.71 7.35 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.817 -1.313 . . . . 0.33000000000000002 109.817 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 7.9 t -152.13 165.63 34.16 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.083 -1.245 . . . . 1.0600000000000001 109.77 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' NEP . . . . . 0.749 ' P ' ' NE2' ' B' ' 10' ' ' NEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.53 -138.94 19.03 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.327 -1.416 . . . . 0.42999999999999999 110.93 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -131.25 32.04 4.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.469 -1.018 . . . . 0.90000000000000002 110.628 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.5 -27.17 58.66 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 115.216 1.562 . . . . 0.31 115.216 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.559 ' HB2' HG23 ' B' ' 7' ' ' ILE . . . -54.74 -46.44 74.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.887 0.767 . . . . 0.28999999999999998 112.834 -176.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.79 -40.35 88.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.958 -0.464 . . . . 0.39000000000000001 111.265 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.19 -35.46 73.97 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.056 1.132 . . . . 0.37 114.056 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.02 -39.95 95.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.09 -1.448 . . . . 0.20999999999999999 107.09 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' LEU . . . . . 0.502 HD11 HG11 ' B' ' 31' ' ' VAL . 18.6 tp -65.21 -43.39 91.68 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 109.192 -0.67 . . . . 0.27000000000000002 109.192 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -61.62 -39.11 90.1 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 121.242 0.544 . . . . 0.39000000000000001 111.266 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.9 -47.64 79.77 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-N 115.056 -0.975 . . . . 0.23999999999999999 108.59 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.7 86.26 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.681 -0.808 . . . . 0.23999999999999999 111.49 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.98 -23.21 65.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.014 -0.539 . . . . 2.54 110.755 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.66 -31.87 68.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.689 -1.967 . . . . 3.1000000000000001 105.689 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 45.6 mt -84.75 -38.3 19.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.837 1.051 . . . . 1.1100000000000001 113.837 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 91.3 mt -109.66 -11.98 14.69 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 119.046 2.98 . . . . 1.0900000000000001 119.046 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.83 165.08 31.57 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 105.521 -3.032 . . . . 0.35999999999999999 105.521 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.69 138.99 56.72 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.338 1.066 . . . . 0.41999999999999998 112.687 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -106.06 146.7 29.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.272 -1.785 . . . . 0.29999999999999999 112.963 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -106.37 157.34 17.69 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 114.434 -1.257 . . . . 0.39000000000000001 107.794 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.13 41.3 20.68 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.085 1.142 . . . . 0.34000000000000002 114.085 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.502 HG11 HD11 ' B' ' 18' ' ' LEU . 93.7 t -131.08 134.62 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.31 -0.996 . . . . 0.29999999999999999 108.31 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.73 18.91 Favored Glycine 0 N--CA 1.469 0.886 0 N-CA-C 109.82 -1.312 . . . . 0.32000000000000001 109.82 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.26 157.69 36.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.167 0.983 . . . . 0.41999999999999998 108.953 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.79 159.1 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.577 -0.738 . . . . 0.42999999999999999 110.306 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.36 162.78 15.66 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.713 -0.676 . . . . 0.46999999999999997 109.617 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' B' ' 36' ' ' PHE . 2.3 t80 -134.16 117.56 16.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.888 -1.523 . . . . 0.56999999999999995 106.888 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.454 HG12 ' HD2' ' B' ' 38' ' ' PRO . 95.0 t -108.1 145.42 31.42 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.943 -1.481 . . . . 0.60999999999999999 110.855 -176.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.454 ' HD2' HG12 ' B' ' 37' ' ' VAL . 58.6 Cg_exo -57.01 136.14 74.96 Favored 'Trans proline' 0 C--N 1.352 0.719 0 N-CA-C 107.949 -1.597 . . . . 0.64000000000000001 107.949 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.48 -25.78 16.61 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.126 -1.19 . . . . 0.69999999999999996 110.126 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.27 157.66 21.48 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.336 0.588 . . . . 0.65000000000000002 110.031 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' B' ' 41' ' ' ASN . 29.5 p-10 -125.06 179.31 5.1 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.372 -0.973 . . . . 2.6699999999999999 108.372 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.13 73.0 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 112.972 0.73 . . . . 0.63 112.972 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.77 -36.58 84.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.934 0.873 . . . . 2.8199999999999998 112.163 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 89.4 m -63.9 -47.53 80.25 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 105.987 -1.857 . . . . 0.65000000000000002 105.987 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.411 HD12 ' HB3' ' B' ' 72' ' ' SER . 36.5 mt -62.74 -37.68 87.52 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 112.979 0.733 . . . . 0.56999999999999995 112.979 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.47 -43.14 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.635 -0.876 . . . . 0.62 108.635 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -62.66 -42.72 99.77 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 119.984 -0.686 . . . . 0.66000000000000003 110.825 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.52 -44.42 97.1 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 119.346 -0.942 . . . . 0.55000000000000004 111.47 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -60.89 -45.72 93.5 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 119.986 -0.686 . . . . 0.47999999999999998 109.637 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -60.09 -40.14 88.55 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 113.131 0.789 . . . . 0.58999999999999997 113.131 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.5 -35.61 81.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.434 0.635 . . . . 0.55000000000000004 110.17 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.11 -43.83 70.23 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 119.572 -0.851 . . . . 0.46000000000000002 110.141 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' B' ' 53' ' ' LEU . 91.0 mt -59.55 -38.0 79.92 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.261 -0.427 . . . . 0.46999999999999997 112.048 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.27 -26.32 28.39 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.744 0.646 . . . . 0.52000000000000002 112.744 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -95.57 -4.73 44.13 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 113.126 0.787 . . . . 0.5 113.126 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 69.4 mt -105.77 157.43 17.45 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.396 0.888 . . . . 0.40999999999999998 113.396 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -89.34 107.99 19.38 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 102.557 -3.127 . . . . 0.41999999999999998 102.557 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 72.9 p -107.09 15.4 25.26 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 124.153 0.908 . . . . 0.46000000000000002 111.064 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 73.0 p -63.95 -34.29 77.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 115.595 1.702 . . . . 0.48999999999999999 115.595 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.87 -9.35 43.61 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.267 0.556 . . . . 0.47999999999999998 112.202 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.74 172.19 13.02 Favored Glycine 0 C--O 1.242 0.642 0 C-N-CA 119.484 -1.341 . . . . 0.44 113.383 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.41 130.25 32.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 109.259 -0.645 . . . . 0.41999999999999998 109.259 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.55 ' HG ' HD23 ' B' ' 65' ' ' LEU . 27.9 tp -115.84 113.42 23.34 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.497 1.748 . . . . 0.35999999999999999 108.411 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.78 122.17 33.29 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.491 -1.67 . . . . 0.42999999999999999 106.491 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.55 HD23 ' HG ' ' B' ' 63' ' ' LEU . 83.2 mt -109.52 115.27 29.61 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 104.531 -2.396 . . . . 0.28000000000000003 104.531 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 26.0 m -120.01 163.4 17.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 113.186 0.81 . . . . 0.35999999999999999 113.186 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' B' ' 67' ' ' ASP . 14.8 p-10 -64.9 -54.07 36.53 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 118.069 2.618 . . . . 0.39000000000000001 118.069 -177.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 45.3 p -142.23 151.4 42.06 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.533 1.158 . . . . 1.0900000000000001 112.692 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' TRP . . . . . . . . . . . . . 32.8 t-105 -66.27 134.45 52.67 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.153 -1.385 . . . . 0.64000000000000001 107.818 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.73 -8.14 70.6 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 121.218 3.247 . . . . 0.52000000000000002 121.218 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.2 174.92 55.25 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 119.282 -1.437 . . . . 0.48999999999999999 110.109 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.411 ' HB3' HD12 ' B' ' 45' ' ' LEU . 0.6 OUTLIER -57.15 -47.84 98.4 Favored Pre-proline 0 C--N 1.329 -0.291 0 O-C-N 122.017 -0.696 . . . . 1.78 112.01 179.536 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -53.44 -41.6 71.92 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 118.391 -0.606 . . . . 0.45000000000000001 110.619 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -67.2 -48.37 68.1 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 123.458 0.474 . . . . 0.53000000000000003 109.845 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -60.05 -42.71 95.08 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.972 1.101 . . . . 2.4199999999999999 113.972 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.46 85.71 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.242 -0.983 . . . . 0.55000000000000004 111.721 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.05 -38.83 90.25 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 108.618 -0.882 . . . . 0.48999999999999999 108.618 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 70.5 m -58.65 -39.89 81.88 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.416 0.524 . . . . 1.8700000000000001 112.416 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -67.2 -29.58 69.28 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 113.042 0.756 . . . . 4.0899999999999999 113.042 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 76.1 mt -77.2 -42.15 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.697 0.629 . . . . 0.56000000000000005 112.697 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' B' ' 87' ' ' TYR . 2.6 m -80.03 -16.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.901 0 N-CA-C 115.465 1.654 . . . . 0.56000000000000005 115.465 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -29.4 -55.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.352 1 N-CA-C 122.096 4.11 . . . . 1.3 122.096 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.49 39.3 3.99 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 116.394 -2.122 . . . . 0.71999999999999997 109.601 178.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.37 133.55 54.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.442 -1.254 . . . . 0.60999999999999999 109.748 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.25 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 106.707 -1.59 . . . . 0.63 106.707 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.68 15.24 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 115.406 1.632 . . . . 0.56999999999999995 115.406 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' TYR . . . . . 0.476 ' HB3' ' HB ' ' B' ' 81' ' ' VAL . 6.1 m-85 -127.45 130.89 50.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 105.506 -2.035 . . . . 0.51000000000000001 105.506 175.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . 0.404 ' HG2' HG13 ' B' ' 115' ' ' VAL . 6.7 tp10 -146.6 154.66 41.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.228 -0.589 . . . . 0.48999999999999999 110.357 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.77 128.47 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 106.235 -1.765 . . . . 0.46000000000000002 106.235 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 34.2 mt -124.14 119.52 56.93 Favored 'Isoleucine or valine' 0 C--O 1.255 1.378 0 N-CA-C 108.245 -1.02 . . . . 0.38 108.245 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.46 163.21 19.59 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 114.738 -1.119 . . . . 0.38 112.314 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.89 24.49 55.33 Favored Glycine 0 CA--C 1.499 -0.911 0 N-CA-C 114.817 0.687 . . . . 0.28999999999999998 114.817 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.85 132.85 6.69 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 N-CA-C 113.461 0.911 . . . . 0.23999999999999999 113.461 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' ASN . . . . . 0.577 ' HB3' ' HB3' ' A' ' 94' ' ' ASN . 51.2 p30 -141.98 169.48 17.52 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.688 -1.227 . . . . 0.22 107.688 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 51.3 mm -60.2 -43.37 93.54 Favored Pre-proline 0 C--O 1.24 0.588 0 N-CA-C 114.491 1.293 . . . . 1.04 114.491 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.55 -42.85 56.53 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 117.575 -1.15 . . . . 0.25 110.34 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' MET . . . . . 0.462 ' CE ' HG13 ' A' ' 126' ' ' VAL . 39.9 ttm -61.72 -48.85 78.86 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 120.377 -0.529 . . . . 0.28000000000000003 109.633 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' B' ' 98' ' ' LEU . 14.3 tp -60.46 -48.01 83.62 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 112.822 0.675 . . . . 0.20000000000000001 112.822 -177.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.52 -49.9 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 112.715 0.635 . . . . 1.0700000000000001 112.715 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -63.52 -40.59 97.43 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 120.235 -0.586 . . . . 2.0099999999999998 111.696 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' THR . . . . . . . . . . . . . 53.5 m -66.23 -46.12 78.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.731 -0.668 . . . . 0.28999999999999998 110.892 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.406 HD12 ' HG ' ' B' ' 98' ' ' LEU . 97.6 mt -64.47 -37.79 88.76 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 123.607 0.567 . . . . 0.28999999999999998 110.563 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' MET . . . . . . . . . . . . . 72.6 mtp -66.1 -45.81 79.84 Favored 'General case' 0 C--O 1.242 0.695 0 O-C-N 121.264 -0.897 . . . . 2.2200000000000002 112.132 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.81 75.62 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.3 0.852 . . . . 1.0700000000000001 113.3 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 1.44 ' NE ' ' HE ' ' B' ' 105' ' ' ARG . 15.8 ttp180 -52.56 -32.69 42.16 Favored 'General case' 0 C--O 1.21 -1.013 0 N-CA-C 113.4 0.889 . . . . 0.37 113.4 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.57 -19.59 60.85 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 114.1 1.148 . . . . 2.1299999999999999 114.1 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -90.62 18.15 6.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 122.159 0.981 . . . . 2.27 109.476 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 12.7 t70 46.79 58.47 16.88 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 117.269 2.322 . . . . 0.47999999999999998 117.269 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -74.09 168.43 24.82 Favored 'Trans proline' 0 C--O 1.206 -1.109 0 C-N-CA 120.55 0.833 . . . . 0.47999999999999998 110.604 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' SER . . . . . 0.484 ' HG ' ' CG ' ' B' ' 113' ' ' GLU . 54.3 p -77.0 162.78 27.28 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.706 -1.59 . . . . 0.55000000000000004 106.706 175.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -55.94 -51.48 67.5 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 112.445 0.535 . . . . 0.5 112.445 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -58.67 -37.67 76.51 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 112.897 0.703 . . . . 0.59999999999999998 112.897 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . 0.484 ' CG ' ' HG ' ' B' ' 110' ' ' SER . 88.7 mt-10 -62.84 -46.77 86.37 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 116.417 -0.356 . . . . 0.56999999999999995 110.141 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 15.1 tp -64.41 -45.86 85.77 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 121.019 -0.272 . . . . 0.44 111.191 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.404 HG13 ' HG2' ' B' ' 88' ' ' GLU . 63.5 t -56.88 -48.32 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 O-C-N 121.891 -0.506 . . . . 0.46000000000000002 110.52 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.25 94.3 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.133 0.492 . . . . 0.51000000000000001 112.326 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 tp -62.4 -42.8 99.71 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 122.125 -0.359 . . . . 1.1299999999999999 110.989 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.29 -45.1 94.51 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 119.798 -0.761 . . . . 0.35999999999999999 112.059 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.61 -46.26 89.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.803 -0.443 . . . . 0.45000000000000001 109.803 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -63.71 -45.22 90.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 113.717 1.006 . . . . 0.52000000000000002 113.717 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 34.6 p -71.44 -32.28 68.16 Favored 'General case' 0 C--O 1.216 -0.681 0 C-N-CA 120.585 -0.446 . . . . 1.1100000000000001 111.987 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.38 -45.74 95.31 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.332 -1.507 . . . . 0.31 109.332 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.21 -42.15 66.11 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 112.622 0.601 . . . . 0.48999999999999999 112.622 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.43 -20.27 62.92 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 119.578 -0.849 . . . . 2.4199999999999999 111.964 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.78 -16.6 76.3 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 124.246 0.966 . . . . 0.31 113.511 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 93.7 t -88.99 113.07 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 106.171 -1.789 . . . . 0.34000000000000002 106.171 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -156.45 136.84 13.03 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.409 -0.96 . . . . 3.3900000000000001 108.409 -173.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.6 146.71 23.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.031 0.92 . . . . 1.1000000000000001 109.986 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 tp -66.94 -56.78 8.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.337 -0.847 . . . . 1.1200000000000001 111.37 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 62.63 178.8 0.14 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.612 0.72 . . . . 3.2000000000000002 110.401 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.97 146.22 53.78 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.719 -0.845 . . . . 1.4299999999999999 108.719 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.419 ' H ' ' HG2' ' B' ' 132' ' ' LYS . 0.8 OUTLIER -112.87 145.23 32.61 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.513 -0.742 . . . . 5.2800000000000002 109.219 -179.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -64.41 146.97 90.57 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.474 2.116 . . . . 3.3199999999999998 112.42 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.988 -1.006 . . . . 4.1900000000000004 109.133 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 159' ' ' ASN . . . . . 0.75 ' ND2' ' HZ2' ' C' ' 259' ' ' LYS . 1.8 t-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 108.992 -0.744 . . . . 6.8399999999999999 108.992 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 160' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -85.87 25.5 1.1 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.59 -0.893 . . . . 3.8900000000000001 108.59 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 161' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -118.63 -141.88 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.583 -0.895 . . . . 2.21 108.583 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 162' ' ' MET . . . . . 0.556 ' SD ' ' CG2' ' C' ' 240' ' ' VAL . 0.3 OUTLIER -61.63 156.19 20.55 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.764 -1.21 . . . . 2.48 110.562 -178.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 163' ' ' VAL . . . . . . . . . . . . . 94.9 t -113.11 117.68 56.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.06 -0.719 . . . . 1.24 109.06 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 164' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.73 103.39 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.49 -0.929 . . . . 1.0900000000000001 108.49 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.59 -35.33 80.7 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.211 -1.555 . . . . 0.46999999999999997 109.211 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 tp -172.04 147.97 2.18 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.771 -1.172 . . . . 1.0800000000000001 111.209 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 167' ' ' ALA . . . . . . . . . . . . . . . -117.69 104.39 10.96 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.048 -0.723 . . . . 1.0700000000000001 109.048 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 168' ' ' ARG . . . . . 0.522 ' NH1' ' CG1' ' C' ' 178' ' ' VAL . 44.4 ttp180 -106.37 126.09 51.81 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.972 0.891 . . . . 3.7000000000000002 110.835 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 169' ' ' ILE . . . . . . . . . . . . . 82.3 mt -95.5 129.21 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 109.222 -0.659 . . . . 1.05 109.222 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 170' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -165.95 117.04 1.04 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.812 -0.755 . . . . 0.48999999999999999 110.327 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 171' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.97 -9.94 11.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.429 -0.794 . . . . 2.3300000000000001 109.759 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 172' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' C' ' 174' ' ' ILE . 12.4 mtt180 -101.71 -6.49 23.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 3.5299999999999998 110.47 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 173' ' ' LEU . . . . . . . . . . . . . 13.7 mt 59.1 -89.16 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.44 -0.948 . . . . 2.0099999999999998 108.44 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 174' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' C' ' 172' ' ' ARG . 70.8 mt -109.98 116.77 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.069 -1.02 . . . . 1.23 110.227 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 175' ' ' HIS . . . . . 0.742 ' ND1' ' P ' ' B' ' 10' ' ' NEP . 10.0 p80 -139.35 117.61 11.95 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.947 -1.095 . . . . 0.76000000000000001 109.033 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.55 -152.74 45.05 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 110.066 -1.214 . . . . 0.58999999999999997 110.066 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 177' ' ' GLN . . . . . 0.746 ' H ' ' NE2' ' C' ' 177' ' ' GLN . 0.1 OUTLIER -91.15 12.21 20.76 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.744 -0.856 . . . . 3.5299999999999998 109.332 -178.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . 0.522 ' CG1' ' NH1' ' C' ' 168' ' ' ARG . 48.1 t -61.54 -42.83 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 1.1499999999999999 108.953 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 179' ' ' ALA . . . . . 0.502 ' O ' ' OG1' ' C' ' 183' ' ' THR . . . -73.16 -36.38 66.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.929 -1.107 . . . . 1.1599999999999999 110.187 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 180' ' ' THR . . . . . . . . . . . . . 21.5 m -66.34 -54.42 24.82 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.697 -0.801 . . . . 1.25 109.79 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 181' ' ' ARG . . . . . 0.539 ' NH2' ' CG2' ' C' ' 308' ' ' THR . 55.1 ttt-85 -64.7 -43.62 92.88 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.013 -0.675 . . . . 3.7400000000000002 110.608 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 182' ' ' TRP . . . . . 0.468 ' CH2' ' ND2' ' C' ' 264' ' ' ASN . 19.5 m95 -65.82 -32.2 73.6 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.034 -1.041 . . . . 1.01 109.591 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 183' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' C' ' 179' ' ' ALA . 71.9 m -65.29 -47.1 77.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.946 -1.096 . . . . 1.2 110.252 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -69.66 -42.93 73.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 2.6099999999999999 110.806 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 185' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -68.32 -39.61 81.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.95 -1.094 . . . . 2.52 109.569 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 186' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' C' ' 182' ' ' TRP . 72.6 p -81.42 -1.26 45.03 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.282 -0.886 . . . . 1.1399999999999999 109.685 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 187' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 52.14 48.42 22.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.055 -1.028 . . . . 2.6200000000000001 108.604 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 188' ' ' VAL . . . . . 0.44 HG11 ' H ' ' C' ' 190' ' ' ARG . 47.8 t -105.05 133.46 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.164 -0.96 . . . . 1.99 110.122 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 189' ' ' SER . . . . . . . . . . . . . 27.8 p -109.75 -6.33 15.32 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.761 -0.829 . . . . 1.8899999999999999 108.761 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 190' ' ' ARG . . . . . 0.44 ' H ' HG11 ' C' ' 188' ' ' VAL . 29.4 mtt-85 -135.92 142.83 44.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.555 -0.716 . . . . 4.0499999999999998 110.441 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 191' ' ' ILE . . . . . . . . . . . . . 87.6 mt -133.38 127.61 54.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.173 -1.047 . . . . 1.1399999999999999 108.173 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 192' ' ' ILE . . . . . . . . . . . . . 97.1 mt -115.66 128.68 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.257 -0.902 . . . . 1.1299999999999999 109.665 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 193' ' ' VAL . . . . . . . . . . . . . 53.3 t -99.7 128.88 51.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.825 -0.806 . . . . 1.3799999999999999 108.825 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 194' ' ' VAL . . . . . . . . . . . . . 43.0 t -112.51 103.57 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.535 -0.728 . . . . 1.1200000000000001 109.479 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 195' ' ' SER . . . . . . . . . . . . . 38.0 t -167.25 125.61 1.31 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.342 -0.943 . . . . 1.9099999999999999 109.31 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 196' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.01 -34.88 66.65 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.574 -0.704 . . . . 0.97999999999999998 109.984 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 197' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -65.55 -45.49 83.21 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.147 -0.971 . . . . 2.3199999999999998 109.959 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 198' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.11 -43.21 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.102 -0.998 . . . . 1.3400000000000001 109.028 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.6 -26.5 55.72 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.79 -0.764 . . . . 1.24 109.168 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 200' ' ' ALA . . . . . . . . . . . . . . . -84.9 -5.38 59.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.028 -1.045 . . . . 1.3 109.882 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 201' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -102.75 95.38 6.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.9 -1.125 . . . . 1.1499999999999999 109.554 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 202' ' ' THR . . . . . . . . . . . . . 24.7 p -66.22 -33.21 75.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.407 -0.808 . . . . 2.1600000000000001 110.631 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 203' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.33 -47.49 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.851 -1.156 . . . . 1.3799999999999999 109.598 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 204' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -63.69 -42.24 98.04 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.349 -0.94 . . . . 3.6000000000000001 109.576 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 205' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -58.01 -42.42 85.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 2.27 109.482 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 206' ' ' THR . . . . . . . . . . . . . 73.2 m -60.63 -48.71 80.55 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.088 -1.045 . . . . 1.4099999999999999 109.564 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 207' ' ' LEU . . . . . . . . . . . . . 30.6 mt -62.62 -44.45 96.26 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.934 -1.107 . . . . 1.3700000000000001 110.736 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.5 -41.45 98.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.718 -1.239 . . . . 1.3400000000000001 110.055 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 209' ' ' THR . . . . . . . . . . . . . 35.8 p -67.89 -31.83 71.89 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.371 -0.831 . . . . 1.3999999999999999 110.28 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 210' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -80.37 -17.54 51.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.782 -1.199 . . . . 2.7400000000000002 110.857 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 17.5 m -107.69 17.65 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.952 -1.092 . . . . 1.4399999999999999 108.639 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.29 123.42 82.48 Favored Pre-proline 0 N--CA 1.483 1.221 0 N-CA-C 107.82 -1.178 . . . . 1.27 107.82 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 213' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -44.31 144.48 2.95 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.037 1.825 . . . . 1.25 112.731 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 214' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -56.52 134.85 66.98 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.196 1.931 . . . . 1.47 112.028 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 215' ' ' GLY . . . . . . . . . . . . . . . 79.91 -8.52 50.03 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.922 -1.271 . . . . 0.87 109.922 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 216' ' ' VAL . . . . . . . . . . . . . 58.6 t -114.8 136.78 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -1.076 . . . . 1.5600000000000001 108.8 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.87 135.77 45.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.438 -0.789 . . . . 1.99 109.836 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 218' ' ' ALA . . . . . . . . . . . . . . . -110.17 131.37 55.12 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.315 -0.994 . . . . 1.1299999999999999 108.315 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -120.97 153.51 37.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.401 -0.812 . . . . 1.0 109.808 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 54.8 t -126.35 117.83 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.624 0.726 . . . . 1.24 109.07 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 31.7 m -141.01 165.14 19.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.412 -0.805 . . . . 1.1699999999999999 109.622 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 222' ' ' ASP . . . . . 0.709 ' OD1' ' N ' ' C' ' 225' ' ' LYS . 6.8 p30 -94.18 167.23 11.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.479 -0.763 . . . . 1.3400000000000001 109.305 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.46 -44.82 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.151 -0.968 . . . . 1.1599999999999999 110.455 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 224' ' ' ALA . . . . . 0.474 ' O ' HG23 ' C' ' 227' ' ' ILE . . . -62.72 -44.73 95.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.934 -1.104 . . . . 1.3 109.398 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 225' ' ' LYS . . . . . 0.709 ' N ' ' OD1' ' C' ' 222' ' ' ASP . 45.7 tttm -68.14 -35.35 77.95 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.775 -1.203 . . . . 2.5800000000000001 109.674 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 226' ' ' MET . . . . . . . . . . . . . 10.3 tpt -62.08 -40.4 95.71 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.934 -1.104 . . . . 1.54 111.191 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . 0.53 HG23 ' N ' ' C' ' 228' ' ' ARG . 17.4 tt -60.9 -34.56 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.611 -0.885 . . . . 1.3400000000000001 108.611 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . 0.53 ' N ' HG23 ' C' ' 227' ' ' ILE . 0.4 OUTLIER -74.47 -38.86 62.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.722 -0.611 . . . . 4.6600000000000001 110.948 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 70.3 t -62.18 -41.73 92.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.864 -1.162 . . . . 1.1799999999999999 107.864 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 230' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' C' ' 230' ' ' TYR . 36.7 t80 -67.04 -32.13 73.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.102 -0.999 . . . . 1.0700000000000001 109.927 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 231' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.76 6.73 2.34 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.119 -0.988 . . . . 0.98999999999999999 110.104 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 232' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -110.18 117.78 50.87 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.246 -0.909 . . . . 1.0600000000000001 109.435 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 233' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -65.73 1.51 2.19 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.646 1.564 . . . . 1.3300000000000001 111.98 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 234' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.36 -24.76 65.33 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 2.1899999999999999 108.807 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 235' ' ' TYR . . . . . 0.482 ' O ' ' HB2' ' C' ' 238' ' ' GLU . 81.1 m-85 -105.49 15.71 26.66 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.594 -0.842 . . . . 1.75 109.003 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 236' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' C' ' 238' ' ' GLU . . . -54.81 135.62 47.44 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.076 -1.64 . . . . 1.23 109.65 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.78 -33.41 1.9 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.288 -1.525 . . . . 0.67000000000000004 109.288 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 238' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' C' ' 235' ' ' TYR . 4.0 mm-40 -54.25 138.93 37.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.805 -1.409 . . . . 2.48 109.437 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 239' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -99.1 116.33 31.08 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.463 -0.939 . . . . 3.46 108.463 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . 0.556 ' CG2' ' SD ' ' C' ' 162' ' ' MET . 26.3 t -121.85 148.78 25.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.876 0.846 . . . . 1.29 110.448 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 241' ' ' MET . . . . . . . . . . . . . 13.8 ttm -102.9 134.95 45.47 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.925 -1.139 . . . . 2.25 107.925 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 242' ' ' LEU . . . . . . . . . . . . . 61.2 mt -102.04 127.28 49.0 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.689 -0.804 . . . . 1.1100000000000001 109.877 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 243' ' ' LEU . . . . . . . . . . . . . 97.6 mt -109.5 126.08 53.15 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.981 0.896 . . . . 1.29 109.045 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 244' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -127.0 162.03 26.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.771 0.796 . . . . 0.33000000000000002 109.275 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 245' ' ' THR . . . . . . . . . . . . . 70.2 p -109.48 -19.47 13.23 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.958 -0.756 . . . . 1.1000000000000001 108.958 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 246' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' C' ' 246' ' ' ASN . 17.3 p30 -151.08 141.85 14.91 Favored Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 120.003 -0.679 . . . . 1.5700000000000001 109.872 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 247' ' ' PRO . . . . . 0.424 ' HG3' ' CE2' ' C' ' 291' ' ' PHE . 7.3 Cg_endo -60.85 -14.63 33.4 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.683 2.255 . . . . 0.93000000000000005 112.1 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 248' ' ' THR . . . . . . . . . . . . . 95.7 m -64.99 -42.66 94.31 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.151 0.976 . . . . 1.3 108.624 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 249' ' ' ASP . . . . . 0.44 ' O ' HD11 ' C' ' 253' ' ' LEU . 97.8 m-20 -67.48 -23.4 65.48 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.54 -0.725 . . . . 0.53000000000000003 109.801 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 250' ' ' VAL . . . . . . . . . . . . . 98.3 t -73.62 -43.77 54.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.672 -1.267 . . . . 1.1000000000000001 109.848 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 251' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.41 -35.02 77.92 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.426 -0.953 . . . . 1.51 108.426 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 252' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -62.48 -44.09 97.23 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.723 -0.791 . . . . 3.73 110.156 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 253' ' ' LEU . . . . . 0.44 HD11 ' O ' ' C' ' 249' ' ' ASP . 1.2 mp -64.07 -40.42 96.22 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 117.999 -1.48 . . . . 1.72 108.876 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 254' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.7 -44.61 97.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 120.835 -1.165 . . . . 1.1599999999999999 108.948 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 255' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.23 -30.97 69.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.018 -1.052 . . . . 2.4700000000000002 109.917 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 256' ' ' GLY . . . . . . . . . . . . . . . -74.28 2.8 43.16 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.498 -1.441 . . . . 0.57999999999999996 109.498 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 257' ' ' GLY . . . . . . . . . . . . . . . 94.37 15.79 45.94 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.627 -1.389 . . . . 0.53000000000000003 109.627 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 258' ' ' VAL . . . . . . . . . . . . . 96.7 t -77.66 139.72 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.034 -1.469 . . . . 1.1599999999999999 107.034 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 259' ' ' LYS . . . . . 0.75 ' HZ2' ' ND2' ' C' ' 159' ' ' ASN . 17.9 tttt -99.01 123.93 43.64 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.089 -1.007 . . . . 3.6600000000000001 110.811 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 260' ' ' ILE . . . . . . . . . . . . . 98.1 mt -129.99 125.67 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.43 -0.794 . . . . 1.1000000000000001 109.147 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 65.9 p -89.51 -31.44 17.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.776 -1.202 . . . . 1.24 110.238 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 262' ' ' SER . . . . . . . . . . . . . 15.8 m -159.06 153.51 24.15 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.176 -0.953 . . . . 1.01 110.092 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 263' ' ' VAL . . . . . . . . . . . . . 50.9 t -122.74 134.61 65.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.538 -0.912 . . . . 1.1299999999999999 108.538 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 264' ' ' ASN . . . . . 0.468 ' ND2' ' CH2' ' C' ' 182' ' ' TRP . 33.7 t30 -108.57 128.08 54.51 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.517 0.675 . . . . 1.9399999999999999 110.607 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 265' ' ' VAL . . . . . 0.421 HG22 ' SD ' ' C' ' 314' ' ' MET . 3.2 t -90.64 108.43 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 120.058 -0.657 . . . . 1.1399999999999999 109.68 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 266' ' ' GLY . . . . . . . . . . . . . . . -80.75 -53.94 3.84 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.153 -1.179 . . . . 0.40999999999999998 110.153 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . -172.57 152.93 17.73 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.646 -1.74 . . . . 0.42999999999999999 111.476 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 268' ' ' MET . . . . . . . . . . . . . 97.0 mtp -143.1 118.08 10.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.481 -1.011 . . . . 1.1200000000000001 110.443 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.34 128.21 21.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.371 -0.831 . . . . 1.21 109.523 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 270' ' ' PHE . . . . . 0.536 ' CG ' ' N ' ' C' ' 271' ' ' ARG . 13.3 t80 -69.5 161.8 28.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 1.0700000000000001 109.618 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 271' ' ' ARG . . . . . 0.536 ' N ' ' CG ' ' C' ' 270' ' ' PHE . 32.7 ttm180 -160.66 158.67 29.24 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.27 -0.972 . . . . 3.77 109.676 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 272' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -66.48 138.25 57.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.081 -1.012 . . . . 3.6299999999999999 110.459 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 273' ' ' GLY . . . . . . . . . . . . . . . 95.52 -12.32 67.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.818 -1.713 . . . . 0.91000000000000003 108.818 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 274' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -101.81 163.37 12.29 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.484 -1.01 . . . . 2.1299999999999999 109.388 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 275' ' ' THR . . . . . . . . . . . . . 20.8 m -109.95 135.83 50.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.674 -0.862 . . . . 1.27 108.674 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 276' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -82.02 119.21 23.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.246 -0.909 . . . . 3.2400000000000002 110.176 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 277' ' ' VAL . . . . . 0.435 HG22 ' N ' ' C' ' 278' ' ' ASN . 27.5 m -99.22 -28.18 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.81 -0.756 . . . . 1.3100000000000001 109.612 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 278' ' ' ASN . . . . . 0.464 HD21 HG13 ' C' ' 303' ' ' VAL . 10.2 t-20 -135.99 -177.16 4.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.658 0.742 . . . . 1.52 109.761 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . 0.414 ' N ' ' OD1' ' C' ' 278' ' ' ASN . 39.5 m-20 -56.93 -29.88 63.5 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.791 -0.568 . . . . 2.73 110.787 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . -148.06 27.01 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.829 -1.169 . . . . 1.25 109.538 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 281' ' ' VAL . . . . . . . . . . . . . 60.8 t -118.99 121.98 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.825 0.822 . . . . 1.23 109.678 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 282' ' ' SER . . . . . . . . . . . . . 29.0 m -118.64 147.61 43.58 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.447 0.642 . . . . 1.21 110.02 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 283' ' ' VAL . . . . . 0.43 HG22 HG11 ' C' ' 277' ' ' VAL . 16.7 m -135.26 142.84 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.446 1.117 . . . . 1.27 110.539 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 284' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' C' ' 287' ' ' ASP . 44.1 p-10 -110.61 171.67 7.33 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 106.923 -1.51 . . . . 0.77000000000000002 106.923 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 285' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.18 -24.21 40.12 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.833 -1.167 . . . . 2.3399999999999999 109.587 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 286' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -79.59 -43.46 22.89 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.233 -0.917 . . . . 2.48 110.026 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 287' ' ' ASP . . . . . 0.57 ' N ' ' OD1' ' C' ' 284' ' ' ASP . 93.3 m-20 -64.25 -42.08 96.67 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.237 -0.915 . . . . 0.64000000000000001 109.096 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 288' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.48 -45.77 97.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.387 -0.821 . . . . 1.29 109.518 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 289' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -57.44 -39.6 76.6 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.216 -0.928 . . . . 2.52 110.262 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.37 -41.01 85.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.82 -1.175 . . . . 1.1299999999999999 109.9 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 291' ' ' PHE . . . . . 0.449 ' CE2' ' HE3' ' C' ' 314' ' ' MET . 40.0 m-85 -63.93 -39.02 93.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.56999999999999995 109.73 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 292' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -64.08 -39.5 94.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.149 -0.969 . . . . 2.5499999999999998 110.226 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 293' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -65.78 -41.54 91.86 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.943 -1.098 . . . . 2.3300000000000001 109.635 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 294' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.18 -43.22 99.32 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.871 -1.143 . . . . 1.1799999999999999 108.867 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 295' ' ' ASN . . . . . 0.529 HD21 ' HG3' ' C' ' 315' ' ' MET . 40.3 t-20 -64.01 -40.01 95.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 2.02 109.953 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.66 -21.38 65.67 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.815 -1.178 . . . . 1.26 109.242 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 297' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -90.13 8.85 30.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.769 -1.207 . . . . 2.9700000000000002 109.91 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.44 11.43 82.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.903 -1.279 . . . . 0.63 109.903 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 299' ' ' ILE . . . . . 0.419 HD12 HG23 ' C' ' 299' ' ' ILE . 97.8 mt -84.71 134.56 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.974 -1.309 . . . . 1.1399999999999999 109.151 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 300' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -82.0 141.66 33.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.869 . . . . 2.2999999999999998 110.615 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 301' ' ' LEU . . . . . . . . . . . . . 66.9 mt -123.08 111.27 16.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.269 -0.641 . . . . 1.1899999999999999 109.269 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 302' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.57 139.87 49.69 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.9 . . . . 2.2599999999999998 110.289 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 303' ' ' VAL . . . . . 0.611 ' CG2' ' SD ' ' C' ' 314' ' ' MET . 51.8 t -111.99 124.77 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.673 -0.862 . . . . 1.1299999999999999 108.673 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 304' ' ' ARG . . . . . 0.42 ' HE ' ' CG ' ' C' ' 264' ' ' ASN . 33.4 ptt180 -164.93 137.87 4.64 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.505 -0.878 . . . . 3.1800000000000002 110.343 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 305' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -80.82 -45.42 16.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 3.6099999999999999 109.817 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 306' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.33 154.01 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.106 -0.996 . . . . 1.24 108.737 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 307' ' ' SER . . . . . . . . . . . . . 83.5 p -64.55 -16.29 62.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.983 -1.073 . . . . 1.8100000000000001 109.516 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 308' ' ' THR . . . . . 0.539 ' CG2' ' NH2' ' C' ' 181' ' ' ARG . 44.5 p -86.14 -9.07 57.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.047 -1.033 . . . . 1.3600000000000001 110.005 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 309' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -92.49 152.69 42.35 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.025 -1.047 . . . . 0.81000000000000005 109.936 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 310' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -55.37 139.15 81.42 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.968 1.779 . . . . 1.21 111.755 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 311' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -84.24 132.82 34.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 3.6099999999999999 109.823 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 312' ' ' LEU . . . . . . . . . . . . . 80.2 mt -117.51 154.74 30.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.103 -0.998 . . . . 1.3100000000000001 108.309 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 313' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -91.26 130.49 37.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.076 -1.015 . . . . 2.77 109.827 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 314' ' ' MET . . . . . 0.611 ' SD ' ' CG2' ' C' ' 303' ' ' VAL . 8.2 tpt -56.39 -44.17 79.97 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.67 -0.644 . . . . 1.54 109.63 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 315' ' ' MET . . . . . 0.529 ' HG3' HD21 ' C' ' 295' ' ' ASN . 95.9 mmm -61.18 -40.39 93.73 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.299 -0.876 . . . . 2.1499999999999999 110.22 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 316' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.9 -44.0 97.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.319 -0.863 . . . . 0.81999999999999995 109.81 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 317' ' ' LEU . . . . . . . . . . . . . 92.8 mt -66.49 -41.98 88.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.877 . . . . 1.3100000000000001 110.036 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 318' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.26 -24.49 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.311 -0.868 . . . . 1.3500000000000001 109.957 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 319' ' ' SER . . . . . 0.475 ' O ' ' C ' ' C' ' 323' ' ' LYS . 0.9 OUTLIER -72.72 -31.56 65.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.084 -1.01 . . . . 2.02 109.518 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 320' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -84.19 -2.45 56.9 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.78 -1.168 . . . . 2.5099999999999998 109.167 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 321' ' ' ILE . . . . . . . . . . . . . 93.2 mt -113.76 -58.74 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.914 -1.143 . . . . 1.72 107.914 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 322' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' C' ' 323' ' ' LYS . 12.3 t0 -95.01 85.11 4.26 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.16 -1.792 . . . . 2.2599999999999998 106.16 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 323' ' ' LYS . . . . . 1.166 ' HA ' ' NZ ' ' C' ' 323' ' ' LYS . 0.0 OUTLIER . . . . . 1 C--O 1.524 15.537 0 CA-C-O 126.309 2.957 . . . . 6.29 109.465 -177.693 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.548 ' HB ' ' HG2' ' A' ' 105' ' ' ARG . 76.6 p . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 121.106 0.479 . . . . 0.44 111.038 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.614 ' O ' ' HD2' ' A' ' 105' ' ' ARG . 47.0 mt -71.24 136.2 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.736 -1.95 . . . . 0.38 105.736 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.98 144.42 36.76 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 115.292 -0.867 . . . . 0.34999999999999998 110.744 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.3 mt -126.27 130.14 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.825 0.85 . . . . 0.31 109.053 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.29 129.28 74.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.035 -1.839 . . . . 0.32000000000000001 106.035 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 mt -109.11 132.24 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.445 -0.576 . . . . 0.26000000000000001 109.445 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.55 133.01 6.17 Favored Glycine 0 N--CA 1.463 0.476 0 C-N-CA 120.271 -0.966 . . . . 0.23999999999999999 111.849 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.68 HG21 ' HB3' ' A' ' 13' ' ' ALA . 14.4 t . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 107.422 -1.325 . . . . 0.26000000000000001 107.422 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 114.981 0.752 . . . . 0.31 114.981 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -121.95 25.66 9.01 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 114.486 1.291 . . . . 0.78000000000000003 114.486 -174.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.68 ' HB3' HG21 ' A' ' 9' ' ' THR . . . -78.92 -27.27 43.73 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 115.277 1.584 . . . . 0.25 115.277 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.7 -46.48 74.15 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.827 0.74 . . . . 0.26000000000000001 112.799 -176.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -59.79 -40.39 88.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.593 -0.443 . . . . 0.44 111.224 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.31 -35.22 73.53 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.105 1.15 . . . . 0.38 114.105 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.05 -39.99 95.3 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.139 -1.43 . . . . 0.27000000000000002 107.139 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.13 -43.47 91.81 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.149 -0.685 . . . . 0.34000000000000002 109.149 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -61.56 -39.18 90.2 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.242 0.544 . . . . 0.44 111.234 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.96 -47.64 79.64 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 115.048 -0.978 . . . . 0.37 108.609 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.71 86.11 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 119.754 -0.778 . . . . 0.39000000000000001 111.465 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.96 -23.34 65.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.103 -0.499 . . . . 2.5 110.692 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.47 -32.01 69.39 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 105.703 -1.962 . . . . 2.5899999999999999 105.703 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.8 mt -84.74 -38.38 19.74 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 113.817 1.043 . . . . 0.48999999999999999 113.817 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -109.6 -12.03 14.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 119.025 2.972 . . . . 0.5 119.025 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.98 165.07 31.38 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 105.457 -3.057 . . . . 0.51000000000000001 105.457 -175.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -58.82 138.97 56.96 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 122.41 1.1 . . . . 0.57999999999999996 112.611 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -105.91 146.75 29.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.264 -1.789 . . . . 0.45000000000000001 113.038 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -106.46 157.34 17.72 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.497 -1.229 . . . . 0.54000000000000004 107.816 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.25 41.22 20.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.096 1.147 . . . . 0.41999999999999998 114.096 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.8 t -131.09 134.53 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.381 -0.97 . . . . 0.38 108.381 177.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.66 18.93 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 109.899 -1.28 . . . . 0.34999999999999998 109.899 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.22 157.76 36.4 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 118.203 1.001 . . . . 0.40999999999999998 108.921 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.84 159.15 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.453 -0.794 . . . . 0.35999999999999999 110.29 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -113.46 162.85 15.63 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.757 -0.656 . . . . 0.41999999999999998 109.592 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 36' ' ' PHE . 1.9 t80 -134.19 117.5 16.57 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.886 -1.524 . . . . 0.40999999999999998 106.886 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.6 t -108.11 145.44 31.45 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 113.92 -1.491 . . . . 0.48999999999999999 110.848 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -57.06 136.08 74.54 Favored 'Trans proline' 0 C--N 1.352 0.752 0 N-CA-C 107.929 -1.604 . . . . 0.53000000000000003 107.929 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.55 -25.75 16.55 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.065 -1.214 . . . . 0.57999999999999996 110.065 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.34 157.66 21.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.373 0.606 . . . . 0.52000000000000002 110.009 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -125.08 179.29 5.11 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.343 -0.984 . . . . 2.23 108.343 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.19 72.97 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 113.003 0.742 . . . . 0.48999999999999999 113.003 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.86 -36.45 84.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.84 0.828 . . . . 2.8300000000000001 112.164 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.5 m -63.92 -47.58 79.99 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 106.01 -1.848 . . . . 0.56000000000000005 106.01 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.71 -37.48 86.7 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.108 0.781 . . . . 0.46999999999999997 113.108 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.1 mt -58.59 -43.15 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.587 -0.894 . . . . 0.5 108.587 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -62.58 -42.73 99.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.966 -0.694 . . . . 0.58999999999999997 110.875 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -61.58 -44.34 97.21 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 119.347 -0.941 . . . . 0.47999999999999998 111.34 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -61.02 -45.65 93.96 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 120.015 -0.674 . . . . 0.41999999999999998 109.595 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -60.15 -40.04 88.44 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 113.158 0.799 . . . . 0.51000000000000001 113.158 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.58 -35.64 81.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.449 0.643 . . . . 0.52000000000000002 110.135 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.17 -43.61 70.47 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 119.578 -0.849 . . . . 0.45000000000000001 110.205 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.73 -37.92 80.28 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.281 -0.418 . . . . 0.45000000000000001 112.041 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.31 -26.36 29.07 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.699 0.629 . . . . 0.53000000000000003 112.699 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -95.49 -4.75 44.35 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.224 0.824 . . . . 0.53000000000000003 113.224 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 69.8 mt -105.85 157.54 17.4 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 113.313 0.857 . . . . 0.46000000000000002 113.313 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -89.34 107.94 19.35 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 102.541 -3.133 . . . . 0.46999999999999997 102.541 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.9 p -106.98 15.38 25.39 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 124.097 0.873 . . . . 0.44 111.05 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.3 p -64.03 -34.27 77.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 115.553 1.686 . . . . 0.48999999999999999 115.553 -177.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.77 -9.39 43.79 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.274 0.559 . . . . 0.48999999999999999 112.271 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.71 172.22 13.03 Favored Glycine 0 C--O 1.242 0.598 0 C-N-CA 119.486 -1.34 . . . . 0.40000000000000002 113.406 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.3 t -139.47 130.17 32.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 N-CA-C 109.273 -0.639 . . . . 0.35999999999999999 109.273 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.8 tp -115.86 113.37 23.26 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.549 1.781 . . . . 0.29999999999999999 108.446 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.68 122.19 33.23 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 106.507 -1.664 . . . . 0.34000000000000002 106.507 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.0 mt -109.55 115.25 29.56 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 104.519 -2.4 . . . . 0.22 104.519 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.4 m -119.93 163.31 17.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 113.221 0.823 . . . . 0.23000000000000001 113.221 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 14.3 p-10 -64.94 -54.05 36.8 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 118.031 2.604 . . . . 0.27000000000000002 118.031 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -142.23 151.41 42.09 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 122.541 1.163 . . . . 0.26000000000000001 112.693 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -66.32 134.47 52.67 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.178 -1.374 . . . . 0.45000000000000001 107.857 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.72 -8.14 70.59 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 121.281 3.272 . . . . 0.38 121.281 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.23 174.9 55.24 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 119.341 -1.409 . . . . 0.34000000000000002 110.065 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.18 -47.77 98.5 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 122.089 -0.653 . . . . 1.24 112.057 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -53.5 -41.56 72.46 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 118.293 -0.671 . . . . 0.32000000000000001 110.604 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -67.28 -48.26 68.2 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 123.506 0.504 . . . . 0.37 109.865 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -60.1 -42.71 95.24 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.945 1.091 . . . . 1.99 113.945 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.6 85.57 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.388 -0.925 . . . . 0.40999999999999998 111.675 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.83 89.97 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.7 -0.852 . . . . 0.38 108.7 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.685 ' O ' HG13 ' A' ' 82' ' ' VAL . 70.3 m -58.72 -39.82 81.96 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.423 0.527 . . . . 1.3799999999999999 112.423 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.611 ' O ' HG22 ' A' ' 82' ' ' VAL . 33.8 mtt180 -67.31 -29.55 69.15 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 112.957 0.725 . . . . 3.3799999999999999 112.957 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.408 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 76.5 mt -77.15 -42.18 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.755 0.65 . . . . 0.45000000000000001 112.755 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 87' ' ' TYR . 2.6 m -80.15 -16.72 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 115.456 1.65 . . . . 0.45000000000000001 115.456 -175.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 78' ' ' SER . 2.9 m -29.31 -55.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 1 N-CA-C 122.123 4.12 . . . . 0.62 122.123 -177.007 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.55 39.4 3.97 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 116.387 -2.125 . . . . 0.58999999999999997 109.525 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -112.33 133.55 54.37 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 114.505 -1.225 . . . . 0.48999999999999999 109.745 -179.401 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.23 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 106.732 -1.581 . . . . 0.52000000000000002 106.732 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.67 15.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 115.395 1.628 . . . . 0.46999999999999997 115.395 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.477 ' HB3' ' HB ' ' A' ' 81' ' ' VAL . 6.1 m-85 -127.47 130.92 50.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.538 -2.023 . . . . 0.41999999999999998 105.538 175.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.59 154.67 41.76 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.29 -0.564 . . . . 0.39000000000000001 110.311 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 t -121.69 128.48 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 106.315 -1.735 . . . . 0.33000000000000002 106.315 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.3 mt -124.16 119.51 56.87 Favored 'Isoleucine or valine' 0 C--O 1.256 1.405 0 N-CA-C 108.258 -1.016 . . . . 0.28999999999999998 108.258 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.4 163.29 19.6 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 114.674 -1.148 . . . . 0.25 112.388 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.71 24.62 55.53 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 114.821 0.688 . . . . 0.19 114.821 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.82 132.73 6.61 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 N-CA-C 113.483 0.92 . . . . 0.16 113.483 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' B' ' 94' ' ' ASN . 50.9 p30 -141.88 169.61 17.28 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.65 -1.241 . . . . 0.23999999999999999 107.65 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 95' ' ' ILE . 50.4 mm -60.22 -43.37 93.47 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 114.522 1.304 . . . . 0.28999999999999998 114.522 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.55 -42.94 55.52 Favored 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 117.584 -1.144 . . . . 0.31 110.343 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 39.8 ttm -61.56 -48.93 78.75 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 120.348 -0.541 . . . . 0.28000000000000003 109.704 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.44 -48.05 83.43 Favored 'General case' 0 C--O 1.201 -1.487 0 N-CA-C 112.784 0.661 . . . . 0.29999999999999999 112.784 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.642 HG11 ' CG ' ' C' ' 177' ' ' GLN . 84.7 t -61.51 -49.8 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 112.729 0.641 . . . . 0.41999999999999998 112.729 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -63.67 -40.51 97.01 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.253 -0.579 . . . . 2.04 111.671 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.3 m -66.24 -46.09 78.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.34999999999999998 110.89 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.5 -37.84 88.93 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 123.537 0.523 . . . . 0.40000000000000002 110.571 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 69.8 mtp -66.12 -45.74 80.0 Favored 'General case' 0 C--O 1.243 0.717 0 O-C-N 121.353 -0.842 . . . . 1.7 112.099 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.86 75.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.179 0.807 . . . . 0.44 113.179 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.614 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 15.7 ttp180 -52.6 -32.63 42.43 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 113.4 0.889 . . . . 0.42999999999999999 113.4 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -73.6 -19.6 60.83 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 114.001 1.111 . . . . 2.1899999999999999 114.001 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -90.67 18.24 6.64 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.204 1.002 . . . . 2.2000000000000002 109.49 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.6 t70 46.69 58.55 16.73 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 117.248 2.314 . . . . 0.51000000000000001 117.248 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.413 ' HG3' HD13 ' A' ' 114' ' ' LEU . 44.8 Cg_endo -74.13 168.5 24.66 Favored 'Trans proline' 0 C--O 1.206 -1.1 0 C-N-CA 120.455 0.77 . . . . 0.46999999999999997 110.659 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.4 p -77.05 162.74 27.27 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.613 -1.625 . . . . 0.48999999999999999 106.613 175.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -55.95 -51.55 67.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 112.373 0.509 . . . . 0.42999999999999999 112.373 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.51 -37.73 76.21 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 112.924 0.712 . . . . 0.51000000000000001 112.924 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -62.8 -46.87 85.94 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.416 -0.356 . . . . 0.54000000000000004 110.156 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.413 HD13 ' HG3' ' A' ' 109' ' ' PRO . 15.0 tp -64.26 -45.97 85.78 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 121.087 -0.245 . . . . 0.40999999999999998 111.235 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.91 -48.3 81.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.583 -0.447 . . . . 0.37 110.478 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.83 -44.31 94.1 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.202 0.525 . . . . 0.45000000000000001 112.338 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.34 -42.93 99.79 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 122.071 -0.393 . . . . 0.44 111.009 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.06 94.48 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 119.748 -0.781 . . . . 0.34999999999999998 112.096 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.65 -46.26 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.83 -0.433 . . . . 0.38 109.83 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -63.65 -45.29 90.84 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.678 0.992 . . . . 0.52000000000000002 113.678 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.2 p -71.42 -32.35 68.29 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 120.607 -0.437 . . . . 0.40999999999999998 111.867 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.41 -45.58 95.63 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.362 -1.495 . . . . 0.32000000000000001 109.362 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.43 -42.01 65.53 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 112.588 0.588 . . . . 0.46000000000000002 112.588 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.52 -20.32 62.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 119.609 -0.836 . . . . 2.3999999999999999 111.899 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.61 -16.69 76.03 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 124.203 0.939 . . . . 0.37 113.559 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.6 t -88.97 112.98 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 106.193 -1.78 . . . . 0.40000000000000002 106.193 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -156.43 136.92 13.11 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.387 -0.968 . . . . 2.8799999999999999 108.387 -173.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.65 146.67 23.98 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 122.043 0.925 . . . . 0.5 109.996 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.497 HD11 ' CE ' ' A' ' 132' ' ' LYS . 42.3 tp -66.84 -56.86 8.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.314 -0.857 . . . . 0.56999999999999995 111.407 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.5 mttt 62.97 178.54 0.15 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.655 0.741 . . . . 2.7999999999999998 110.518 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.13 146.74 53.15 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.345 -0.983 . . . . 1.1599999999999999 108.345 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.71 ' HD3' HD11 ' C' ' 207' ' ' LEU . 0.2 OUTLIER -113.53 147.66 38.02 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.484 -0.76 . . . . 4.8099999999999996 109.529 -179.148 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.442 ' HG2' HG21 ' C' ' 206' ' ' THR . 19.1 Cg_endo -64.66 148.64 90.36 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.305 2.003 . . . . 2.9500000000000002 112.415 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.633 HG12 HG22 ' C' ' 203' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.014 -0.993 . . . . 3.7400000000000002 109.17 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 2' ' ' THR . . . . . 0.531 ' HB ' ' HG2' ' B' ' 105' ' ' ARG . 77.3 p . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.166 0.508 . . . . 0.37 111.01 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.633 ' O ' ' HD2' ' B' ' 105' ' ' ARG . 47.1 mt -71.25 136.18 26.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 105.791 -1.929 . . . . 0.39000000000000001 105.791 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.99 144.43 36.73 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.387 -0.824 . . . . 0.34000000000000002 110.795 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 44.6 mt -126.23 130.25 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.764 0.826 . . . . 0.28000000000000003 108.981 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 86.4 t -124.42 129.27 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.004 -1.85 . . . . 0.33000000000000002 106.004 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 35.7 mt -109.06 132.27 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 109.548 -0.538 . . . . 0.28999999999999998 109.548 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.52 133.04 6.19 Favored Glycine 0 N--CA 1.462 0.384 0 C-N-CA 120.326 -0.94 . . . . 0.31 111.885 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.739 HG21 ' HB3' ' B' ' 13' ' ' ALA . 15.0 t . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 107.363 -1.347 . . . . 0.35999999999999999 107.363 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 114.863 0.705 . . . . 0.40000000000000002 114.863 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 12' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -123.57 25.67 8.1 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 114.44 1.274 . . . . 0.78000000000000003 114.44 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.739 ' HB3' HG21 ' B' ' 9' ' ' THR . . . -79.03 -27.17 43.15 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 115.216 1.562 . . . . 0.29999999999999999 115.216 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.74 -46.44 74.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.887 0.767 . . . . 0.27000000000000002 112.834 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.79 -40.35 88.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.958 -0.464 . . . . 0.39000000000000001 111.265 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.19 -35.46 73.97 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.056 1.132 . . . . 0.34999999999999998 114.056 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.02 -39.95 95.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.09 -1.448 . . . . 0.20000000000000001 107.09 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 18.6 tp -65.21 -43.39 91.68 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 109.192 -0.67 . . . . 0.25 109.192 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -61.62 -39.11 90.1 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 121.242 0.544 . . . . 0.35999999999999999 111.266 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.9 -47.64 79.77 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-N 115.056 -0.975 . . . . 0.23000000000000001 108.59 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.7 86.26 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.681 -0.808 . . . . 0.23999999999999999 111.49 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.98 -23.21 65.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.014 -0.539 . . . . 2.54 110.755 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.66 -31.87 68.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.689 -1.967 . . . . 2.5899999999999999 105.689 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 45.6 mt -84.75 -38.3 19.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.837 1.051 . . . . 0.34000000000000002 113.837 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 91.3 mt -109.66 -11.98 14.69 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 119.046 2.98 . . . . 0.34999999999999998 119.046 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.83 165.08 31.57 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 105.521 -3.032 . . . . 0.34000000000000002 105.521 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.69 138.99 56.72 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.338 1.066 . . . . 0.41999999999999998 112.687 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -106.06 146.7 29.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.272 -1.785 . . . . 0.29999999999999999 112.963 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -106.37 157.34 17.69 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 114.434 -1.257 . . . . 0.39000000000000001 107.794 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.13 41.3 20.68 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.085 1.142 . . . . 0.34000000000000002 114.085 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 93.7 t -131.08 134.62 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.31 -0.996 . . . . 0.29999999999999999 108.31 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.73 18.91 Favored Glycine 0 N--CA 1.469 0.886 0 N-CA-C 109.82 -1.312 . . . . 0.31 109.82 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.26 157.69 36.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.167 0.983 . . . . 0.39000000000000001 108.953 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.79 159.1 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.577 -0.738 . . . . 0.40999999999999998 110.306 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.36 162.78 15.66 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.713 -0.676 . . . . 0.46999999999999997 109.617 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' B' ' 36' ' ' PHE . 2.3 t80 -134.16 117.56 16.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.888 -1.523 . . . . 0.53000000000000003 106.888 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 95.0 t -108.1 145.42 31.42 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.943 -1.481 . . . . 0.57999999999999996 110.855 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -57.01 136.14 74.96 Favored 'Trans proline' 0 C--N 1.352 0.719 0 N-CA-C 107.949 -1.597 . . . . 0.64000000000000001 107.949 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.48 -25.78 16.61 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.126 -1.19 . . . . 0.68999999999999995 110.126 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.27 157.66 21.48 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.336 0.588 . . . . 0.64000000000000001 110.031 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' B' ' 41' ' ' ASN . 29.5 p-10 -125.06 179.31 5.1 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.372 -0.973 . . . . 2.3199999999999998 108.372 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.13 73.0 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 112.972 0.73 . . . . 0.60999999999999999 112.972 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.77 -36.58 84.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.934 0.873 . . . . 2.8199999999999998 112.163 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 89.4 m -63.9 -47.53 80.25 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 105.987 -1.857 . . . . 0.65000000000000002 105.987 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.74 -37.68 87.52 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 112.979 0.733 . . . . 0.56000000000000005 112.979 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.47 -43.14 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.635 -0.876 . . . . 0.60999999999999999 108.635 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -62.66 -42.72 99.77 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 119.984 -0.686 . . . . 0.65000000000000002 110.825 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.52 -44.42 97.1 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 119.346 -0.942 . . . . 0.53000000000000003 111.47 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -60.89 -45.72 93.5 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 119.986 -0.686 . . . . 0.46999999999999997 109.637 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -60.09 -40.14 88.55 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 113.131 0.789 . . . . 0.56999999999999995 113.131 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.5 -35.61 81.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.434 0.635 . . . . 0.52000000000000002 110.17 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.11 -43.83 70.23 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 119.572 -0.851 . . . . 0.45000000000000001 110.141 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.55 -38.0 79.92 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.261 -0.427 . . . . 0.45000000000000001 112.048 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.27 -26.32 28.39 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.744 0.646 . . . . 0.51000000000000001 112.744 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -95.57 -4.73 44.13 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 113.126 0.787 . . . . 0.47999999999999998 113.126 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 69.4 mt -105.77 157.43 17.45 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.396 0.888 . . . . 0.40999999999999998 113.396 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -89.34 107.99 19.38 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 102.557 -3.127 . . . . 0.41999999999999998 102.557 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 72.9 p -107.09 15.4 25.26 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 124.153 0.908 . . . . 0.45000000000000001 111.064 -177.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 73.0 p -63.95 -34.29 77.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 115.595 1.702 . . . . 0.47999999999999998 115.595 -177.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.87 -9.35 43.61 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.267 0.556 . . . . 0.46999999999999997 112.202 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.74 172.19 13.02 Favored Glycine 0 C--O 1.242 0.642 0 C-N-CA 119.484 -1.341 . . . . 0.42999999999999999 113.383 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.41 130.25 32.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 109.259 -0.645 . . . . 0.40000000000000002 109.259 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp -115.84 113.42 23.34 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.497 1.748 . . . . 0.34999999999999998 108.411 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.78 122.17 33.29 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.491 -1.67 . . . . 0.40999999999999998 106.491 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 83.2 mt -109.52 115.27 29.61 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 104.531 -2.396 . . . . 0.28000000000000003 104.531 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 26.0 m -120.01 163.4 17.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 113.186 0.81 . . . . 0.34000000000000002 113.186 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' B' ' 67' ' ' ASP . 14.8 p-10 -64.9 -54.07 36.53 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 118.069 2.618 . . . . 0.39000000000000001 118.069 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 45.3 p -142.23 151.4 42.06 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.533 1.158 . . . . 0.39000000000000001 112.692 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' TRP . . . . . 0.58 ' HE1' HG11 ' C' ' 211' ' ' VAL . 32.8 t-105 -66.27 134.45 52.67 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.153 -1.385 . . . . 0.59999999999999998 107.818 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.73 -8.14 70.6 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 121.218 3.247 . . . . 0.52000000000000002 121.218 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.2 174.92 55.25 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 119.282 -1.437 . . . . 0.47999999999999998 110.109 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.15 -47.84 98.4 Favored Pre-proline 0 C--N 1.329 -0.291 0 O-C-N 122.017 -0.696 . . . . 1.3100000000000001 112.01 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -53.44 -41.6 71.92 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 118.391 -0.606 . . . . 0.45000000000000001 110.619 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -67.2 -48.37 68.1 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 123.458 0.474 . . . . 0.5 109.845 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -60.05 -42.71 95.08 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.972 1.101 . . . . 2.04 113.972 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.46 85.71 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.242 -0.983 . . . . 0.52000000000000002 111.721 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.05 -38.83 90.25 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 108.618 -0.882 . . . . 0.48999999999999999 108.618 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.684 ' O ' HG13 ' B' ' 82' ' ' VAL . 70.5 m -58.65 -39.89 81.88 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.416 0.524 . . . . 1.3999999999999999 112.416 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.619 ' O ' HG22 ' B' ' 82' ' ' VAL . 34.0 mtt180 -67.2 -29.58 69.28 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 113.042 0.756 . . . . 3.4700000000000002 113.042 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 76.1 mt -77.2 -42.15 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.697 0.629 . . . . 0.55000000000000004 112.697 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' B' ' 87' ' ' TYR . 2.6 m -80.03 -16.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.901 0 N-CA-C 115.465 1.654 . . . . 0.56000000000000005 115.465 -175.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' VAL . . . . . 0.684 HG13 ' O ' ' B' ' 78' ' ' SER . 2.9 m -29.4 -55.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.352 1 N-CA-C 122.096 4.11 . . . . 0.73999999999999999 122.096 -176.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.49 39.3 3.99 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 116.394 -2.122 . . . . 0.71999999999999997 109.601 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.37 133.55 54.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.442 -1.254 . . . . 0.60999999999999999 109.748 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.25 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 106.707 -1.59 . . . . 0.63 106.707 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.68 15.24 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 115.406 1.632 . . . . 0.55000000000000004 115.406 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' TYR . . . . . 0.479 ' HB3' ' HB ' ' B' ' 81' ' ' VAL . 6.1 m-85 -127.45 130.89 50.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 105.506 -2.035 . . . . 0.48999999999999999 105.506 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.6 154.66 41.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.228 -0.589 . . . . 0.48999999999999999 110.357 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.77 128.47 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 106.235 -1.765 . . . . 0.44 106.235 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 34.2 mt -124.14 119.52 56.93 Favored 'Isoleucine or valine' 0 C--O 1.255 1.378 0 N-CA-C 108.245 -1.02 . . . . 0.35999999999999999 108.245 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.46 163.21 19.59 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 114.738 -1.119 . . . . 0.35999999999999999 112.314 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.89 24.49 55.33 Favored Glycine 0 CA--C 1.499 -0.911 0 N-CA-C 114.817 0.687 . . . . 0.28999999999999998 114.817 176.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.85 132.85 6.69 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 N-CA-C 113.461 0.911 . . . . 0.22 113.461 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' A' ' 94' ' ' ASN . 51.2 p30 -141.98 169.48 17.52 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.688 -1.227 . . . . 0.20000000000000001 107.688 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 51.3 mm -60.2 -43.37 93.54 Favored Pre-proline 0 C--O 1.24 0.588 0 N-CA-C 114.491 1.293 . . . . 0.17000000000000001 114.491 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.55 -42.85 56.53 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 117.575 -1.15 . . . . 0.23000000000000001 110.34 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 39.9 ttm -61.72 -48.85 78.86 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 120.377 -0.529 . . . . 0.26000000000000001 109.633 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.46 -48.01 83.62 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 112.822 0.675 . . . . 0.20000000000000001 112.822 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.52 -49.9 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 112.715 0.635 . . . . 0.26000000000000001 112.715 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -63.52 -40.59 97.43 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 120.235 -0.586 . . . . 2.0099999999999998 111.696 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' THR . . . . . . . . . . . . . 53.5 m -66.23 -46.12 78.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.731 -0.668 . . . . 0.28000000000000003 110.892 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.47 -37.79 88.76 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 123.607 0.567 . . . . 0.28999999999999998 110.563 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' MET . . . . . . . . . . . . . 72.6 mtp -66.1 -45.81 79.84 Favored 'General case' 0 C--O 1.242 0.695 0 O-C-N 121.264 -0.897 . . . . 1.76 112.132 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' B' ' 109' ' ' PRO . . . -67.72 -33.81 75.62 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.3 0.852 . . . . 0.38 113.3 -178.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.633 ' HD2' ' O ' ' B' ' 3' ' ' ILE . 15.8 ttp180 -52.56 -32.69 42.16 Favored 'General case' 0 C--O 1.21 -1.013 0 N-CA-C 113.4 0.889 . . . . 0.37 113.4 -178.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.57 -19.59 60.85 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 114.1 1.148 . . . . 2.1299999999999999 114.1 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -90.62 18.15 6.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 122.159 0.981 . . . . 2.27 109.476 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 12.7 t70 46.79 58.47 16.88 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 117.269 2.322 . . . . 0.47999999999999998 117.269 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.42 ' HG3' HD13 ' B' ' 114' ' ' LEU . 44.9 Cg_endo -74.09 168.43 24.82 Favored 'Trans proline' 0 C--O 1.206 -1.109 0 C-N-CA 120.55 0.833 . . . . 0.46999999999999997 110.604 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 54.3 p -77.0 162.78 27.28 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.706 -1.59 . . . . 0.53000000000000003 106.706 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 111' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -55.94 -51.48 67.5 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 112.445 0.535 . . . . 0.47999999999999998 112.445 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -58.67 -37.67 76.51 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 112.897 0.703 . . . . 0.59999999999999998 112.897 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -62.84 -46.77 86.37 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 116.417 -0.356 . . . . 0.56999999999999995 110.141 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.42 HD13 ' HG3' ' B' ' 109' ' ' PRO . 15.1 tp -64.41 -45.86 85.77 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 121.019 -0.272 . . . . 0.42999999999999999 111.191 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 63.5 t -56.88 -48.32 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 O-C-N 121.891 -0.506 . . . . 0.44 110.52 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.25 94.3 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.133 0.492 . . . . 0.48999999999999999 112.326 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 tp -62.4 -42.8 99.71 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 122.125 -0.359 . . . . 0.41999999999999998 110.989 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.29 -45.1 94.51 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 119.798 -0.761 . . . . 0.34999999999999998 112.059 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.61 -46.26 89.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.803 -0.443 . . . . 0.41999999999999998 109.803 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -63.71 -45.22 90.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 113.717 1.006 . . . . 0.52000000000000002 113.717 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 34.6 p -71.44 -32.28 68.16 Favored 'General case' 0 C--O 1.216 -0.681 0 C-N-CA 120.585 -0.446 . . . . 0.35999999999999999 111.987 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.38 -45.74 95.31 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.332 -1.507 . . . . 0.29999999999999999 109.332 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.21 -42.15 66.11 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 112.622 0.601 . . . . 0.47999999999999998 112.622 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.43 -20.27 62.92 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 119.578 -0.849 . . . . 2.4199999999999999 111.964 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.78 -16.6 76.3 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 124.246 0.966 . . . . 0.31 113.511 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 93.7 t -88.99 113.07 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 106.171 -1.789 . . . . 0.34000000000000002 106.171 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -156.45 136.84 13.03 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.409 -0.96 . . . . 2.9500000000000002 108.409 -173.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.6 146.71 23.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.031 0.92 . . . . 0.40000000000000002 109.986 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 129' ' ' LEU . . . . . 0.5 HD11 ' CE ' ' B' ' 132' ' ' LYS . 42.3 tp -66.94 -57.09 7.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.337 -0.847 . . . . 0.45000000000000001 111.37 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 63.01 178.65 0.15 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.646 0.736 . . . . 2.8300000000000001 110.595 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.03 146.61 53.36 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.353 -0.98 . . . . 1.3400000000000001 108.353 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 132' ' ' LYS . . . . . 0.5 ' CE ' HD11 ' B' ' 129' ' ' LEU . 0.2 OUTLIER -113.33 147.94 38.5 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.444 -0.785 . . . . 4.96 109.476 -179.224 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 133' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -64.76 148.7 90.21 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.415 2.076 . . . . 3.1000000000000001 112.368 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.011 -0.995 . . . . 3.8900000000000001 109.12 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 159' ' ' ASN . . . . . 0.559 ' OD1' ' NZ ' ' C' ' 259' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 108.992 -0.744 . . . . 6.3399999999999999 108.992 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 160' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -85.87 25.5 1.1 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.59 -0.893 . . . . 3.8900000000000001 108.59 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 161' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -118.63 -141.88 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.583 -0.895 . . . . 1.72 108.583 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 162' ' ' MET . . . . . 0.594 ' SD ' HG21 ' C' ' 240' ' ' VAL . 0.3 OUTLIER -61.63 156.19 20.55 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.764 -1.21 . . . . 2.0 110.562 -178.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 163' ' ' VAL . . . . . . . . . . . . . 94.9 t -113.11 117.68 56.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.06 -0.719 . . . . 0.63 109.06 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 164' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.73 103.39 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.49 -0.929 . . . . 0.46000000000000002 108.49 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.59 -35.33 80.7 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.211 -1.555 . . . . 0.44 109.211 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 tp -172.04 147.97 2.18 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.771 -1.172 . . . . 0.46999999999999997 111.209 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 167' ' ' ALA . . . . . . . . . . . . . . . -117.69 104.39 10.96 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.048 -0.723 . . . . 0.28999999999999998 109.048 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 168' ' ' ARG . . . . . 0.941 ' NH1' HG12 ' C' ' 178' ' ' VAL . 44.4 ttp180 -106.37 126.09 51.81 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.972 0.891 . . . . 3.1400000000000001 110.835 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 169' ' ' ILE . . . . . . . . . . . . . 82.3 mt -95.5 129.21 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 109.222 -0.659 . . . . 0.34000000000000002 109.222 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 170' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -165.95 117.04 1.04 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.812 -0.755 . . . . 0.48999999999999999 110.327 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 171' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.97 -9.94 11.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.429 -0.794 . . . . 2.3300000000000001 109.759 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 172' ' ' ARG . . . . . . . . . . . . . 12.4 mtt180 -101.71 -5.16 25.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 2.9500000000000002 110.47 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 173' ' ' LEU . . . . . . . . . . . . . 14.5 mt 59.0 -100.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.141 -0.974 . . . . 1.3899999999999999 109.917 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 174' ' ' ILE . . . . . 0.438 HG23 ' CB ' ' C' ' 179' ' ' ALA . 77.7 mt -97.71 121.3 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.026 -1.046 . . . . 0.53000000000000003 108.285 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 175' ' ' HIS . . . . . 0.672 ' CE1' HG21 ' C' ' 178' ' ' VAL . 2.6 p80 -143.19 127.57 17.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.131 -0.98 . . . . 0.65000000000000002 109.426 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 176' ' ' GLY . . . . . . . . . . . . . . . 60.33 -152.63 37.16 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.833 -1.307 . . . . 0.56999999999999995 109.833 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 177' ' ' GLN . . . . . 0.642 ' CG ' HG11 ' A' ' 99' ' ' VAL . 18.9 mp0 -89.36 12.21 16.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.573 -0.957 . . . . 3.2599999999999998 109.332 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 178' ' ' VAL . . . . . 0.941 HG12 ' NH1' ' C' ' 168' ' ' ARG . 48.1 t -61.54 -42.83 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 0.51000000000000001 108.953 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 179' ' ' ALA . . . . . 0.448 ' O ' ' OG1' ' C' ' 183' ' ' THR . . . -73.16 -36.38 66.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.929 -1.107 . . . . 0.53000000000000003 110.187 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 180' ' ' THR . . . . . . . . . . . . . 21.5 m -66.34 -54.42 24.82 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.697 -0.801 . . . . 0.68000000000000005 109.79 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 181' ' ' ARG . . . . . 0.539 ' NH2' ' CG2' ' C' ' 308' ' ' THR . 55.1 ttt-85 -64.7 -43.62 92.88 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.013 -0.675 . . . . 3.1200000000000001 110.608 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 182' ' ' TRP . . . . . 0.533 ' O ' HG23 ' C' ' 186' ' ' THR . 19.5 m95 -65.82 -32.2 73.6 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.034 -1.041 . . . . 0.90000000000000002 109.591 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 183' ' ' THR . . . . . 0.803 HG21 HG21 ' C' ' 216' ' ' VAL . 71.9 m -65.29 -47.1 77.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.946 -1.096 . . . . 0.58999999999999997 110.252 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -69.66 -42.93 73.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 2.2000000000000002 110.806 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 185' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -68.32 -39.61 81.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.95 -1.094 . . . . 2.52 109.569 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 186' ' ' THR . . . . . 0.533 HG23 ' O ' ' C' ' 182' ' ' TRP . 72.6 p -81.42 -1.26 45.03 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.282 -0.886 . . . . 0.58999999999999997 109.685 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 187' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 52.14 48.42 22.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.055 -1.028 . . . . 2.1000000000000001 108.604 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 188' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.05 133.46 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.164 -0.96 . . . . 1.3700000000000001 110.122 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 189' ' ' SER . . . . . . . . . . . . . 27.8 p -109.75 -6.33 15.32 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.761 -0.829 . . . . 1.3999999999999999 108.761 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 190' ' ' ARG . . . . . . . . . . . . . 29.4 mtt-85 -135.92 142.83 44.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.555 -0.716 . . . . 3.52 110.441 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 191' ' ' ILE . . . . . . . . . . . . . 87.6 mt -133.38 127.61 54.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.173 -1.047 . . . . 0.51000000000000001 108.173 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 192' ' ' ILE . . . . . 0.455 HD12 HG11 ' C' ' 240' ' ' VAL . 97.1 mt -115.66 128.68 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.257 -0.902 . . . . 0.46000000000000002 109.665 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 193' ' ' VAL . . . . . . . . . . . . . 53.3 t -99.7 128.88 51.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.825 -0.806 . . . . 0.70999999999999996 108.825 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 194' ' ' VAL . . . . . . . . . . . . . 43.0 t -112.51 103.57 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.535 -0.728 . . . . 0.42999999999999999 109.479 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 195' ' ' SER . . . . . . . . . . . . . 38.0 t -167.25 125.61 1.31 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.342 -0.943 . . . . 1.3799999999999999 109.31 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 196' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.01 -34.88 66.65 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.574 -0.704 . . . . 0.97999999999999998 109.984 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 197' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -65.55 -45.49 83.21 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.147 -0.971 . . . . 2.3199999999999998 109.959 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 198' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.11 -43.21 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.102 -0.998 . . . . 0.70999999999999996 109.028 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.6 -26.5 55.72 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.79 -0.764 . . . . 0.73999999999999999 109.168 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 200' ' ' ALA . . . . . . . . . . . . . . . -84.9 -5.38 59.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.028 -1.045 . . . . 0.89000000000000001 109.882 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 201' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -102.75 95.38 6.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.9 -1.125 . . . . 1.1499999999999999 109.554 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 202' ' ' THR . . . . . . . . . . . . . 24.7 p -66.22 -33.21 75.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.407 -0.808 . . . . 1.6100000000000001 110.631 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 203' ' ' VAL . . . . . 0.633 HG22 HG12 ' A' ' 134' ' ' VAL . 55.8 t -66.33 -47.49 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.851 -1.156 . . . . 0.90000000000000002 109.598 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 204' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -63.69 -42.24 98.04 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.349 -0.94 . . . . 3.0699999999999998 109.576 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 205' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -58.01 -42.42 85.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 1.72 109.482 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 206' ' ' THR . . . . . 0.442 HG21 ' HG2' ' A' ' 133' ' ' PRO . 73.2 m -60.63 -48.71 80.55 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.088 -1.045 . . . . 0.92000000000000004 109.564 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 207' ' ' LEU . . . . . 0.71 HD11 ' HD3' ' A' ' 132' ' ' LYS . 30.6 mt -62.62 -44.45 96.26 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.934 -1.107 . . . . 0.81999999999999995 110.736 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 208' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' C' ' 208' ' ' LEU . 81.6 mt -62.5 -41.45 98.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.718 -1.239 . . . . 0.72999999999999998 110.055 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 209' ' ' THR . . . . . . . . . . . . . 35.8 p -67.89 -31.83 71.89 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.371 -0.831 . . . . 0.83999999999999997 110.28 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 210' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -80.37 -17.54 51.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.782 -1.199 . . . . 2.3199999999999998 110.857 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 211' ' ' VAL . . . . . 0.58 HG11 ' HE1' ' B' ' 69' ' ' TRP . 17.5 m -107.69 17.65 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.952 -1.092 . . . . 0.93000000000000005 108.639 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.29 123.42 82.48 Favored Pre-proline 0 N--CA 1.483 1.221 0 N-CA-C 107.82 -1.178 . . . . 0.76000000000000001 107.82 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 213' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -44.31 144.48 2.95 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.037 1.825 . . . . 0.93000000000000005 112.731 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 214' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -56.52 134.85 66.98 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.196 1.931 . . . . 1.1399999999999999 112.028 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 215' ' ' GLY . . . . . . . . . . . . . . . 79.91 -8.52 50.03 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.922 -1.271 . . . . 0.84999999999999998 109.922 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 216' ' ' VAL . . . . . 0.803 HG21 HG21 ' C' ' 183' ' ' THR . 58.6 t -114.8 136.78 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -1.076 . . . . 0.92000000000000004 108.8 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.87 135.77 45.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.438 -0.789 . . . . 1.4199999999999999 109.836 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 218' ' ' ALA . . . . . . . . . . . . . . . -110.17 131.37 55.12 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.315 -0.994 . . . . 0.64000000000000001 108.315 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -120.97 153.51 37.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.401 -0.812 . . . . 0.71999999999999997 109.808 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 54.8 t -126.35 117.83 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.624 0.726 . . . . 0.59999999999999998 109.07 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 31.7 m -141.01 165.14 19.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.412 -0.805 . . . . 0.56999999999999995 109.622 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 222' ' ' ASP . . . . . 0.709 ' OD1' ' N ' ' C' ' 225' ' ' LYS . 6.8 p30 -94.18 167.23 11.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.479 -0.763 . . . . 1.3400000000000001 109.305 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.46 -44.82 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.151 -0.968 . . . . 0.54000000000000004 110.455 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 224' ' ' ALA . . . . . 0.852 ' O ' HG22 ' C' ' 227' ' ' ILE . . . -62.72 -44.73 95.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.934 -1.104 . . . . 0.67000000000000004 109.398 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 225' ' ' LYS . . . . . 0.709 ' N ' ' OD1' ' C' ' 222' ' ' ASP . 45.7 tttm -68.14 -35.35 77.95 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.775 -1.203 . . . . 2.1099999999999999 109.674 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 226' ' ' MET . . . . . . . . . . . . . 10.3 tpt -62.08 -40.4 95.71 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.934 -1.104 . . . . 1.54 111.191 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 227' ' ' ILE . . . . . 0.852 HG22 ' O ' ' C' ' 224' ' ' ALA . 17.4 tt -60.9 -34.56 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.611 -0.885 . . . . 0.68999999999999995 108.611 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.47 -38.86 62.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.722 -0.611 . . . . 4.0099999999999998 110.948 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 70.3 t -62.18 -41.73 92.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.864 -1.162 . . . . 0.63 107.864 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 230' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' C' ' 230' ' ' TYR . 36.7 t80 -67.04 -32.13 73.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.102 -0.999 . . . . 0.64000000000000001 109.927 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 231' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.76 6.73 2.34 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.119 -0.988 . . . . 0.94999999999999996 110.104 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 232' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -110.18 117.78 50.87 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.246 -0.909 . . . . 0.93000000000000005 109.435 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 233' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -65.73 1.51 2.19 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.646 1.564 . . . . 0.98999999999999999 111.98 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 234' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.36 -24.76 65.33 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 1.5900000000000001 108.807 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 235' ' ' TYR . . . . . 0.501 ' O ' ' HB2' ' C' ' 238' ' ' GLU . 81.1 m-85 -105.49 15.71 26.66 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.594 -0.842 . . . . 1.1899999999999999 109.003 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.81 135.62 47.44 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.076 -1.64 . . . . 0.67000000000000004 109.65 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.78 -33.41 1.9 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.288 -1.525 . . . . 0.64000000000000001 109.288 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 238' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' C' ' 235' ' ' TYR . 4.0 mm-40 -54.25 138.93 37.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.805 -1.409 . . . . 2.48 109.437 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 239' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -99.1 116.33 31.08 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.463 -0.939 . . . . 2.96 108.463 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 240' ' ' VAL . . . . . 0.594 HG21 ' SD ' ' C' ' 162' ' ' MET . 26.3 t -121.85 148.78 25.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.876 0.846 . . . . 0.66000000000000003 110.448 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 241' ' ' MET . . . . . . . . . . . . . 13.8 ttm -102.9 134.95 45.47 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.925 -1.139 . . . . 1.6299999999999999 107.925 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 242' ' ' LEU . . . . . 0.402 ' HB3' ' CE2' ' C' ' 244' ' ' PHE . 61.2 mt -102.04 127.28 49.0 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.689 -0.804 . . . . 0.34999999999999998 109.877 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 243' ' ' LEU . . . . . . . . . . . . . 97.6 mt -109.5 126.08 53.15 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.981 0.896 . . . . 0.68000000000000005 109.045 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 244' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' C' ' 242' ' ' LEU . 77.7 m-85 -127.0 162.03 26.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.771 0.796 . . . . 0.29999999999999999 109.275 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 245' ' ' THR . . . . . . . . . . . . . 70.2 p -109.48 -19.47 13.23 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.958 -0.756 . . . . 0.42999999999999999 108.958 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 246' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' C' ' 246' ' ' ASN . 17.3 p30 -151.08 141.85 14.91 Favored Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 120.003 -0.679 . . . . 1.0 109.872 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 247' ' ' PRO . . . . . 0.451 ' HG3' ' CE2' ' C' ' 291' ' ' PHE . 7.3 Cg_endo -60.85 -14.63 33.4 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.683 2.255 . . . . 0.58999999999999997 112.1 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 248' ' ' THR . . . . . . . . . . . . . 95.7 m -64.99 -42.66 94.31 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.151 0.976 . . . . 0.64000000000000001 108.624 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 249' ' ' ASP . . . . . 0.42 ' O ' HD12 ' C' ' 253' ' ' LEU . 97.8 m-20 -67.48 -23.4 65.48 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.54 -0.725 . . . . 0.53000000000000003 109.801 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 250' ' ' VAL . . . . . . . . . . . . . 98.3 t -73.62 -43.77 54.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.672 -1.267 . . . . 0.40000000000000002 109.848 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 251' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.41 -35.02 77.92 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.426 -0.953 . . . . 1.51 108.426 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 252' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -62.48 -44.09 97.23 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.723 -0.791 . . . . 3.2400000000000002 110.156 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 253' ' ' LEU . . . . . 0.42 HD12 ' O ' ' C' ' 249' ' ' ASP . 1.2 mp -64.07 -40.42 96.22 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 117.999 -1.48 . . . . 1.0600000000000001 108.876 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 254' ' ' VAL . . . . . 0.57 ' CG2' HD12 ' C' ' 260' ' ' ILE . 70.6 t -60.7 -44.61 97.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 120.835 -1.165 . . . . 0.47999999999999998 108.948 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 255' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.23 -30.97 69.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.018 -1.052 . . . . 2.4700000000000002 109.917 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 256' ' ' GLY . . . . . . . . . . . . . . . -74.28 2.8 43.16 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.498 -1.441 . . . . 0.55000000000000004 109.498 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 257' ' ' GLY . . . . . . . . . . . . . . . 94.37 15.79 45.94 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.627 -1.389 . . . . 0.51000000000000001 109.627 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 258' ' ' VAL . . . . . . . . . . . . . 96.7 t -77.66 139.72 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.034 -1.469 . . . . 0.45000000000000001 107.034 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 259' ' ' LYS . . . . . 0.559 ' NZ ' ' OD1' ' C' ' 159' ' ' ASN . 17.9 tttt -99.01 123.93 43.64 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.089 -1.007 . . . . 3.1200000000000001 110.811 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 260' ' ' ILE . . . . . 0.57 HD12 ' CG2' ' C' ' 254' ' ' VAL . 98.1 mt -129.99 125.67 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.43 -0.794 . . . . 0.40999999999999998 109.147 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 65.9 p -89.51 -31.44 17.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.776 -1.202 . . . . 0.56999999999999995 110.238 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 262' ' ' SER . . . . . . . . . . . . . 15.8 m -159.06 153.51 24.15 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.176 -0.953 . . . . 0.46000000000000002 110.092 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 263' ' ' VAL . . . . . . . . . . . . . 50.9 t -122.74 134.61 65.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.538 -0.912 . . . . 0.37 108.538 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 264' ' ' ASN . . . . . 0.468 ' ND2' ' CH2' ' C' ' 182' ' ' TRP . 33.7 t30 -108.57 128.08 54.51 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.517 0.675 . . . . 1.1699999999999999 110.607 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 265' ' ' VAL . . . . . 0.451 HG21 ' SD ' ' C' ' 314' ' ' MET . 3.2 t -90.64 108.43 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 120.058 -0.657 . . . . 0.40000000000000002 109.68 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 266' ' ' GLY . . . . . . . . . . . . . . . -80.75 -53.94 3.84 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.153 -1.179 . . . . 0.40999999999999998 110.153 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . -172.57 152.93 17.73 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.646 -1.74 . . . . 0.40999999999999998 111.476 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 268' ' ' MET . . . . . 0.44 ' HB2' ' H ' ' C' ' 282' ' ' SER . 97.0 mtp -143.1 118.08 10.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.481 -1.011 . . . . 0.5 110.443 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.34 128.21 21.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.371 -0.831 . . . . 0.56999999999999995 109.523 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 270' ' ' PHE . . . . . 0.536 ' CG ' ' N ' ' C' ' 271' ' ' ARG . 13.3 t80 -69.5 161.8 28.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.92000000000000004 109.618 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 271' ' ' ARG . . . . . 0.536 ' N ' ' CG ' ' C' ' 270' ' ' PHE . 32.7 ttm180 -160.66 158.67 29.24 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.27 -0.972 . . . . 3.23 109.676 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 272' ' ' GLN . . . . . 0.4 ' N ' ' HG2' ' C' ' 271' ' ' ARG . 73.9 mt-30 -66.48 138.25 57.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.081 -1.012 . . . . 2.98 110.459 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 273' ' ' GLY . . . . . . . . . . . . . . . 95.52 -12.32 67.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.818 -1.713 . . . . 0.87 108.818 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 274' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -101.81 163.37 12.29 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.484 -1.01 . . . . 1.6599999999999999 109.388 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 275' ' ' THR . . . . . 0.561 HG21 HG21 ' C' ' 321' ' ' ILE . 20.8 m -109.95 135.83 50.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.674 -0.862 . . . . 0.83999999999999997 108.674 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 276' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -82.02 119.21 23.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.246 -0.909 . . . . 2.77 110.176 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 277' ' ' VAL . . . . . 0.519 HG12 ' CD1' ' C' ' 321' ' ' ILE . 27.5 m -99.22 -28.18 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.81 -0.756 . . . . 0.73999999999999999 109.612 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 278' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' C' ' 279' ' ' ASN . 10.2 t-20 -135.99 -177.16 4.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.658 0.742 . . . . 1.52 109.761 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 279' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' C' ' 278' ' ' ASN . 39.5 m-20 -56.93 -29.88 63.5 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.791 -0.568 . . . . 2.29 110.787 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . -148.06 27.01 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.829 -1.169 . . . . 0.59999999999999998 109.538 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 281' ' ' VAL . . . . . 0.498 ' O ' HG22 ' C' ' 277' ' ' VAL . 60.8 t -118.99 121.98 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.825 0.822 . . . . 0.60999999999999999 109.678 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 282' ' ' SER . . . . . 0.44 ' H ' ' HB2' ' C' ' 268' ' ' MET . 29.0 m -118.64 147.61 43.58 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.447 0.642 . . . . 0.75 110.02 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 283' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.26 142.84 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.446 1.117 . . . . 0.69999999999999996 110.539 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 284' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' C' ' 287' ' ' ASP . 44.1 p-10 -110.61 171.67 7.33 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 106.923 -1.51 . . . . 0.77000000000000002 106.923 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 285' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.18 -24.21 40.12 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.833 -1.167 . . . . 2.3399999999999999 109.587 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 286' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -79.59 -43.46 22.89 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.233 -0.917 . . . . 2.0 110.026 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 287' ' ' ASP . . . . . 0.57 ' N ' ' OD1' ' C' ' 284' ' ' ASP . 93.3 m-20 -64.25 -42.08 96.67 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.237 -0.915 . . . . 0.62 109.096 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 288' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.48 -45.77 97.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.387 -0.821 . . . . 0.72999999999999998 109.518 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 289' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -57.44 -39.6 76.6 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.216 -0.928 . . . . 2.52 110.262 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.37 -41.01 85.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.82 -1.175 . . . . 0.59999999999999998 109.9 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 291' ' ' PHE . . . . . 0.451 ' CE2' ' HG3' ' C' ' 247' ' ' PRO . 40.0 m-85 -63.93 -39.02 93.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.56999999999999995 109.73 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 292' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -64.08 -39.5 94.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.149 -0.969 . . . . 2.0499999999999998 110.226 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 293' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -65.78 -41.54 91.86 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.943 -1.098 . . . . 1.8 109.635 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 294' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.18 -43.22 99.32 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.871 -1.143 . . . . 0.53000000000000003 108.867 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 295' ' ' ASN . . . . . 0.849 ' C ' HD21 ' C' ' 295' ' ' ASN . 0.1 OUTLIER -64.01 -40.01 95.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 1.45 109.953 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.66 -21.38 65.67 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.815 -1.178 . . . . 0.68999999999999995 109.242 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 297' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -90.13 8.85 30.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.769 -1.207 . . . . 2.4900000000000002 109.91 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.44 11.43 82.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.903 -1.279 . . . . 0.59999999999999998 109.903 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 299' ' ' ILE . . . . . . . . . . . . . 97.8 mt -84.71 134.56 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.974 -1.309 . . . . 0.53000000000000003 109.151 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 300' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -82.0 141.66 33.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.869 . . . . 2.2999999999999998 110.615 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 301' ' ' LEU . . . . . . . . . . . . . 66.9 mt -123.08 111.27 16.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.269 -0.641 . . . . 0.54000000000000004 109.269 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 302' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.57 139.87 49.69 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.9 . . . . 2.2599999999999998 110.289 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 303' ' ' VAL . . . . . 0.611 ' CG2' ' SD ' ' C' ' 314' ' ' MET . 51.8 t -111.99 124.77 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.673 -0.862 . . . . 0.55000000000000004 108.673 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 304' ' ' ARG . . . . . 0.459 ' HE ' ' CG ' ' C' ' 264' ' ' ASN . 33.4 ptt180 -164.93 137.87 4.64 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.505 -0.878 . . . . 2.7000000000000002 110.343 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 305' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -80.82 -45.42 16.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 3.1899999999999999 109.817 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 306' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.33 154.01 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.106 -0.996 . . . . 0.65000000000000002 108.737 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 307' ' ' SER . . . . . . . . . . . . . 83.5 p -64.55 -16.29 62.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.983 -1.073 . . . . 1.3600000000000001 109.516 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 308' ' ' THR . . . . . 0.539 ' CG2' ' NH2' ' C' ' 181' ' ' ARG . 44.5 p -86.14 -9.07 57.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.047 -1.033 . . . . 0.84999999999999998 110.005 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 309' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -92.49 152.69 42.35 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.025 -1.047 . . . . 0.81000000000000005 109.936 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 310' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -55.37 139.15 81.42 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.968 1.779 . . . . 0.93000000000000005 111.755 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 311' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -84.24 132.82 34.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 3.0899999999999999 109.823 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 312' ' ' LEU . . . . . . . . . . . . . 80.2 mt -117.51 154.74 30.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.103 -0.998 . . . . 0.72999999999999998 108.309 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 313' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -91.26 130.49 37.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.076 -1.015 . . . . 2.2400000000000002 109.827 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 314' ' ' MET . . . . . 0.611 ' SD ' ' CG2' ' C' ' 303' ' ' VAL . 8.2 tpt -56.39 -44.17 79.97 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.67 -0.644 . . . . 1.03 109.63 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 315' ' ' MET . . . . . . . . . . . . . 95.9 mmm -61.18 -40.39 93.73 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.299 -0.876 . . . . 1.71 110.22 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 316' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.9 -44.0 97.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.319 -0.863 . . . . 0.81999999999999995 109.81 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 317' ' ' LEU . . . . . . . . . . . . . 92.8 mt -66.49 -41.98 88.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.877 . . . . 0.80000000000000004 110.036 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 318' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.26 -24.49 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.311 -0.868 . . . . 0.85999999999999999 109.957 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 319' ' ' SER . . . . . 0.475 ' O ' ' C ' ' C' ' 323' ' ' LYS . 0.9 OUTLIER -72.72 -31.56 65.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.084 -1.01 . . . . 1.52 109.518 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 320' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -84.19 -2.45 56.9 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.78 -1.168 . . . . 2.04 109.167 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 321' ' ' ILE . . . . . 0.561 HG21 HG21 ' C' ' 275' ' ' THR . 93.2 mt -113.76 -58.74 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.914 -1.143 . . . . 1.1699999999999999 107.914 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 322' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' C' ' 323' ' ' LYS . 12.3 t0 -95.01 85.11 4.26 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.16 -1.792 . . . . 2.2599999999999998 106.16 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 323' ' ' LYS . . . . . 1.262 ' HA ' ' NZ ' ' C' ' 323' ' ' LYS . 0.0 OUTLIER . . . . . 1 C--O 1.524 15.537 0 CA-C-O 126.309 2.957 . . . . 5.9199999999999999 109.465 -177.693 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.548 ' HB ' ' HG2' ' A' ' 105' ' ' ARG . 76.6 p . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 121.106 0.479 . . . . 0.44 111.038 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.614 ' O ' ' HD2' ' A' ' 105' ' ' ARG . 47.0 mt -71.24 136.2 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.736 -1.95 . . . . 0.38 105.736 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.98 144.42 36.76 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 115.292 -0.867 . . . . 0.34999999999999998 110.744 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.3 mt -126.27 130.14 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.825 0.85 . . . . 0.31 109.053 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.29 129.28 74.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.035 -1.839 . . . . 0.32000000000000001 106.035 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 mt -109.11 131.73 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.445 -0.576 . . . . 0.26000000000000001 109.445 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.75 135.83 7.43 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.791 -1.324 . . . . 0.23999999999999999 109.791 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 13' ' ' ALA . 8.2 t . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.025 -1.28 . . . . 0.26000000000000001 109.592 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.553 0 N-CA-C 110.02 -1.232 . . . . 0.31 110.02 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -130.69 32.1 4.43 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.233 -1.157 . . . . 0.78000000000000003 110.447 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.521 ' HB3' HG21 ' A' ' 9' ' ' THR . . . -75.51 -27.27 58.68 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 115.277 1.584 . . . . 0.25 115.277 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.7 -46.48 74.15 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.827 0.74 . . . . 0.26000000000000001 112.799 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -59.79 -40.39 88.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.593 -0.443 . . . . 0.44 111.224 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.31 -35.22 73.53 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.105 1.15 . . . . 0.38 114.105 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.05 -39.99 95.3 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.139 -1.43 . . . . 0.27000000000000002 107.139 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.13 -43.47 91.81 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.149 -0.685 . . . . 0.34000000000000002 109.149 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -61.56 -39.18 90.2 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.242 0.544 . . . . 0.44 111.234 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.96 -47.64 79.64 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 115.048 -0.978 . . . . 0.37 108.609 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.71 86.11 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 119.754 -0.778 . . . . 0.39000000000000001 111.465 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.96 -23.34 65.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.103 -0.499 . . . . 2.5 110.692 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.47 -32.01 69.39 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 105.703 -1.962 . . . . 2.5899999999999999 105.703 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.8 mt -84.74 -38.38 19.74 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 113.817 1.043 . . . . 0.48999999999999999 113.817 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -109.6 -12.03 14.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 119.025 2.972 . . . . 0.5 119.025 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.98 165.07 31.38 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 105.457 -3.057 . . . . 0.51000000000000001 105.457 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -58.82 138.97 56.96 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 122.41 1.1 . . . . 0.57999999999999996 112.611 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -105.91 146.75 29.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.264 -1.789 . . . . 0.45000000000000001 113.038 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -106.46 157.34 17.72 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.497 -1.229 . . . . 0.54000000000000004 107.816 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.25 41.22 20.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.096 1.147 . . . . 0.41999999999999998 114.096 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.8 t -131.09 134.53 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.381 -0.97 . . . . 0.38 108.381 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.66 18.93 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 109.899 -1.28 . . . . 0.34999999999999998 109.899 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.22 157.76 36.4 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 118.203 1.001 . . . . 0.40999999999999998 108.921 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.84 159.15 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.453 -0.794 . . . . 0.35999999999999999 110.29 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -113.46 162.85 15.63 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.757 -0.656 . . . . 0.41999999999999998 109.592 173.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 36' ' ' PHE . 1.9 t80 -134.19 117.5 16.57 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.886 -1.524 . . . . 0.40999999999999998 106.886 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.6 t -108.11 145.44 31.45 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 113.92 -1.491 . . . . 0.48999999999999999 110.848 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -57.06 136.08 74.54 Favored 'Trans proline' 0 C--N 1.352 0.752 0 N-CA-C 107.929 -1.604 . . . . 0.53000000000000003 107.929 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.55 -25.75 16.55 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.065 -1.214 . . . . 0.57999999999999996 110.065 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.34 157.66 21.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.373 0.606 . . . . 0.52000000000000002 110.009 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -125.08 179.29 5.11 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.343 -0.984 . . . . 2.23 108.343 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.19 72.97 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 113.003 0.742 . . . . 0.48999999999999999 113.003 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.86 -36.45 84.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.84 0.828 . . . . 2.8300000000000001 112.164 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.5 m -63.92 -47.58 79.99 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 106.01 -1.848 . . . . 0.56000000000000005 106.01 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.71 -37.48 86.7 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.108 0.781 . . . . 0.46999999999999997 113.108 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.1 mt -58.59 -43.15 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.587 -0.894 . . . . 0.5 108.587 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -62.58 -42.73 99.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.966 -0.694 . . . . 0.58999999999999997 110.875 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -61.58 -44.34 97.21 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 119.347 -0.941 . . . . 0.47999999999999998 111.34 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -61.02 -45.65 93.96 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 120.015 -0.674 . . . . 0.41999999999999998 109.595 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -60.15 -40.04 88.44 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 113.158 0.799 . . . . 0.51000000000000001 113.158 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.58 -35.64 81.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.449 0.643 . . . . 0.52000000000000002 110.135 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.17 -43.61 70.47 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 119.578 -0.849 . . . . 0.45000000000000001 110.205 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.73 -37.92 80.28 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.281 -0.418 . . . . 0.45000000000000001 112.041 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.31 -26.36 29.07 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.699 0.629 . . . . 0.53000000000000003 112.699 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -95.49 -4.75 44.35 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.224 0.824 . . . . 0.53000000000000003 113.224 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 69.8 mt -105.85 157.54 17.4 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 113.313 0.857 . . . . 0.46000000000000002 113.313 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -89.34 107.94 19.35 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 102.541 -3.133 . . . . 0.46999999999999997 102.541 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.9 p -106.98 15.38 25.39 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 124.097 0.873 . . . . 0.44 111.05 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.3 p -64.03 -34.27 77.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 115.553 1.686 . . . . 0.48999999999999999 115.553 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.77 -9.39 43.79 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.274 0.559 . . . . 0.48999999999999999 112.271 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.71 172.22 13.03 Favored Glycine 0 C--O 1.242 0.598 0 C-N-CA 119.486 -1.34 . . . . 0.40000000000000002 113.406 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.3 t -139.47 130.17 32.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 N-CA-C 109.273 -0.639 . . . . 0.35999999999999999 109.273 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.8 tp -115.86 113.37 23.26 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.549 1.781 . . . . 0.29999999999999999 108.446 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.68 122.19 33.23 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 106.507 -1.664 . . . . 0.34000000000000002 106.507 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.0 mt -109.55 115.25 29.56 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 104.519 -2.4 . . . . 0.22 104.519 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.4 m -119.93 163.31 17.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 113.221 0.823 . . . . 0.23000000000000001 113.221 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 14.3 p-10 -64.94 -54.05 36.8 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 118.031 2.604 . . . . 0.27000000000000002 118.031 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -142.23 151.41 42.09 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 122.541 1.163 . . . . 0.26000000000000001 112.693 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -66.32 134.47 52.67 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.178 -1.374 . . . . 0.45000000000000001 107.857 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.72 -8.14 70.59 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 121.281 3.272 . . . . 0.38 121.281 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.23 174.9 55.24 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 119.341 -1.409 . . . . 0.34000000000000002 110.065 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.18 -47.77 98.5 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 122.089 -0.653 . . . . 1.24 112.057 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -53.5 -41.56 72.46 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 118.293 -0.671 . . . . 0.32000000000000001 110.604 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -67.28 -48.26 68.2 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 123.506 0.504 . . . . 0.37 109.865 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -60.1 -42.71 95.24 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.945 1.091 . . . . 1.99 113.945 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.6 85.57 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.388 -0.925 . . . . 0.40999999999999998 111.675 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.83 89.97 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.7 -0.852 . . . . 0.38 108.7 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.685 ' O ' HG13 ' A' ' 82' ' ' VAL . 70.3 m -58.72 -39.82 81.96 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.423 0.527 . . . . 1.3799999999999999 112.423 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.611 ' O ' HG22 ' A' ' 82' ' ' VAL . 33.8 mtt180 -67.31 -29.55 69.15 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 112.957 0.725 . . . . 3.3799999999999999 112.957 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.408 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 76.5 mt -77.15 -42.18 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.755 0.65 . . . . 0.45000000000000001 112.755 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 87' ' ' TYR . 2.6 m -80.15 -16.72 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 115.456 1.65 . . . . 0.45000000000000001 115.456 -175.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 78' ' ' SER . 2.9 m -29.31 -55.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 1 N-CA-C 122.123 4.12 . . . . 0.62 122.123 -177.007 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.55 39.4 3.97 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 116.387 -2.125 . . . . 0.58999999999999997 109.525 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -112.33 133.55 54.37 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 114.505 -1.225 . . . . 0.48999999999999999 109.745 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.23 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 106.732 -1.581 . . . . 0.52000000000000002 106.732 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.67 15.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 115.395 1.628 . . . . 0.46999999999999997 115.395 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.477 ' HB3' ' HB ' ' A' ' 81' ' ' VAL . 6.1 m-85 -127.47 130.92 50.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.538 -2.023 . . . . 0.41999999999999998 105.538 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.59 154.67 41.76 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.29 -0.564 . . . . 0.39000000000000001 110.311 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 t -121.69 128.48 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 106.315 -1.735 . . . . 0.33000000000000002 106.315 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.3 mt -124.16 119.51 56.87 Favored 'Isoleucine or valine' 0 C--O 1.256 1.405 0 N-CA-C 108.258 -1.016 . . . . 0.28999999999999998 108.258 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.4 163.29 19.6 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 114.674 -1.148 . . . . 0.25 112.388 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.71 24.62 55.53 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 114.821 0.688 . . . . 0.19 114.821 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.82 132.73 6.61 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 N-CA-C 113.483 0.92 . . . . 0.16 113.483 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' B' ' 94' ' ' ASN . 50.9 p30 -141.88 169.61 17.28 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.65 -1.241 . . . . 0.23999999999999999 107.65 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 95' ' ' ILE . 50.4 mm -60.22 -43.37 93.47 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 114.522 1.304 . . . . 0.28999999999999998 114.522 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.55 -42.94 55.52 Favored 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 117.584 -1.144 . . . . 0.31 110.343 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 39.8 ttm -61.56 -48.93 78.75 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 120.348 -0.541 . . . . 0.28000000000000003 109.704 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.44 -48.05 83.43 Favored 'General case' 0 C--O 1.201 -1.487 0 N-CA-C 112.784 0.661 . . . . 0.29999999999999999 112.784 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.642 HG11 ' CG ' ' C' ' 177' ' ' GLN . 84.7 t -61.51 -49.8 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 112.729 0.641 . . . . 0.41999999999999998 112.729 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -63.67 -40.51 97.01 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.253 -0.579 . . . . 2.04 111.671 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.3 m -66.24 -46.09 78.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.34999999999999998 110.89 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.5 -37.84 88.93 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 123.537 0.523 . . . . 0.40000000000000002 110.571 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 69.8 mtp -66.12 -45.74 80.0 Favored 'General case' 0 C--O 1.243 0.717 0 O-C-N 121.353 -0.842 . . . . 1.7 112.099 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.86 75.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.179 0.807 . . . . 0.44 113.179 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.614 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 15.7 ttp180 -52.6 -32.63 42.43 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 113.4 0.889 . . . . 0.42999999999999999 113.4 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -73.6 -19.6 60.83 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 114.001 1.111 . . . . 2.1899999999999999 114.001 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -90.67 18.24 6.64 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.204 1.002 . . . . 2.2000000000000002 109.49 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.6 t70 46.69 58.55 16.73 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 117.248 2.314 . . . . 0.51000000000000001 117.248 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.413 ' HG3' HD13 ' A' ' 114' ' ' LEU . 44.8 Cg_endo -74.13 168.5 24.66 Favored 'Trans proline' 0 C--O 1.206 -1.1 0 C-N-CA 120.455 0.77 . . . . 0.46999999999999997 110.659 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.4 p -77.05 162.74 27.27 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.613 -1.625 . . . . 0.48999999999999999 106.613 175.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -55.95 -51.55 67.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 112.373 0.509 . . . . 0.42999999999999999 112.373 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.51 -37.73 76.21 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 112.924 0.712 . . . . 0.51000000000000001 112.924 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -62.8 -46.87 85.94 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.416 -0.356 . . . . 0.54000000000000004 110.156 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.413 HD13 ' HG3' ' A' ' 109' ' ' PRO . 15.0 tp -64.26 -45.97 85.78 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 121.087 -0.245 . . . . 0.40999999999999998 111.235 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.91 -48.3 81.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.583 -0.447 . . . . 0.37 110.478 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.83 -44.31 94.1 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.202 0.525 . . . . 0.45000000000000001 112.338 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.34 -42.93 99.79 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 122.071 -0.393 . . . . 0.44 111.009 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.06 94.48 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 119.748 -0.781 . . . . 0.34999999999999998 112.096 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.65 -46.26 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.83 -0.433 . . . . 0.38 109.83 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -63.65 -45.29 90.84 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.678 0.992 . . . . 0.52000000000000002 113.678 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.2 p -71.42 -32.35 68.29 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 120.607 -0.437 . . . . 0.40999999999999998 111.867 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.41 -45.58 95.63 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.362 -1.495 . . . . 0.32000000000000001 109.362 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.43 -42.01 65.53 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 112.588 0.588 . . . . 0.46000000000000002 112.588 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.52 -20.32 62.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 119.609 -0.836 . . . . 2.3999999999999999 111.899 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.61 -16.69 76.03 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 124.203 0.939 . . . . 0.37 113.559 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.6 t -88.97 112.98 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 106.193 -1.78 . . . . 0.40000000000000002 106.193 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -156.43 136.92 13.11 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.387 -0.968 . . . . 2.8799999999999999 108.387 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.65 146.67 23.98 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 122.043 0.925 . . . . 0.5 109.996 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 tp -66.84 -56.53 9.97 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.314 -0.857 . . . . 0.56999999999999995 111.407 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 62.48 178.69 0.14 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.653 0.739 . . . . 2.7999999999999998 110.403 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.18 146.25 53.57 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.691 -0.855 . . . . 1.1599999999999999 108.691 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.716 ' HD3' HD11 ' C' ' 207' ' ' LEU . 0.8 OUTLIER -113.01 145.21 32.61 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.581 -0.699 . . . . 4.8099999999999996 109.317 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.437 ' HG2' HG21 ' C' ' 206' ' ' THR . 21.8 Cg_endo -64.24 146.97 91.09 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.513 2.142 . . . . 2.9500000000000002 112.472 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.615 HG12 HG22 ' C' ' 203' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 118.043 -0.979 . . . . 3.7400000000000002 109.095 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 2' ' ' THR . . . . . 0.531 ' HB ' ' HG2' ' B' ' 105' ' ' ARG . 77.3 p . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.166 0.508 . . . . 0.37 111.01 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.633 ' O ' ' HD2' ' B' ' 105' ' ' ARG . 47.1 mt -71.25 136.18 26.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 105.791 -1.929 . . . . 0.39000000000000001 105.791 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.99 144.43 36.73 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.387 -0.824 . . . . 0.34000000000000002 110.795 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 44.6 mt -126.23 130.25 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.764 0.826 . . . . 0.28000000000000003 108.981 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 86.4 t -124.42 129.27 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.004 -1.85 . . . . 0.33000000000000002 106.004 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 35.7 mt -109.06 131.71 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 109.548 -0.538 . . . . 0.28999999999999998 109.548 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.79 135.71 7.35 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.817 -1.313 . . . . 0.31 109.817 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.496 HG21 ' HB3' ' B' ' 13' ' ' ALA . 7.9 t . . . . . 0 N--CA 1.497 1.896 0 O-C-N 121.083 -1.245 . . . . 0.35999999999999999 109.77 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 110.93 -0.868 . . . . 0.40000000000000002 110.93 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 12' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -131.25 32.04 4.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.469 -1.018 . . . . 0.78000000000000003 110.628 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.496 ' HB3' HG21 ' B' ' 9' ' ' THR . . . -75.5 -27.17 58.66 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 115.216 1.562 . . . . 0.29999999999999999 115.216 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' B' ' 9' ' ' THR . . . -54.74 -46.44 74.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.887 0.767 . . . . 0.27000000000000002 112.834 -176.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.79 -40.35 88.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.958 -0.464 . . . . 0.39000000000000001 111.265 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.19 -35.46 73.97 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.056 1.132 . . . . 0.34999999999999998 114.056 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.02 -39.95 95.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.09 -1.448 . . . . 0.20000000000000001 107.09 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 18.6 tp -65.21 -43.39 91.68 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 109.192 -0.67 . . . . 0.25 109.192 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -61.62 -39.11 90.1 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 121.242 0.544 . . . . 0.35999999999999999 111.266 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.9 -47.64 79.77 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-N 115.056 -0.975 . . . . 0.23000000000000001 108.59 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.7 86.26 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.681 -0.808 . . . . 0.23999999999999999 111.49 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.98 -23.21 65.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.014 -0.539 . . . . 2.54 110.755 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.66 -31.87 68.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.689 -1.967 . . . . 2.5899999999999999 105.689 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 45.6 mt -84.75 -38.3 19.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.837 1.051 . . . . 0.34000000000000002 113.837 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 91.3 mt -109.66 -11.98 14.69 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 119.046 2.98 . . . . 0.34999999999999998 119.046 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.83 165.08 31.57 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 105.521 -3.032 . . . . 0.34000000000000002 105.521 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.69 138.99 56.72 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.338 1.066 . . . . 0.41999999999999998 112.687 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -106.06 146.7 29.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.272 -1.785 . . . . 0.29999999999999999 112.963 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -106.37 157.34 17.69 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 114.434 -1.257 . . . . 0.39000000000000001 107.794 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.13 41.3 20.68 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.085 1.142 . . . . 0.34000000000000002 114.085 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 93.7 t -131.08 134.62 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.31 -0.996 . . . . 0.29999999999999999 108.31 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.73 18.91 Favored Glycine 0 N--CA 1.469 0.886 0 N-CA-C 109.82 -1.312 . . . . 0.31 109.82 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.26 157.69 36.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.167 0.983 . . . . 0.39000000000000001 108.953 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.79 159.1 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.577 -0.738 . . . . 0.40999999999999998 110.306 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.36 162.78 15.66 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.713 -0.676 . . . . 0.46999999999999997 109.617 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' B' ' 36' ' ' PHE . 2.3 t80 -134.16 117.56 16.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.888 -1.523 . . . . 0.53000000000000003 106.888 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 95.0 t -108.1 145.42 31.42 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.943 -1.481 . . . . 0.57999999999999996 110.855 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -57.01 136.14 74.96 Favored 'Trans proline' 0 C--N 1.352 0.719 0 N-CA-C 107.949 -1.597 . . . . 0.64000000000000001 107.949 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.48 -25.78 16.61 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.126 -1.19 . . . . 0.68999999999999995 110.126 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.27 157.66 21.48 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.336 0.588 . . . . 0.64000000000000001 110.031 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' B' ' 41' ' ' ASN . 29.5 p-10 -125.06 179.31 5.1 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.372 -0.973 . . . . 2.3199999999999998 108.372 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.13 73.0 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 112.972 0.73 . . . . 0.60999999999999999 112.972 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.77 -36.58 84.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.934 0.873 . . . . 2.8199999999999998 112.163 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 89.4 m -63.9 -47.53 80.25 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 105.987 -1.857 . . . . 0.65000000000000002 105.987 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.74 -37.68 87.52 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 112.979 0.733 . . . . 0.56000000000000005 112.979 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.47 -43.14 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.635 -0.876 . . . . 0.60999999999999999 108.635 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -62.66 -42.72 99.77 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 119.984 -0.686 . . . . 0.65000000000000002 110.825 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.52 -44.42 97.1 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 119.346 -0.942 . . . . 0.53000000000000003 111.47 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -60.89 -45.72 93.5 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 119.986 -0.686 . . . . 0.46999999999999997 109.637 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -60.09 -40.14 88.55 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 113.131 0.789 . . . . 0.56999999999999995 113.131 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.5 -35.61 81.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.434 0.635 . . . . 0.52000000000000002 110.17 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.11 -43.83 70.23 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 119.572 -0.851 . . . . 0.45000000000000001 110.141 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.55 -38.0 79.92 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.261 -0.427 . . . . 0.45000000000000001 112.048 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.27 -26.32 28.39 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.744 0.646 . . . . 0.51000000000000001 112.744 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -95.57 -4.73 44.13 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 113.126 0.787 . . . . 0.47999999999999998 113.126 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 69.4 mt -105.77 157.43 17.45 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.396 0.888 . . . . 0.40999999999999998 113.396 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -89.34 107.99 19.38 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 102.557 -3.127 . . . . 0.41999999999999998 102.557 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 72.9 p -107.09 15.4 25.26 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 124.153 0.908 . . . . 0.45000000000000001 111.064 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 73.0 p -63.95 -34.29 77.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 115.595 1.702 . . . . 0.47999999999999998 115.595 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.87 -9.35 43.61 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.267 0.556 . . . . 0.46999999999999997 112.202 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.74 172.19 13.02 Favored Glycine 0 C--O 1.242 0.642 0 C-N-CA 119.484 -1.341 . . . . 0.42999999999999999 113.383 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.41 130.25 32.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 109.259 -0.645 . . . . 0.40000000000000002 109.259 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp -115.84 113.42 23.34 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.497 1.748 . . . . 0.34999999999999998 108.411 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.78 122.17 33.29 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.491 -1.67 . . . . 0.40999999999999998 106.491 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 83.2 mt -109.52 115.27 29.61 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 104.531 -2.396 . . . . 0.28000000000000003 104.531 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 26.0 m -120.01 163.4 17.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 113.186 0.81 . . . . 0.34000000000000002 113.186 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' B' ' 67' ' ' ASP . 14.8 p-10 -64.9 -54.07 36.53 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 118.069 2.618 . . . . 0.39000000000000001 118.069 -177.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 45.3 p -142.23 151.4 42.06 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.533 1.158 . . . . 0.39000000000000001 112.692 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' TRP . . . . . 0.58 ' HE1' HG11 ' C' ' 211' ' ' VAL . 32.8 t-105 -66.27 134.45 52.67 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.153 -1.385 . . . . 0.59999999999999998 107.818 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.73 -8.14 70.6 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 121.218 3.247 . . . . 0.52000000000000002 121.218 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.2 174.92 55.25 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 119.282 -1.437 . . . . 0.47999999999999998 110.109 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.15 -47.84 98.4 Favored Pre-proline 0 C--N 1.329 -0.291 0 O-C-N 122.017 -0.696 . . . . 1.3100000000000001 112.01 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 73' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -53.44 -41.6 71.92 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 118.391 -0.606 . . . . 0.45000000000000001 110.619 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -67.2 -48.37 68.1 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 123.458 0.474 . . . . 0.5 109.845 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -60.05 -42.71 95.08 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.972 1.101 . . . . 2.04 113.972 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.46 85.71 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.242 -0.983 . . . . 0.52000000000000002 111.721 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.05 -38.83 90.25 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 108.618 -0.882 . . . . 0.48999999999999999 108.618 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.684 ' O ' HG13 ' B' ' 82' ' ' VAL . 70.5 m -58.65 -39.89 81.88 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.416 0.524 . . . . 1.3999999999999999 112.416 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.619 ' O ' HG22 ' B' ' 82' ' ' VAL . 34.0 mtt180 -67.2 -29.58 69.28 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 113.042 0.756 . . . . 3.4700000000000002 113.042 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 76.1 mt -77.2 -42.15 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.697 0.629 . . . . 0.55000000000000004 112.697 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' B' ' 87' ' ' TYR . 2.6 m -80.03 -16.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.901 0 N-CA-C 115.465 1.654 . . . . 0.56000000000000005 115.465 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' VAL . . . . . 0.684 HG13 ' O ' ' B' ' 78' ' ' SER . 2.9 m -29.4 -55.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.352 1 N-CA-C 122.096 4.11 . . . . 0.73999999999999999 122.096 -176.86 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.49 39.3 3.99 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 116.394 -2.122 . . . . 0.71999999999999997 109.601 178.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.37 133.55 54.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.442 -1.254 . . . . 0.60999999999999999 109.748 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.25 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 106.707 -1.59 . . . . 0.63 106.707 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.68 15.24 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 115.406 1.632 . . . . 0.55000000000000004 115.406 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' TYR . . . . . 0.479 ' HB3' ' HB ' ' B' ' 81' ' ' VAL . 6.1 m-85 -127.45 130.89 50.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 105.506 -2.035 . . . . 0.48999999999999999 105.506 175.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.6 154.66 41.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.228 -0.589 . . . . 0.48999999999999999 110.357 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.77 128.47 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 106.235 -1.765 . . . . 0.44 106.235 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 34.2 mt -124.14 119.52 56.93 Favored 'Isoleucine or valine' 0 C--O 1.255 1.378 0 N-CA-C 108.245 -1.02 . . . . 0.35999999999999999 108.245 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.46 163.21 19.59 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 114.738 -1.119 . . . . 0.35999999999999999 112.314 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.89 24.49 55.33 Favored Glycine 0 CA--C 1.499 -0.911 0 N-CA-C 114.817 0.687 . . . . 0.28999999999999998 114.817 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.85 132.85 6.69 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 N-CA-C 113.461 0.911 . . . . 0.22 113.461 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' A' ' 94' ' ' ASN . 51.2 p30 -141.98 169.48 17.52 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.688 -1.227 . . . . 0.20000000000000001 107.688 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 51.3 mm -60.2 -43.37 93.54 Favored Pre-proline 0 C--O 1.24 0.588 0 N-CA-C 114.491 1.293 . . . . 0.17000000000000001 114.491 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.55 -42.85 56.53 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 117.575 -1.15 . . . . 0.23000000000000001 110.34 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 39.9 ttm -61.72 -48.85 78.86 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 120.377 -0.529 . . . . 0.26000000000000001 109.633 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.46 -48.01 83.62 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 112.822 0.675 . . . . 0.20000000000000001 112.822 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.52 -49.9 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 112.715 0.635 . . . . 0.26000000000000001 112.715 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -63.52 -40.59 97.43 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 120.235 -0.586 . . . . 2.0099999999999998 111.696 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' THR . . . . . . . . . . . . . 53.5 m -66.23 -46.12 78.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.731 -0.668 . . . . 0.28000000000000003 110.892 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.47 -37.79 88.76 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 123.607 0.567 . . . . 0.28999999999999998 110.563 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' MET . . . . . . . . . . . . . 72.6 mtp -66.1 -45.81 79.84 Favored 'General case' 0 C--O 1.242 0.695 0 O-C-N 121.264 -0.897 . . . . 1.76 112.132 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' B' ' 109' ' ' PRO . . . -67.72 -33.81 75.62 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.3 0.852 . . . . 0.38 113.3 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.633 ' HD2' ' O ' ' B' ' 3' ' ' ILE . 15.8 ttp180 -52.56 -32.69 42.16 Favored 'General case' 0 C--O 1.21 -1.013 0 N-CA-C 113.4 0.889 . . . . 0.37 113.4 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.57 -19.59 60.85 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 114.1 1.148 . . . . 2.1299999999999999 114.1 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -90.62 18.15 6.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 122.159 0.981 . . . . 2.27 109.476 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 12.7 t70 46.79 58.47 16.88 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 117.269 2.322 . . . . 0.47999999999999998 117.269 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.42 ' HG3' HD13 ' B' ' 114' ' ' LEU . 44.9 Cg_endo -74.09 168.43 24.82 Favored 'Trans proline' 0 C--O 1.206 -1.109 0 C-N-CA 120.55 0.833 . . . . 0.46999999999999997 110.604 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 54.3 p -77.0 162.78 27.28 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.706 -1.59 . . . . 0.53000000000000003 106.706 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -55.94 -51.48 67.5 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 112.445 0.535 . . . . 0.47999999999999998 112.445 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -58.67 -37.67 76.51 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 112.897 0.703 . . . . 0.59999999999999998 112.897 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -62.84 -46.77 86.37 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 116.417 -0.356 . . . . 0.56999999999999995 110.141 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.42 HD13 ' HG3' ' B' ' 109' ' ' PRO . 15.1 tp -64.41 -45.86 85.77 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 121.019 -0.272 . . . . 0.42999999999999999 111.191 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 63.5 t -56.88 -48.32 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 O-C-N 121.891 -0.506 . . . . 0.44 110.52 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.25 94.3 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.133 0.492 . . . . 0.48999999999999999 112.326 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 tp -62.4 -42.8 99.71 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 122.125 -0.359 . . . . 0.41999999999999998 110.989 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.29 -45.1 94.51 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 119.798 -0.761 . . . . 0.34999999999999998 112.059 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.61 -46.26 89.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.803 -0.443 . . . . 0.41999999999999998 109.803 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -63.71 -45.22 90.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 113.717 1.006 . . . . 0.52000000000000002 113.717 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 34.6 p -71.44 -32.28 68.16 Favored 'General case' 0 C--O 1.216 -0.681 0 C-N-CA 120.585 -0.446 . . . . 0.35999999999999999 111.987 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.38 -45.74 95.31 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.332 -1.507 . . . . 0.29999999999999999 109.332 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.21 -42.15 66.11 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 112.622 0.601 . . . . 0.47999999999999998 112.622 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.43 -20.27 62.92 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 119.578 -0.849 . . . . 2.4199999999999999 111.964 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.78 -16.6 76.3 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 124.246 0.966 . . . . 0.31 113.511 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 93.7 t -88.99 113.07 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 106.171 -1.789 . . . . 0.34000000000000002 106.171 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -156.45 136.84 13.03 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.409 -0.96 . . . . 2.9500000000000002 108.409 -173.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.6 146.71 23.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.031 0.92 . . . . 0.40000000000000002 109.986 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 tp -66.94 -56.78 8.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.337 -0.847 . . . . 0.45000000000000001 111.37 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 62.63 178.8 0.14 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.612 0.72 . . . . 2.8300000000000001 110.401 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.97 146.22 53.78 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.719 -0.845 . . . . 1.3400000000000001 108.719 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' LYS . . . . . 0.413 ' H ' ' HG2' ' B' ' 132' ' ' LYS . 0.8 OUTLIER -112.87 145.23 32.61 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.513 -0.742 . . . . 4.96 109.219 -179.621 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 133' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -64.41 146.97 90.57 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.474 2.116 . . . . 3.1000000000000001 112.42 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.988 -1.006 . . . . 3.8900000000000001 109.133 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 159' ' ' ASN . . . . . 0.559 ' OD1' ' NZ ' ' C' ' 259' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 108.992 -0.744 . . . . 6.3399999999999999 108.992 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 160' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -85.87 25.5 1.1 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.59 -0.893 . . . . 3.8900000000000001 108.59 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 161' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -118.63 -141.88 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.583 -0.895 . . . . 1.72 108.583 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 162' ' ' MET . . . . . 0.594 ' SD ' HG21 ' C' ' 240' ' ' VAL . 0.3 OUTLIER -61.63 156.19 20.55 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.764 -1.21 . . . . 2.0 110.562 -178.858 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 163' ' ' VAL . . . . . . . . . . . . . 94.9 t -113.11 117.68 56.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.06 -0.719 . . . . 0.63 109.06 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 164' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.73 103.39 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.49 -0.929 . . . . 0.46000000000000002 108.49 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.59 -35.33 80.7 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.211 -1.555 . . . . 0.44 109.211 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 tp -172.04 147.97 2.18 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.771 -1.172 . . . . 0.46999999999999997 111.209 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 167' ' ' ALA . . . . . . . . . . . . . . . -117.69 104.39 10.96 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.048 -0.723 . . . . 0.28999999999999998 109.048 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 168' ' ' ARG . . . . . 0.941 ' NH1' HG12 ' C' ' 178' ' ' VAL . 44.4 ttp180 -106.37 126.09 51.81 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.972 0.891 . . . . 3.1400000000000001 110.835 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 169' ' ' ILE . . . . . . . . . . . . . 82.3 mt -95.5 129.21 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 109.222 -0.659 . . . . 0.34000000000000002 109.222 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 170' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -165.95 117.04 1.04 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.812 -0.755 . . . . 0.48999999999999999 110.327 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 171' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.97 -9.94 11.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.429 -0.794 . . . . 2.3300000000000001 109.759 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 172' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' C' ' 174' ' ' ILE . 12.4 mtt180 -101.71 -6.49 23.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 2.9500000000000002 110.47 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 173' ' ' LEU . . . . . . . . . . . . . 13.7 mt 59.1 -89.16 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.44 -0.948 . . . . 1.3899999999999999 108.44 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 174' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' C' ' 172' ' ' ARG . 70.8 mt -109.98 116.77 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.069 -1.02 . . . . 0.53000000000000003 110.227 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 175' ' ' HIS . . . . . 0.465 ' O ' ' CG ' ' C' ' 175' ' ' HIS . 49.6 p-80 -139.35 117.61 11.95 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.947 -1.095 . . . . 0.65000000000000002 109.033 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.55 -152.74 45.05 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 110.066 -1.214 . . . . 0.56999999999999995 110.066 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 177' ' ' GLN . . . . . 0.642 ' CG ' HG11 ' A' ' 99' ' ' VAL . 18.9 mp0 -91.15 12.21 20.76 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.744 -0.856 . . . . 3.2599999999999998 109.332 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 178' ' ' VAL . . . . . 0.941 HG12 ' NH1' ' C' ' 168' ' ' ARG . 48.1 t -61.54 -42.83 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 0.51000000000000001 108.953 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 179' ' ' ALA . . . . . 0.448 ' O ' ' OG1' ' C' ' 183' ' ' THR . . . -73.16 -36.38 66.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.929 -1.107 . . . . 0.53000000000000003 110.187 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 180' ' ' THR . . . . . . . . . . . . . 21.5 m -66.34 -54.42 24.82 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.697 -0.801 . . . . 0.68000000000000005 109.79 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 181' ' ' ARG . . . . . 0.539 ' NH2' ' CG2' ' C' ' 308' ' ' THR . 55.1 ttt-85 -64.7 -43.62 92.88 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.013 -0.675 . . . . 3.1200000000000001 110.608 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 182' ' ' TRP . . . . . 0.533 ' O ' HG23 ' C' ' 186' ' ' THR . 19.5 m95 -65.82 -32.2 73.6 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.034 -1.041 . . . . 0.90000000000000002 109.591 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 183' ' ' THR . . . . . 0.803 HG21 HG21 ' C' ' 216' ' ' VAL . 71.9 m -65.29 -47.1 77.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.946 -1.096 . . . . 0.58999999999999997 110.252 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -69.66 -42.93 73.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 2.2000000000000002 110.806 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 185' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -68.32 -39.61 81.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.95 -1.094 . . . . 2.52 109.569 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 186' ' ' THR . . . . . 0.533 HG23 ' O ' ' C' ' 182' ' ' TRP . 72.6 p -81.42 -1.26 45.03 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.282 -0.886 . . . . 0.58999999999999997 109.685 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 187' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 52.14 48.42 22.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.055 -1.028 . . . . 2.1000000000000001 108.604 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 188' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.05 133.46 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.164 -0.96 . . . . 1.3700000000000001 110.122 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 189' ' ' SER . . . . . . . . . . . . . 27.8 p -109.75 -6.33 15.32 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.761 -0.829 . . . . 1.3999999999999999 108.761 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 190' ' ' ARG . . . . . . . . . . . . . 29.4 mtt-85 -135.92 142.83 44.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.555 -0.716 . . . . 3.52 110.441 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 191' ' ' ILE . . . . . . . . . . . . . 87.6 mt -133.38 127.61 54.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.173 -1.047 . . . . 0.51000000000000001 108.173 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 192' ' ' ILE . . . . . 0.455 HD12 HG11 ' C' ' 240' ' ' VAL . 97.1 mt -115.66 128.68 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.257 -0.902 . . . . 0.46000000000000002 109.665 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 193' ' ' VAL . . . . . . . . . . . . . 53.3 t -99.7 128.88 51.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.825 -0.806 . . . . 0.70999999999999996 108.825 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 194' ' ' VAL . . . . . . . . . . . . . 43.0 t -112.51 103.57 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.535 -0.728 . . . . 0.42999999999999999 109.479 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 195' ' ' SER . . . . . . . . . . . . . 38.0 t -167.25 125.61 1.31 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.342 -0.943 . . . . 1.3799999999999999 109.31 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 196' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.01 -34.88 66.65 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.574 -0.704 . . . . 0.97999999999999998 109.984 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 197' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -65.55 -45.49 83.21 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.147 -0.971 . . . . 2.3199999999999998 109.959 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 198' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.11 -43.21 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.102 -0.998 . . . . 0.70999999999999996 109.028 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.6 -26.5 55.72 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.79 -0.764 . . . . 0.73999999999999999 109.168 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 200' ' ' ALA . . . . . . . . . . . . . . . -84.9 -5.38 59.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.028 -1.045 . . . . 0.89000000000000001 109.882 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 201' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -102.75 95.38 6.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.9 -1.125 . . . . 1.1499999999999999 109.554 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 202' ' ' THR . . . . . . . . . . . . . 24.7 p -66.22 -33.21 75.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.407 -0.808 . . . . 1.6100000000000001 110.631 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 203' ' ' VAL . . . . . 0.615 HG22 HG12 ' A' ' 134' ' ' VAL . 55.8 t -66.33 -47.49 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.851 -1.156 . . . . 0.90000000000000002 109.598 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 204' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -63.69 -42.24 98.04 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.349 -0.94 . . . . 3.0699999999999998 109.576 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 205' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -58.01 -42.42 85.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 1.72 109.482 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 206' ' ' THR . . . . . 0.437 HG21 ' HG2' ' A' ' 133' ' ' PRO . 73.2 m -60.63 -48.71 80.55 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.088 -1.045 . . . . 0.92000000000000004 109.564 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 207' ' ' LEU . . . . . 0.716 HD11 ' HD3' ' A' ' 132' ' ' LYS . 30.6 mt -62.62 -44.45 96.26 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.934 -1.107 . . . . 0.81999999999999995 110.736 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 208' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' C' ' 208' ' ' LEU . 81.6 mt -62.5 -41.45 98.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.718 -1.239 . . . . 0.72999999999999998 110.055 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 209' ' ' THR . . . . . . . . . . . . . 35.8 p -67.89 -31.83 71.89 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.371 -0.831 . . . . 0.83999999999999997 110.28 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 210' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -80.37 -17.54 51.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.782 -1.199 . . . . 2.3199999999999998 110.857 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 211' ' ' VAL . . . . . 0.58 HG11 ' HE1' ' B' ' 69' ' ' TRP . 17.5 m -107.69 17.65 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.952 -1.092 . . . . 0.93000000000000005 108.639 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.29 123.42 82.48 Favored Pre-proline 0 N--CA 1.483 1.221 0 N-CA-C 107.82 -1.178 . . . . 0.76000000000000001 107.82 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 213' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -44.31 144.48 2.95 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.037 1.825 . . . . 0.93000000000000005 112.731 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 214' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -56.52 134.85 66.98 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.196 1.931 . . . . 1.1399999999999999 112.028 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 215' ' ' GLY . . . . . . . . . . . . . . . 79.91 -8.52 50.03 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.922 -1.271 . . . . 0.84999999999999998 109.922 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 216' ' ' VAL . . . . . 0.803 HG21 HG21 ' C' ' 183' ' ' THR . 58.6 t -114.8 136.78 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -1.076 . . . . 0.92000000000000004 108.8 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.87 135.77 45.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.438 -0.789 . . . . 1.4199999999999999 109.836 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 218' ' ' ALA . . . . . . . . . . . . . . . -110.17 131.37 55.12 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.315 -0.994 . . . . 0.64000000000000001 108.315 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -120.97 153.51 37.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.401 -0.812 . . . . 0.71999999999999997 109.808 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 54.8 t -126.35 117.83 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.624 0.726 . . . . 0.59999999999999998 109.07 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 31.7 m -141.01 165.14 19.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.412 -0.805 . . . . 0.56999999999999995 109.622 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 222' ' ' ASP . . . . . 0.709 ' OD1' ' N ' ' C' ' 225' ' ' LYS . 6.8 p30 -94.18 167.23 11.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.479 -0.763 . . . . 1.3400000000000001 109.305 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.46 -44.82 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.151 -0.968 . . . . 0.54000000000000004 110.455 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 224' ' ' ALA . . . . . 0.852 ' O ' HG22 ' C' ' 227' ' ' ILE . . . -62.72 -44.73 95.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.934 -1.104 . . . . 0.67000000000000004 109.398 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 225' ' ' LYS . . . . . 0.709 ' N ' ' OD1' ' C' ' 222' ' ' ASP . 45.7 tttm -68.14 -35.35 77.95 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.775 -1.203 . . . . 2.1099999999999999 109.674 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 226' ' ' MET . . . . . . . . . . . . . 10.3 tpt -62.08 -40.4 95.71 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.934 -1.104 . . . . 1.54 111.191 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 227' ' ' ILE . . . . . 0.852 HG22 ' O ' ' C' ' 224' ' ' ALA . 17.4 tt -60.9 -34.56 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.611 -0.885 . . . . 0.68999999999999995 108.611 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.47 -38.86 62.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.722 -0.611 . . . . 4.0099999999999998 110.948 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 70.3 t -62.18 -41.73 92.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.864 -1.162 . . . . 0.63 107.864 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 230' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' C' ' 230' ' ' TYR . 36.7 t80 -67.04 -32.13 73.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.102 -0.999 . . . . 0.64000000000000001 109.927 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 231' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.76 6.73 2.34 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.119 -0.988 . . . . 0.94999999999999996 110.104 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 232' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -110.18 117.78 50.87 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.246 -0.909 . . . . 0.93000000000000005 109.435 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 233' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -65.73 1.51 2.19 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.646 1.564 . . . . 0.98999999999999999 111.98 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 234' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.36 -24.76 65.33 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 1.5900000000000001 108.807 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 235' ' ' TYR . . . . . 0.501 ' O ' ' HB2' ' C' ' 238' ' ' GLU . 81.1 m-85 -105.49 15.71 26.66 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.594 -0.842 . . . . 1.1899999999999999 109.003 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.81 135.62 47.44 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.076 -1.64 . . . . 0.67000000000000004 109.65 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.78 -33.41 1.9 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.288 -1.525 . . . . 0.64000000000000001 109.288 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 238' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' C' ' 235' ' ' TYR . 4.0 mm-40 -54.25 138.93 37.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.805 -1.409 . . . . 2.48 109.437 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 239' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -99.1 116.33 31.08 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.463 -0.939 . . . . 2.96 108.463 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 240' ' ' VAL . . . . . 0.594 HG21 ' SD ' ' C' ' 162' ' ' MET . 26.3 t -121.85 148.78 25.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.876 0.846 . . . . 0.66000000000000003 110.448 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 241' ' ' MET . . . . . . . . . . . . . 13.8 ttm -102.9 134.95 45.47 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.925 -1.139 . . . . 1.6299999999999999 107.925 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 242' ' ' LEU . . . . . 0.402 ' HB3' ' CE2' ' C' ' 244' ' ' PHE . 61.2 mt -102.04 127.28 49.0 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.689 -0.804 . . . . 0.34999999999999998 109.877 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 243' ' ' LEU . . . . . . . . . . . . . 97.6 mt -109.5 126.08 53.15 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.981 0.896 . . . . 0.68000000000000005 109.045 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 244' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' C' ' 242' ' ' LEU . 77.7 m-85 -127.0 162.03 26.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.771 0.796 . . . . 0.29999999999999999 109.275 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 245' ' ' THR . . . . . . . . . . . . . 70.2 p -109.48 -19.47 13.23 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.958 -0.756 . . . . 0.42999999999999999 108.958 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 246' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' C' ' 246' ' ' ASN . 17.3 p30 -151.08 141.85 14.91 Favored Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 120.003 -0.679 . . . . 1.0 109.872 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 247' ' ' PRO . . . . . 0.451 ' HG3' ' CE2' ' C' ' 291' ' ' PHE . 7.3 Cg_endo -60.85 -14.63 33.4 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.683 2.255 . . . . 0.58999999999999997 112.1 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 248' ' ' THR . . . . . . . . . . . . . 95.7 m -64.99 -42.66 94.31 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.151 0.976 . . . . 0.64000000000000001 108.624 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 249' ' ' ASP . . . . . 0.42 ' O ' HD12 ' C' ' 253' ' ' LEU . 97.8 m-20 -67.48 -23.4 65.48 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.54 -0.725 . . . . 0.53000000000000003 109.801 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 250' ' ' VAL . . . . . . . . . . . . . 98.3 t -73.62 -43.77 54.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.672 -1.267 . . . . 0.40000000000000002 109.848 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 251' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.41 -35.02 77.92 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.426 -0.953 . . . . 1.51 108.426 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 252' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -62.48 -44.09 97.23 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.723 -0.791 . . . . 3.2400000000000002 110.156 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 253' ' ' LEU . . . . . 0.42 HD12 ' O ' ' C' ' 249' ' ' ASP . 1.2 mp -64.07 -40.42 96.22 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 117.999 -1.48 . . . . 1.0600000000000001 108.876 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 254' ' ' VAL . . . . . 0.57 ' CG2' HD12 ' C' ' 260' ' ' ILE . 70.6 t -60.7 -44.61 97.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 120.835 -1.165 . . . . 0.47999999999999998 108.948 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 255' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.23 -30.97 69.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.018 -1.052 . . . . 2.4700000000000002 109.917 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 256' ' ' GLY . . . . . . . . . . . . . . . -74.28 2.8 43.16 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.498 -1.441 . . . . 0.55000000000000004 109.498 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 257' ' ' GLY . . . . . . . . . . . . . . . 94.37 15.79 45.94 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.627 -1.389 . . . . 0.51000000000000001 109.627 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 258' ' ' VAL . . . . . . . . . . . . . 96.7 t -77.66 139.72 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.034 -1.469 . . . . 0.45000000000000001 107.034 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 259' ' ' LYS . . . . . 0.559 ' NZ ' ' OD1' ' C' ' 159' ' ' ASN . 17.9 tttt -99.01 123.93 43.64 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.089 -1.007 . . . . 3.1200000000000001 110.811 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 260' ' ' ILE . . . . . 0.57 HD12 ' CG2' ' C' ' 254' ' ' VAL . 98.1 mt -129.99 125.67 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.43 -0.794 . . . . 0.40999999999999998 109.147 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 65.9 p -89.51 -31.44 17.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.776 -1.202 . . . . 0.56999999999999995 110.238 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 262' ' ' SER . . . . . . . . . . . . . 15.8 m -159.06 153.51 24.15 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.176 -0.953 . . . . 0.46000000000000002 110.092 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 263' ' ' VAL . . . . . . . . . . . . . 50.9 t -122.74 134.61 65.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.538 -0.912 . . . . 0.37 108.538 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 264' ' ' ASN . . . . . 0.468 ' ND2' ' CH2' ' C' ' 182' ' ' TRP . 33.7 t30 -108.57 128.08 54.51 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.517 0.675 . . . . 1.1699999999999999 110.607 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 265' ' ' VAL . . . . . 0.451 HG21 ' SD ' ' C' ' 314' ' ' MET . 3.2 t -90.64 108.43 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 120.058 -0.657 . . . . 0.40000000000000002 109.68 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 266' ' ' GLY . . . . . . . . . . . . . . . -80.75 -53.94 3.84 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.153 -1.179 . . . . 0.40999999999999998 110.153 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . -172.57 152.93 17.73 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.646 -1.74 . . . . 0.40999999999999998 111.476 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 268' ' ' MET . . . . . 0.44 ' HB2' ' H ' ' C' ' 282' ' ' SER . 97.0 mtp -143.1 118.08 10.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.481 -1.011 . . . . 0.5 110.443 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.34 128.21 21.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.371 -0.831 . . . . 0.56999999999999995 109.523 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 270' ' ' PHE . . . . . 0.536 ' CG ' ' N ' ' C' ' 271' ' ' ARG . 13.3 t80 -69.5 161.8 28.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.92000000000000004 109.618 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 271' ' ' ARG . . . . . 0.536 ' N ' ' CG ' ' C' ' 270' ' ' PHE . 32.7 ttm180 -160.66 158.67 29.24 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.27 -0.972 . . . . 3.23 109.676 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 272' ' ' GLN . . . . . 0.4 ' N ' ' HG2' ' C' ' 271' ' ' ARG . 73.9 mt-30 -66.48 138.25 57.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.081 -1.012 . . . . 2.98 110.459 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 273' ' ' GLY . . . . . . . . . . . . . . . 95.52 -12.32 67.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.818 -1.713 . . . . 0.87 108.818 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 274' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -101.81 163.37 12.29 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.484 -1.01 . . . . 1.6599999999999999 109.388 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 275' ' ' THR . . . . . 0.561 HG21 HG21 ' C' ' 321' ' ' ILE . 20.8 m -109.95 135.83 50.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.674 -0.862 . . . . 0.83999999999999997 108.674 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 276' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -82.02 119.21 23.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.246 -0.909 . . . . 2.77 110.176 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 277' ' ' VAL . . . . . 0.519 HG12 ' CD1' ' C' ' 321' ' ' ILE . 27.5 m -99.22 -28.18 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.81 -0.756 . . . . 0.73999999999999999 109.612 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 278' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' C' ' 279' ' ' ASN . 10.2 t-20 -135.99 -177.16 4.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.658 0.742 . . . . 1.52 109.761 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 279' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' C' ' 278' ' ' ASN . 39.5 m-20 -56.93 -29.88 63.5 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.791 -0.568 . . . . 2.29 110.787 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . -148.06 27.01 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.829 -1.169 . . . . 0.59999999999999998 109.538 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 281' ' ' VAL . . . . . 0.498 ' O ' HG22 ' C' ' 277' ' ' VAL . 60.8 t -118.99 121.98 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.825 0.822 . . . . 0.60999999999999999 109.678 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 282' ' ' SER . . . . . 0.44 ' H ' ' HB2' ' C' ' 268' ' ' MET . 29.0 m -118.64 147.61 43.58 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.447 0.642 . . . . 0.75 110.02 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 283' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.26 142.84 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.446 1.117 . . . . 0.69999999999999996 110.539 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 284' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' C' ' 287' ' ' ASP . 44.1 p-10 -110.61 171.67 7.33 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 106.923 -1.51 . . . . 0.77000000000000002 106.923 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 285' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.18 -24.21 40.12 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.833 -1.167 . . . . 2.3399999999999999 109.587 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 286' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -79.59 -43.46 22.89 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.233 -0.917 . . . . 2.0 110.026 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 287' ' ' ASP . . . . . 0.57 ' N ' ' OD1' ' C' ' 284' ' ' ASP . 93.3 m-20 -64.25 -42.08 96.67 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.237 -0.915 . . . . 0.62 109.096 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 288' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.48 -45.77 97.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.387 -0.821 . . . . 0.72999999999999998 109.518 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 289' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -57.44 -39.6 76.6 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.216 -0.928 . . . . 2.52 110.262 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.37 -41.01 85.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.82 -1.175 . . . . 0.59999999999999998 109.9 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 291' ' ' PHE . . . . . 0.451 ' CE2' ' HG3' ' C' ' 247' ' ' PRO . 40.0 m-85 -63.93 -39.02 93.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.56999999999999995 109.73 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 292' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -64.08 -39.5 94.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.149 -0.969 . . . . 2.0499999999999998 110.226 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 293' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -65.78 -41.54 91.86 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.943 -1.098 . . . . 1.8 109.635 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 294' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.18 -43.22 99.32 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.871 -1.143 . . . . 0.53000000000000003 108.867 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 295' ' ' ASN . . . . . 0.849 ' C ' HD21 ' C' ' 295' ' ' ASN . 0.1 OUTLIER -64.01 -40.01 95.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 1.45 109.953 179.473 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.66 -21.38 65.67 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.815 -1.178 . . . . 0.68999999999999995 109.242 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 297' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -90.13 8.85 30.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.769 -1.207 . . . . 2.4900000000000002 109.91 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.44 11.43 82.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.903 -1.279 . . . . 0.59999999999999998 109.903 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 299' ' ' ILE . . . . . . . . . . . . . 97.8 mt -84.71 134.56 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.974 -1.309 . . . . 0.53000000000000003 109.151 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 300' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -82.0 141.66 33.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.869 . . . . 2.2999999999999998 110.615 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 301' ' ' LEU . . . . . . . . . . . . . 66.9 mt -123.08 111.27 16.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.269 -0.641 . . . . 0.54000000000000004 109.269 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 302' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.57 139.87 49.69 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.9 . . . . 2.2599999999999998 110.289 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 303' ' ' VAL . . . . . 0.611 ' CG2' ' SD ' ' C' ' 314' ' ' MET . 51.8 t -111.99 124.77 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.673 -0.862 . . . . 0.55000000000000004 108.673 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 304' ' ' ARG . . . . . 0.459 ' HE ' ' CG ' ' C' ' 264' ' ' ASN . 33.4 ptt180 -164.93 137.87 4.64 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.505 -0.878 . . . . 2.7000000000000002 110.343 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 305' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -80.82 -45.42 16.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 3.1899999999999999 109.817 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 306' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.33 154.01 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.106 -0.996 . . . . 0.65000000000000002 108.737 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 307' ' ' SER . . . . . . . . . . . . . 83.5 p -64.55 -16.29 62.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.983 -1.073 . . . . 1.3600000000000001 109.516 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 308' ' ' THR . . . . . 0.539 ' CG2' ' NH2' ' C' ' 181' ' ' ARG . 44.5 p -86.14 -9.07 57.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.047 -1.033 . . . . 0.84999999999999998 110.005 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 309' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -92.49 152.69 42.35 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.025 -1.047 . . . . 0.81000000000000005 109.936 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 310' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -55.37 139.15 81.42 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.968 1.779 . . . . 0.93000000000000005 111.755 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 311' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -84.24 132.82 34.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 3.0899999999999999 109.823 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 312' ' ' LEU . . . . . . . . . . . . . 80.2 mt -117.51 154.74 30.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.103 -0.998 . . . . 0.72999999999999998 108.309 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 313' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -91.26 130.49 37.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.076 -1.015 . . . . 2.2400000000000002 109.827 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 314' ' ' MET . . . . . 0.611 ' SD ' ' CG2' ' C' ' 303' ' ' VAL . 8.2 tpt -56.39 -44.17 79.97 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.67 -0.644 . . . . 1.03 109.63 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 315' ' ' MET . . . . . . . . . . . . . 95.9 mmm -61.18 -40.39 93.73 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.299 -0.876 . . . . 1.71 110.22 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 316' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.9 -44.0 97.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.319 -0.863 . . . . 0.81999999999999995 109.81 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 317' ' ' LEU . . . . . . . . . . . . . 92.8 mt -66.49 -41.98 88.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.877 . . . . 0.80000000000000004 110.036 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 318' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.26 -24.49 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.311 -0.868 . . . . 0.85999999999999999 109.957 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 319' ' ' SER . . . . . 0.475 ' O ' ' C ' ' C' ' 323' ' ' LYS . 0.9 OUTLIER -72.72 -31.56 65.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.084 -1.01 . . . . 1.52 109.518 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 320' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -84.19 -2.45 56.9 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.78 -1.168 . . . . 2.04 109.167 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 321' ' ' ILE . . . . . 0.561 HG21 HG21 ' C' ' 275' ' ' THR . 93.2 mt -113.76 -58.74 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.914 -1.143 . . . . 1.1699999999999999 107.914 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 322' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' C' ' 323' ' ' LYS . 12.3 t0 -95.01 85.11 4.26 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.16 -1.792 . . . . 2.2599999999999998 106.16 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 323' ' ' LYS . . . . . 1.262 ' HA ' ' NZ ' ' C' ' 323' ' ' LYS . 0.0 OUTLIER . . . . . 1 C--O 1.524 15.537 0 CA-C-O 126.309 2.957 . . . . 5.9199999999999999 109.465 -177.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.548 ' HB ' ' HG2' ' A' ' 105' ' ' ARG . 76.6 p . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 121.106 0.479 . . . . 0.44 111.038 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.614 ' O ' ' HD2' ' A' ' 105' ' ' ARG . 47.0 mt -71.24 136.2 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.736 -1.95 . . . . 0.38 105.736 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.98 144.42 36.76 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 115.292 -0.867 . . . . 0.34999999999999998 110.744 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.3 mt -126.27 130.14 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.825 0.85 . . . . 0.31 109.053 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.29 129.28 74.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.035 -1.839 . . . . 0.32000000000000001 106.035 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 mt -109.11 132.24 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.445 -0.576 . . . . 0.26000000000000001 109.445 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.55 133.01 6.17 Favored Glycine 0 N--CA 1.463 0.476 0 C-N-CA 120.271 -0.966 . . . . 0.23999999999999999 111.849 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.68 HG21 ' HB3' ' A' ' 13' ' ' ALA . 14.4 t -141.61 163.83 31.87 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 107.422 -1.325 . . . . 0.26000000000000001 107.422 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' NEP . . . . . 0.586 ' ND1' ' OD2' ' A' ' 67' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 73.28 -147.27 38.96 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 116.57 -2.728 . . . . 0.31 114.981 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -121.95 25.66 9.01 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 114.486 1.291 . . . . 0.78000000000000003 114.486 -174.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.68 ' HB3' HG21 ' A' ' 9' ' ' THR . . . -78.92 -27.27 43.73 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 115.277 1.584 . . . . 0.25 115.277 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.7 -46.48 74.15 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.827 0.74 . . . . 0.26000000000000001 112.799 -176.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -59.79 -40.39 88.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.593 -0.443 . . . . 0.44 111.224 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.31 -35.22 73.53 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.105 1.15 . . . . 0.38 114.105 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.05 -39.99 95.3 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.139 -1.43 . . . . 0.27000000000000002 107.139 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.13 -43.47 91.81 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.149 -0.685 . . . . 0.34000000000000002 109.149 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -61.56 -39.18 90.2 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.242 0.544 . . . . 0.44 111.234 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.96 -47.64 79.64 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 115.048 -0.978 . . . . 0.37 108.609 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.71 86.11 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 119.754 -0.778 . . . . 0.39000000000000001 111.465 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.96 -23.34 65.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.103 -0.499 . . . . 2.5 110.692 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.47 -32.01 69.39 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 105.703 -1.962 . . . . 2.5899999999999999 105.703 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.8 mt -84.74 -38.38 19.74 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 113.817 1.043 . . . . 0.48999999999999999 113.817 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -109.6 -12.03 14.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 119.025 2.972 . . . . 0.5 119.025 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.98 165.07 31.38 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 105.457 -3.057 . . . . 0.51000000000000001 105.457 -175.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -58.82 138.97 56.96 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 122.41 1.1 . . . . 0.57999999999999996 112.611 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -105.91 146.75 29.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.264 -1.789 . . . . 0.45000000000000001 113.038 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -106.46 157.34 17.72 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.497 -1.229 . . . . 0.54000000000000004 107.816 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.25 41.22 20.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.096 1.147 . . . . 0.41999999999999998 114.096 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.8 t -131.09 134.53 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.381 -0.97 . . . . 0.38 108.381 177.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.66 18.93 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 109.899 -1.28 . . . . 0.34999999999999998 109.899 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.22 157.76 36.4 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 118.203 1.001 . . . . 0.40999999999999998 108.921 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.84 159.15 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.453 -0.794 . . . . 0.35999999999999999 110.29 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -113.46 162.85 15.63 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.757 -0.656 . . . . 0.41999999999999998 109.592 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 36' ' ' PHE . 1.9 t80 -134.19 117.5 16.57 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.886 -1.524 . . . . 0.40999999999999998 106.886 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.6 t -108.11 145.44 31.45 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 113.92 -1.491 . . . . 0.48999999999999999 110.848 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -57.06 136.08 74.54 Favored 'Trans proline' 0 C--N 1.352 0.752 0 N-CA-C 107.929 -1.604 . . . . 0.53000000000000003 107.929 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.55 -25.75 16.55 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.065 -1.214 . . . . 0.57999999999999996 110.065 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.34 157.66 21.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.373 0.606 . . . . 0.52000000000000002 110.009 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -125.08 179.29 5.11 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.343 -0.984 . . . . 2.23 108.343 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.19 72.97 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 113.003 0.742 . . . . 0.48999999999999999 113.003 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.86 -36.45 84.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.84 0.828 . . . . 2.8300000000000001 112.164 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.5 m -63.92 -47.58 79.99 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 106.01 -1.848 . . . . 0.56000000000000005 106.01 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.71 -37.48 86.7 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.108 0.781 . . . . 0.46999999999999997 113.108 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.1 mt -58.59 -43.15 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.587 -0.894 . . . . 0.5 108.587 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -62.58 -42.73 99.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.966 -0.694 . . . . 0.58999999999999997 110.875 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -61.58 -44.34 97.21 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 119.347 -0.941 . . . . 0.47999999999999998 111.34 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -61.02 -45.65 93.96 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 120.015 -0.674 . . . . 0.41999999999999998 109.595 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -60.15 -40.04 88.44 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 113.158 0.799 . . . . 0.51000000000000001 113.158 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.58 -35.64 81.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.449 0.643 . . . . 0.52000000000000002 110.135 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.17 -43.61 70.47 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 119.578 -0.849 . . . . 0.45000000000000001 110.205 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.73 -37.92 80.28 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.281 -0.418 . . . . 0.45000000000000001 112.041 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.31 -26.36 29.07 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.699 0.629 . . . . 0.53000000000000003 112.699 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -95.49 -4.75 44.35 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.224 0.824 . . . . 0.53000000000000003 113.224 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 69.8 mt -105.85 157.54 17.4 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 113.313 0.857 . . . . 0.46000000000000002 113.313 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -89.34 107.94 19.35 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 102.541 -3.133 . . . . 0.46999999999999997 102.541 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.9 p -106.98 15.38 25.39 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 124.097 0.873 . . . . 0.44 111.05 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.3 p -64.03 -34.27 77.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 115.553 1.686 . . . . 0.48999999999999999 115.553 -177.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.77 -9.39 43.79 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.274 0.559 . . . . 0.48999999999999999 112.271 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.71 172.22 13.03 Favored Glycine 0 C--O 1.242 0.598 0 C-N-CA 119.486 -1.34 . . . . 0.40000000000000002 113.406 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.3 t -139.47 130.17 32.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 N-CA-C 109.273 -0.639 . . . . 0.35999999999999999 109.273 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.8 tp -115.86 113.37 23.26 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.549 1.781 . . . . 0.29999999999999999 108.446 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.68 122.19 33.23 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 106.507 -1.664 . . . . 0.34000000000000002 106.507 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.0 mt -109.55 115.25 29.56 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 104.519 -2.4 . . . . 0.22 104.519 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.4 m -119.93 163.31 17.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 113.221 0.823 . . . . 0.23000000000000001 113.221 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.586 ' OD2' ' ND1' ' A' ' 10' ' ' NEP . 14.3 p-10 -64.94 -54.05 36.8 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 118.031 2.604 . . . . 0.27000000000000002 118.031 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -142.23 151.41 42.09 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 122.541 1.163 . . . . 0.26000000000000001 112.693 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -66.32 134.47 52.67 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.178 -1.374 . . . . 0.45000000000000001 107.857 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.72 -8.14 70.59 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 121.281 3.272 . . . . 0.38 121.281 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.23 174.9 55.24 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 119.341 -1.409 . . . . 0.34000000000000002 110.065 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.18 -47.77 98.5 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 122.089 -0.653 . . . . 1.24 112.057 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -53.5 -41.56 72.46 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 118.293 -0.671 . . . . 0.32000000000000001 110.604 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -67.28 -48.26 68.2 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 123.506 0.504 . . . . 0.37 109.865 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -60.1 -42.71 95.24 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.945 1.091 . . . . 1.99 113.945 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.6 85.57 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.388 -0.925 . . . . 0.40999999999999998 111.675 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.83 89.97 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.7 -0.852 . . . . 0.38 108.7 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.685 ' O ' HG13 ' A' ' 82' ' ' VAL . 70.3 m -58.72 -39.82 81.96 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.423 0.527 . . . . 1.3799999999999999 112.423 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.611 ' O ' HG22 ' A' ' 82' ' ' VAL . 33.8 mtt180 -67.31 -29.55 69.15 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 112.957 0.725 . . . . 3.3799999999999999 112.957 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.408 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 76.5 mt -77.15 -42.18 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.755 0.65 . . . . 0.45000000000000001 112.755 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 87' ' ' TYR . 2.6 m -80.15 -16.72 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 115.456 1.65 . . . . 0.45000000000000001 115.456 -175.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 78' ' ' SER . 2.9 m -29.31 -55.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 1 N-CA-C 122.123 4.12 . . . . 0.62 122.123 -177.007 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.55 39.4 3.97 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 116.387 -2.125 . . . . 0.58999999999999997 109.525 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -112.33 133.55 54.37 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 114.505 -1.225 . . . . 0.48999999999999999 109.745 -179.401 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.23 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 106.732 -1.581 . . . . 0.52000000000000002 106.732 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.67 15.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 115.395 1.628 . . . . 0.46999999999999997 115.395 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.477 ' HB3' ' HB ' ' A' ' 81' ' ' VAL . 6.1 m-85 -127.47 130.92 50.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.538 -2.023 . . . . 0.41999999999999998 105.538 175.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.59 154.67 41.76 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.29 -0.564 . . . . 0.39000000000000001 110.311 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 t -121.69 128.48 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 106.315 -1.735 . . . . 0.33000000000000002 106.315 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.3 mt -124.16 119.51 56.87 Favored 'Isoleucine or valine' 0 C--O 1.256 1.405 0 N-CA-C 108.258 -1.016 . . . . 0.28999999999999998 108.258 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.4 163.29 19.6 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 114.674 -1.148 . . . . 0.25 112.388 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.71 24.62 55.53 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 114.821 0.688 . . . . 0.19 114.821 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.82 132.73 6.61 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 N-CA-C 113.483 0.92 . . . . 0.16 113.483 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' B' ' 94' ' ' ASN . 50.9 p30 -141.88 169.61 17.28 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.65 -1.241 . . . . 0.23999999999999999 107.65 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 95' ' ' ILE . 50.4 mm -60.22 -43.37 93.47 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 114.522 1.304 . . . . 0.28999999999999998 114.522 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.55 -42.94 55.52 Favored 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 117.584 -1.144 . . . . 0.31 110.343 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 39.8 ttm -61.56 -48.93 78.75 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 120.348 -0.541 . . . . 0.28000000000000003 109.704 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.44 -48.05 83.43 Favored 'General case' 0 C--O 1.201 -1.487 0 N-CA-C 112.784 0.661 . . . . 0.29999999999999999 112.784 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.642 HG11 ' CG ' ' C' ' 177' ' ' GLN . 84.7 t -61.51 -49.8 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 112.729 0.641 . . . . 0.41999999999999998 112.729 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -63.67 -40.51 97.01 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.253 -0.579 . . . . 2.04 111.671 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.3 m -66.24 -46.09 78.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.34999999999999998 110.89 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.5 -37.84 88.93 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 123.537 0.523 . . . . 0.40000000000000002 110.571 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 69.8 mtp -66.12 -45.74 80.0 Favored 'General case' 0 C--O 1.243 0.717 0 O-C-N 121.353 -0.842 . . . . 1.7 112.099 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.86 75.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.179 0.807 . . . . 0.44 113.179 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.614 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 15.7 ttp180 -52.6 -32.63 42.43 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 113.4 0.889 . . . . 0.42999999999999999 113.4 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -73.6 -19.6 60.83 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 114.001 1.111 . . . . 2.1899999999999999 114.001 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -90.67 18.24 6.64 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.204 1.002 . . . . 2.2000000000000002 109.49 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.6 t70 46.69 58.55 16.73 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 117.248 2.314 . . . . 0.51000000000000001 117.248 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.413 ' HG3' HD13 ' A' ' 114' ' ' LEU . 44.8 Cg_endo -74.13 168.5 24.66 Favored 'Trans proline' 0 C--O 1.206 -1.1 0 C-N-CA 120.455 0.77 . . . . 0.46999999999999997 110.659 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.4 p -77.05 162.74 27.27 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.613 -1.625 . . . . 0.48999999999999999 106.613 175.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -55.95 -51.55 67.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 112.373 0.509 . . . . 0.42999999999999999 112.373 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.51 -37.73 76.21 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 112.924 0.712 . . . . 0.51000000000000001 112.924 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -62.8 -46.87 85.94 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.416 -0.356 . . . . 0.54000000000000004 110.156 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.413 HD13 ' HG3' ' A' ' 109' ' ' PRO . 15.0 tp -64.26 -45.97 85.78 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 121.087 -0.245 . . . . 0.40999999999999998 111.235 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.91 -48.3 81.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.583 -0.447 . . . . 0.37 110.478 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.83 -44.31 94.1 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.202 0.525 . . . . 0.45000000000000001 112.338 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.34 -42.93 99.79 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 122.071 -0.393 . . . . 0.44 111.009 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.06 94.48 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 119.748 -0.781 . . . . 0.34999999999999998 112.096 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.65 -46.26 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.83 -0.433 . . . . 0.38 109.83 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -63.65 -45.29 90.84 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.678 0.992 . . . . 0.52000000000000002 113.678 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.2 p -71.42 -32.35 68.29 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 120.607 -0.437 . . . . 0.40999999999999998 111.867 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.41 -45.58 95.63 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.362 -1.495 . . . . 0.32000000000000001 109.362 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.43 -42.01 65.53 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 112.588 0.588 . . . . 0.46000000000000002 112.588 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.52 -20.32 62.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 119.609 -0.836 . . . . 2.3999999999999999 111.899 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.61 -16.69 76.03 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 124.203 0.939 . . . . 0.37 113.559 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.6 t -88.97 112.98 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 106.193 -1.78 . . . . 0.40000000000000002 106.193 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -156.43 136.92 13.11 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.387 -0.968 . . . . 2.8799999999999999 108.387 -173.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.65 146.67 23.98 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 122.043 0.925 . . . . 0.5 109.996 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.497 HD11 ' CE ' ' A' ' 132' ' ' LYS . 42.3 tp -66.84 -56.86 8.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.314 -0.857 . . . . 0.56999999999999995 111.407 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.5 mttt 62.97 178.54 0.15 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.655 0.741 . . . . 2.7999999999999998 110.518 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.13 146.74 53.15 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.345 -0.983 . . . . 1.1599999999999999 108.345 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.71 ' HD3' HD11 ' C' ' 207' ' ' LEU . 0.2 OUTLIER -113.53 147.66 38.02 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.484 -0.76 . . . . 4.8099999999999996 109.529 -179.148 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.442 ' HG2' HG21 ' C' ' 206' ' ' THR . 19.1 Cg_endo -64.66 148.64 90.36 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.305 2.003 . . . . 2.9500000000000002 112.415 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.633 HG12 HG22 ' C' ' 203' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.014 -0.993 . . . . 3.7400000000000002 109.17 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 2' ' ' THR . . . . . 0.531 ' HB ' ' HG2' ' B' ' 105' ' ' ARG . 77.3 p . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.166 0.508 . . . . 0.37 111.01 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.633 ' O ' ' HD2' ' B' ' 105' ' ' ARG . 47.1 mt -71.25 136.18 26.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 105.791 -1.929 . . . . 0.39000000000000001 105.791 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.99 144.43 36.73 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.387 -0.824 . . . . 0.34000000000000002 110.795 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 44.6 mt -126.23 130.25 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.764 0.826 . . . . 0.28000000000000003 108.981 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 86.4 t -124.42 129.27 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.004 -1.85 . . . . 0.33000000000000002 106.004 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 35.7 mt -109.06 132.27 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 109.548 -0.538 . . . . 0.28999999999999998 109.548 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.52 133.04 6.19 Favored Glycine 0 N--CA 1.462 0.384 0 C-N-CA 120.326 -0.94 . . . . 0.31 111.885 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.739 HG21 ' HB3' ' B' ' 13' ' ' ALA . 15.0 t -145.94 160.12 42.28 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.363 -1.347 . . . . 0.35999999999999999 107.363 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' NEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.48 -141.86 26.25 Favored Glycine 0 C--N 1.315 -0.623 0 C-N-CA 116.756 -2.64 . . . . 0.40000000000000002 114.863 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -123.57 25.67 8.1 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 114.44 1.274 . . . . 0.78000000000000003 114.44 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.739 ' HB3' HG21 ' B' ' 9' ' ' THR . . . -79.03 -27.17 43.15 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 115.216 1.562 . . . . 0.29999999999999999 115.216 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.74 -46.44 74.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.887 0.767 . . . . 0.27000000000000002 112.834 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.79 -40.35 88.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.958 -0.464 . . . . 0.39000000000000001 111.265 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.19 -35.46 73.97 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.056 1.132 . . . . 0.34999999999999998 114.056 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.02 -39.95 95.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.09 -1.448 . . . . 0.20000000000000001 107.09 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 18.6 tp -65.21 -43.39 91.68 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 109.192 -0.67 . . . . 0.25 109.192 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -61.62 -39.11 90.1 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 121.242 0.544 . . . . 0.35999999999999999 111.266 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.9 -47.64 79.77 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-N 115.056 -0.975 . . . . 0.23000000000000001 108.59 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.7 86.26 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.681 -0.808 . . . . 0.23999999999999999 111.49 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.98 -23.21 65.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.014 -0.539 . . . . 2.54 110.755 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.66 -31.87 68.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.689 -1.967 . . . . 2.5899999999999999 105.689 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 45.6 mt -84.75 -38.3 19.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.837 1.051 . . . . 0.34000000000000002 113.837 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 91.3 mt -109.66 -11.98 14.69 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 119.046 2.98 . . . . 0.34999999999999998 119.046 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.83 165.08 31.57 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 105.521 -3.032 . . . . 0.34000000000000002 105.521 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.69 138.99 56.72 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.338 1.066 . . . . 0.41999999999999998 112.687 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -106.06 146.7 29.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.272 -1.785 . . . . 0.29999999999999999 112.963 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -106.37 157.34 17.69 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 114.434 -1.257 . . . . 0.39000000000000001 107.794 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.13 41.3 20.68 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.085 1.142 . . . . 0.34000000000000002 114.085 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 93.7 t -131.08 134.62 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.31 -0.996 . . . . 0.29999999999999999 108.31 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.73 18.91 Favored Glycine 0 N--CA 1.469 0.886 0 N-CA-C 109.82 -1.312 . . . . 0.31 109.82 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.26 157.69 36.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.167 0.983 . . . . 0.39000000000000001 108.953 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.79 159.1 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.577 -0.738 . . . . 0.40999999999999998 110.306 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.36 162.78 15.66 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.713 -0.676 . . . . 0.46999999999999997 109.617 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' B' ' 36' ' ' PHE . 2.3 t80 -134.16 117.56 16.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.888 -1.523 . . . . 0.53000000000000003 106.888 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 95.0 t -108.1 145.42 31.42 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.943 -1.481 . . . . 0.57999999999999996 110.855 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -57.01 136.14 74.96 Favored 'Trans proline' 0 C--N 1.352 0.719 0 N-CA-C 107.949 -1.597 . . . . 0.64000000000000001 107.949 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.48 -25.78 16.61 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.126 -1.19 . . . . 0.68999999999999995 110.126 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.27 157.66 21.48 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.336 0.588 . . . . 0.64000000000000001 110.031 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' B' ' 41' ' ' ASN . 29.5 p-10 -125.06 179.31 5.1 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.372 -0.973 . . . . 2.3199999999999998 108.372 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.13 73.0 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 112.972 0.73 . . . . 0.60999999999999999 112.972 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.77 -36.58 84.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.934 0.873 . . . . 2.8199999999999998 112.163 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 89.4 m -63.9 -47.53 80.25 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 105.987 -1.857 . . . . 0.65000000000000002 105.987 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.74 -37.68 87.52 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 112.979 0.733 . . . . 0.56000000000000005 112.979 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.47 -43.14 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.635 -0.876 . . . . 0.60999999999999999 108.635 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -62.66 -42.72 99.77 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 119.984 -0.686 . . . . 0.65000000000000002 110.825 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.52 -44.42 97.1 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 119.346 -0.942 . . . . 0.53000000000000003 111.47 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -60.89 -45.72 93.5 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 119.986 -0.686 . . . . 0.46999999999999997 109.637 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -60.09 -40.14 88.55 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 113.131 0.789 . . . . 0.56999999999999995 113.131 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.5 -35.61 81.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.434 0.635 . . . . 0.52000000000000002 110.17 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.11 -43.83 70.23 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 119.572 -0.851 . . . . 0.45000000000000001 110.141 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.55 -38.0 79.92 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.261 -0.427 . . . . 0.45000000000000001 112.048 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.27 -26.32 28.39 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.744 0.646 . . . . 0.51000000000000001 112.744 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -95.57 -4.73 44.13 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 113.126 0.787 . . . . 0.47999999999999998 113.126 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 69.4 mt -105.77 157.43 17.45 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.396 0.888 . . . . 0.40999999999999998 113.396 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -89.34 107.99 19.38 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 102.557 -3.127 . . . . 0.41999999999999998 102.557 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 72.9 p -107.09 15.4 25.26 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 124.153 0.908 . . . . 0.45000000000000001 111.064 -177.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 73.0 p -63.95 -34.29 77.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 115.595 1.702 . . . . 0.47999999999999998 115.595 -177.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.87 -9.35 43.61 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.267 0.556 . . . . 0.46999999999999997 112.202 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.74 172.19 13.02 Favored Glycine 0 C--O 1.242 0.642 0 C-N-CA 119.484 -1.341 . . . . 0.42999999999999999 113.383 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.41 130.25 32.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 109.259 -0.645 . . . . 0.40000000000000002 109.259 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp -115.84 113.42 23.34 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.497 1.748 . . . . 0.34999999999999998 108.411 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.78 122.17 33.29 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.491 -1.67 . . . . 0.40999999999999998 106.491 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 83.2 mt -109.52 115.27 29.61 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 104.531 -2.396 . . . . 0.28000000000000003 104.531 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 26.0 m -120.01 163.4 17.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 113.186 0.81 . . . . 0.34000000000000002 113.186 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' B' ' 67' ' ' ASP . 14.8 p-10 -64.9 -54.07 36.53 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 118.069 2.618 . . . . 0.39000000000000001 118.069 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 45.3 p -142.23 151.4 42.06 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.533 1.158 . . . . 0.39000000000000001 112.692 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' TRP . . . . . 0.58 ' HE1' HG11 ' C' ' 211' ' ' VAL . 32.8 t-105 -66.27 134.45 52.67 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.153 -1.385 . . . . 0.59999999999999998 107.818 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.73 -8.14 70.6 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 121.218 3.247 . . . . 0.52000000000000002 121.218 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.2 174.92 55.25 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 119.282 -1.437 . . . . 0.47999999999999998 110.109 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.15 -47.84 98.4 Favored Pre-proline 0 C--N 1.329 -0.291 0 O-C-N 122.017 -0.696 . . . . 1.3100000000000001 112.01 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -53.44 -41.6 71.92 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 118.391 -0.606 . . . . 0.45000000000000001 110.619 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -67.2 -48.37 68.1 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 123.458 0.474 . . . . 0.5 109.845 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -60.05 -42.71 95.08 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.972 1.101 . . . . 2.04 113.972 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.46 85.71 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.242 -0.983 . . . . 0.52000000000000002 111.721 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.05 -38.83 90.25 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 108.618 -0.882 . . . . 0.48999999999999999 108.618 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.684 ' O ' HG13 ' B' ' 82' ' ' VAL . 70.5 m -58.65 -39.89 81.88 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.416 0.524 . . . . 1.3999999999999999 112.416 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.619 ' O ' HG22 ' B' ' 82' ' ' VAL . 34.0 mtt180 -67.2 -29.58 69.28 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 113.042 0.756 . . . . 3.4700000000000002 113.042 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 76.1 mt -77.2 -42.15 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.697 0.629 . . . . 0.55000000000000004 112.697 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' B' ' 87' ' ' TYR . 2.6 m -80.03 -16.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.901 0 N-CA-C 115.465 1.654 . . . . 0.56000000000000005 115.465 -175.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' VAL . . . . . 0.684 HG13 ' O ' ' B' ' 78' ' ' SER . 2.9 m -29.4 -55.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.352 1 N-CA-C 122.096 4.11 . . . . 0.73999999999999999 122.096 -176.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.49 39.3 3.99 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 116.394 -2.122 . . . . 0.71999999999999997 109.601 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.37 133.55 54.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.442 -1.254 . . . . 0.60999999999999999 109.748 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.25 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 106.707 -1.59 . . . . 0.63 106.707 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.68 15.24 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 115.406 1.632 . . . . 0.55000000000000004 115.406 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' TYR . . . . . 0.479 ' HB3' ' HB ' ' B' ' 81' ' ' VAL . 6.1 m-85 -127.45 130.89 50.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 105.506 -2.035 . . . . 0.48999999999999999 105.506 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.6 154.66 41.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.228 -0.589 . . . . 0.48999999999999999 110.357 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.77 128.47 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 106.235 -1.765 . . . . 0.44 106.235 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 34.2 mt -124.14 119.52 56.93 Favored 'Isoleucine or valine' 0 C--O 1.255 1.378 0 N-CA-C 108.245 -1.02 . . . . 0.35999999999999999 108.245 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.46 163.21 19.59 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 114.738 -1.119 . . . . 0.35999999999999999 112.314 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.89 24.49 55.33 Favored Glycine 0 CA--C 1.499 -0.911 0 N-CA-C 114.817 0.687 . . . . 0.28999999999999998 114.817 176.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.85 132.85 6.69 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 N-CA-C 113.461 0.911 . . . . 0.22 113.461 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' A' ' 94' ' ' ASN . 51.2 p30 -141.98 169.48 17.52 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.688 -1.227 . . . . 0.20000000000000001 107.688 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 51.3 mm -60.2 -43.37 93.54 Favored Pre-proline 0 C--O 1.24 0.588 0 N-CA-C 114.491 1.293 . . . . 0.17000000000000001 114.491 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.55 -42.85 56.53 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 117.575 -1.15 . . . . 0.23000000000000001 110.34 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 39.9 ttm -61.72 -48.85 78.86 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 120.377 -0.529 . . . . 0.26000000000000001 109.633 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.46 -48.01 83.62 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 112.822 0.675 . . . . 0.20000000000000001 112.822 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.52 -49.9 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 112.715 0.635 . . . . 0.26000000000000001 112.715 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -63.52 -40.59 97.43 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 120.235 -0.586 . . . . 2.0099999999999998 111.696 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' THR . . . . . . . . . . . . . 53.5 m -66.23 -46.12 78.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.731 -0.668 . . . . 0.28000000000000003 110.892 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.47 -37.79 88.76 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 123.607 0.567 . . . . 0.28999999999999998 110.563 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' MET . . . . . . . . . . . . . 72.6 mtp -66.1 -45.81 79.84 Favored 'General case' 0 C--O 1.242 0.695 0 O-C-N 121.264 -0.897 . . . . 1.76 112.132 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' B' ' 109' ' ' PRO . . . -67.72 -33.81 75.62 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.3 0.852 . . . . 0.38 113.3 -178.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.633 ' HD2' ' O ' ' B' ' 3' ' ' ILE . 15.8 ttp180 -52.56 -32.69 42.16 Favored 'General case' 0 C--O 1.21 -1.013 0 N-CA-C 113.4 0.889 . . . . 0.37 113.4 -178.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.57 -19.59 60.85 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 114.1 1.148 . . . . 2.1299999999999999 114.1 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -90.62 18.15 6.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 122.159 0.981 . . . . 2.27 109.476 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 12.7 t70 46.79 58.47 16.88 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 117.269 2.322 . . . . 0.47999999999999998 117.269 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.42 ' HG3' HD13 ' B' ' 114' ' ' LEU . 44.9 Cg_endo -74.09 168.43 24.82 Favored 'Trans proline' 0 C--O 1.206 -1.109 0 C-N-CA 120.55 0.833 . . . . 0.46999999999999997 110.604 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 54.3 p -77.0 162.78 27.28 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.706 -1.59 . . . . 0.53000000000000003 106.706 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -55.94 -51.48 67.5 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 112.445 0.535 . . . . 0.47999999999999998 112.445 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -58.67 -37.67 76.51 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 112.897 0.703 . . . . 0.59999999999999998 112.897 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -62.84 -46.77 86.37 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 116.417 -0.356 . . . . 0.56999999999999995 110.141 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.42 HD13 ' HG3' ' B' ' 109' ' ' PRO . 15.1 tp -64.41 -45.86 85.77 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 121.019 -0.272 . . . . 0.42999999999999999 111.191 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 63.5 t -56.88 -48.32 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 O-C-N 121.891 -0.506 . . . . 0.44 110.52 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.25 94.3 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.133 0.492 . . . . 0.48999999999999999 112.326 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 tp -62.4 -42.8 99.71 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 122.125 -0.359 . . . . 0.41999999999999998 110.989 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.29 -45.1 94.51 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 119.798 -0.761 . . . . 0.34999999999999998 112.059 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.61 -46.26 89.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.803 -0.443 . . . . 0.41999999999999998 109.803 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -63.71 -45.22 90.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 113.717 1.006 . . . . 0.52000000000000002 113.717 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 34.6 p -71.44 -32.28 68.16 Favored 'General case' 0 C--O 1.216 -0.681 0 C-N-CA 120.585 -0.446 . . . . 0.35999999999999999 111.987 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.38 -45.74 95.31 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.332 -1.507 . . . . 0.29999999999999999 109.332 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.21 -42.15 66.11 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 112.622 0.601 . . . . 0.47999999999999998 112.622 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.43 -20.27 62.92 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 119.578 -0.849 . . . . 2.4199999999999999 111.964 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.78 -16.6 76.3 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 124.246 0.966 . . . . 0.31 113.511 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 93.7 t -88.99 113.07 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 106.171 -1.789 . . . . 0.34000000000000002 106.171 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -156.45 136.84 13.03 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.409 -0.96 . . . . 2.9500000000000002 108.409 -173.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.6 146.71 23.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.031 0.92 . . . . 0.40000000000000002 109.986 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' LEU . . . . . 0.5 HD11 ' CE ' ' B' ' 132' ' ' LYS . 42.3 tp -66.94 -57.09 7.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.337 -0.847 . . . . 0.45000000000000001 111.37 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 63.01 178.65 0.15 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.646 0.736 . . . . 2.8300000000000001 110.595 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.03 146.61 53.36 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.353 -0.98 . . . . 1.3400000000000001 108.353 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.5 ' CE ' HD11 ' B' ' 129' ' ' LEU . 0.2 OUTLIER -113.33 147.94 38.5 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.444 -0.785 . . . . 4.96 109.476 -179.224 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 133' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -64.76 148.7 90.21 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.415 2.076 . . . . 3.1000000000000001 112.368 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.011 -0.995 . . . . 3.8900000000000001 109.12 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 159' ' ' ASN . . . . . 0.559 ' OD1' ' NZ ' ' C' ' 259' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 108.992 -0.744 . . . . 6.3399999999999999 108.992 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 160' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -85.87 25.5 1.1 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.59 -0.893 . . . . 3.8900000000000001 108.59 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 161' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -118.63 -141.88 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.583 -0.895 . . . . 1.72 108.583 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 162' ' ' MET . . . . . 0.594 ' SD ' HG21 ' C' ' 240' ' ' VAL . 0.3 OUTLIER -61.63 156.19 20.55 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.764 -1.21 . . . . 2.0 110.562 -178.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 163' ' ' VAL . . . . . . . . . . . . . 94.9 t -113.11 117.68 56.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.06 -0.719 . . . . 0.63 109.06 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 164' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.73 103.39 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.49 -0.929 . . . . 0.46000000000000002 108.49 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.59 -35.33 80.7 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.211 -1.555 . . . . 0.44 109.211 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 tp -172.04 147.97 2.18 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.771 -1.172 . . . . 0.46999999999999997 111.209 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 167' ' ' ALA . . . . . . . . . . . . . . . -117.69 104.39 10.96 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.048 -0.723 . . . . 0.28999999999999998 109.048 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 168' ' ' ARG . . . . . 0.941 ' NH1' HG12 ' C' ' 178' ' ' VAL . 44.4 ttp180 -106.37 126.09 51.81 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.972 0.891 . . . . 3.1400000000000001 110.835 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 169' ' ' ILE . . . . . . . . . . . . . 82.3 mt -95.5 129.21 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 109.222 -0.659 . . . . 0.34000000000000002 109.222 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 170' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -165.95 117.04 1.04 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.812 -0.755 . . . . 0.48999999999999999 110.327 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 171' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.97 -9.94 11.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.429 -0.794 . . . . 2.3300000000000001 109.759 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 172' ' ' ARG . . . . . . . . . . . . . 12.4 mtt180 -101.71 -5.16 25.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 2.9500000000000002 110.47 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 173' ' ' LEU . . . . . . . . . . . . . 14.5 mt 59.0 -100.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.141 -0.974 . . . . 1.3899999999999999 109.917 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 174' ' ' ILE . . . . . 0.438 HG23 ' CB ' ' C' ' 179' ' ' ALA . 77.7 mt -97.71 121.3 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.026 -1.046 . . . . 0.53000000000000003 108.285 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 175' ' ' HIS . . . . . 0.672 ' CE1' HG21 ' C' ' 178' ' ' VAL . 2.6 p80 -143.19 127.57 17.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.131 -0.98 . . . . 0.65000000000000002 109.426 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 176' ' ' GLY . . . . . . . . . . . . . . . 60.33 -152.63 37.16 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.833 -1.307 . . . . 0.56999999999999995 109.833 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 177' ' ' GLN . . . . . 0.642 ' CG ' HG11 ' A' ' 99' ' ' VAL . 18.9 mp0 -89.36 12.21 16.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.573 -0.957 . . . . 3.2599999999999998 109.332 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 178' ' ' VAL . . . . . 0.941 HG12 ' NH1' ' C' ' 168' ' ' ARG . 48.1 t -61.54 -42.83 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 0.51000000000000001 108.953 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 179' ' ' ALA . . . . . 0.448 ' O ' ' OG1' ' C' ' 183' ' ' THR . . . -73.16 -36.38 66.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.929 -1.107 . . . . 0.53000000000000003 110.187 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 180' ' ' THR . . . . . . . . . . . . . 21.5 m -66.34 -54.42 24.82 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.697 -0.801 . . . . 0.68000000000000005 109.79 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 181' ' ' ARG . . . . . 0.539 ' NH2' ' CG2' ' C' ' 308' ' ' THR . 55.1 ttt-85 -64.7 -43.62 92.88 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.013 -0.675 . . . . 3.1200000000000001 110.608 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 182' ' ' TRP . . . . . 0.533 ' O ' HG23 ' C' ' 186' ' ' THR . 19.5 m95 -65.82 -32.2 73.6 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.034 -1.041 . . . . 0.90000000000000002 109.591 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 183' ' ' THR . . . . . 0.803 HG21 HG21 ' C' ' 216' ' ' VAL . 71.9 m -65.29 -47.1 77.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.946 -1.096 . . . . 0.58999999999999997 110.252 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -69.66 -42.93 73.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 2.2000000000000002 110.806 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 185' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -68.32 -39.61 81.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.95 -1.094 . . . . 2.52 109.569 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 186' ' ' THR . . . . . 0.533 HG23 ' O ' ' C' ' 182' ' ' TRP . 72.6 p -81.42 -1.26 45.03 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.282 -0.886 . . . . 0.58999999999999997 109.685 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 187' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 52.14 48.42 22.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.055 -1.028 . . . . 2.1000000000000001 108.604 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 188' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.05 133.46 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.164 -0.96 . . . . 1.3700000000000001 110.122 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 189' ' ' SER . . . . . . . . . . . . . 27.8 p -109.75 -6.33 15.32 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.761 -0.829 . . . . 1.3999999999999999 108.761 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 190' ' ' ARG . . . . . . . . . . . . . 29.4 mtt-85 -135.92 142.83 44.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.555 -0.716 . . . . 3.52 110.441 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 191' ' ' ILE . . . . . . . . . . . . . 87.6 mt -133.38 127.61 54.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.173 -1.047 . . . . 0.51000000000000001 108.173 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 192' ' ' ILE . . . . . 0.455 HD12 HG11 ' C' ' 240' ' ' VAL . 97.1 mt -115.66 128.68 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.257 -0.902 . . . . 0.46000000000000002 109.665 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 193' ' ' VAL . . . . . . . . . . . . . 53.3 t -99.7 128.88 51.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.825 -0.806 . . . . 0.70999999999999996 108.825 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 194' ' ' VAL . . . . . . . . . . . . . 43.0 t -112.51 103.57 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.535 -0.728 . . . . 0.42999999999999999 109.479 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 195' ' ' SER . . . . . . . . . . . . . 38.0 t -167.25 125.61 1.31 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.342 -0.943 . . . . 1.3799999999999999 109.31 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 196' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.01 -34.88 66.65 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.574 -0.704 . . . . 0.97999999999999998 109.984 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 197' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -65.55 -45.49 83.21 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.147 -0.971 . . . . 2.3199999999999998 109.959 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 198' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.11 -43.21 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.102 -0.998 . . . . 0.70999999999999996 109.028 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.6 -26.5 55.72 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.79 -0.764 . . . . 0.73999999999999999 109.168 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 200' ' ' ALA . . . . . . . . . . . . . . . -84.9 -5.38 59.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.028 -1.045 . . . . 0.89000000000000001 109.882 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 201' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -102.75 95.38 6.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.9 -1.125 . . . . 1.1499999999999999 109.554 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 202' ' ' THR . . . . . . . . . . . . . 24.7 p -66.22 -33.21 75.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.407 -0.808 . . . . 1.6100000000000001 110.631 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 203' ' ' VAL . . . . . 0.633 HG22 HG12 ' A' ' 134' ' ' VAL . 55.8 t -66.33 -47.49 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.851 -1.156 . . . . 0.90000000000000002 109.598 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 204' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -63.69 -42.24 98.04 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.349 -0.94 . . . . 3.0699999999999998 109.576 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 205' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -58.01 -42.42 85.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 1.72 109.482 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 206' ' ' THR . . . . . 0.442 HG21 ' HG2' ' A' ' 133' ' ' PRO . 73.2 m -60.63 -48.71 80.55 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.088 -1.045 . . . . 0.92000000000000004 109.564 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 207' ' ' LEU . . . . . 0.71 HD11 ' HD3' ' A' ' 132' ' ' LYS . 30.6 mt -62.62 -44.45 96.26 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.934 -1.107 . . . . 0.81999999999999995 110.736 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 208' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' C' ' 208' ' ' LEU . 81.6 mt -62.5 -41.45 98.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.718 -1.239 . . . . 0.72999999999999998 110.055 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 209' ' ' THR . . . . . . . . . . . . . 35.8 p -67.89 -31.83 71.89 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.371 -0.831 . . . . 0.83999999999999997 110.28 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 210' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -80.37 -17.54 51.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.782 -1.199 . . . . 2.3199999999999998 110.857 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 211' ' ' VAL . . . . . 0.58 HG11 ' HE1' ' B' ' 69' ' ' TRP . 17.5 m -107.69 17.65 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.952 -1.092 . . . . 0.93000000000000005 108.639 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.29 123.42 82.48 Favored Pre-proline 0 N--CA 1.483 1.221 0 N-CA-C 107.82 -1.178 . . . . 0.76000000000000001 107.82 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 213' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -44.31 144.48 2.95 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.037 1.825 . . . . 0.93000000000000005 112.731 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 214' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -56.52 134.85 66.98 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.196 1.931 . . . . 1.1399999999999999 112.028 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 215' ' ' GLY . . . . . . . . . . . . . . . 79.91 -8.52 50.03 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.922 -1.271 . . . . 0.84999999999999998 109.922 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 216' ' ' VAL . . . . . 0.803 HG21 HG21 ' C' ' 183' ' ' THR . 58.6 t -114.8 136.78 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -1.076 . . . . 0.92000000000000004 108.8 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.87 135.77 45.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.438 -0.789 . . . . 1.4199999999999999 109.836 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 218' ' ' ALA . . . . . . . . . . . . . . . -110.17 131.37 55.12 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.315 -0.994 . . . . 0.64000000000000001 108.315 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -120.97 153.51 37.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.401 -0.812 . . . . 0.71999999999999997 109.808 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 54.8 t -126.35 117.83 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.624 0.726 . . . . 0.59999999999999998 109.07 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 31.7 m -141.01 165.14 19.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.412 -0.805 . . . . 0.56999999999999995 109.622 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 222' ' ' ASP . . . . . 0.709 ' OD1' ' N ' ' C' ' 225' ' ' LYS . 6.8 p30 -94.18 167.23 11.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.479 -0.763 . . . . 1.3400000000000001 109.305 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.46 -44.82 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.151 -0.968 . . . . 0.54000000000000004 110.455 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 224' ' ' ALA . . . . . 0.852 ' O ' HG22 ' C' ' 227' ' ' ILE . . . -62.72 -44.73 95.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.934 -1.104 . . . . 0.67000000000000004 109.398 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 225' ' ' LYS . . . . . 0.709 ' N ' ' OD1' ' C' ' 222' ' ' ASP . 45.7 tttm -68.14 -35.35 77.95 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.775 -1.203 . . . . 2.1099999999999999 109.674 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 226' ' ' MET . . . . . . . . . . . . . 10.3 tpt -62.08 -40.4 95.71 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.934 -1.104 . . . . 1.54 111.191 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 227' ' ' ILE . . . . . 0.852 HG22 ' O ' ' C' ' 224' ' ' ALA . 17.4 tt -60.9 -34.56 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.611 -0.885 . . . . 0.68999999999999995 108.611 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.47 -38.86 62.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.722 -0.611 . . . . 4.0099999999999998 110.948 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 70.3 t -62.18 -41.73 92.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.864 -1.162 . . . . 0.63 107.864 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 230' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' C' ' 230' ' ' TYR . 36.7 t80 -67.04 -32.13 73.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.102 -0.999 . . . . 0.64000000000000001 109.927 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 231' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.76 6.73 2.34 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.119 -0.988 . . . . 0.94999999999999996 110.104 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 232' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -110.18 117.78 50.87 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.246 -0.909 . . . . 0.93000000000000005 109.435 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 233' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -65.73 1.51 2.19 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.646 1.564 . . . . 0.98999999999999999 111.98 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 234' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.36 -24.76 65.33 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 1.5900000000000001 108.807 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 235' ' ' TYR . . . . . 0.501 ' O ' ' HB2' ' C' ' 238' ' ' GLU . 81.1 m-85 -105.49 15.71 26.66 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.594 -0.842 . . . . 1.1899999999999999 109.003 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.81 135.62 47.44 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.076 -1.64 . . . . 0.67000000000000004 109.65 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.78 -33.41 1.9 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.288 -1.525 . . . . 0.64000000000000001 109.288 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 238' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' C' ' 235' ' ' TYR . 4.0 mm-40 -54.25 138.93 37.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.805 -1.409 . . . . 2.48 109.437 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 239' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -99.1 116.33 31.08 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.463 -0.939 . . . . 2.96 108.463 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 240' ' ' VAL . . . . . 0.594 HG21 ' SD ' ' C' ' 162' ' ' MET . 26.3 t -121.85 148.78 25.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.876 0.846 . . . . 0.66000000000000003 110.448 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 241' ' ' MET . . . . . . . . . . . . . 13.8 ttm -102.9 134.95 45.47 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.925 -1.139 . . . . 1.6299999999999999 107.925 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 242' ' ' LEU . . . . . 0.402 ' HB3' ' CE2' ' C' ' 244' ' ' PHE . 61.2 mt -102.04 127.28 49.0 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.689 -0.804 . . . . 0.34999999999999998 109.877 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 243' ' ' LEU . . . . . . . . . . . . . 97.6 mt -109.5 126.08 53.15 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.981 0.896 . . . . 0.68000000000000005 109.045 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 244' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' C' ' 242' ' ' LEU . 77.7 m-85 -127.0 162.03 26.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.771 0.796 . . . . 0.29999999999999999 109.275 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 245' ' ' THR . . . . . . . . . . . . . 70.2 p -109.48 -19.47 13.23 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.958 -0.756 . . . . 0.42999999999999999 108.958 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 246' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' C' ' 246' ' ' ASN . 17.3 p30 -151.08 141.85 14.91 Favored Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 120.003 -0.679 . . . . 1.0 109.872 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 247' ' ' PRO . . . . . 0.451 ' HG3' ' CE2' ' C' ' 291' ' ' PHE . 7.3 Cg_endo -60.85 -14.63 33.4 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.683 2.255 . . . . 0.58999999999999997 112.1 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 248' ' ' THR . . . . . . . . . . . . . 95.7 m -64.99 -42.66 94.31 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.151 0.976 . . . . 0.64000000000000001 108.624 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 249' ' ' ASP . . . . . 0.42 ' O ' HD12 ' C' ' 253' ' ' LEU . 97.8 m-20 -67.48 -23.4 65.48 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.54 -0.725 . . . . 0.53000000000000003 109.801 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 250' ' ' VAL . . . . . . . . . . . . . 98.3 t -73.62 -43.77 54.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.672 -1.267 . . . . 0.40000000000000002 109.848 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 251' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.41 -35.02 77.92 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.426 -0.953 . . . . 1.51 108.426 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 252' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -62.48 -44.09 97.23 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.723 -0.791 . . . . 3.2400000000000002 110.156 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 253' ' ' LEU . . . . . 0.42 HD12 ' O ' ' C' ' 249' ' ' ASP . 1.2 mp -64.07 -40.42 96.22 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 117.999 -1.48 . . . . 1.0600000000000001 108.876 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 254' ' ' VAL . . . . . 0.57 ' CG2' HD12 ' C' ' 260' ' ' ILE . 70.6 t -60.7 -44.61 97.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 120.835 -1.165 . . . . 0.47999999999999998 108.948 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 255' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.23 -30.97 69.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.018 -1.052 . . . . 2.4700000000000002 109.917 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 256' ' ' GLY . . . . . . . . . . . . . . . -74.28 2.8 43.16 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.498 -1.441 . . . . 0.55000000000000004 109.498 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 257' ' ' GLY . . . . . . . . . . . . . . . 94.37 15.79 45.94 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.627 -1.389 . . . . 0.51000000000000001 109.627 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 258' ' ' VAL . . . . . . . . . . . . . 96.7 t -77.66 139.72 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.034 -1.469 . . . . 0.45000000000000001 107.034 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 259' ' ' LYS . . . . . 0.559 ' NZ ' ' OD1' ' C' ' 159' ' ' ASN . 17.9 tttt -99.01 123.93 43.64 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.089 -1.007 . . . . 3.1200000000000001 110.811 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 260' ' ' ILE . . . . . 0.57 HD12 ' CG2' ' C' ' 254' ' ' VAL . 98.1 mt -129.99 125.67 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.43 -0.794 . . . . 0.40999999999999998 109.147 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 65.9 p -89.51 -31.44 17.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.776 -1.202 . . . . 0.56999999999999995 110.238 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 262' ' ' SER . . . . . . . . . . . . . 15.8 m -159.06 153.51 24.15 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.176 -0.953 . . . . 0.46000000000000002 110.092 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 263' ' ' VAL . . . . . . . . . . . . . 50.9 t -122.74 134.61 65.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.538 -0.912 . . . . 0.37 108.538 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 264' ' ' ASN . . . . . 0.468 ' ND2' ' CH2' ' C' ' 182' ' ' TRP . 33.7 t30 -108.57 128.08 54.51 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.517 0.675 . . . . 1.1699999999999999 110.607 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 265' ' ' VAL . . . . . 0.451 HG21 ' SD ' ' C' ' 314' ' ' MET . 3.2 t -90.64 108.43 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 120.058 -0.657 . . . . 0.40000000000000002 109.68 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 266' ' ' GLY . . . . . . . . . . . . . . . -80.75 -53.94 3.84 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.153 -1.179 . . . . 0.40999999999999998 110.153 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . -172.57 152.93 17.73 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.646 -1.74 . . . . 0.40999999999999998 111.476 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 268' ' ' MET . . . . . 0.44 ' HB2' ' H ' ' C' ' 282' ' ' SER . 97.0 mtp -143.1 118.08 10.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.481 -1.011 . . . . 0.5 110.443 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.34 128.21 21.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.371 -0.831 . . . . 0.56999999999999995 109.523 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 270' ' ' PHE . . . . . 0.536 ' CG ' ' N ' ' C' ' 271' ' ' ARG . 13.3 t80 -69.5 161.8 28.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.92000000000000004 109.618 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 271' ' ' ARG . . . . . 0.536 ' N ' ' CG ' ' C' ' 270' ' ' PHE . 32.7 ttm180 -160.66 158.67 29.24 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.27 -0.972 . . . . 3.23 109.676 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 272' ' ' GLN . . . . . 0.4 ' N ' ' HG2' ' C' ' 271' ' ' ARG . 73.9 mt-30 -66.48 138.25 57.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.081 -1.012 . . . . 2.98 110.459 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 273' ' ' GLY . . . . . . . . . . . . . . . 95.52 -12.32 67.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.818 -1.713 . . . . 0.87 108.818 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 274' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -101.81 163.37 12.29 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.484 -1.01 . . . . 1.6599999999999999 109.388 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 275' ' ' THR . . . . . 0.561 HG21 HG21 ' C' ' 321' ' ' ILE . 20.8 m -109.95 135.83 50.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.674 -0.862 . . . . 0.83999999999999997 108.674 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 276' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -82.02 119.21 23.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.246 -0.909 . . . . 2.77 110.176 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 277' ' ' VAL . . . . . 0.519 HG12 ' CD1' ' C' ' 321' ' ' ILE . 27.5 m -99.22 -28.18 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.81 -0.756 . . . . 0.73999999999999999 109.612 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 278' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' C' ' 279' ' ' ASN . 10.2 t-20 -135.99 -177.16 4.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.658 0.742 . . . . 1.52 109.761 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 279' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' C' ' 278' ' ' ASN . 39.5 m-20 -56.93 -29.88 63.5 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.791 -0.568 . . . . 2.29 110.787 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . -148.06 27.01 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.829 -1.169 . . . . 0.59999999999999998 109.538 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 281' ' ' VAL . . . . . 0.498 ' O ' HG22 ' C' ' 277' ' ' VAL . 60.8 t -118.99 121.98 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.825 0.822 . . . . 0.60999999999999999 109.678 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 282' ' ' SER . . . . . 0.44 ' H ' ' HB2' ' C' ' 268' ' ' MET . 29.0 m -118.64 147.61 43.58 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.447 0.642 . . . . 0.75 110.02 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 283' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.26 142.84 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.446 1.117 . . . . 0.69999999999999996 110.539 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 284' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' C' ' 287' ' ' ASP . 44.1 p-10 -110.61 171.67 7.33 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 106.923 -1.51 . . . . 0.77000000000000002 106.923 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 285' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.18 -24.21 40.12 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.833 -1.167 . . . . 2.3399999999999999 109.587 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 286' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -79.59 -43.46 22.89 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.233 -0.917 . . . . 2.0 110.026 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 287' ' ' ASP . . . . . 0.57 ' N ' ' OD1' ' C' ' 284' ' ' ASP . 93.3 m-20 -64.25 -42.08 96.67 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.237 -0.915 . . . . 0.62 109.096 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 288' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.48 -45.77 97.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.387 -0.821 . . . . 0.72999999999999998 109.518 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 289' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -57.44 -39.6 76.6 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.216 -0.928 . . . . 2.52 110.262 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.37 -41.01 85.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.82 -1.175 . . . . 0.59999999999999998 109.9 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 291' ' ' PHE . . . . . 0.451 ' CE2' ' HG3' ' C' ' 247' ' ' PRO . 40.0 m-85 -63.93 -39.02 93.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.56999999999999995 109.73 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 292' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -64.08 -39.5 94.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.149 -0.969 . . . . 2.0499999999999998 110.226 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 293' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -65.78 -41.54 91.86 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.943 -1.098 . . . . 1.8 109.635 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 294' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.18 -43.22 99.32 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.871 -1.143 . . . . 0.53000000000000003 108.867 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 295' ' ' ASN . . . . . 0.849 ' C ' HD21 ' C' ' 295' ' ' ASN . 0.1 OUTLIER -64.01 -40.01 95.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 1.45 109.953 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.66 -21.38 65.67 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.815 -1.178 . . . . 0.68999999999999995 109.242 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 297' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -90.13 8.85 30.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.769 -1.207 . . . . 2.4900000000000002 109.91 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.44 11.43 82.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.903 -1.279 . . . . 0.59999999999999998 109.903 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 299' ' ' ILE . . . . . . . . . . . . . 97.8 mt -84.71 134.56 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.974 -1.309 . . . . 0.53000000000000003 109.151 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 300' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -82.0 141.66 33.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.869 . . . . 2.2999999999999998 110.615 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 301' ' ' LEU . . . . . . . . . . . . . 66.9 mt -123.08 111.27 16.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.269 -0.641 . . . . 0.54000000000000004 109.269 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 302' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.57 139.87 49.69 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.9 . . . . 2.2599999999999998 110.289 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 303' ' ' VAL . . . . . 0.611 ' CG2' ' SD ' ' C' ' 314' ' ' MET . 51.8 t -111.99 124.77 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.673 -0.862 . . . . 0.55000000000000004 108.673 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 304' ' ' ARG . . . . . 0.459 ' HE ' ' CG ' ' C' ' 264' ' ' ASN . 33.4 ptt180 -164.93 137.87 4.64 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.505 -0.878 . . . . 2.7000000000000002 110.343 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 305' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -80.82 -45.42 16.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 3.1899999999999999 109.817 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 306' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.33 154.01 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.106 -0.996 . . . . 0.65000000000000002 108.737 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 307' ' ' SER . . . . . . . . . . . . . 83.5 p -64.55 -16.29 62.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.983 -1.073 . . . . 1.3600000000000001 109.516 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 308' ' ' THR . . . . . 0.539 ' CG2' ' NH2' ' C' ' 181' ' ' ARG . 44.5 p -86.14 -9.07 57.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.047 -1.033 . . . . 0.84999999999999998 110.005 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 309' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -92.49 152.69 42.35 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.025 -1.047 . . . . 0.81000000000000005 109.936 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 310' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -55.37 139.15 81.42 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.968 1.779 . . . . 0.93000000000000005 111.755 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 311' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -84.24 132.82 34.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 3.0899999999999999 109.823 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 312' ' ' LEU . . . . . . . . . . . . . 80.2 mt -117.51 154.74 30.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.103 -0.998 . . . . 0.72999999999999998 108.309 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 313' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -91.26 130.49 37.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.076 -1.015 . . . . 2.2400000000000002 109.827 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 314' ' ' MET . . . . . 0.611 ' SD ' ' CG2' ' C' ' 303' ' ' VAL . 8.2 tpt -56.39 -44.17 79.97 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.67 -0.644 . . . . 1.03 109.63 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 315' ' ' MET . . . . . . . . . . . . . 95.9 mmm -61.18 -40.39 93.73 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.299 -0.876 . . . . 1.71 110.22 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 316' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.9 -44.0 97.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.319 -0.863 . . . . 0.81999999999999995 109.81 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 317' ' ' LEU . . . . . . . . . . . . . 92.8 mt -66.49 -41.98 88.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.877 . . . . 0.80000000000000004 110.036 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 318' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.26 -24.49 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.311 -0.868 . . . . 0.85999999999999999 109.957 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 319' ' ' SER . . . . . 0.475 ' O ' ' C ' ' C' ' 323' ' ' LYS . 0.9 OUTLIER -72.72 -31.56 65.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.084 -1.01 . . . . 1.52 109.518 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 320' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -84.19 -2.45 56.9 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.78 -1.168 . . . . 2.04 109.167 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 321' ' ' ILE . . . . . 0.561 HG21 HG21 ' C' ' 275' ' ' THR . 93.2 mt -113.76 -58.74 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.914 -1.143 . . . . 1.1699999999999999 107.914 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 322' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' C' ' 323' ' ' LYS . 12.3 t0 -95.01 85.11 4.26 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.16 -1.792 . . . . 2.2599999999999998 106.16 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 323' ' ' LYS . . . . . 1.262 ' HA ' ' NZ ' ' C' ' 323' ' ' LYS . 0.0 OUTLIER . . . . . 1 C--O 1.524 15.537 0 CA-C-O 126.309 2.957 . . . . 5.9199999999999999 109.465 -177.693 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.548 ' HB ' ' HG2' ' A' ' 105' ' ' ARG . 76.6 p . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 121.106 0.479 . . . . 0.44 111.038 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.614 ' O ' ' HD2' ' A' ' 105' ' ' ARG . 47.0 mt -71.24 136.2 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.736 -1.95 . . . . 0.38 105.736 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.98 144.42 36.76 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 115.292 -0.867 . . . . 0.34999999999999998 110.744 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.3 mt -126.27 130.14 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.825 0.85 . . . . 0.31 109.053 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.29 129.28 74.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.035 -1.839 . . . . 0.32000000000000001 106.035 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 mt -109.11 131.73 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.445 -0.576 . . . . 0.26000000000000001 109.445 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.75 135.83 7.43 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.791 -1.324 . . . . 0.23999999999999999 109.791 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 13' ' ' ALA . 8.2 t -151.78 164.71 36.44 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.025 -1.28 . . . . 0.26000000000000001 109.592 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' NEP . . . . . 0.568 ' ND1' ' OD2' ' A' ' 67' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.89 -140.3 15.77 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.02 -1.232 . . . . 0.31 110.02 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -130.69 32.1 4.43 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.233 -1.157 . . . . 0.78000000000000003 110.447 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.521 ' HB3' HG21 ' A' ' 9' ' ' THR . . . -75.51 -27.27 58.68 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 115.277 1.584 . . . . 0.25 115.277 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.7 -46.48 74.15 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.827 0.74 . . . . 0.26000000000000001 112.799 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -59.79 -40.39 88.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.593 -0.443 . . . . 0.44 111.224 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.31 -35.22 73.53 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.105 1.15 . . . . 0.38 114.105 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.05 -39.99 95.3 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.139 -1.43 . . . . 0.27000000000000002 107.139 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.13 -43.47 91.81 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.149 -0.685 . . . . 0.34000000000000002 109.149 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -61.56 -39.18 90.2 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.242 0.544 . . . . 0.44 111.234 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.432 HG23 ' HB3' ' B' ' 10' ' ' NEP . 17.4 m -63.96 -47.64 79.64 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 115.048 -0.978 . . . . 0.37 108.609 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.71 86.11 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 119.754 -0.778 . . . . 0.39000000000000001 111.465 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.96 -23.34 65.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.103 -0.499 . . . . 2.5 110.692 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.47 -32.01 69.39 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 105.703 -1.962 . . . . 2.5899999999999999 105.703 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.8 mt -84.74 -38.38 19.74 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 113.817 1.043 . . . . 0.48999999999999999 113.817 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -109.6 -12.03 14.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 119.025 2.972 . . . . 0.5 119.025 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.98 165.07 31.38 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 105.457 -3.057 . . . . 0.51000000000000001 105.457 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -58.82 138.97 56.96 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 122.41 1.1 . . . . 0.57999999999999996 112.611 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -105.91 146.75 29.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.264 -1.789 . . . . 0.45000000000000001 113.038 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -106.46 157.34 17.72 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.497 -1.229 . . . . 0.54000000000000004 107.816 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.25 41.22 20.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.096 1.147 . . . . 0.41999999999999998 114.096 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.8 t -131.09 134.53 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.381 -0.97 . . . . 0.38 108.381 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.66 18.93 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 109.899 -1.28 . . . . 0.34999999999999998 109.899 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.22 157.76 36.4 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 118.203 1.001 . . . . 0.40999999999999998 108.921 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.84 159.15 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.453 -0.794 . . . . 0.35999999999999999 110.29 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -113.46 162.85 15.63 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.757 -0.656 . . . . 0.41999999999999998 109.592 173.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 36' ' ' PHE . 1.9 t80 -134.19 117.5 16.57 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.886 -1.524 . . . . 0.40999999999999998 106.886 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.6 t -108.11 145.44 31.45 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 113.92 -1.491 . . . . 0.48999999999999999 110.848 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -57.06 136.08 74.54 Favored 'Trans proline' 0 C--N 1.352 0.752 0 N-CA-C 107.929 -1.604 . . . . 0.53000000000000003 107.929 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.55 -25.75 16.55 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.065 -1.214 . . . . 0.57999999999999996 110.065 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.34 157.66 21.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.373 0.606 . . . . 0.52000000000000002 110.009 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -125.08 179.29 5.11 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.343 -0.984 . . . . 2.23 108.343 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.19 72.97 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 113.003 0.742 . . . . 0.48999999999999999 113.003 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.86 -36.45 84.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.84 0.828 . . . . 2.8300000000000001 112.164 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.5 m -63.92 -47.58 79.99 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 106.01 -1.848 . . . . 0.56000000000000005 106.01 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.71 -37.48 86.7 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.108 0.781 . . . . 0.46999999999999997 113.108 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.1 mt -58.59 -43.15 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.587 -0.894 . . . . 0.5 108.587 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -62.58 -42.73 99.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.966 -0.694 . . . . 0.58999999999999997 110.875 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -61.58 -44.34 97.21 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 119.347 -0.941 . . . . 0.47999999999999998 111.34 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -61.02 -45.65 93.96 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 120.015 -0.674 . . . . 0.41999999999999998 109.595 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -60.15 -40.04 88.44 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 113.158 0.799 . . . . 0.51000000000000001 113.158 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.58 -35.64 81.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.449 0.643 . . . . 0.52000000000000002 110.135 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.17 -43.61 70.47 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 119.578 -0.849 . . . . 0.45000000000000001 110.205 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.73 -37.92 80.28 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.281 -0.418 . . . . 0.45000000000000001 112.041 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.31 -26.36 29.07 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.699 0.629 . . . . 0.53000000000000003 112.699 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -95.49 -4.75 44.35 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.224 0.824 . . . . 0.53000000000000003 113.224 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 69.8 mt -105.85 157.54 17.4 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 113.313 0.857 . . . . 0.46000000000000002 113.313 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -89.34 107.94 19.35 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 102.541 -3.133 . . . . 0.46999999999999997 102.541 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.9 p -106.98 15.38 25.39 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 124.097 0.873 . . . . 0.44 111.05 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.3 p -64.03 -34.27 77.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 115.553 1.686 . . . . 0.48999999999999999 115.553 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.77 -9.39 43.79 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.274 0.559 . . . . 0.48999999999999999 112.271 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.71 172.22 13.03 Favored Glycine 0 C--O 1.242 0.598 0 C-N-CA 119.486 -1.34 . . . . 0.40000000000000002 113.406 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.3 t -139.47 130.17 32.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 N-CA-C 109.273 -0.639 . . . . 0.35999999999999999 109.273 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.8 tp -115.86 113.37 23.26 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.549 1.781 . . . . 0.29999999999999999 108.446 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.68 122.19 33.23 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 106.507 -1.664 . . . . 0.34000000000000002 106.507 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.0 mt -109.55 115.25 29.56 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 104.519 -2.4 . . . . 0.22 104.519 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.4 m -119.93 163.31 17.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 113.221 0.823 . . . . 0.23000000000000001 113.221 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.568 ' OD2' ' ND1' ' A' ' 10' ' ' NEP . 14.3 p-10 -64.94 -54.05 36.8 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 118.031 2.604 . . . . 0.27000000000000002 118.031 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -142.23 151.41 42.09 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 122.541 1.163 . . . . 0.26000000000000001 112.693 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -66.32 134.47 52.67 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.178 -1.374 . . . . 0.45000000000000001 107.857 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.72 -8.14 70.59 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 121.281 3.272 . . . . 0.38 121.281 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.23 174.9 55.24 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 119.341 -1.409 . . . . 0.34000000000000002 110.065 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.18 -47.77 98.5 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 122.089 -0.653 . . . . 1.24 112.057 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.434 ' HD2' ' NE2' ' A' ' 10' ' ' NEP . 83.3 Cg_exo -53.5 -41.56 72.46 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 118.293 -0.671 . . . . 0.32000000000000001 110.604 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -67.28 -48.26 68.2 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 123.506 0.504 . . . . 0.37 109.865 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -60.1 -42.71 95.24 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.945 1.091 . . . . 1.99 113.945 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.6 85.57 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.388 -0.925 . . . . 0.40999999999999998 111.675 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.83 89.97 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.7 -0.852 . . . . 0.38 108.7 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.685 ' O ' HG13 ' A' ' 82' ' ' VAL . 70.3 m -58.72 -39.82 81.96 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.423 0.527 . . . . 1.3799999999999999 112.423 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.611 ' O ' HG22 ' A' ' 82' ' ' VAL . 33.8 mtt180 -67.31 -29.55 69.15 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 112.957 0.725 . . . . 3.3799999999999999 112.957 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.408 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 76.5 mt -77.15 -42.18 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.755 0.65 . . . . 0.45000000000000001 112.755 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 87' ' ' TYR . 2.6 m -80.15 -16.72 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 115.456 1.65 . . . . 0.45000000000000001 115.456 -175.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 78' ' ' SER . 2.9 m -29.31 -55.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 1 N-CA-C 122.123 4.12 . . . . 0.62 122.123 -177.007 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.55 39.4 3.97 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 116.387 -2.125 . . . . 0.58999999999999997 109.525 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -112.33 133.55 54.37 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 114.505 -1.225 . . . . 0.48999999999999999 109.745 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.23 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 106.732 -1.581 . . . . 0.52000000000000002 106.732 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.67 15.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 115.395 1.628 . . . . 0.46999999999999997 115.395 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.477 ' HB3' ' HB ' ' A' ' 81' ' ' VAL . 6.1 m-85 -127.47 130.92 50.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.538 -2.023 . . . . 0.41999999999999998 105.538 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.59 154.67 41.76 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.29 -0.564 . . . . 0.39000000000000001 110.311 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 t -121.69 128.48 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 106.315 -1.735 . . . . 0.33000000000000002 106.315 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.3 mt -124.16 119.51 56.87 Favored 'Isoleucine or valine' 0 C--O 1.256 1.405 0 N-CA-C 108.258 -1.016 . . . . 0.28999999999999998 108.258 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.4 163.29 19.6 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 114.674 -1.148 . . . . 0.25 112.388 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.71 24.62 55.53 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 114.821 0.688 . . . . 0.19 114.821 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.82 132.73 6.61 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 N-CA-C 113.483 0.92 . . . . 0.16 113.483 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' B' ' 94' ' ' ASN . 50.9 p30 -141.88 169.61 17.28 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.65 -1.241 . . . . 0.23999999999999999 107.65 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 95' ' ' ILE . 50.4 mm -60.22 -43.37 93.47 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 114.522 1.304 . . . . 0.28999999999999998 114.522 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.55 -42.94 55.52 Favored 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 117.584 -1.144 . . . . 0.31 110.343 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 39.8 ttm -61.56 -48.93 78.75 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 120.348 -0.541 . . . . 0.28000000000000003 109.704 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.44 -48.05 83.43 Favored 'General case' 0 C--O 1.201 -1.487 0 N-CA-C 112.784 0.661 . . . . 0.29999999999999999 112.784 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.642 HG11 ' CG ' ' C' ' 177' ' ' GLN . 84.7 t -61.51 -49.8 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 112.729 0.641 . . . . 0.41999999999999998 112.729 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -63.67 -40.51 97.01 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.253 -0.579 . . . . 2.04 111.671 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.3 m -66.24 -46.09 78.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.34999999999999998 110.89 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.5 -37.84 88.93 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 123.537 0.523 . . . . 0.40000000000000002 110.571 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 69.8 mtp -66.12 -45.74 80.0 Favored 'General case' 0 C--O 1.243 0.717 0 O-C-N 121.353 -0.842 . . . . 1.7 112.099 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.86 75.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.179 0.807 . . . . 0.44 113.179 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.614 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 15.7 ttp180 -52.6 -32.63 42.43 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 113.4 0.889 . . . . 0.42999999999999999 113.4 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -73.6 -19.6 60.83 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 114.001 1.111 . . . . 2.1899999999999999 114.001 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -90.67 18.24 6.64 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.204 1.002 . . . . 2.2000000000000002 109.49 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.6 t70 46.69 58.55 16.73 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 117.248 2.314 . . . . 0.51000000000000001 117.248 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.413 ' HG3' HD13 ' A' ' 114' ' ' LEU . 44.8 Cg_endo -74.13 168.5 24.66 Favored 'Trans proline' 0 C--O 1.206 -1.1 0 C-N-CA 120.455 0.77 . . . . 0.46999999999999997 110.659 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.4 p -77.05 162.74 27.27 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.613 -1.625 . . . . 0.48999999999999999 106.613 175.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -55.95 -51.55 67.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 112.373 0.509 . . . . 0.42999999999999999 112.373 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.51 -37.73 76.21 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 112.924 0.712 . . . . 0.51000000000000001 112.924 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -62.8 -46.87 85.94 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.416 -0.356 . . . . 0.54000000000000004 110.156 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.413 HD13 ' HG3' ' A' ' 109' ' ' PRO . 15.0 tp -64.26 -45.97 85.78 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 121.087 -0.245 . . . . 0.40999999999999998 111.235 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.91 -48.3 81.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.583 -0.447 . . . . 0.37 110.478 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.83 -44.31 94.1 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.202 0.525 . . . . 0.45000000000000001 112.338 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.34 -42.93 99.79 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 122.071 -0.393 . . . . 0.44 111.009 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.06 94.48 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 119.748 -0.781 . . . . 0.34999999999999998 112.096 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.65 -46.26 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.83 -0.433 . . . . 0.38 109.83 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -63.65 -45.29 90.84 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.678 0.992 . . . . 0.52000000000000002 113.678 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.2 p -71.42 -32.35 68.29 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 120.607 -0.437 . . . . 0.40999999999999998 111.867 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.41 -45.58 95.63 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.362 -1.495 . . . . 0.32000000000000001 109.362 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.43 -42.01 65.53 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 112.588 0.588 . . . . 0.46000000000000002 112.588 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.52 -20.32 62.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 119.609 -0.836 . . . . 2.3999999999999999 111.899 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.61 -16.69 76.03 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 124.203 0.939 . . . . 0.37 113.559 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.6 t -88.97 112.98 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 106.193 -1.78 . . . . 0.40000000000000002 106.193 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -156.43 136.92 13.11 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.387 -0.968 . . . . 2.8799999999999999 108.387 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.65 146.67 23.98 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 122.043 0.925 . . . . 0.5 109.996 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 tp -66.84 -56.53 9.97 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.314 -0.857 . . . . 0.56999999999999995 111.407 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 62.48 178.69 0.14 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.653 0.739 . . . . 2.7999999999999998 110.403 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.18 146.25 53.57 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.691 -0.855 . . . . 1.1599999999999999 108.691 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.716 ' HD3' HD11 ' C' ' 207' ' ' LEU . 0.8 OUTLIER -113.01 145.21 32.61 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.581 -0.699 . . . . 4.8099999999999996 109.317 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.437 ' HG2' HG21 ' C' ' 206' ' ' THR . 21.8 Cg_endo -64.24 146.97 91.09 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.513 2.142 . . . . 2.9500000000000002 112.472 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.615 HG12 HG22 ' C' ' 203' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 118.043 -0.979 . . . . 3.7400000000000002 109.095 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 2' ' ' THR . . . . . 0.531 ' HB ' ' HG2' ' B' ' 105' ' ' ARG . 77.3 p . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.166 0.508 . . . . 0.37 111.01 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.633 ' O ' ' HD2' ' B' ' 105' ' ' ARG . 47.1 mt -71.25 136.18 26.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 105.791 -1.929 . . . . 0.39000000000000001 105.791 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.99 144.43 36.73 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.387 -0.824 . . . . 0.34000000000000002 110.795 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 44.6 mt -126.23 130.25 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.764 0.826 . . . . 0.28000000000000003 108.981 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 86.4 t -124.42 129.27 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.004 -1.85 . . . . 0.33000000000000002 106.004 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 35.7 mt -109.06 131.71 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 109.548 -0.538 . . . . 0.28999999999999998 109.548 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.79 135.71 7.35 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.817 -1.313 . . . . 0.31 109.817 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.496 HG21 ' HB3' ' B' ' 13' ' ' ALA . 7.9 t -152.13 165.63 34.16 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.083 -1.245 . . . . 0.35999999999999999 109.77 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' NEP . . . . . 0.749 ' P ' ' NE2' ' B' ' 10' ' ' NEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.53 -138.94 19.03 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.327 -1.416 . . . . 0.40000000000000002 110.93 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -131.25 32.04 4.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.469 -1.018 . . . . 0.78000000000000003 110.628 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.496 ' HB3' HG21 ' B' ' 9' ' ' THR . . . -75.5 -27.17 58.66 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 115.216 1.562 . . . . 0.29999999999999999 115.216 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' B' ' 9' ' ' THR . . . -54.74 -46.44 74.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.887 0.767 . . . . 0.27000000000000002 112.834 -176.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.79 -40.35 88.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.958 -0.464 . . . . 0.39000000000000001 111.265 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.19 -35.46 73.97 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.056 1.132 . . . . 0.34999999999999998 114.056 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.02 -39.95 95.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.09 -1.448 . . . . 0.20000000000000001 107.09 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 18.6 tp -65.21 -43.39 91.68 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 109.192 -0.67 . . . . 0.25 109.192 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -61.62 -39.11 90.1 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 121.242 0.544 . . . . 0.35999999999999999 111.266 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.9 -47.64 79.77 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-N 115.056 -0.975 . . . . 0.23000000000000001 108.59 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.7 86.26 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.681 -0.808 . . . . 0.23999999999999999 111.49 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.98 -23.21 65.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.014 -0.539 . . . . 2.54 110.755 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.66 -31.87 68.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.689 -1.967 . . . . 2.5899999999999999 105.689 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 45.6 mt -84.75 -38.3 19.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.837 1.051 . . . . 0.34000000000000002 113.837 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 91.3 mt -109.66 -11.98 14.69 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 119.046 2.98 . . . . 0.34999999999999998 119.046 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.83 165.08 31.57 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 105.521 -3.032 . . . . 0.34000000000000002 105.521 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.69 138.99 56.72 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.338 1.066 . . . . 0.41999999999999998 112.687 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -106.06 146.7 29.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.272 -1.785 . . . . 0.29999999999999999 112.963 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -106.37 157.34 17.69 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 114.434 -1.257 . . . . 0.39000000000000001 107.794 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.13 41.3 20.68 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.085 1.142 . . . . 0.34000000000000002 114.085 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 93.7 t -131.08 134.62 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.31 -0.996 . . . . 0.29999999999999999 108.31 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.73 18.91 Favored Glycine 0 N--CA 1.469 0.886 0 N-CA-C 109.82 -1.312 . . . . 0.31 109.82 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.26 157.69 36.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.167 0.983 . . . . 0.39000000000000001 108.953 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.79 159.1 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.577 -0.738 . . . . 0.40999999999999998 110.306 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.36 162.78 15.66 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.713 -0.676 . . . . 0.46999999999999997 109.617 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' B' ' 36' ' ' PHE . 2.3 t80 -134.16 117.56 16.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.888 -1.523 . . . . 0.53000000000000003 106.888 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 95.0 t -108.1 145.42 31.42 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.943 -1.481 . . . . 0.57999999999999996 110.855 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -57.01 136.14 74.96 Favored 'Trans proline' 0 C--N 1.352 0.719 0 N-CA-C 107.949 -1.597 . . . . 0.64000000000000001 107.949 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.48 -25.78 16.61 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.126 -1.19 . . . . 0.68999999999999995 110.126 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.27 157.66 21.48 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.336 0.588 . . . . 0.64000000000000001 110.031 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' B' ' 41' ' ' ASN . 29.5 p-10 -125.06 179.31 5.1 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.372 -0.973 . . . . 2.3199999999999998 108.372 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.13 73.0 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 112.972 0.73 . . . . 0.60999999999999999 112.972 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.77 -36.58 84.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.934 0.873 . . . . 2.8199999999999998 112.163 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 89.4 m -63.9 -47.53 80.25 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 105.987 -1.857 . . . . 0.65000000000000002 105.987 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.74 -37.68 87.52 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 112.979 0.733 . . . . 0.56000000000000005 112.979 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.47 -43.14 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.635 -0.876 . . . . 0.60999999999999999 108.635 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -62.66 -42.72 99.77 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 119.984 -0.686 . . . . 0.65000000000000002 110.825 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.52 -44.42 97.1 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 119.346 -0.942 . . . . 0.53000000000000003 111.47 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -60.89 -45.72 93.5 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 119.986 -0.686 . . . . 0.46999999999999997 109.637 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -60.09 -40.14 88.55 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 113.131 0.789 . . . . 0.56999999999999995 113.131 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.5 -35.61 81.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.434 0.635 . . . . 0.52000000000000002 110.17 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.11 -43.83 70.23 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 119.572 -0.851 . . . . 0.45000000000000001 110.141 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.55 -38.0 79.92 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.261 -0.427 . . . . 0.45000000000000001 112.048 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.27 -26.32 28.39 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.744 0.646 . . . . 0.51000000000000001 112.744 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -95.57 -4.73 44.13 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 113.126 0.787 . . . . 0.47999999999999998 113.126 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 69.4 mt -105.77 157.43 17.45 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.396 0.888 . . . . 0.40999999999999998 113.396 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -89.34 107.99 19.38 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 102.557 -3.127 . . . . 0.41999999999999998 102.557 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 72.9 p -107.09 15.4 25.26 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 124.153 0.908 . . . . 0.45000000000000001 111.064 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 73.0 p -63.95 -34.29 77.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 115.595 1.702 . . . . 0.47999999999999998 115.595 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.87 -9.35 43.61 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.267 0.556 . . . . 0.46999999999999997 112.202 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.74 172.19 13.02 Favored Glycine 0 C--O 1.242 0.642 0 C-N-CA 119.484 -1.341 . . . . 0.42999999999999999 113.383 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.41 130.25 32.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 109.259 -0.645 . . . . 0.40000000000000002 109.259 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp -115.84 113.42 23.34 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.497 1.748 . . . . 0.34999999999999998 108.411 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.78 122.17 33.29 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.491 -1.67 . . . . 0.40999999999999998 106.491 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 83.2 mt -109.52 115.27 29.61 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 104.531 -2.396 . . . . 0.28000000000000003 104.531 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 26.0 m -120.01 163.4 17.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 113.186 0.81 . . . . 0.34000000000000002 113.186 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' B' ' 67' ' ' ASP . 14.8 p-10 -64.9 -54.07 36.53 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 118.069 2.618 . . . . 0.39000000000000001 118.069 -177.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 45.3 p -142.23 151.4 42.06 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.533 1.158 . . . . 0.39000000000000001 112.692 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' TRP . . . . . 0.58 ' HE1' HG11 ' C' ' 211' ' ' VAL . 32.8 t-105 -66.27 134.45 52.67 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.153 -1.385 . . . . 0.59999999999999998 107.818 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.73 -8.14 70.6 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 121.218 3.247 . . . . 0.52000000000000002 121.218 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.2 174.92 55.25 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 119.282 -1.437 . . . . 0.47999999999999998 110.109 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.15 -47.84 98.4 Favored Pre-proline 0 C--N 1.329 -0.291 0 O-C-N 122.017 -0.696 . . . . 1.3100000000000001 112.01 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -53.44 -41.6 71.92 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 118.391 -0.606 . . . . 0.45000000000000001 110.619 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -67.2 -48.37 68.1 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 123.458 0.474 . . . . 0.5 109.845 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -60.05 -42.71 95.08 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.972 1.101 . . . . 2.04 113.972 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.46 85.71 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.242 -0.983 . . . . 0.52000000000000002 111.721 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.05 -38.83 90.25 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 108.618 -0.882 . . . . 0.48999999999999999 108.618 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.684 ' O ' HG13 ' B' ' 82' ' ' VAL . 70.5 m -58.65 -39.89 81.88 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.416 0.524 . . . . 1.3999999999999999 112.416 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.619 ' O ' HG22 ' B' ' 82' ' ' VAL . 34.0 mtt180 -67.2 -29.58 69.28 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 113.042 0.756 . . . . 3.4700000000000002 113.042 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 76.1 mt -77.2 -42.15 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.697 0.629 . . . . 0.55000000000000004 112.697 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' B' ' 87' ' ' TYR . 2.6 m -80.03 -16.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.901 0 N-CA-C 115.465 1.654 . . . . 0.56000000000000005 115.465 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' VAL . . . . . 0.684 HG13 ' O ' ' B' ' 78' ' ' SER . 2.9 m -29.4 -55.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.352 1 N-CA-C 122.096 4.11 . . . . 0.73999999999999999 122.096 -176.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.49 39.3 3.99 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 116.394 -2.122 . . . . 0.71999999999999997 109.601 178.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.37 133.55 54.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.442 -1.254 . . . . 0.60999999999999999 109.748 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.25 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 106.707 -1.59 . . . . 0.63 106.707 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.68 15.24 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 115.406 1.632 . . . . 0.55000000000000004 115.406 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' TYR . . . . . 0.479 ' HB3' ' HB ' ' B' ' 81' ' ' VAL . 6.1 m-85 -127.45 130.89 50.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 105.506 -2.035 . . . . 0.48999999999999999 105.506 175.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.6 154.66 41.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.228 -0.589 . . . . 0.48999999999999999 110.357 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.77 128.47 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 106.235 -1.765 . . . . 0.44 106.235 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 34.2 mt -124.14 119.52 56.93 Favored 'Isoleucine or valine' 0 C--O 1.255 1.378 0 N-CA-C 108.245 -1.02 . . . . 0.35999999999999999 108.245 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.46 163.21 19.59 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 114.738 -1.119 . . . . 0.35999999999999999 112.314 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.89 24.49 55.33 Favored Glycine 0 CA--C 1.499 -0.911 0 N-CA-C 114.817 0.687 . . . . 0.28999999999999998 114.817 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.85 132.85 6.69 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 N-CA-C 113.461 0.911 . . . . 0.22 113.461 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' A' ' 94' ' ' ASN . 51.2 p30 -141.98 169.48 17.52 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.688 -1.227 . . . . 0.20000000000000001 107.688 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 51.3 mm -60.2 -43.37 93.54 Favored Pre-proline 0 C--O 1.24 0.588 0 N-CA-C 114.491 1.293 . . . . 0.17000000000000001 114.491 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.55 -42.85 56.53 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 117.575 -1.15 . . . . 0.23000000000000001 110.34 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 39.9 ttm -61.72 -48.85 78.86 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 120.377 -0.529 . . . . 0.26000000000000001 109.633 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.46 -48.01 83.62 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 112.822 0.675 . . . . 0.20000000000000001 112.822 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.52 -49.9 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 112.715 0.635 . . . . 0.26000000000000001 112.715 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -63.52 -40.59 97.43 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 120.235 -0.586 . . . . 2.0099999999999998 111.696 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' THR . . . . . . . . . . . . . 53.5 m -66.23 -46.12 78.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.731 -0.668 . . . . 0.28000000000000003 110.892 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.47 -37.79 88.76 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 123.607 0.567 . . . . 0.28999999999999998 110.563 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' MET . . . . . . . . . . . . . 72.6 mtp -66.1 -45.81 79.84 Favored 'General case' 0 C--O 1.242 0.695 0 O-C-N 121.264 -0.897 . . . . 1.76 112.132 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' B' ' 109' ' ' PRO . . . -67.72 -33.81 75.62 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.3 0.852 . . . . 0.38 113.3 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.633 ' HD2' ' O ' ' B' ' 3' ' ' ILE . 15.8 ttp180 -52.56 -32.69 42.16 Favored 'General case' 0 C--O 1.21 -1.013 0 N-CA-C 113.4 0.889 . . . . 0.37 113.4 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.57 -19.59 60.85 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 114.1 1.148 . . . . 2.1299999999999999 114.1 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -90.62 18.15 6.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 122.159 0.981 . . . . 2.27 109.476 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 12.7 t70 46.79 58.47 16.88 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 117.269 2.322 . . . . 0.47999999999999998 117.269 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.42 ' HG3' HD13 ' B' ' 114' ' ' LEU . 44.9 Cg_endo -74.09 168.43 24.82 Favored 'Trans proline' 0 C--O 1.206 -1.109 0 C-N-CA 120.55 0.833 . . . . 0.46999999999999997 110.604 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 54.3 p -77.0 162.78 27.28 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.706 -1.59 . . . . 0.53000000000000003 106.706 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -55.94 -51.48 67.5 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 112.445 0.535 . . . . 0.47999999999999998 112.445 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -58.67 -37.67 76.51 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 112.897 0.703 . . . . 0.59999999999999998 112.897 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -62.84 -46.77 86.37 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 116.417 -0.356 . . . . 0.56999999999999995 110.141 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.42 HD13 ' HG3' ' B' ' 109' ' ' PRO . 15.1 tp -64.41 -45.86 85.77 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 121.019 -0.272 . . . . 0.42999999999999999 111.191 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 63.5 t -56.88 -48.32 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 O-C-N 121.891 -0.506 . . . . 0.44 110.52 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.25 94.3 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.133 0.492 . . . . 0.48999999999999999 112.326 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 tp -62.4 -42.8 99.71 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 122.125 -0.359 . . . . 0.41999999999999998 110.989 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.29 -45.1 94.51 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 119.798 -0.761 . . . . 0.34999999999999998 112.059 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.61 -46.26 89.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.803 -0.443 . . . . 0.41999999999999998 109.803 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -63.71 -45.22 90.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 113.717 1.006 . . . . 0.52000000000000002 113.717 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 34.6 p -71.44 -32.28 68.16 Favored 'General case' 0 C--O 1.216 -0.681 0 C-N-CA 120.585 -0.446 . . . . 0.35999999999999999 111.987 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.38 -45.74 95.31 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.332 -1.507 . . . . 0.29999999999999999 109.332 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.21 -42.15 66.11 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 112.622 0.601 . . . . 0.47999999999999998 112.622 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.43 -20.27 62.92 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 119.578 -0.849 . . . . 2.4199999999999999 111.964 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.78 -16.6 76.3 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 124.246 0.966 . . . . 0.31 113.511 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 93.7 t -88.99 113.07 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 106.171 -1.789 . . . . 0.34000000000000002 106.171 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -156.45 136.84 13.03 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.409 -0.96 . . . . 2.9500000000000002 108.409 -173.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.6 146.71 23.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.031 0.92 . . . . 0.40000000000000002 109.986 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 tp -66.94 -56.78 8.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.337 -0.847 . . . . 0.45000000000000001 111.37 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 62.63 178.8 0.14 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.612 0.72 . . . . 2.8300000000000001 110.401 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.97 146.22 53.78 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.719 -0.845 . . . . 1.3400000000000001 108.719 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.413 ' H ' ' HG2' ' B' ' 132' ' ' LYS . 0.8 OUTLIER -112.87 145.23 32.61 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.513 -0.742 . . . . 4.96 109.219 -179.621 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 133' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -64.41 146.97 90.57 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.474 2.116 . . . . 3.1000000000000001 112.42 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.988 -1.006 . . . . 3.8900000000000001 109.133 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 159' ' ' ASN . . . . . 0.559 ' OD1' ' NZ ' ' C' ' 259' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 108.992 -0.744 . . . . 6.3399999999999999 108.992 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 160' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -85.87 25.5 1.1 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.59 -0.893 . . . . 3.8900000000000001 108.59 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 161' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -118.63 -141.88 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.583 -0.895 . . . . 1.72 108.583 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 162' ' ' MET . . . . . 0.594 ' SD ' HG21 ' C' ' 240' ' ' VAL . 0.3 OUTLIER -61.63 156.19 20.55 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.764 -1.21 . . . . 2.0 110.562 -178.858 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 163' ' ' VAL . . . . . . . . . . . . . 94.9 t -113.11 117.68 56.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.06 -0.719 . . . . 0.63 109.06 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 164' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.73 103.39 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.49 -0.929 . . . . 0.46000000000000002 108.49 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.59 -35.33 80.7 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.211 -1.555 . . . . 0.44 109.211 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 tp -172.04 147.97 2.18 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.771 -1.172 . . . . 0.46999999999999997 111.209 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 167' ' ' ALA . . . . . . . . . . . . . . . -117.69 104.39 10.96 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.048 -0.723 . . . . 0.28999999999999998 109.048 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 168' ' ' ARG . . . . . 0.941 ' NH1' HG12 ' C' ' 178' ' ' VAL . 44.4 ttp180 -106.37 126.09 51.81 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.972 0.891 . . . . 3.1400000000000001 110.835 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 169' ' ' ILE . . . . . . . . . . . . . 82.3 mt -95.5 129.21 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 109.222 -0.659 . . . . 0.34000000000000002 109.222 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 170' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -165.95 117.04 1.04 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.812 -0.755 . . . . 0.48999999999999999 110.327 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 171' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.97 -9.94 11.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.429 -0.794 . . . . 2.3300000000000001 109.759 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 172' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' C' ' 174' ' ' ILE . 12.4 mtt180 -101.71 -6.49 23.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 2.9500000000000002 110.47 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 173' ' ' LEU . . . . . . . . . . . . . 13.7 mt 59.1 -89.16 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.44 -0.948 . . . . 1.3899999999999999 108.44 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 174' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' C' ' 172' ' ' ARG . 70.8 mt -109.98 116.77 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.069 -1.02 . . . . 0.53000000000000003 110.227 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 175' ' ' HIS . . . . . 0.742 ' ND1' ' P ' ' B' ' 10' ' ' NEP . 10.0 p80 -139.35 117.61 11.95 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.947 -1.095 . . . . 0.65000000000000002 109.033 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.55 -152.74 45.05 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 110.066 -1.214 . . . . 0.56999999999999995 110.066 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 177' ' ' GLN . . . . . 0.642 ' CG ' HG11 ' A' ' 99' ' ' VAL . 18.9 mp0 -91.15 12.21 20.76 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.744 -0.856 . . . . 3.2599999999999998 109.332 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 178' ' ' VAL . . . . . 0.941 HG12 ' NH1' ' C' ' 168' ' ' ARG . 48.1 t -61.54 -42.83 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 0.51000000000000001 108.953 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 179' ' ' ALA . . . . . 0.448 ' O ' ' OG1' ' C' ' 183' ' ' THR . . . -73.16 -36.38 66.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.929 -1.107 . . . . 0.53000000000000003 110.187 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 180' ' ' THR . . . . . . . . . . . . . 21.5 m -66.34 -54.42 24.82 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.697 -0.801 . . . . 0.68000000000000005 109.79 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 181' ' ' ARG . . . . . 0.539 ' NH2' ' CG2' ' C' ' 308' ' ' THR . 55.1 ttt-85 -64.7 -43.62 92.88 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.013 -0.675 . . . . 3.1200000000000001 110.608 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 182' ' ' TRP . . . . . 0.533 ' O ' HG23 ' C' ' 186' ' ' THR . 19.5 m95 -65.82 -32.2 73.6 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.034 -1.041 . . . . 0.90000000000000002 109.591 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 183' ' ' THR . . . . . 0.803 HG21 HG21 ' C' ' 216' ' ' VAL . 71.9 m -65.29 -47.1 77.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.946 -1.096 . . . . 0.58999999999999997 110.252 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -69.66 -42.93 73.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 2.2000000000000002 110.806 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 185' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -68.32 -39.61 81.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.95 -1.094 . . . . 2.52 109.569 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 186' ' ' THR . . . . . 0.533 HG23 ' O ' ' C' ' 182' ' ' TRP . 72.6 p -81.42 -1.26 45.03 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.282 -0.886 . . . . 0.58999999999999997 109.685 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 187' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 52.14 48.42 22.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.055 -1.028 . . . . 2.1000000000000001 108.604 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 188' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.05 133.46 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.164 -0.96 . . . . 1.3700000000000001 110.122 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 189' ' ' SER . . . . . . . . . . . . . 27.8 p -109.75 -6.33 15.32 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.761 -0.829 . . . . 1.3999999999999999 108.761 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 190' ' ' ARG . . . . . . . . . . . . . 29.4 mtt-85 -135.92 142.83 44.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.555 -0.716 . . . . 3.52 110.441 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 191' ' ' ILE . . . . . . . . . . . . . 87.6 mt -133.38 127.61 54.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.173 -1.047 . . . . 0.51000000000000001 108.173 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 192' ' ' ILE . . . . . 0.455 HD12 HG11 ' C' ' 240' ' ' VAL . 97.1 mt -115.66 128.68 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.257 -0.902 . . . . 0.46000000000000002 109.665 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 193' ' ' VAL . . . . . . . . . . . . . 53.3 t -99.7 128.88 51.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.825 -0.806 . . . . 0.70999999999999996 108.825 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 194' ' ' VAL . . . . . . . . . . . . . 43.0 t -112.51 103.57 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.535 -0.728 . . . . 0.42999999999999999 109.479 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 195' ' ' SER . . . . . . . . . . . . . 38.0 t -167.25 125.61 1.31 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.342 -0.943 . . . . 1.3799999999999999 109.31 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 196' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.01 -34.88 66.65 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.574 -0.704 . . . . 0.97999999999999998 109.984 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 197' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -65.55 -45.49 83.21 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.147 -0.971 . . . . 2.3199999999999998 109.959 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 198' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.11 -43.21 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.102 -0.998 . . . . 0.70999999999999996 109.028 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.6 -26.5 55.72 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.79 -0.764 . . . . 0.73999999999999999 109.168 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 200' ' ' ALA . . . . . . . . . . . . . . . -84.9 -5.38 59.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.028 -1.045 . . . . 0.89000000000000001 109.882 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 201' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -102.75 95.38 6.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.9 -1.125 . . . . 1.1499999999999999 109.554 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 202' ' ' THR . . . . . . . . . . . . . 24.7 p -66.22 -33.21 75.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.407 -0.808 . . . . 1.6100000000000001 110.631 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 203' ' ' VAL . . . . . 0.615 HG22 HG12 ' A' ' 134' ' ' VAL . 55.8 t -66.33 -47.49 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.851 -1.156 . . . . 0.90000000000000002 109.598 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 204' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -63.69 -42.24 98.04 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.349 -0.94 . . . . 3.0699999999999998 109.576 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 205' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -58.01 -42.42 85.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 1.72 109.482 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 206' ' ' THR . . . . . 0.437 HG21 ' HG2' ' A' ' 133' ' ' PRO . 73.2 m -60.63 -48.71 80.55 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.088 -1.045 . . . . 0.92000000000000004 109.564 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 207' ' ' LEU . . . . . 0.716 HD11 ' HD3' ' A' ' 132' ' ' LYS . 30.6 mt -62.62 -44.45 96.26 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.934 -1.107 . . . . 0.81999999999999995 110.736 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 208' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' C' ' 208' ' ' LEU . 81.6 mt -62.5 -41.45 98.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.718 -1.239 . . . . 0.72999999999999998 110.055 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 209' ' ' THR . . . . . . . . . . . . . 35.8 p -67.89 -31.83 71.89 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.371 -0.831 . . . . 0.83999999999999997 110.28 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 210' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -80.37 -17.54 51.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.782 -1.199 . . . . 2.3199999999999998 110.857 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 211' ' ' VAL . . . . . 0.58 HG11 ' HE1' ' B' ' 69' ' ' TRP . 17.5 m -107.69 17.65 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.952 -1.092 . . . . 0.93000000000000005 108.639 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.29 123.42 82.48 Favored Pre-proline 0 N--CA 1.483 1.221 0 N-CA-C 107.82 -1.178 . . . . 0.76000000000000001 107.82 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 213' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -44.31 144.48 2.95 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.037 1.825 . . . . 0.93000000000000005 112.731 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 214' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -56.52 134.85 66.98 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.196 1.931 . . . . 1.1399999999999999 112.028 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 215' ' ' GLY . . . . . . . . . . . . . . . 79.91 -8.52 50.03 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.922 -1.271 . . . . 0.84999999999999998 109.922 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 216' ' ' VAL . . . . . 0.803 HG21 HG21 ' C' ' 183' ' ' THR . 58.6 t -114.8 136.78 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -1.076 . . . . 0.92000000000000004 108.8 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.87 135.77 45.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.438 -0.789 . . . . 1.4199999999999999 109.836 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 218' ' ' ALA . . . . . . . . . . . . . . . -110.17 131.37 55.12 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.315 -0.994 . . . . 0.64000000000000001 108.315 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -120.97 153.51 37.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.401 -0.812 . . . . 0.71999999999999997 109.808 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 54.8 t -126.35 117.83 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.624 0.726 . . . . 0.59999999999999998 109.07 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 31.7 m -141.01 165.14 19.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.412 -0.805 . . . . 0.56999999999999995 109.622 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 222' ' ' ASP . . . . . 0.709 ' OD1' ' N ' ' C' ' 225' ' ' LYS . 6.8 p30 -94.18 167.23 11.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.479 -0.763 . . . . 1.3400000000000001 109.305 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.46 -44.82 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.151 -0.968 . . . . 0.54000000000000004 110.455 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 224' ' ' ALA . . . . . 0.852 ' O ' HG22 ' C' ' 227' ' ' ILE . . . -62.72 -44.73 95.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.934 -1.104 . . . . 0.67000000000000004 109.398 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 225' ' ' LYS . . . . . 0.709 ' N ' ' OD1' ' C' ' 222' ' ' ASP . 45.7 tttm -68.14 -35.35 77.95 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.775 -1.203 . . . . 2.1099999999999999 109.674 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 226' ' ' MET . . . . . . . . . . . . . 10.3 tpt -62.08 -40.4 95.71 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.934 -1.104 . . . . 1.54 111.191 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 227' ' ' ILE . . . . . 0.852 HG22 ' O ' ' C' ' 224' ' ' ALA . 17.4 tt -60.9 -34.56 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.611 -0.885 . . . . 0.68999999999999995 108.611 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.47 -38.86 62.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.722 -0.611 . . . . 4.0099999999999998 110.948 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 70.3 t -62.18 -41.73 92.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.864 -1.162 . . . . 0.63 107.864 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 230' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' C' ' 230' ' ' TYR . 36.7 t80 -67.04 -32.13 73.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.102 -0.999 . . . . 0.64000000000000001 109.927 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 231' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.76 6.73 2.34 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.119 -0.988 . . . . 0.94999999999999996 110.104 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 232' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -110.18 117.78 50.87 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.246 -0.909 . . . . 0.93000000000000005 109.435 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 233' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -65.73 1.51 2.19 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.646 1.564 . . . . 0.98999999999999999 111.98 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 234' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.36 -24.76 65.33 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 1.5900000000000001 108.807 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 235' ' ' TYR . . . . . 0.501 ' O ' ' HB2' ' C' ' 238' ' ' GLU . 81.1 m-85 -105.49 15.71 26.66 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.594 -0.842 . . . . 1.1899999999999999 109.003 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.81 135.62 47.44 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.076 -1.64 . . . . 0.67000000000000004 109.65 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.78 -33.41 1.9 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.288 -1.525 . . . . 0.64000000000000001 109.288 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 238' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' C' ' 235' ' ' TYR . 4.0 mm-40 -54.25 138.93 37.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.805 -1.409 . . . . 2.48 109.437 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 239' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -99.1 116.33 31.08 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.463 -0.939 . . . . 2.96 108.463 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 240' ' ' VAL . . . . . 0.594 HG21 ' SD ' ' C' ' 162' ' ' MET . 26.3 t -121.85 148.78 25.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.876 0.846 . . . . 0.66000000000000003 110.448 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 241' ' ' MET . . . . . . . . . . . . . 13.8 ttm -102.9 134.95 45.47 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.925 -1.139 . . . . 1.6299999999999999 107.925 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 242' ' ' LEU . . . . . 0.402 ' HB3' ' CE2' ' C' ' 244' ' ' PHE . 61.2 mt -102.04 127.28 49.0 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.689 -0.804 . . . . 0.34999999999999998 109.877 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 243' ' ' LEU . . . . . . . . . . . . . 97.6 mt -109.5 126.08 53.15 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.981 0.896 . . . . 0.68000000000000005 109.045 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 244' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' C' ' 242' ' ' LEU . 77.7 m-85 -127.0 162.03 26.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.771 0.796 . . . . 0.29999999999999999 109.275 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 245' ' ' THR . . . . . . . . . . . . . 70.2 p -109.48 -19.47 13.23 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.958 -0.756 . . . . 0.42999999999999999 108.958 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 246' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' C' ' 246' ' ' ASN . 17.3 p30 -151.08 141.85 14.91 Favored Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 120.003 -0.679 . . . . 1.0 109.872 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 247' ' ' PRO . . . . . 0.451 ' HG3' ' CE2' ' C' ' 291' ' ' PHE . 7.3 Cg_endo -60.85 -14.63 33.4 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.683 2.255 . . . . 0.58999999999999997 112.1 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 248' ' ' THR . . . . . . . . . . . . . 95.7 m -64.99 -42.66 94.31 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.151 0.976 . . . . 0.64000000000000001 108.624 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 249' ' ' ASP . . . . . 0.42 ' O ' HD12 ' C' ' 253' ' ' LEU . 97.8 m-20 -67.48 -23.4 65.48 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.54 -0.725 . . . . 0.53000000000000003 109.801 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 250' ' ' VAL . . . . . . . . . . . . . 98.3 t -73.62 -43.77 54.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.672 -1.267 . . . . 0.40000000000000002 109.848 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 251' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.41 -35.02 77.92 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.426 -0.953 . . . . 1.51 108.426 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 252' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -62.48 -44.09 97.23 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.723 -0.791 . . . . 3.2400000000000002 110.156 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 253' ' ' LEU . . . . . 0.42 HD12 ' O ' ' C' ' 249' ' ' ASP . 1.2 mp -64.07 -40.42 96.22 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 117.999 -1.48 . . . . 1.0600000000000001 108.876 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 254' ' ' VAL . . . . . 0.57 ' CG2' HD12 ' C' ' 260' ' ' ILE . 70.6 t -60.7 -44.61 97.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 120.835 -1.165 . . . . 0.47999999999999998 108.948 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 255' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.23 -30.97 69.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.018 -1.052 . . . . 2.4700000000000002 109.917 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 256' ' ' GLY . . . . . . . . . . . . . . . -74.28 2.8 43.16 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.498 -1.441 . . . . 0.55000000000000004 109.498 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 257' ' ' GLY . . . . . . . . . . . . . . . 94.37 15.79 45.94 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.627 -1.389 . . . . 0.51000000000000001 109.627 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 258' ' ' VAL . . . . . . . . . . . . . 96.7 t -77.66 139.72 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.034 -1.469 . . . . 0.45000000000000001 107.034 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 259' ' ' LYS . . . . . 0.559 ' NZ ' ' OD1' ' C' ' 159' ' ' ASN . 17.9 tttt -99.01 123.93 43.64 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.089 -1.007 . . . . 3.1200000000000001 110.811 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 260' ' ' ILE . . . . . 0.57 HD12 ' CG2' ' C' ' 254' ' ' VAL . 98.1 mt -129.99 125.67 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.43 -0.794 . . . . 0.40999999999999998 109.147 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 65.9 p -89.51 -31.44 17.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.776 -1.202 . . . . 0.56999999999999995 110.238 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 262' ' ' SER . . . . . . . . . . . . . 15.8 m -159.06 153.51 24.15 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.176 -0.953 . . . . 0.46000000000000002 110.092 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 263' ' ' VAL . . . . . . . . . . . . . 50.9 t -122.74 134.61 65.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.538 -0.912 . . . . 0.37 108.538 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 264' ' ' ASN . . . . . 0.468 ' ND2' ' CH2' ' C' ' 182' ' ' TRP . 33.7 t30 -108.57 128.08 54.51 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.517 0.675 . . . . 1.1699999999999999 110.607 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 265' ' ' VAL . . . . . 0.451 HG21 ' SD ' ' C' ' 314' ' ' MET . 3.2 t -90.64 108.43 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 120.058 -0.657 . . . . 0.40000000000000002 109.68 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 266' ' ' GLY . . . . . . . . . . . . . . . -80.75 -53.94 3.84 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.153 -1.179 . . . . 0.40999999999999998 110.153 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . -172.57 152.93 17.73 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.646 -1.74 . . . . 0.40999999999999998 111.476 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 268' ' ' MET . . . . . 0.44 ' HB2' ' H ' ' C' ' 282' ' ' SER . 97.0 mtp -143.1 118.08 10.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.481 -1.011 . . . . 0.5 110.443 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.34 128.21 21.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.371 -0.831 . . . . 0.56999999999999995 109.523 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 270' ' ' PHE . . . . . 0.536 ' CG ' ' N ' ' C' ' 271' ' ' ARG . 13.3 t80 -69.5 161.8 28.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.92000000000000004 109.618 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 271' ' ' ARG . . . . . 0.536 ' N ' ' CG ' ' C' ' 270' ' ' PHE . 32.7 ttm180 -160.66 158.67 29.24 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.27 -0.972 . . . . 3.23 109.676 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 272' ' ' GLN . . . . . 0.4 ' N ' ' HG2' ' C' ' 271' ' ' ARG . 73.9 mt-30 -66.48 138.25 57.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.081 -1.012 . . . . 2.98 110.459 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 273' ' ' GLY . . . . . . . . . . . . . . . 95.52 -12.32 67.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.818 -1.713 . . . . 0.87 108.818 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 274' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -101.81 163.37 12.29 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.484 -1.01 . . . . 1.6599999999999999 109.388 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 275' ' ' THR . . . . . 0.561 HG21 HG21 ' C' ' 321' ' ' ILE . 20.8 m -109.95 135.83 50.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.674 -0.862 . . . . 0.83999999999999997 108.674 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 276' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -82.02 119.21 23.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.246 -0.909 . . . . 2.77 110.176 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 277' ' ' VAL . . . . . 0.519 HG12 ' CD1' ' C' ' 321' ' ' ILE . 27.5 m -99.22 -28.18 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.81 -0.756 . . . . 0.73999999999999999 109.612 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 278' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' C' ' 279' ' ' ASN . 10.2 t-20 -135.99 -177.16 4.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.658 0.742 . . . . 1.52 109.761 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 279' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' C' ' 278' ' ' ASN . 39.5 m-20 -56.93 -29.88 63.5 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.791 -0.568 . . . . 2.29 110.787 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . -148.06 27.01 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.829 -1.169 . . . . 0.59999999999999998 109.538 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 281' ' ' VAL . . . . . 0.498 ' O ' HG22 ' C' ' 277' ' ' VAL . 60.8 t -118.99 121.98 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.825 0.822 . . . . 0.60999999999999999 109.678 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 282' ' ' SER . . . . . 0.44 ' H ' ' HB2' ' C' ' 268' ' ' MET . 29.0 m -118.64 147.61 43.58 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.447 0.642 . . . . 0.75 110.02 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 283' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.26 142.84 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.446 1.117 . . . . 0.69999999999999996 110.539 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 284' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' C' ' 287' ' ' ASP . 44.1 p-10 -110.61 171.67 7.33 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 106.923 -1.51 . . . . 0.77000000000000002 106.923 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 285' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.18 -24.21 40.12 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.833 -1.167 . . . . 2.3399999999999999 109.587 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 286' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -79.59 -43.46 22.89 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.233 -0.917 . . . . 2.0 110.026 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 287' ' ' ASP . . . . . 0.57 ' N ' ' OD1' ' C' ' 284' ' ' ASP . 93.3 m-20 -64.25 -42.08 96.67 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.237 -0.915 . . . . 0.62 109.096 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 288' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.48 -45.77 97.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.387 -0.821 . . . . 0.72999999999999998 109.518 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 289' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -57.44 -39.6 76.6 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.216 -0.928 . . . . 2.52 110.262 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.37 -41.01 85.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.82 -1.175 . . . . 0.59999999999999998 109.9 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 291' ' ' PHE . . . . . 0.451 ' CE2' ' HG3' ' C' ' 247' ' ' PRO . 40.0 m-85 -63.93 -39.02 93.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.56999999999999995 109.73 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 292' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -64.08 -39.5 94.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.149 -0.969 . . . . 2.0499999999999998 110.226 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 293' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -65.78 -41.54 91.86 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.943 -1.098 . . . . 1.8 109.635 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 294' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.18 -43.22 99.32 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.871 -1.143 . . . . 0.53000000000000003 108.867 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 295' ' ' ASN . . . . . 0.849 ' C ' HD21 ' C' ' 295' ' ' ASN . 0.1 OUTLIER -64.01 -40.01 95.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 1.45 109.953 179.473 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.66 -21.38 65.67 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.815 -1.178 . . . . 0.68999999999999995 109.242 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 297' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -90.13 8.85 30.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.769 -1.207 . . . . 2.4900000000000002 109.91 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.44 11.43 82.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.903 -1.279 . . . . 0.59999999999999998 109.903 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 299' ' ' ILE . . . . . . . . . . . . . 97.8 mt -84.71 134.56 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.974 -1.309 . . . . 0.53000000000000003 109.151 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 300' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -82.0 141.66 33.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.869 . . . . 2.2999999999999998 110.615 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 301' ' ' LEU . . . . . . . . . . . . . 66.9 mt -123.08 111.27 16.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.269 -0.641 . . . . 0.54000000000000004 109.269 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 302' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.57 139.87 49.69 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.9 . . . . 2.2599999999999998 110.289 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 303' ' ' VAL . . . . . 0.611 ' CG2' ' SD ' ' C' ' 314' ' ' MET . 51.8 t -111.99 124.77 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.673 -0.862 . . . . 0.55000000000000004 108.673 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 304' ' ' ARG . . . . . 0.459 ' HE ' ' CG ' ' C' ' 264' ' ' ASN . 33.4 ptt180 -164.93 137.87 4.64 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.505 -0.878 . . . . 2.7000000000000002 110.343 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 305' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -80.82 -45.42 16.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 3.1899999999999999 109.817 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 306' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.33 154.01 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.106 -0.996 . . . . 0.65000000000000002 108.737 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 307' ' ' SER . . . . . . . . . . . . . 83.5 p -64.55 -16.29 62.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.983 -1.073 . . . . 1.3600000000000001 109.516 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 308' ' ' THR . . . . . 0.539 ' CG2' ' NH2' ' C' ' 181' ' ' ARG . 44.5 p -86.14 -9.07 57.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.047 -1.033 . . . . 0.84999999999999998 110.005 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 309' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -92.49 152.69 42.35 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.025 -1.047 . . . . 0.81000000000000005 109.936 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 310' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -55.37 139.15 81.42 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.968 1.779 . . . . 0.93000000000000005 111.755 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 311' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -84.24 132.82 34.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 3.0899999999999999 109.823 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 312' ' ' LEU . . . . . . . . . . . . . 80.2 mt -117.51 154.74 30.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.103 -0.998 . . . . 0.72999999999999998 108.309 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 313' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -91.26 130.49 37.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.076 -1.015 . . . . 2.2400000000000002 109.827 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 314' ' ' MET . . . . . 0.611 ' SD ' ' CG2' ' C' ' 303' ' ' VAL . 8.2 tpt -56.39 -44.17 79.97 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.67 -0.644 . . . . 1.03 109.63 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 315' ' ' MET . . . . . . . . . . . . . 95.9 mmm -61.18 -40.39 93.73 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.299 -0.876 . . . . 1.71 110.22 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 316' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.9 -44.0 97.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.319 -0.863 . . . . 0.81999999999999995 109.81 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 317' ' ' LEU . . . . . . . . . . . . . 92.8 mt -66.49 -41.98 88.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.877 . . . . 0.80000000000000004 110.036 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 318' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.26 -24.49 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.311 -0.868 . . . . 0.85999999999999999 109.957 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 319' ' ' SER . . . . . 0.475 ' O ' ' C ' ' C' ' 323' ' ' LYS . 0.9 OUTLIER -72.72 -31.56 65.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.084 -1.01 . . . . 1.52 109.518 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 320' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -84.19 -2.45 56.9 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.78 -1.168 . . . . 2.04 109.167 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 321' ' ' ILE . . . . . 0.561 HG21 HG21 ' C' ' 275' ' ' THR . 93.2 mt -113.76 -58.74 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.914 -1.143 . . . . 1.1699999999999999 107.914 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 322' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' C' ' 323' ' ' LYS . 12.3 t0 -95.01 85.11 4.26 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.16 -1.792 . . . . 2.2599999999999998 106.16 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 323' ' ' LYS . . . . . 1.262 ' HA ' ' NZ ' ' C' ' 323' ' ' LYS . 0.0 OUTLIER . . . . . 1 C--O 1.524 15.537 0 CA-C-O 126.309 2.957 . . . . 5.9199999999999999 109.465 -177.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.548 ' HB ' ' HG2' ' A' ' 105' ' ' ARG . 76.6 p . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 121.106 0.479 . . . . 0.44 111.038 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.614 ' O ' ' HD2' ' A' ' 105' ' ' ARG . 47.0 mt -71.24 136.2 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.736 -1.95 . . . . 0.38 105.736 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.98 144.42 36.76 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 115.292 -0.867 . . . . 0.35 110.744 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.3 mt -126.27 130.14 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.825 0.85 . . . . 0.31 109.053 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.29 129.28 74.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.035 -1.839 . . . . 0.32 106.035 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 mt -109.11 132.24 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.445 -0.576 . . . . 0.26 109.445 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.55 133.01 6.17 Favored Glycine 0 N--CA 1.463 0.476 0 C-N-CA 120.271 -0.966 . . . . 0.24 111.849 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.68 HG21 ' HB3' ' A' ' 13' ' ' ALA . 14.4 t . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 107.422 -1.325 . . . . 0.26 107.422 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 114.981 0.752 . . . . 0.31 114.981 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -121.95 25.66 9.01 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 114.486 1.291 . . . . 0.78 114.486 -174.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.68 ' HB3' HG21 ' A' ' 9' ' ' THR . . . -78.92 -27.27 43.73 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 115.277 1.584 . . . . 0.25 115.277 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.7 -46.48 74.15 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.827 0.74 . . . . 0.26 112.799 -176.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -59.79 -40.39 88.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.593 -0.443 . . . . 0.44 111.224 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.31 -35.22 73.53 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.105 1.15 . . . . 0.38 114.105 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.05 -39.99 95.3 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.139 -1.43 . . . . 0.27 107.139 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.13 -43.47 91.81 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.149 -0.685 . . . . 0.34 109.149 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -61.56 -39.18 90.2 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.242 0.544 . . . . 0.44 111.234 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.96 -47.64 79.64 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 115.048 -0.978 . . . . 0.37 108.609 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.71 86.11 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 119.754 -0.778 . . . . 0.39 111.465 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.96 -23.34 65.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.103 -0.499 . . . . 2.5 110.692 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.47 -32.01 69.39 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 105.703 -1.962 . . . . 2.59 105.703 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.8 mt -84.74 -38.38 19.74 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 113.817 1.043 . . . . 0.49 113.817 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -109.6 -12.03 14.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 119.025 2.972 . . . . 0.5 119.025 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.98 165.07 31.38 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 105.457 -3.057 . . . . 0.51 105.457 -175.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -58.82 138.97 56.96 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 122.41 1.1 . . . . 0.58 112.611 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -105.91 146.75 29.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.264 -1.789 . . . . 0.45 113.038 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -106.46 157.34 17.72 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.497 -1.229 . . . . 0.54 107.816 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.25 41.22 20.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.096 1.147 . . . . 0.42 114.096 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.8 t -131.09 134.53 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.381 -0.97 . . . . 0.38 108.381 177.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.66 18.93 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 109.899 -1.28 . . . . 0.35 109.899 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.22 157.76 36.4 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 118.203 1.001 . . . . 0.41 108.921 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.84 159.15 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.453 -0.794 . . . . 0.36 110.29 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -113.46 162.85 15.63 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.757 -0.656 . . . . 0.42 109.592 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 36' ' ' PHE . 1.9 t80 -134.19 117.5 16.57 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.886 -1.524 . . . . 0.41 106.886 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.6 t -108.11 145.44 31.45 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 113.92 -1.491 . . . . 0.49 110.848 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -57.06 136.08 74.54 Favored 'Trans proline' 0 C--N 1.352 0.752 0 N-CA-C 107.929 -1.604 . . . . 0.53 107.929 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.55 -25.75 16.55 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.065 -1.214 . . . . 0.58 110.065 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.34 157.66 21.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.373 0.606 . . . . 0.52 110.009 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -125.08 179.29 5.11 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.343 -0.984 . . . . 2.23 108.343 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.19 72.97 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 113.003 0.742 . . . . 0.49 113.003 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.86 -36.45 84.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.84 0.828 . . . . 2.83 112.164 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.5 m -63.92 -47.58 79.99 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 106.01 -1.848 . . . . 0.56 106.01 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.71 -37.48 86.7 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.108 0.781 . . . . 0.47 113.108 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.1 mt -58.59 -43.15 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.587 -0.894 . . . . 0.5 108.587 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -62.58 -42.73 99.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.966 -0.694 . . . . 0.59 110.875 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -61.58 -44.34 97.21 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 119.347 -0.941 . . . . 0.48 111.34 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -61.02 -45.65 93.96 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 120.015 -0.674 . . . . 0.42 109.595 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -60.15 -40.04 88.44 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 113.158 0.799 . . . . 0.51 113.158 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.58 -35.64 81.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.449 0.643 . . . . 0.52 110.135 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.17 -43.61 70.47 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 119.578 -0.849 . . . . 0.45 110.205 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.73 -37.92 80.28 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.281 -0.418 . . . . 0.45 112.041 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.31 -26.36 29.07 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.699 0.629 . . . . 0.53 112.699 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -95.49 -4.75 44.35 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.224 0.824 . . . . 0.53 113.224 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 69.8 mt -105.85 157.54 17.4 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 113.313 0.857 . . . . 0.46 113.313 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -89.34 107.94 19.35 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 102.541 -3.133 . . . . 0.47 102.541 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.9 p -106.98 15.38 25.39 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 124.097 0.873 . . . . 0.44 111.05 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.3 p -64.03 -34.27 77.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 115.553 1.686 . . . . 0.49 115.553 -177.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.77 -9.39 43.79 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.274 0.559 . . . . 0.49 112.271 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.71 172.22 13.03 Favored Glycine 0 C--O 1.242 0.598 0 C-N-CA 119.486 -1.34 . . . . 0.4 113.406 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.3 t -139.47 130.17 32.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 N-CA-C 109.273 -0.639 . . . . 0.36 109.273 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.8 tp -115.86 113.37 23.26 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.549 1.781 . . . . 0.3 108.446 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.68 122.19 33.23 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 106.507 -1.664 . . . . 0.34 106.507 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.0 mt -109.55 115.25 29.56 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 104.519 -2.4 . . . . 0.22 104.519 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.4 m -119.93 163.31 17.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 113.221 0.823 . . . . 0.23 113.221 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 14.3 p-10 -64.94 -54.05 36.8 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 118.031 2.604 . . . . 0.27 118.031 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -142.23 151.41 42.09 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 122.541 1.163 . . . . 0.26 112.693 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -66.32 134.47 52.67 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.178 -1.374 . . . . 0.45 107.857 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.72 -8.14 70.59 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 121.281 3.272 . . . . 0.38 121.281 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.23 174.9 55.24 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 119.341 -1.409 . . . . 0.34 110.065 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.18 -47.77 98.5 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 122.089 -0.653 . . . . 1.24 112.057 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -53.5 -41.56 72.46 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 118.293 -0.671 . . . . 0.32 110.604 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -67.28 -48.26 68.2 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 123.506 0.504 . . . . 0.37 109.865 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -60.1 -42.71 95.24 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.945 1.091 . . . . 1.99 113.945 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.6 85.57 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.388 -0.925 . . . . 0.41 111.675 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.83 89.97 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.7 -0.852 . . . . 0.38 108.7 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.685 ' O ' HG13 ' A' ' 82' ' ' VAL . 70.3 m -58.72 -39.82 81.96 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.423 0.527 . . . . 1.38 112.423 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.611 ' O ' HG22 ' A' ' 82' ' ' VAL . 33.8 mtt180 -67.31 -29.55 69.15 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 112.957 0.725 . . . . 3.38 112.957 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.408 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 76.5 mt -77.15 -42.18 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.755 0.65 . . . . 0.45 112.755 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 87' ' ' TYR . 2.6 m -80.15 -16.72 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 115.456 1.65 . . . . 0.45 115.456 -175.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 78' ' ' SER . 2.9 m -29.31 -55.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 1 N-CA-C 122.123 4.12 . . . . 0.62 122.123 -177.007 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.55 39.4 3.97 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 116.387 -2.125 . . . . 0.59 109.525 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -112.33 133.55 54.37 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 114.505 -1.225 . . . . 0.49 109.745 -179.401 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.23 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 106.732 -1.581 . . . . 0.52 106.732 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.67 15.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 115.395 1.628 . . . . 0.47 115.395 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.477 ' HB3' ' HB ' ' A' ' 81' ' ' VAL . 6.1 m-85 -127.47 130.92 50.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.538 -2.023 . . . . 0.42 105.538 175.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.59 154.67 41.76 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.29 -0.564 . . . . 0.39 110.311 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 t -121.69 128.48 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 106.315 -1.735 . . . . 0.33 106.315 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.3 mt -124.16 119.51 56.87 Favored 'Isoleucine or valine' 0 C--O 1.256 1.405 0 N-CA-C 108.258 -1.016 . . . . 0.29 108.258 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.4 163.29 19.6 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 114.674 -1.148 . . . . 0.25 112.388 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.71 24.62 55.53 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 114.821 0.688 . . . . 0.19 114.821 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.82 132.73 6.61 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 N-CA-C 113.483 0.92 . . . . 0.16 113.483 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' B' ' 94' ' ' ASN . 50.9 p30 -141.88 169.61 17.28 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.65 -1.241 . . . . 0.24 107.65 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 95' ' ' ILE . 50.4 mm -60.22 -43.37 93.47 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 114.522 1.304 . . . . 0.29 114.522 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.55 -42.94 55.52 Favored 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 117.584 -1.144 . . . . 0.31 110.343 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 39.8 ttm -61.56 -48.93 78.75 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 120.348 -0.541 . . . . 0.28 109.704 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.44 -48.05 83.43 Favored 'General case' 0 C--O 1.201 -1.487 0 N-CA-C 112.784 0.661 . . . . 0.3 112.784 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.642 HG11 ' CG ' ' C' ' 177' ' ' GLN . 84.7 t -61.51 -49.8 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 112.729 0.641 . . . . 0.42 112.729 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -63.67 -40.51 97.01 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.253 -0.579 . . . . 2.04 111.671 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.3 m -66.24 -46.09 78.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.35 110.89 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.5 -37.84 88.93 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 123.537 0.523 . . . . 0.4 110.571 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 69.8 mtp -66.12 -45.74 80.0 Favored 'General case' 0 C--O 1.243 0.717 0 O-C-N 121.353 -0.842 . . . . 1.7 112.099 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.86 75.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.179 0.807 . . . . 0.44 113.179 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.614 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 15.7 ttp180 -52.6 -32.63 42.43 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 113.4 0.889 . . . . 0.43 113.4 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -73.6 -19.6 60.83 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 114.001 1.111 . . . . 2.19 114.001 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -90.67 18.24 6.64 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.204 1.002 . . . . 2.2 109.49 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.6 t70 46.69 58.55 16.73 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 117.248 2.314 . . . . 0.51 117.248 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.413 ' HG3' HD13 ' A' ' 114' ' ' LEU . 44.8 Cg_endo -74.13 168.5 24.66 Favored 'Trans proline' 0 C--O 1.206 -1.1 0 C-N-CA 120.455 0.77 . . . . 0.47 110.659 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.4 p -77.05 162.74 27.27 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.613 -1.625 . . . . 0.49 106.613 175.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -55.95 -51.55 67.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 112.373 0.509 . . . . 0.43 112.373 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.51 -37.73 76.21 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 112.924 0.712 . . . . 0.51 112.924 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -62.8 -46.87 85.94 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.416 -0.356 . . . . 0.54 110.156 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.413 HD13 ' HG3' ' A' ' 109' ' ' PRO . 15.0 tp -64.26 -45.97 85.78 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 121.087 -0.245 . . . . 0.41 111.235 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.91 -48.3 81.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.583 -0.447 . . . . 0.37 110.478 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.83 -44.31 94.1 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.202 0.525 . . . . 0.45 112.338 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.34 -42.93 99.79 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 122.071 -0.393 . . . . 0.44 111.009 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.06 94.48 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 119.748 -0.781 . . . . 0.35 112.096 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.65 -46.26 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.83 -0.433 . . . . 0.38 109.83 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -63.65 -45.29 90.84 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.678 0.992 . . . . 0.52 113.678 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.2 p -71.42 -32.35 68.29 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 120.607 -0.437 . . . . 0.41 111.867 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.41 -45.58 95.63 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.362 -1.495 . . . . 0.32 109.362 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.43 -42.01 65.53 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 112.588 0.588 . . . . 0.46 112.588 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.52 -20.32 62.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 119.609 -0.836 . . . . 2.4 111.899 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.61 -16.69 76.03 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 124.203 0.939 . . . . 0.37 113.559 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.6 t -88.97 112.98 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 106.193 -1.78 . . . . 0.4 106.193 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -156.43 136.92 13.11 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.387 -0.968 . . . . 2.88 108.387 -173.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.65 146.67 23.98 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 122.043 0.925 . . . . 0.5 109.996 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.497 HD11 ' CE ' ' A' ' 132' ' ' LYS . 42.3 tp -66.84 -56.86 8.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.314 -0.857 . . . . 0.57 111.407 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.5 mttt 62.97 178.54 0.15 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.655 0.741 . . . . 2.8 110.518 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.13 146.74 53.15 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.345 -0.983 . . . . 1.16 108.345 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.71 ' HD3' HD11 ' C' ' 207' ' ' LEU . 0.2 OUTLIER -113.53 147.66 38.02 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.484 -0.76 . . . . 4.81 109.529 -179.148 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.442 ' HG2' HG21 ' C' ' 206' ' ' THR . 19.1 Cg_endo -64.66 148.64 90.36 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.305 2.003 . . . . 2.95 112.415 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.633 HG12 HG22 ' C' ' 203' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.014 -0.993 . . . . 3.74 109.17 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' THR . . . . . 0.531 ' HB ' ' HG2' ' B' ' 105' ' ' ARG . 77.3 p . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.166 0.508 . . . . 0.37 111.01 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.633 ' O ' ' HD2' ' B' ' 105' ' ' ARG . 47.1 mt -71.25 136.18 26.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 105.791 -1.929 . . . . 0.39 105.791 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.99 144.43 36.73 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.387 -0.824 . . . . 0.34 110.795 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 44.6 mt -126.23 130.25 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.764 0.826 . . . . 0.28 108.981 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 86.4 t -124.42 129.27 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.004 -1.85 . . . . 0.33 106.004 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 35.7 mt -109.06 132.27 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 109.548 -0.538 . . . . 0.29 109.548 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.52 133.04 6.19 Favored Glycine 0 N--CA 1.462 0.384 0 C-N-CA 120.326 -0.94 . . . . 0.31 111.885 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.739 HG21 ' HB3' ' B' ' 13' ' ' ALA . 15.0 t . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 107.363 -1.347 . . . . 0.36 107.363 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 114.863 0.705 . . . . 0.4 114.863 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -123.57 25.67 8.1 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 114.44 1.274 . . . . 0.78 114.44 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.739 ' HB3' HG21 ' B' ' 9' ' ' THR . . . -79.03 -27.17 43.15 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 115.216 1.562 . . . . 0.3 115.216 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.74 -46.44 74.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.887 0.767 . . . . 0.27 112.834 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.79 -40.35 88.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.958 -0.464 . . . . 0.39 111.265 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.19 -35.46 73.97 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.056 1.132 . . . . 0.35 114.056 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.02 -39.95 95.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.09 -1.448 . . . . 0.2 107.09 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 18.6 tp -65.21 -43.39 91.68 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 109.192 -0.67 . . . . 0.25 109.192 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -61.62 -39.11 90.1 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 121.242 0.544 . . . . 0.36 111.266 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.9 -47.64 79.77 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-N 115.056 -0.975 . . . . 0.23 108.59 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.7 86.26 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.681 -0.808 . . . . 0.24 111.49 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.98 -23.21 65.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.014 -0.539 . . . . 2.54 110.755 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.66 -31.87 68.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.689 -1.967 . . . . 2.59 105.689 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 45.6 mt -84.75 -38.3 19.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.837 1.051 . . . . 0.34 113.837 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 91.3 mt -109.66 -11.98 14.69 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 119.046 2.98 . . . . 0.35 119.046 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.83 165.08 31.57 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 105.521 -3.032 . . . . 0.34 105.521 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.69 138.99 56.72 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.338 1.066 . . . . 0.42 112.687 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -106.06 146.7 29.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.272 -1.785 . . . . 0.3 112.963 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -106.37 157.34 17.69 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 114.434 -1.257 . . . . 0.39 107.794 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.13 41.3 20.68 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.085 1.142 . . . . 0.34 114.085 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 93.7 t -131.08 134.62 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.31 -0.996 . . . . 0.3 108.31 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.73 18.91 Favored Glycine 0 N--CA 1.469 0.886 0 N-CA-C 109.82 -1.312 . . . . 0.31 109.82 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.26 157.69 36.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.167 0.983 . . . . 0.39 108.953 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.79 159.1 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.577 -0.738 . . . . 0.41 110.306 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.36 162.78 15.66 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.713 -0.676 . . . . 0.47 109.617 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' B' ' 36' ' ' PHE . 2.3 t80 -134.16 117.56 16.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.888 -1.523 . . . . 0.53 106.888 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 95.0 t -108.1 145.42 31.42 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.943 -1.481 . . . . 0.58 110.855 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -57.01 136.14 74.96 Favored 'Trans proline' 0 C--N 1.352 0.719 0 N-CA-C 107.949 -1.597 . . . . 0.64 107.949 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.48 -25.78 16.61 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.126 -1.19 . . . . 0.69 110.126 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.27 157.66 21.48 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.336 0.588 . . . . 0.64 110.031 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' B' ' 41' ' ' ASN . 29.5 p-10 -125.06 179.31 5.1 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.372 -0.973 . . . . 2.32 108.372 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.13 73.0 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 112.972 0.73 . . . . 0.61 112.972 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.77 -36.58 84.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.934 0.873 . . . . 2.82 112.163 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 89.4 m -63.9 -47.53 80.25 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 105.987 -1.857 . . . . 0.65 105.987 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.74 -37.68 87.52 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 112.979 0.733 . . . . 0.56 112.979 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.47 -43.14 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.635 -0.876 . . . . 0.61 108.635 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -62.66 -42.72 99.77 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 119.984 -0.686 . . . . 0.65 110.825 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.52 -44.42 97.1 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 119.346 -0.942 . . . . 0.53 111.47 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -60.89 -45.72 93.5 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 119.986 -0.686 . . . . 0.47 109.637 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -60.09 -40.14 88.55 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 113.131 0.789 . . . . 0.57 113.131 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.5 -35.61 81.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.434 0.635 . . . . 0.52 110.17 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.11 -43.83 70.23 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 119.572 -0.851 . . . . 0.45 110.141 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.55 -38.0 79.92 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.261 -0.427 . . . . 0.45 112.048 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.27 -26.32 28.39 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.744 0.646 . . . . 0.51 112.744 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -95.57 -4.73 44.13 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 113.126 0.787 . . . . 0.48 113.126 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 69.4 mt -105.77 157.43 17.45 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.396 0.888 . . . . 0.41 113.396 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -89.34 107.99 19.38 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 102.557 -3.127 . . . . 0.42 102.557 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 72.9 p -107.09 15.4 25.26 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 124.153 0.908 . . . . 0.45 111.064 -177.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 73.0 p -63.95 -34.29 77.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 115.595 1.702 . . . . 0.48 115.595 -177.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.87 -9.35 43.61 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.267 0.556 . . . . 0.47 112.202 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.74 172.19 13.02 Favored Glycine 0 C--O 1.242 0.642 0 C-N-CA 119.484 -1.341 . . . . 0.43 113.383 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.41 130.25 32.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 109.259 -0.645 . . . . 0.4 109.259 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp -115.84 113.42 23.34 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.497 1.748 . . . . 0.35 108.411 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.78 122.17 33.29 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.491 -1.67 . . . . 0.41 106.491 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 83.2 mt -109.52 115.27 29.61 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 104.531 -2.396 . . . . 0.28 104.531 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 26.0 m -120.01 163.4 17.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 113.186 0.81 . . . . 0.34 113.186 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' B' ' 67' ' ' ASP . 14.8 p-10 -64.9 -54.07 36.53 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 118.069 2.618 . . . . 0.39 118.069 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 45.3 p -142.23 151.4 42.06 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.533 1.158 . . . . 0.39 112.692 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' TRP . . . . . 0.58 ' HE1' HG11 ' C' ' 211' ' ' VAL . 32.8 t-105 -66.27 134.45 52.67 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.153 -1.385 . . . . 0.6 107.818 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.73 -8.14 70.6 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 121.218 3.247 . . . . 0.52 121.218 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.2 174.92 55.25 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 119.282 -1.437 . . . . 0.48 110.109 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.15 -47.84 98.4 Favored Pre-proline 0 C--N 1.329 -0.291 0 O-C-N 122.017 -0.696 . . . . 1.31 112.01 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -53.44 -41.6 71.92 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 118.391 -0.606 . . . . 0.45 110.619 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -67.2 -48.37 68.1 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 123.458 0.474 . . . . 0.5 109.845 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -60.05 -42.71 95.08 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.972 1.101 . . . . 2.04 113.972 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.46 85.71 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.242 -0.983 . . . . 0.52 111.721 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.05 -38.83 90.25 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 108.618 -0.882 . . . . 0.49 108.618 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.684 ' O ' HG13 ' B' ' 82' ' ' VAL . 70.5 m -58.65 -39.89 81.88 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.416 0.524 . . . . 1.4 112.416 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.619 ' O ' HG22 ' B' ' 82' ' ' VAL . 34.0 mtt180 -67.2 -29.58 69.28 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 113.042 0.756 . . . . 3.47 113.042 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 76.1 mt -77.2 -42.15 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.697 0.629 . . . . 0.55 112.697 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' B' ' 87' ' ' TYR . 2.6 m -80.03 -16.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.901 0 N-CA-C 115.465 1.654 . . . . 0.56 115.465 -175.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . 0.684 HG13 ' O ' ' B' ' 78' ' ' SER . 2.9 m -29.4 -55.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.352 1 N-CA-C 122.096 4.11 . . . . 0.74 122.096 -176.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.49 39.3 3.99 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 116.394 -2.122 . . . . 0.72 109.601 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.37 133.55 54.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.442 -1.254 . . . . 0.61 109.748 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.25 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 106.707 -1.59 . . . . 0.63 106.707 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.68 15.24 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 115.406 1.632 . . . . 0.55 115.406 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' TYR . . . . . 0.479 ' HB3' ' HB ' ' B' ' 81' ' ' VAL . 6.1 m-85 -127.45 130.89 50.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 105.506 -2.035 . . . . 0.49 105.506 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.6 154.66 41.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.228 -0.589 . . . . 0.49 110.357 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.77 128.47 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 106.235 -1.765 . . . . 0.44 106.235 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 34.2 mt -124.14 119.52 56.93 Favored 'Isoleucine or valine' 0 C--O 1.255 1.378 0 N-CA-C 108.245 -1.02 . . . . 0.36 108.245 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.46 163.21 19.59 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 114.738 -1.119 . . . . 0.36 112.314 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.89 24.49 55.33 Favored Glycine 0 CA--C 1.499 -0.911 0 N-CA-C 114.817 0.687 . . . . 0.29 114.817 176.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.85 132.85 6.69 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 N-CA-C 113.461 0.911 . . . . 0.22 113.461 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' A' ' 94' ' ' ASN . 51.2 p30 -141.98 169.48 17.52 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.688 -1.227 . . . . 0.2 107.688 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 51.3 mm -60.2 -43.37 93.54 Favored Pre-proline 0 C--O 1.24 0.588 0 N-CA-C 114.491 1.293 . . . . 0.17 114.491 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.55 -42.85 56.53 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 117.575 -1.15 . . . . 0.23 110.34 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 39.9 ttm -61.72 -48.85 78.86 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 120.377 -0.529 . . . . 0.26 109.633 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.46 -48.01 83.62 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 112.822 0.675 . . . . 0.2 112.822 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.52 -49.9 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 112.715 0.635 . . . . 0.26 112.715 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -63.52 -40.59 97.43 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 120.235 -0.586 . . . . 2.01 111.696 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' THR . . . . . . . . . . . . . 53.5 m -66.23 -46.12 78.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.731 -0.668 . . . . 0.28 110.892 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.47 -37.79 88.76 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 123.607 0.567 . . . . 0.29 110.563 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' MET . . . . . . . . . . . . . 72.6 mtp -66.1 -45.81 79.84 Favored 'General case' 0 C--O 1.242 0.695 0 O-C-N 121.264 -0.897 . . . . 1.76 112.132 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' B' ' 109' ' ' PRO . . . -67.72 -33.81 75.62 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.3 0.852 . . . . 0.38 113.3 -178.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.633 ' HD2' ' O ' ' B' ' 3' ' ' ILE . 15.8 ttp180 -52.56 -32.69 42.16 Favored 'General case' 0 C--O 1.21 -1.013 0 N-CA-C 113.4 0.889 . . . . 0.37 113.4 -178.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.57 -19.59 60.85 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 114.1 1.148 . . . . 2.13 114.1 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -90.62 18.15 6.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 122.159 0.981 . . . . 2.27 109.476 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 12.7 t70 46.79 58.47 16.88 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 117.269 2.322 . . . . 0.48 117.269 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.42 ' HG3' HD13 ' B' ' 114' ' ' LEU . 44.9 Cg_endo -74.09 168.43 24.82 Favored 'Trans proline' 0 C--O 1.206 -1.109 0 C-N-CA 120.55 0.833 . . . . 0.47 110.604 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 54.3 p -77.0 162.78 27.28 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.706 -1.59 . . . . 0.53 106.706 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -55.94 -51.48 67.5 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 112.445 0.535 . . . . 0.48 112.445 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -58.67 -37.67 76.51 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 112.897 0.703 . . . . 0.6 112.897 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -62.84 -46.77 86.37 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 116.417 -0.356 . . . . 0.57 110.141 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.42 HD13 ' HG3' ' B' ' 109' ' ' PRO . 15.1 tp -64.41 -45.86 85.77 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 121.019 -0.272 . . . . 0.43 111.191 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 63.5 t -56.88 -48.32 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 O-C-N 121.891 -0.506 . . . . 0.44 110.52 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.25 94.3 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.133 0.492 . . . . 0.49 112.326 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 tp -62.4 -42.8 99.71 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 122.125 -0.359 . . . . 0.42 110.989 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.29 -45.1 94.51 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 119.798 -0.761 . . . . 0.35 112.059 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.61 -46.26 89.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.803 -0.443 . . . . 0.42 109.803 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -63.71 -45.22 90.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 113.717 1.006 . . . . 0.52 113.717 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 34.6 p -71.44 -32.28 68.16 Favored 'General case' 0 C--O 1.216 -0.681 0 C-N-CA 120.585 -0.446 . . . . 0.36 111.987 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.38 -45.74 95.31 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.332 -1.507 . . . . 0.3 109.332 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.21 -42.15 66.11 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 112.622 0.601 . . . . 0.48 112.622 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.43 -20.27 62.92 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 119.578 -0.849 . . . . 2.42 111.964 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.78 -16.6 76.3 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 124.246 0.966 . . . . 0.31 113.511 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 93.7 t -88.99 113.07 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 106.171 -1.789 . . . . 0.34 106.171 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -156.45 136.84 13.03 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.409 -0.96 . . . . 2.95 108.409 -173.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.6 146.71 23.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.031 0.92 . . . . 0.4 109.986 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . 0.5 HD11 ' CE ' ' B' ' 132' ' ' LYS . 42.3 tp -66.94 -57.09 7.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.337 -0.847 . . . . 0.45 111.37 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 63.01 178.65 0.15 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.646 0.736 . . . . 2.83 110.595 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.03 146.61 53.36 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.353 -0.98 . . . . 1.34 108.353 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . 0.5 ' CE ' HD11 ' B' ' 129' ' ' LEU . 0.2 OUTLIER -113.33 147.94 38.5 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.444 -0.785 . . . . 4.96 109.476 -179.224 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -64.76 148.7 90.21 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.415 2.076 . . . . 3.1 112.368 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.011 -0.995 . . . . 3.89 109.12 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 159' ' ' ASN . . . . . 0.709 ' ND2' ' NZ ' ' C' ' 259' ' ' LYS . 1.8 t-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 108.992 -0.744 . . . . 6.34 108.992 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 160' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -85.87 25.5 1.1 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.59 -0.893 . . . . 3.89 108.59 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 161' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -118.63 -141.88 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.583 -0.895 . . . . 1.72 108.583 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 162' ' ' MET . . . . . 0.594 ' SD ' HG21 ' C' ' 240' ' ' VAL . 0.3 OUTLIER -61.63 156.19 20.55 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.764 -1.21 . . . . 2.0 110.562 -178.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 163' ' ' VAL . . . . . . . . . . . . . 94.9 t -113.11 117.68 56.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.06 -0.719 . . . . 0.63 109.06 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 164' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.73 103.39 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.49 -0.929 . . . . 0.46 108.49 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.59 -35.33 80.7 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.211 -1.555 . . . . 0.44 109.211 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 tp -172.04 147.97 2.18 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.771 -1.172 . . . . 0.47 111.209 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 167' ' ' ALA . . . . . . . . . . . . . . . -117.69 104.39 10.96 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.048 -0.723 . . . . 0.29 109.048 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 168' ' ' ARG . . . . . 0.941 ' NH1' HG12 ' C' ' 178' ' ' VAL . 44.4 ttp180 -106.37 126.09 51.81 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.972 0.891 . . . . 3.14 110.835 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 169' ' ' ILE . . . . . . . . . . . . . 82.3 mt -95.5 129.21 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 109.222 -0.659 . . . . 0.34 109.222 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 170' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -165.95 117.04 1.04 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.812 -0.755 . . . . 0.49 110.327 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 171' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.97 -9.94 11.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.429 -0.794 . . . . 2.33 109.759 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 172' ' ' ARG . . . . . . . . . . . . . 12.4 mtt180 -101.71 -5.16 25.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 2.95 110.47 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 173' ' ' LEU . . . . . . . . . . . . . 14.5 mt 59.0 -100.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.141 -0.974 . . . . 1.39 109.917 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 174' ' ' ILE . . . . . 0.438 HG23 ' CB ' ' C' ' 179' ' ' ALA . 77.7 mt -97.71 121.3 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.026 -1.046 . . . . 0.53 108.285 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 175' ' ' HIS . . . . . 0.672 ' CE1' HG21 ' C' ' 178' ' ' VAL . 2.6 p80 -143.19 127.57 17.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.131 -0.98 . . . . 0.65 109.426 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 176' ' ' GLY . . . . . . . . . . . . . . . 60.33 -152.63 37.16 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.833 -1.307 . . . . 0.57 109.833 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 177' ' ' GLN . . . . . 0.799 ' H ' ' NE2' ' C' ' 177' ' ' GLN . 0.1 OUTLIER -89.36 12.21 16.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.573 -0.957 . . . . 3.26 109.332 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . 0.941 HG12 ' NH1' ' C' ' 168' ' ' ARG . 48.1 t -61.54 -42.83 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 0.51 108.953 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 179' ' ' ALA . . . . . 0.448 ' O ' ' OG1' ' C' ' 183' ' ' THR . . . -73.16 -36.38 66.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.929 -1.107 . . . . 0.53 110.187 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 180' ' ' THR . . . . . . . . . . . . . 21.5 m -66.34 -54.42 24.82 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.697 -0.801 . . . . 0.68 109.79 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 181' ' ' ARG . . . . . 0.539 ' NH2' ' CG2' ' C' ' 308' ' ' THR . 55.1 ttt-85 -64.7 -43.62 92.88 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.013 -0.675 . . . . 3.12 110.608 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 182' ' ' TRP . . . . . 0.533 ' O ' HG23 ' C' ' 186' ' ' THR . 19.5 m95 -65.82 -32.2 73.6 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.034 -1.041 . . . . 0.9 109.591 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 183' ' ' THR . . . . . 0.803 HG21 HG21 ' C' ' 216' ' ' VAL . 71.9 m -65.29 -47.1 77.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.946 -1.096 . . . . 0.59 110.252 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -69.66 -42.93 73.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 2.2 110.806 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 185' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -68.32 -39.61 81.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.95 -1.094 . . . . 2.52 109.569 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 186' ' ' THR . . . . . 0.533 HG23 ' O ' ' C' ' 182' ' ' TRP . 72.6 p -81.42 -1.26 45.03 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.282 -0.886 . . . . 0.59 109.685 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 187' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 52.14 48.42 22.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.055 -1.028 . . . . 2.1 108.604 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 188' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.05 133.46 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.164 -0.96 . . . . 1.37 110.122 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 189' ' ' SER . . . . . . . . . . . . . 27.8 p -109.75 -6.33 15.32 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.761 -0.829 . . . . 1.4 108.761 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 190' ' ' ARG . . . . . . . . . . . . . 29.4 mtt-85 -135.92 142.83 44.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.555 -0.716 . . . . 3.52 110.441 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 191' ' ' ILE . . . . . . . . . . . . . 87.6 mt -133.38 127.61 54.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.173 -1.047 . . . . 0.51 108.173 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 192' ' ' ILE . . . . . 0.455 HD12 HG11 ' C' ' 240' ' ' VAL . 97.1 mt -115.66 128.68 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.257 -0.902 . . . . 0.46 109.665 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 193' ' ' VAL . . . . . . . . . . . . . 53.3 t -99.7 128.88 51.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.825 -0.806 . . . . 0.71 108.825 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 194' ' ' VAL . . . . . . . . . . . . . 43.0 t -112.51 103.57 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.535 -0.728 . . . . 0.43 109.479 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 195' ' ' SER . . . . . . . . . . . . . 38.0 t -167.25 125.61 1.31 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.342 -0.943 . . . . 1.38 109.31 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 196' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.01 -34.88 66.65 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.574 -0.704 . . . . 0.98 109.984 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 197' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -65.55 -45.49 83.21 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.147 -0.971 . . . . 2.32 109.959 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 198' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.11 -43.21 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.102 -0.998 . . . . 0.71 109.028 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.6 -26.5 55.72 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.79 -0.764 . . . . 0.74 109.168 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 200' ' ' ALA . . . . . . . . . . . . . . . -84.9 -5.38 59.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.028 -1.045 . . . . 0.89 109.882 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 201' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -102.75 95.38 6.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.9 -1.125 . . . . 1.15 109.554 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 202' ' ' THR . . . . . . . . . . . . . 24.7 p -66.22 -33.21 75.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.407 -0.808 . . . . 1.61 110.631 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 203' ' ' VAL . . . . . 0.633 HG22 HG12 ' A' ' 134' ' ' VAL . 55.8 t -66.33 -47.49 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.851 -1.156 . . . . 0.9 109.598 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 204' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -63.69 -42.24 98.04 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.349 -0.94 . . . . 3.07 109.576 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 205' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -58.01 -42.42 85.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 1.72 109.482 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 206' ' ' THR . . . . . 0.442 HG21 ' HG2' ' A' ' 133' ' ' PRO . 73.2 m -60.63 -48.71 80.55 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.088 -1.045 . . . . 0.92 109.564 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 207' ' ' LEU . . . . . 0.71 HD11 ' HD3' ' A' ' 132' ' ' LYS . 30.6 mt -62.62 -44.45 96.26 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.934 -1.107 . . . . 0.82 110.736 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 208' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' C' ' 208' ' ' LEU . 81.6 mt -62.5 -41.45 98.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.718 -1.239 . . . . 0.73 110.055 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 209' ' ' THR . . . . . . . . . . . . . 35.8 p -67.89 -31.83 71.89 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.371 -0.831 . . . . 0.84 110.28 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 210' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -80.37 -17.54 51.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.782 -1.199 . . . . 2.32 110.857 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . 0.58 HG11 ' HE1' ' B' ' 69' ' ' TRP . 17.5 m -107.69 17.65 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.952 -1.092 . . . . 0.93 108.639 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.29 123.42 82.48 Favored Pre-proline 0 N--CA 1.483 1.221 0 N-CA-C 107.82 -1.178 . . . . 0.76 107.82 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 213' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -44.31 144.48 2.95 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.037 1.825 . . . . 0.93 112.731 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 214' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -56.52 134.85 66.98 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.196 1.931 . . . . 1.14 112.028 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 215' ' ' GLY . . . . . . . . . . . . . . . 79.91 -8.52 50.03 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.922 -1.271 . . . . 0.85 109.922 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 216' ' ' VAL . . . . . 0.803 HG21 HG21 ' C' ' 183' ' ' THR . 58.6 t -114.8 136.78 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -1.076 . . . . 0.92 108.8 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.87 135.77 45.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.438 -0.789 . . . . 1.42 109.836 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 218' ' ' ALA . . . . . . . . . . . . . . . -110.17 131.37 55.12 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.315 -0.994 . . . . 0.64 108.315 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -120.97 153.51 37.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.401 -0.812 . . . . 0.72 109.808 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 54.8 t -126.35 117.83 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.624 0.726 . . . . 0.6 109.07 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 31.7 m -141.01 165.14 19.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.412 -0.805 . . . . 0.57 109.622 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 222' ' ' ASP . . . . . 0.709 ' OD1' ' N ' ' C' ' 225' ' ' LYS . 6.8 p30 -94.18 167.23 11.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.479 -0.763 . . . . 1.34 109.305 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.46 -44.82 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.151 -0.968 . . . . 0.54 110.455 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 224' ' ' ALA . . . . . 0.852 ' O ' HG22 ' C' ' 227' ' ' ILE . . . -62.72 -44.73 95.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.934 -1.104 . . . . 0.67 109.398 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 225' ' ' LYS . . . . . 0.709 ' N ' ' OD1' ' C' ' 222' ' ' ASP . 45.7 tttm -68.14 -35.35 77.95 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.775 -1.203 . . . . 2.11 109.674 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 226' ' ' MET . . . . . . . . . . . . . 10.3 tpt -62.08 -40.4 95.71 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.934 -1.104 . . . . 1.54 111.191 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 227' ' ' ILE . . . . . 0.852 HG22 ' O ' ' C' ' 224' ' ' ALA . 17.4 tt -60.9 -34.56 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.611 -0.885 . . . . 0.69 108.611 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.47 -38.86 62.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.722 -0.611 . . . . 4.01 110.948 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 70.3 t -62.18 -41.73 92.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.864 -1.162 . . . . 0.63 107.864 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 230' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' C' ' 230' ' ' TYR . 36.7 t80 -67.04 -32.13 73.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.102 -0.999 . . . . 0.64 109.927 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 231' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.76 6.73 2.34 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.119 -0.988 . . . . 0.95 110.104 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 232' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -110.18 117.78 50.87 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.246 -0.909 . . . . 0.93 109.435 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 233' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -65.73 1.51 2.19 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.646 1.564 . . . . 0.99 111.98 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 234' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.36 -24.76 65.33 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 1.59 108.807 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 235' ' ' TYR . . . . . 0.501 ' O ' ' HB2' ' C' ' 238' ' ' GLU . 81.1 m-85 -105.49 15.71 26.66 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.594 -0.842 . . . . 1.19 109.003 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.81 135.62 47.44 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.076 -1.64 . . . . 0.67 109.65 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.78 -33.41 1.9 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.288 -1.525 . . . . 0.64 109.288 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 238' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' C' ' 235' ' ' TYR . 4.0 mm-40 -54.25 138.93 37.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.805 -1.409 . . . . 2.48 109.437 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 239' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -99.1 116.33 31.08 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.463 -0.939 . . . . 2.96 108.463 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 240' ' ' VAL . . . . . 0.594 HG21 ' SD ' ' C' ' 162' ' ' MET . 26.3 t -121.85 148.78 25.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.876 0.846 . . . . 0.66 110.448 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 241' ' ' MET . . . . . . . . . . . . . 13.8 ttm -102.9 134.95 45.47 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.925 -1.139 . . . . 1.63 107.925 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 242' ' ' LEU . . . . . 0.402 ' HB3' ' CE2' ' C' ' 244' ' ' PHE . 61.2 mt -102.04 127.28 49.0 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.689 -0.804 . . . . 0.35 109.877 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 243' ' ' LEU . . . . . . . . . . . . . 97.6 mt -109.5 126.08 53.15 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.981 0.896 . . . . 0.68 109.045 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 244' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' C' ' 242' ' ' LEU . 77.7 m-85 -127.0 162.03 26.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.771 0.796 . . . . 0.3 109.275 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 245' ' ' THR . . . . . . . . . . . . . 70.2 p -109.48 -19.47 13.23 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.958 -0.756 . . . . 0.43 108.958 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 246' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' C' ' 246' ' ' ASN . 17.3 p30 -151.08 141.85 14.91 Favored Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 120.003 -0.679 . . . . 1.0 109.872 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 247' ' ' PRO . . . . . 0.451 ' HG3' ' CE2' ' C' ' 291' ' ' PHE . 7.3 Cg_endo -60.85 -14.63 33.4 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.683 2.255 . . . . 0.59 112.1 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 248' ' ' THR . . . . . . . . . . . . . 95.7 m -64.99 -42.66 94.31 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.151 0.976 . . . . 0.64 108.624 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 249' ' ' ASP . . . . . 0.42 ' O ' HD12 ' C' ' 253' ' ' LEU . 97.8 m-20 -67.48 -23.4 65.48 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.54 -0.725 . . . . 0.53 109.801 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 250' ' ' VAL . . . . . . . . . . . . . 98.3 t -73.62 -43.77 54.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.672 -1.267 . . . . 0.4 109.848 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 251' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.41 -35.02 77.92 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.426 -0.953 . . . . 1.51 108.426 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 252' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -62.48 -44.09 97.23 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.723 -0.791 . . . . 3.24 110.156 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 253' ' ' LEU . . . . . 0.42 HD12 ' O ' ' C' ' 249' ' ' ASP . 1.2 mp -64.07 -40.42 96.22 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 117.999 -1.48 . . . . 1.06 108.876 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 254' ' ' VAL . . . . . 0.57 ' CG2' HD12 ' C' ' 260' ' ' ILE . 70.6 t -60.7 -44.61 97.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 120.835 -1.165 . . . . 0.48 108.948 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 255' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.23 -30.97 69.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.018 -1.052 . . . . 2.47 109.917 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 256' ' ' GLY . . . . . . . . . . . . . . . -74.28 2.8 43.16 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.498 -1.441 . . . . 0.55 109.498 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 257' ' ' GLY . . . . . . . . . . . . . . . 94.37 15.79 45.94 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.627 -1.389 . . . . 0.51 109.627 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 258' ' ' VAL . . . . . . . . . . . . . 96.7 t -77.66 139.72 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.034 -1.469 . . . . 0.45 107.034 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 259' ' ' LYS . . . . . 0.709 ' NZ ' ' ND2' ' C' ' 159' ' ' ASN . 17.9 tttt -99.01 123.93 43.64 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.089 -1.007 . . . . 3.12 110.811 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 260' ' ' ILE . . . . . 0.57 HD12 ' CG2' ' C' ' 254' ' ' VAL . 98.1 mt -129.99 125.67 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.43 -0.794 . . . . 0.41 109.147 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 65.9 p -89.51 -31.44 17.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.776 -1.202 . . . . 0.57 110.238 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 262' ' ' SER . . . . . . . . . . . . . 15.8 m -159.06 153.51 24.15 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.176 -0.953 . . . . 0.46 110.092 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 263' ' ' VAL . . . . . . . . . . . . . 50.9 t -122.74 134.61 65.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.538 -0.912 . . . . 0.37 108.538 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 264' ' ' ASN . . . . . 0.468 ' ND2' ' CH2' ' C' ' 182' ' ' TRP . 33.7 t30 -108.57 128.08 54.51 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.517 0.675 . . . . 1.17 110.607 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 265' ' ' VAL . . . . . 0.451 HG21 ' SD ' ' C' ' 314' ' ' MET . 3.2 t -90.64 108.43 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 120.058 -0.657 . . . . 0.4 109.68 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 266' ' ' GLY . . . . . . . . . . . . . . . -80.75 -53.94 3.84 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.153 -1.179 . . . . 0.41 110.153 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . -172.57 152.93 17.73 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.646 -1.74 . . . . 0.41 111.476 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 268' ' ' MET . . . . . 0.44 ' HB2' ' H ' ' C' ' 282' ' ' SER . 97.0 mtp -143.1 118.08 10.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.481 -1.011 . . . . 0.5 110.443 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.34 128.21 21.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.371 -0.831 . . . . 0.57 109.523 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 270' ' ' PHE . . . . . 0.536 ' CG ' ' N ' ' C' ' 271' ' ' ARG . 13.3 t80 -69.5 161.8 28.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.92 109.618 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 271' ' ' ARG . . . . . 0.536 ' N ' ' CG ' ' C' ' 270' ' ' PHE . 32.7 ttm180 -160.66 158.67 29.24 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.27 -0.972 . . . . 3.23 109.676 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 272' ' ' GLN . . . . . 0.4 ' N ' ' HG2' ' C' ' 271' ' ' ARG . 73.9 mt-30 -66.48 138.25 57.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.081 -1.012 . . . . 2.98 110.459 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 273' ' ' GLY . . . . . . . . . . . . . . . 95.52 -12.32 67.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.818 -1.713 . . . . 0.87 108.818 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 274' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -101.81 163.37 12.29 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.484 -1.01 . . . . 1.66 109.388 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 275' ' ' THR . . . . . 0.561 HG21 HG21 ' C' ' 321' ' ' ILE . 20.8 m -109.95 135.83 50.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.674 -0.862 . . . . 0.84 108.674 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 276' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -82.02 119.21 23.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.246 -0.909 . . . . 2.77 110.176 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 277' ' ' VAL . . . . . 0.519 HG12 ' CD1' ' C' ' 321' ' ' ILE . 27.5 m -99.22 -28.18 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.81 -0.756 . . . . 0.74 109.612 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 278' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' C' ' 279' ' ' ASN . 10.2 t-20 -135.99 -177.16 4.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.658 0.742 . . . . 1.52 109.761 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' C' ' 278' ' ' ASN . 39.5 m-20 -56.93 -29.88 63.5 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.791 -0.568 . . . . 2.29 110.787 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . -148.06 27.01 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.829 -1.169 . . . . 0.6 109.538 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 281' ' ' VAL . . . . . 0.498 ' O ' HG22 ' C' ' 277' ' ' VAL . 60.8 t -118.99 121.98 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.825 0.822 . . . . 0.61 109.678 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 282' ' ' SER . . . . . 0.44 ' H ' ' HB2' ' C' ' 268' ' ' MET . 29.0 m -118.64 147.61 43.58 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.447 0.642 . . . . 0.75 110.02 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 283' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.26 142.84 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.446 1.117 . . . . 0.7 110.539 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 284' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' C' ' 287' ' ' ASP . 44.1 p-10 -110.61 171.67 7.33 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 106.923 -1.51 . . . . 0.77 106.923 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 285' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.18 -24.21 40.12 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.833 -1.167 . . . . 2.34 109.587 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 286' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -79.59 -43.46 22.89 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.233 -0.917 . . . . 2.0 110.026 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 287' ' ' ASP . . . . . 0.57 ' N ' ' OD1' ' C' ' 284' ' ' ASP . 93.3 m-20 -64.25 -42.08 96.67 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.237 -0.915 . . . . 0.62 109.096 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 288' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.48 -45.77 97.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.387 -0.821 . . . . 0.73 109.518 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 289' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -57.44 -39.6 76.6 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.216 -0.928 . . . . 2.52 110.262 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.37 -41.01 85.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.82 -1.175 . . . . 0.6 109.9 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 291' ' ' PHE . . . . . 0.451 ' CE2' ' HG3' ' C' ' 247' ' ' PRO . 40.0 m-85 -63.93 -39.02 93.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.57 109.73 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 292' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -64.08 -39.5 94.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.149 -0.969 . . . . 2.05 110.226 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 293' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -65.78 -41.54 91.86 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.943 -1.098 . . . . 1.8 109.635 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 294' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.18 -43.22 99.32 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.871 -1.143 . . . . 0.53 108.867 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 295' ' ' ASN . . . . . 0.58 HD22 ' HG3' ' C' ' 315' ' ' MET . 40.3 t-20 -64.01 -40.01 95.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 1.45 109.953 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.66 -21.38 65.67 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.815 -1.178 . . . . 0.69 109.242 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 297' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -90.13 8.85 30.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.769 -1.207 . . . . 2.49 109.91 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.44 11.43 82.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.903 -1.279 . . . . 0.6 109.903 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 299' ' ' ILE . . . . . . . . . . . . . 97.8 mt -84.71 134.56 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.974 -1.309 . . . . 0.53 109.151 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 300' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -82.0 141.66 33.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.869 . . . . 2.3 110.615 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 301' ' ' LEU . . . . . . . . . . . . . 66.9 mt -123.08 111.27 16.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.269 -0.641 . . . . 0.54 109.269 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 302' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.57 139.87 49.69 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.9 . . . . 2.26 110.289 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 303' ' ' VAL . . . . . 0.611 ' CG2' ' SD ' ' C' ' 314' ' ' MET . 51.8 t -111.99 124.77 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.673 -0.862 . . . . 0.55 108.673 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 304' ' ' ARG . . . . . 0.459 ' HE ' ' CG ' ' C' ' 264' ' ' ASN . 33.4 ptt180 -164.93 137.87 4.64 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.505 -0.878 . . . . 2.7 110.343 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 305' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -80.82 -45.42 16.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 3.19 109.817 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 306' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.33 154.01 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.106 -0.996 . . . . 0.65 108.737 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 307' ' ' SER . . . . . . . . . . . . . 83.5 p -64.55 -16.29 62.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.983 -1.073 . . . . 1.36 109.516 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 308' ' ' THR . . . . . 0.539 ' CG2' ' NH2' ' C' ' 181' ' ' ARG . 44.5 p -86.14 -9.07 57.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.047 -1.033 . . . . 0.85 110.005 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 309' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -92.49 152.69 42.35 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.025 -1.047 . . . . 0.81 109.936 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 310' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -55.37 139.15 81.42 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.968 1.779 . . . . 0.93 111.755 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 311' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -84.24 132.82 34.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 3.09 109.823 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 312' ' ' LEU . . . . . . . . . . . . . 80.2 mt -117.51 154.74 30.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.103 -0.998 . . . . 0.73 108.309 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 313' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -91.26 130.49 37.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.076 -1.015 . . . . 2.24 109.827 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 314' ' ' MET . . . . . 0.611 ' SD ' ' CG2' ' C' ' 303' ' ' VAL . 8.2 tpt -56.39 -44.17 79.97 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.67 -0.644 . . . . 1.03 109.63 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 315' ' ' MET . . . . . 0.58 ' HG3' HD22 ' C' ' 295' ' ' ASN . 95.9 mmm -61.18 -40.39 93.73 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.299 -0.876 . . . . 1.71 110.22 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 316' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.9 -44.0 97.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.319 -0.863 . . . . 0.82 109.81 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 317' ' ' LEU . . . . . . . . . . . . . 92.8 mt -66.49 -41.98 88.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.877 . . . . 0.8 110.036 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 318' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.26 -24.49 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.311 -0.868 . . . . 0.86 109.957 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 319' ' ' SER . . . . . 0.475 ' O ' ' C ' ' C' ' 323' ' ' LYS . 0.9 OUTLIER -72.72 -31.56 65.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.084 -1.01 . . . . 1.52 109.518 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 320' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -84.19 -2.45 56.9 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.78 -1.168 . . . . 2.04 109.167 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 321' ' ' ILE . . . . . 0.561 HG21 HG21 ' C' ' 275' ' ' THR . 93.2 mt -113.76 -58.74 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.914 -1.143 . . . . 1.17 107.914 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 322' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' C' ' 323' ' ' LYS . 12.3 t0 -95.01 85.11 4.26 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.16 -1.792 . . . . 2.26 106.16 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 323' ' ' LYS . . . . . 1.262 ' HA ' ' NZ ' ' C' ' 323' ' ' LYS . 0.0 OUTLIER . . . . . 1 C--O 1.524 15.537 0 CA-C-O 126.309 2.957 . . . . 5.92 109.465 -177.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.548 ' HB ' ' HG2' ' A' ' 105' ' ' ARG . 76.6 p . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 121.106 0.479 . . . . 0.44 111.038 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.614 ' O ' ' HD2' ' A' ' 105' ' ' ARG . 47.0 mt -71.24 136.2 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.736 -1.95 . . . . 0.38 105.736 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.98 144.42 36.76 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 115.292 -0.867 . . . . 0.35 110.744 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.3 mt -126.27 130.14 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.825 0.85 . . . . 0.31 109.053 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.29 129.28 74.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.035 -1.839 . . . . 0.32 106.035 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 mt -109.11 131.73 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.445 -0.576 . . . . 0.26 109.445 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.75 135.83 7.43 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.791 -1.324 . . . . 0.24 109.791 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 13' ' ' ALA . 8.2 t . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.025 -1.28 . . . . 0.26 109.592 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.553 0 N-CA-C 110.02 -1.232 . . . . 0.31 110.02 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -130.69 32.1 4.43 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.233 -1.157 . . . . 0.78 110.447 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.521 ' HB3' HG21 ' A' ' 9' ' ' THR . . . -75.51 -27.27 58.68 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 115.277 1.584 . . . . 0.25 115.277 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.7 -46.48 74.15 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.827 0.74 . . . . 0.26 112.799 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -59.79 -40.39 88.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.593 -0.443 . . . . 0.44 111.224 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.31 -35.22 73.53 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.105 1.15 . . . . 0.38 114.105 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.05 -39.99 95.3 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.139 -1.43 . . . . 0.27 107.139 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.13 -43.47 91.81 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.149 -0.685 . . . . 0.34 109.149 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -61.56 -39.18 90.2 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.242 0.544 . . . . 0.44 111.234 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.96 -47.64 79.64 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 115.048 -0.978 . . . . 0.37 108.609 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.71 86.11 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 119.754 -0.778 . . . . 0.39 111.465 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.96 -23.34 65.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.103 -0.499 . . . . 2.5 110.692 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.47 -32.01 69.39 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 105.703 -1.962 . . . . 2.59 105.703 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.8 mt -84.74 -38.38 19.74 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 113.817 1.043 . . . . 0.49 113.817 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -109.6 -12.03 14.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 119.025 2.972 . . . . 0.5 119.025 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.98 165.07 31.38 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 105.457 -3.057 . . . . 0.51 105.457 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -58.82 138.97 56.96 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 122.41 1.1 . . . . 0.58 112.611 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -105.91 146.75 29.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.264 -1.789 . . . . 0.45 113.038 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -106.46 157.34 17.72 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.497 -1.229 . . . . 0.54 107.816 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.25 41.22 20.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.096 1.147 . . . . 0.42 114.096 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.8 t -131.09 134.53 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.381 -0.97 . . . . 0.38 108.381 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.66 18.93 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 109.899 -1.28 . . . . 0.35 109.899 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.22 157.76 36.4 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 118.203 1.001 . . . . 0.41 108.921 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.84 159.15 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.453 -0.794 . . . . 0.36 110.29 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -113.46 162.85 15.63 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.757 -0.656 . . . . 0.42 109.592 173.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 36' ' ' PHE . 1.9 t80 -134.19 117.5 16.57 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.886 -1.524 . . . . 0.41 106.886 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.6 t -108.11 145.44 31.45 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 113.92 -1.491 . . . . 0.49 110.848 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -57.06 136.08 74.54 Favored 'Trans proline' 0 C--N 1.352 0.752 0 N-CA-C 107.929 -1.604 . . . . 0.53 107.929 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.55 -25.75 16.55 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.065 -1.214 . . . . 0.58 110.065 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.34 157.66 21.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.373 0.606 . . . . 0.52 110.009 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -125.08 179.29 5.11 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.343 -0.984 . . . . 2.23 108.343 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.19 72.97 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 113.003 0.742 . . . . 0.49 113.003 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.86 -36.45 84.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.84 0.828 . . . . 2.83 112.164 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.5 m -63.92 -47.58 79.99 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 106.01 -1.848 . . . . 0.56 106.01 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.71 -37.48 86.7 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.108 0.781 . . . . 0.47 113.108 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.1 mt -58.59 -43.15 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.587 -0.894 . . . . 0.5 108.587 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -62.58 -42.73 99.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.966 -0.694 . . . . 0.59 110.875 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -61.58 -44.34 97.21 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 119.347 -0.941 . . . . 0.48 111.34 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -61.02 -45.65 93.96 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 120.015 -0.674 . . . . 0.42 109.595 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -60.15 -40.04 88.44 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 113.158 0.799 . . . . 0.51 113.158 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.58 -35.64 81.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.449 0.643 . . . . 0.52 110.135 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.17 -43.61 70.47 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 119.578 -0.849 . . . . 0.45 110.205 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.73 -37.92 80.28 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.281 -0.418 . . . . 0.45 112.041 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.31 -26.36 29.07 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.699 0.629 . . . . 0.53 112.699 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -95.49 -4.75 44.35 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.224 0.824 . . . . 0.53 113.224 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 69.8 mt -105.85 157.54 17.4 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 113.313 0.857 . . . . 0.46 113.313 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -89.34 107.94 19.35 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 102.541 -3.133 . . . . 0.47 102.541 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.9 p -106.98 15.38 25.39 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 124.097 0.873 . . . . 0.44 111.05 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.3 p -64.03 -34.27 77.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 115.553 1.686 . . . . 0.49 115.553 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.77 -9.39 43.79 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.274 0.559 . . . . 0.49 112.271 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.71 172.22 13.03 Favored Glycine 0 C--O 1.242 0.598 0 C-N-CA 119.486 -1.34 . . . . 0.4 113.406 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.3 t -139.47 130.17 32.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 N-CA-C 109.273 -0.639 . . . . 0.36 109.273 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.8 tp -115.86 113.37 23.26 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.549 1.781 . . . . 0.3 108.446 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.68 122.19 33.23 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 106.507 -1.664 . . . . 0.34 106.507 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.0 mt -109.55 115.25 29.56 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 104.519 -2.4 . . . . 0.22 104.519 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.4 m -119.93 163.31 17.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 113.221 0.823 . . . . 0.23 113.221 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 14.3 p-10 -64.94 -54.05 36.8 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 118.031 2.604 . . . . 0.27 118.031 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -142.23 151.41 42.09 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 122.541 1.163 . . . . 0.26 112.693 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -66.32 134.47 52.67 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.178 -1.374 . . . . 0.45 107.857 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.72 -8.14 70.59 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 121.281 3.272 . . . . 0.38 121.281 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.23 174.9 55.24 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 119.341 -1.409 . . . . 0.34 110.065 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.18 -47.77 98.5 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 122.089 -0.653 . . . . 1.24 112.057 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -53.5 -41.56 72.46 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 118.293 -0.671 . . . . 0.32 110.604 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -67.28 -48.26 68.2 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 123.506 0.504 . . . . 0.37 109.865 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -60.1 -42.71 95.24 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.945 1.091 . . . . 1.99 113.945 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.6 85.57 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.388 -0.925 . . . . 0.41 111.675 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.83 89.97 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.7 -0.852 . . . . 0.38 108.7 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.685 ' O ' HG13 ' A' ' 82' ' ' VAL . 70.3 m -58.72 -39.82 81.96 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.423 0.527 . . . . 1.38 112.423 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.611 ' O ' HG22 ' A' ' 82' ' ' VAL . 33.8 mtt180 -67.31 -29.55 69.15 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 112.957 0.725 . . . . 3.38 112.957 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.408 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 76.5 mt -77.15 -42.18 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.755 0.65 . . . . 0.45 112.755 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 87' ' ' TYR . 2.6 m -80.15 -16.72 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 115.456 1.65 . . . . 0.45 115.456 -175.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 78' ' ' SER . 2.9 m -29.31 -55.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 1 N-CA-C 122.123 4.12 . . . . 0.62 122.123 -177.007 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.55 39.4 3.97 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 116.387 -2.125 . . . . 0.59 109.525 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -112.33 133.55 54.37 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 114.505 -1.225 . . . . 0.49 109.745 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.23 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 106.732 -1.581 . . . . 0.52 106.732 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.67 15.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 115.395 1.628 . . . . 0.47 115.395 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.477 ' HB3' ' HB ' ' A' ' 81' ' ' VAL . 6.1 m-85 -127.47 130.92 50.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.538 -2.023 . . . . 0.42 105.538 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.59 154.67 41.76 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.29 -0.564 . . . . 0.39 110.311 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 t -121.69 128.48 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 106.315 -1.735 . . . . 0.33 106.315 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.3 mt -124.16 119.51 56.87 Favored 'Isoleucine or valine' 0 C--O 1.256 1.405 0 N-CA-C 108.258 -1.016 . . . . 0.29 108.258 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.4 163.29 19.6 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 114.674 -1.148 . . . . 0.25 112.388 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.71 24.62 55.53 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 114.821 0.688 . . . . 0.19 114.821 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.82 132.73 6.61 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 N-CA-C 113.483 0.92 . . . . 0.16 113.483 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' B' ' 94' ' ' ASN . 50.9 p30 -141.88 169.61 17.28 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.65 -1.241 . . . . 0.24 107.65 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 95' ' ' ILE . 50.4 mm -60.22 -43.37 93.47 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 114.522 1.304 . . . . 0.29 114.522 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.55 -42.94 55.52 Favored 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 117.584 -1.144 . . . . 0.31 110.343 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 39.8 ttm -61.56 -48.93 78.75 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 120.348 -0.541 . . . . 0.28 109.704 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.44 -48.05 83.43 Favored 'General case' 0 C--O 1.201 -1.487 0 N-CA-C 112.784 0.661 . . . . 0.3 112.784 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.642 HG11 ' CG ' ' C' ' 177' ' ' GLN . 84.7 t -61.51 -49.8 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 112.729 0.641 . . . . 0.42 112.729 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -63.67 -40.51 97.01 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.253 -0.579 . . . . 2.04 111.671 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.3 m -66.24 -46.09 78.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.35 110.89 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.5 -37.84 88.93 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 123.537 0.523 . . . . 0.4 110.571 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 69.8 mtp -66.12 -45.74 80.0 Favored 'General case' 0 C--O 1.243 0.717 0 O-C-N 121.353 -0.842 . . . . 1.7 112.099 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.86 75.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.179 0.807 . . . . 0.44 113.179 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.614 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 15.7 ttp180 -52.6 -32.63 42.43 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 113.4 0.889 . . . . 0.43 113.4 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -73.6 -19.6 60.83 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 114.001 1.111 . . . . 2.19 114.001 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -90.67 18.24 6.64 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.204 1.002 . . . . 2.2 109.49 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.6 t70 46.69 58.55 16.73 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 117.248 2.314 . . . . 0.51 117.248 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.413 ' HG3' HD13 ' A' ' 114' ' ' LEU . 44.8 Cg_endo -74.13 168.5 24.66 Favored 'Trans proline' 0 C--O 1.206 -1.1 0 C-N-CA 120.455 0.77 . . . . 0.47 110.659 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.4 p -77.05 162.74 27.27 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.613 -1.625 . . . . 0.49 106.613 175.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -55.95 -51.55 67.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 112.373 0.509 . . . . 0.43 112.373 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.51 -37.73 76.21 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 112.924 0.712 . . . . 0.51 112.924 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -62.8 -46.87 85.94 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.416 -0.356 . . . . 0.54 110.156 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.413 HD13 ' HG3' ' A' ' 109' ' ' PRO . 15.0 tp -64.26 -45.97 85.78 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 121.087 -0.245 . . . . 0.41 111.235 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.91 -48.3 81.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.583 -0.447 . . . . 0.37 110.478 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.83 -44.31 94.1 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.202 0.525 . . . . 0.45 112.338 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.34 -42.93 99.79 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 122.071 -0.393 . . . . 0.44 111.009 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.06 94.48 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 119.748 -0.781 . . . . 0.35 112.096 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.65 -46.26 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.83 -0.433 . . . . 0.38 109.83 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -63.65 -45.29 90.84 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.678 0.992 . . . . 0.52 113.678 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.2 p -71.42 -32.35 68.29 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 120.607 -0.437 . . . . 0.41 111.867 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.41 -45.58 95.63 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.362 -1.495 . . . . 0.32 109.362 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.43 -42.01 65.53 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 112.588 0.588 . . . . 0.46 112.588 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.52 -20.32 62.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 119.609 -0.836 . . . . 2.4 111.899 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.61 -16.69 76.03 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 124.203 0.939 . . . . 0.37 113.559 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.6 t -88.97 112.98 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 106.193 -1.78 . . . . 0.4 106.193 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -156.43 136.92 13.11 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.387 -0.968 . . . . 2.88 108.387 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.65 146.67 23.98 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 122.043 0.925 . . . . 0.5 109.996 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 tp -66.84 -56.53 9.97 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.314 -0.857 . . . . 0.57 111.407 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 62.48 178.69 0.14 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.653 0.739 . . . . 2.8 110.403 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.18 146.25 53.57 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.691 -0.855 . . . . 1.16 108.691 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.716 ' HD3' HD11 ' C' ' 207' ' ' LEU . 0.8 OUTLIER -113.01 145.21 32.61 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.581 -0.699 . . . . 4.81 109.317 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.437 ' HG2' HG21 ' C' ' 206' ' ' THR . 21.8 Cg_endo -64.24 146.97 91.09 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.513 2.142 . . . . 2.95 112.472 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.615 HG12 HG22 ' C' ' 203' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 118.043 -0.979 . . . . 3.74 109.095 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' THR . . . . . 0.531 ' HB ' ' HG2' ' B' ' 105' ' ' ARG . 77.3 p . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.166 0.508 . . . . 0.37 111.01 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.633 ' O ' ' HD2' ' B' ' 105' ' ' ARG . 47.1 mt -71.25 136.18 26.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 105.791 -1.929 . . . . 0.39 105.791 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.99 144.43 36.73 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.387 -0.824 . . . . 0.34 110.795 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 44.6 mt -126.23 130.25 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.764 0.826 . . . . 0.28 108.981 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 86.4 t -124.42 129.27 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.004 -1.85 . . . . 0.33 106.004 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 35.7 mt -109.06 131.71 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 109.548 -0.538 . . . . 0.29 109.548 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.79 135.71 7.35 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.817 -1.313 . . . . 0.31 109.817 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.496 HG21 ' HB3' ' B' ' 13' ' ' ALA . 7.9 t . . . . . 0 N--CA 1.497 1.896 0 O-C-N 121.083 -1.245 . . . . 0.36 109.77 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 110.93 -0.868 . . . . 0.4 110.93 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -131.25 32.04 4.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.469 -1.018 . . . . 0.78 110.628 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.496 ' HB3' HG21 ' B' ' 9' ' ' THR . . . -75.5 -27.17 58.66 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 115.216 1.562 . . . . 0.3 115.216 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' B' ' 9' ' ' THR . . . -54.74 -46.44 74.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.887 0.767 . . . . 0.27 112.834 -176.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.79 -40.35 88.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.958 -0.464 . . . . 0.39 111.265 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.19 -35.46 73.97 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.056 1.132 . . . . 0.35 114.056 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.02 -39.95 95.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.09 -1.448 . . . . 0.2 107.09 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 18.6 tp -65.21 -43.39 91.68 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 109.192 -0.67 . . . . 0.25 109.192 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -61.62 -39.11 90.1 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 121.242 0.544 . . . . 0.36 111.266 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.9 -47.64 79.77 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-N 115.056 -0.975 . . . . 0.23 108.59 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.7 86.26 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.681 -0.808 . . . . 0.24 111.49 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.98 -23.21 65.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.014 -0.539 . . . . 2.54 110.755 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.66 -31.87 68.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.689 -1.967 . . . . 2.59 105.689 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 45.6 mt -84.75 -38.3 19.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.837 1.051 . . . . 0.34 113.837 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 91.3 mt -109.66 -11.98 14.69 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 119.046 2.98 . . . . 0.35 119.046 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.83 165.08 31.57 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 105.521 -3.032 . . . . 0.34 105.521 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.69 138.99 56.72 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.338 1.066 . . . . 0.42 112.687 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -106.06 146.7 29.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.272 -1.785 . . . . 0.3 112.963 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -106.37 157.34 17.69 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 114.434 -1.257 . . . . 0.39 107.794 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.13 41.3 20.68 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.085 1.142 . . . . 0.34 114.085 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 93.7 t -131.08 134.62 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.31 -0.996 . . . . 0.3 108.31 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.73 18.91 Favored Glycine 0 N--CA 1.469 0.886 0 N-CA-C 109.82 -1.312 . . . . 0.31 109.82 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.26 157.69 36.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.167 0.983 . . . . 0.39 108.953 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.79 159.1 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.577 -0.738 . . . . 0.41 110.306 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.36 162.78 15.66 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.713 -0.676 . . . . 0.47 109.617 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' B' ' 36' ' ' PHE . 2.3 t80 -134.16 117.56 16.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.888 -1.523 . . . . 0.53 106.888 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 95.0 t -108.1 145.42 31.42 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.943 -1.481 . . . . 0.58 110.855 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -57.01 136.14 74.96 Favored 'Trans proline' 0 C--N 1.352 0.719 0 N-CA-C 107.949 -1.597 . . . . 0.64 107.949 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.48 -25.78 16.61 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.126 -1.19 . . . . 0.69 110.126 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.27 157.66 21.48 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.336 0.588 . . . . 0.64 110.031 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' B' ' 41' ' ' ASN . 29.5 p-10 -125.06 179.31 5.1 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.372 -0.973 . . . . 2.32 108.372 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.13 73.0 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 112.972 0.73 . . . . 0.61 112.972 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.77 -36.58 84.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.934 0.873 . . . . 2.82 112.163 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 89.4 m -63.9 -47.53 80.25 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 105.987 -1.857 . . . . 0.65 105.987 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.74 -37.68 87.52 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 112.979 0.733 . . . . 0.56 112.979 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.47 -43.14 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.635 -0.876 . . . . 0.61 108.635 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -62.66 -42.72 99.77 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 119.984 -0.686 . . . . 0.65 110.825 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.52 -44.42 97.1 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 119.346 -0.942 . . . . 0.53 111.47 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -60.89 -45.72 93.5 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 119.986 -0.686 . . . . 0.47 109.637 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -60.09 -40.14 88.55 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 113.131 0.789 . . . . 0.57 113.131 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.5 -35.61 81.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.434 0.635 . . . . 0.52 110.17 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.11 -43.83 70.23 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 119.572 -0.851 . . . . 0.45 110.141 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.55 -38.0 79.92 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.261 -0.427 . . . . 0.45 112.048 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.27 -26.32 28.39 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.744 0.646 . . . . 0.51 112.744 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -95.57 -4.73 44.13 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 113.126 0.787 . . . . 0.48 113.126 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 69.4 mt -105.77 157.43 17.45 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.396 0.888 . . . . 0.41 113.396 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -89.34 107.99 19.38 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 102.557 -3.127 . . . . 0.42 102.557 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 72.9 p -107.09 15.4 25.26 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 124.153 0.908 . . . . 0.45 111.064 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 73.0 p -63.95 -34.29 77.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 115.595 1.702 . . . . 0.48 115.595 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.87 -9.35 43.61 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.267 0.556 . . . . 0.47 112.202 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.74 172.19 13.02 Favored Glycine 0 C--O 1.242 0.642 0 C-N-CA 119.484 -1.341 . . . . 0.43 113.383 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.41 130.25 32.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 109.259 -0.645 . . . . 0.4 109.259 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp -115.84 113.42 23.34 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.497 1.748 . . . . 0.35 108.411 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.78 122.17 33.29 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.491 -1.67 . . . . 0.41 106.491 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 83.2 mt -109.52 115.27 29.61 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 104.531 -2.396 . . . . 0.28 104.531 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 26.0 m -120.01 163.4 17.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 113.186 0.81 . . . . 0.34 113.186 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' B' ' 67' ' ' ASP . 14.8 p-10 -64.9 -54.07 36.53 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 118.069 2.618 . . . . 0.39 118.069 -177.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 45.3 p -142.23 151.4 42.06 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.533 1.158 . . . . 0.39 112.692 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' TRP . . . . . 0.58 ' HE1' HG11 ' C' ' 211' ' ' VAL . 32.8 t-105 -66.27 134.45 52.67 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.153 -1.385 . . . . 0.6 107.818 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.73 -8.14 70.6 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 121.218 3.247 . . . . 0.52 121.218 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.2 174.92 55.25 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 119.282 -1.437 . . . . 0.48 110.109 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.15 -47.84 98.4 Favored Pre-proline 0 C--N 1.329 -0.291 0 O-C-N 122.017 -0.696 . . . . 1.31 112.01 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -53.44 -41.6 71.92 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 118.391 -0.606 . . . . 0.45 110.619 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -67.2 -48.37 68.1 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 123.458 0.474 . . . . 0.5 109.845 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -60.05 -42.71 95.08 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.972 1.101 . . . . 2.04 113.972 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.46 85.71 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.242 -0.983 . . . . 0.52 111.721 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.05 -38.83 90.25 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 108.618 -0.882 . . . . 0.49 108.618 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.684 ' O ' HG13 ' B' ' 82' ' ' VAL . 70.5 m -58.65 -39.89 81.88 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.416 0.524 . . . . 1.4 112.416 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.619 ' O ' HG22 ' B' ' 82' ' ' VAL . 34.0 mtt180 -67.2 -29.58 69.28 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 113.042 0.756 . . . . 3.47 113.042 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 76.1 mt -77.2 -42.15 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.697 0.629 . . . . 0.55 112.697 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' B' ' 87' ' ' TYR . 2.6 m -80.03 -16.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.901 0 N-CA-C 115.465 1.654 . . . . 0.56 115.465 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . 0.684 HG13 ' O ' ' B' ' 78' ' ' SER . 2.9 m -29.4 -55.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.352 1 N-CA-C 122.096 4.11 . . . . 0.74 122.096 -176.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.49 39.3 3.99 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 116.394 -2.122 . . . . 0.72 109.601 178.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.37 133.55 54.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.442 -1.254 . . . . 0.61 109.748 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.25 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 106.707 -1.59 . . . . 0.63 106.707 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.68 15.24 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 115.406 1.632 . . . . 0.55 115.406 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' TYR . . . . . 0.479 ' HB3' ' HB ' ' B' ' 81' ' ' VAL . 6.1 m-85 -127.45 130.89 50.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 105.506 -2.035 . . . . 0.49 105.506 175.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.6 154.66 41.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.228 -0.589 . . . . 0.49 110.357 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.77 128.47 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 106.235 -1.765 . . . . 0.44 106.235 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 34.2 mt -124.14 119.52 56.93 Favored 'Isoleucine or valine' 0 C--O 1.255 1.378 0 N-CA-C 108.245 -1.02 . . . . 0.36 108.245 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.46 163.21 19.59 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 114.738 -1.119 . . . . 0.36 112.314 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.89 24.49 55.33 Favored Glycine 0 CA--C 1.499 -0.911 0 N-CA-C 114.817 0.687 . . . . 0.29 114.817 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.85 132.85 6.69 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 N-CA-C 113.461 0.911 . . . . 0.22 113.461 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' A' ' 94' ' ' ASN . 51.2 p30 -141.98 169.48 17.52 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.688 -1.227 . . . . 0.2 107.688 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 51.3 mm -60.2 -43.37 93.54 Favored Pre-proline 0 C--O 1.24 0.588 0 N-CA-C 114.491 1.293 . . . . 0.17 114.491 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.55 -42.85 56.53 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 117.575 -1.15 . . . . 0.23 110.34 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 39.9 ttm -61.72 -48.85 78.86 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 120.377 -0.529 . . . . 0.26 109.633 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.46 -48.01 83.62 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 112.822 0.675 . . . . 0.2 112.822 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.52 -49.9 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 112.715 0.635 . . . . 0.26 112.715 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -63.52 -40.59 97.43 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 120.235 -0.586 . . . . 2.01 111.696 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' THR . . . . . . . . . . . . . 53.5 m -66.23 -46.12 78.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.731 -0.668 . . . . 0.28 110.892 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.47 -37.79 88.76 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 123.607 0.567 . . . . 0.29 110.563 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' MET . . . . . . . . . . . . . 72.6 mtp -66.1 -45.81 79.84 Favored 'General case' 0 C--O 1.242 0.695 0 O-C-N 121.264 -0.897 . . . . 1.76 112.132 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' B' ' 109' ' ' PRO . . . -67.72 -33.81 75.62 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.3 0.852 . . . . 0.38 113.3 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.633 ' HD2' ' O ' ' B' ' 3' ' ' ILE . 15.8 ttp180 -52.56 -32.69 42.16 Favored 'General case' 0 C--O 1.21 -1.013 0 N-CA-C 113.4 0.889 . . . . 0.37 113.4 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.57 -19.59 60.85 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 114.1 1.148 . . . . 2.13 114.1 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -90.62 18.15 6.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 122.159 0.981 . . . . 2.27 109.476 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 12.7 t70 46.79 58.47 16.88 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 117.269 2.322 . . . . 0.48 117.269 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.42 ' HG3' HD13 ' B' ' 114' ' ' LEU . 44.9 Cg_endo -74.09 168.43 24.82 Favored 'Trans proline' 0 C--O 1.206 -1.109 0 C-N-CA 120.55 0.833 . . . . 0.47 110.604 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 54.3 p -77.0 162.78 27.28 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.706 -1.59 . . . . 0.53 106.706 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -55.94 -51.48 67.5 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 112.445 0.535 . . . . 0.48 112.445 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -58.67 -37.67 76.51 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 112.897 0.703 . . . . 0.6 112.897 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -62.84 -46.77 86.37 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 116.417 -0.356 . . . . 0.57 110.141 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.42 HD13 ' HG3' ' B' ' 109' ' ' PRO . 15.1 tp -64.41 -45.86 85.77 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 121.019 -0.272 . . . . 0.43 111.191 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 63.5 t -56.88 -48.32 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 O-C-N 121.891 -0.506 . . . . 0.44 110.52 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.25 94.3 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.133 0.492 . . . . 0.49 112.326 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 tp -62.4 -42.8 99.71 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 122.125 -0.359 . . . . 0.42 110.989 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.29 -45.1 94.51 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 119.798 -0.761 . . . . 0.35 112.059 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.61 -46.26 89.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.803 -0.443 . . . . 0.42 109.803 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -63.71 -45.22 90.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 113.717 1.006 . . . . 0.52 113.717 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 34.6 p -71.44 -32.28 68.16 Favored 'General case' 0 C--O 1.216 -0.681 0 C-N-CA 120.585 -0.446 . . . . 0.36 111.987 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.38 -45.74 95.31 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.332 -1.507 . . . . 0.3 109.332 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.21 -42.15 66.11 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 112.622 0.601 . . . . 0.48 112.622 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.43 -20.27 62.92 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 119.578 -0.849 . . . . 2.42 111.964 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.78 -16.6 76.3 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 124.246 0.966 . . . . 0.31 113.511 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 93.7 t -88.99 113.07 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 106.171 -1.789 . . . . 0.34 106.171 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -156.45 136.84 13.03 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.409 -0.96 . . . . 2.95 108.409 -173.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.6 146.71 23.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.031 0.92 . . . . 0.4 109.986 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 tp -66.94 -56.78 8.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.337 -0.847 . . . . 0.45 111.37 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 62.63 178.8 0.14 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.612 0.72 . . . . 2.83 110.401 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.97 146.22 53.78 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.719 -0.845 . . . . 1.34 108.719 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . 0.413 ' H ' ' HG2' ' B' ' 132' ' ' LYS . 0.8 OUTLIER -112.87 145.23 32.61 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.513 -0.742 . . . . 4.96 109.219 -179.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -64.41 146.97 90.57 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.474 2.116 . . . . 3.1 112.42 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.988 -1.006 . . . . 3.89 109.133 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 159' ' ' ASN . . . . . 0.709 ' ND2' ' NZ ' ' C' ' 259' ' ' LYS . 1.8 t-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 108.992 -0.744 . . . . 6.34 108.992 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 160' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -85.87 25.5 1.1 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.59 -0.893 . . . . 3.89 108.59 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 161' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -118.63 -141.88 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.583 -0.895 . . . . 1.72 108.583 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 162' ' ' MET . . . . . 0.594 ' SD ' HG21 ' C' ' 240' ' ' VAL . 0.3 OUTLIER -61.63 156.19 20.55 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.764 -1.21 . . . . 2.0 110.562 -178.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 163' ' ' VAL . . . . . . . . . . . . . 94.9 t -113.11 117.68 56.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.06 -0.719 . . . . 0.63 109.06 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 164' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.73 103.39 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.49 -0.929 . . . . 0.46 108.49 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.59 -35.33 80.7 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.211 -1.555 . . . . 0.44 109.211 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 tp -172.04 147.97 2.18 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.771 -1.172 . . . . 0.47 111.209 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 167' ' ' ALA . . . . . . . . . . . . . . . -117.69 104.39 10.96 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.048 -0.723 . . . . 0.29 109.048 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 168' ' ' ARG . . . . . 0.941 ' NH1' HG12 ' C' ' 178' ' ' VAL . 44.4 ttp180 -106.37 126.09 51.81 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.972 0.891 . . . . 3.14 110.835 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 169' ' ' ILE . . . . . . . . . . . . . 82.3 mt -95.5 129.21 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 109.222 -0.659 . . . . 0.34 109.222 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 170' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -165.95 117.04 1.04 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.812 -0.755 . . . . 0.49 110.327 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 171' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.97 -9.94 11.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.429 -0.794 . . . . 2.33 109.759 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 172' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' C' ' 174' ' ' ILE . 12.4 mtt180 -101.71 -6.49 23.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 2.95 110.47 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 173' ' ' LEU . . . . . . . . . . . . . 13.7 mt 59.1 -89.16 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.44 -0.948 . . . . 1.39 108.44 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 174' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' C' ' 172' ' ' ARG . 70.8 mt -109.98 116.77 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.069 -1.02 . . . . 0.53 110.227 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 175' ' ' HIS . . . . . 0.576 ' CE1' HG21 ' C' ' 178' ' ' VAL . 10.0 p80 -139.35 117.61 11.95 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.947 -1.095 . . . . 0.65 109.033 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.55 -152.74 45.05 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 110.066 -1.214 . . . . 0.57 110.066 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 177' ' ' GLN . . . . . 0.785 ' H ' ' NE2' ' C' ' 177' ' ' GLN . 0.1 OUTLIER -91.15 12.21 20.76 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.744 -0.856 . . . . 3.26 109.332 -178.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . 0.941 HG12 ' NH1' ' C' ' 168' ' ' ARG . 48.1 t -61.54 -42.83 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 0.51 108.953 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 179' ' ' ALA . . . . . 0.448 ' O ' ' OG1' ' C' ' 183' ' ' THR . . . -73.16 -36.38 66.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.929 -1.107 . . . . 0.53 110.187 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 180' ' ' THR . . . . . . . . . . . . . 21.5 m -66.34 -54.42 24.82 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.697 -0.801 . . . . 0.68 109.79 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 181' ' ' ARG . . . . . 0.539 ' NH2' ' CG2' ' C' ' 308' ' ' THR . 55.1 ttt-85 -64.7 -43.62 92.88 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.013 -0.675 . . . . 3.12 110.608 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 182' ' ' TRP . . . . . 0.533 ' O ' HG23 ' C' ' 186' ' ' THR . 19.5 m95 -65.82 -32.2 73.6 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.034 -1.041 . . . . 0.9 109.591 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 183' ' ' THR . . . . . 0.803 HG21 HG21 ' C' ' 216' ' ' VAL . 71.9 m -65.29 -47.1 77.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.946 -1.096 . . . . 0.59 110.252 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -69.66 -42.93 73.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 2.2 110.806 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 185' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -68.32 -39.61 81.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.95 -1.094 . . . . 2.52 109.569 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 186' ' ' THR . . . . . 0.533 HG23 ' O ' ' C' ' 182' ' ' TRP . 72.6 p -81.42 -1.26 45.03 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.282 -0.886 . . . . 0.59 109.685 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 187' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 52.14 48.42 22.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.055 -1.028 . . . . 2.1 108.604 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 188' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.05 133.46 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.164 -0.96 . . . . 1.37 110.122 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 189' ' ' SER . . . . . . . . . . . . . 27.8 p -109.75 -6.33 15.32 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.761 -0.829 . . . . 1.4 108.761 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 190' ' ' ARG . . . . . . . . . . . . . 29.4 mtt-85 -135.92 142.83 44.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.555 -0.716 . . . . 3.52 110.441 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 191' ' ' ILE . . . . . . . . . . . . . 87.6 mt -133.38 127.61 54.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.173 -1.047 . . . . 0.51 108.173 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 192' ' ' ILE . . . . . 0.455 HD12 HG11 ' C' ' 240' ' ' VAL . 97.1 mt -115.66 128.68 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.257 -0.902 . . . . 0.46 109.665 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 193' ' ' VAL . . . . . . . . . . . . . 53.3 t -99.7 128.88 51.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.825 -0.806 . . . . 0.71 108.825 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 194' ' ' VAL . . . . . . . . . . . . . 43.0 t -112.51 103.57 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.535 -0.728 . . . . 0.43 109.479 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 195' ' ' SER . . . . . . . . . . . . . 38.0 t -167.25 125.61 1.31 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.342 -0.943 . . . . 1.38 109.31 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 196' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.01 -34.88 66.65 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.574 -0.704 . . . . 0.98 109.984 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 197' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -65.55 -45.49 83.21 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.147 -0.971 . . . . 2.32 109.959 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 198' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.11 -43.21 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.102 -0.998 . . . . 0.71 109.028 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.6 -26.5 55.72 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.79 -0.764 . . . . 0.74 109.168 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 200' ' ' ALA . . . . . . . . . . . . . . . -84.9 -5.38 59.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.028 -1.045 . . . . 0.89 109.882 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 201' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -102.75 95.38 6.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.9 -1.125 . . . . 1.15 109.554 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 202' ' ' THR . . . . . . . . . . . . . 24.7 p -66.22 -33.21 75.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.407 -0.808 . . . . 1.61 110.631 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 203' ' ' VAL . . . . . 0.615 HG22 HG12 ' A' ' 134' ' ' VAL . 55.8 t -66.33 -47.49 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.851 -1.156 . . . . 0.9 109.598 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 204' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -63.69 -42.24 98.04 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.349 -0.94 . . . . 3.07 109.576 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 205' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -58.01 -42.42 85.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 1.72 109.482 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 206' ' ' THR . . . . . 0.437 HG21 ' HG2' ' A' ' 133' ' ' PRO . 73.2 m -60.63 -48.71 80.55 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.088 -1.045 . . . . 0.92 109.564 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 207' ' ' LEU . . . . . 0.716 HD11 ' HD3' ' A' ' 132' ' ' LYS . 30.6 mt -62.62 -44.45 96.26 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.934 -1.107 . . . . 0.82 110.736 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 208' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' C' ' 208' ' ' LEU . 81.6 mt -62.5 -41.45 98.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.718 -1.239 . . . . 0.73 110.055 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 209' ' ' THR . . . . . . . . . . . . . 35.8 p -67.89 -31.83 71.89 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.371 -0.831 . . . . 0.84 110.28 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 210' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -80.37 -17.54 51.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.782 -1.199 . . . . 2.32 110.857 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . 0.58 HG11 ' HE1' ' B' ' 69' ' ' TRP . 17.5 m -107.69 17.65 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.952 -1.092 . . . . 0.93 108.639 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.29 123.42 82.48 Favored Pre-proline 0 N--CA 1.483 1.221 0 N-CA-C 107.82 -1.178 . . . . 0.76 107.82 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 213' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -44.31 144.48 2.95 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.037 1.825 . . . . 0.93 112.731 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 214' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -56.52 134.85 66.98 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.196 1.931 . . . . 1.14 112.028 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 215' ' ' GLY . . . . . . . . . . . . . . . 79.91 -8.52 50.03 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.922 -1.271 . . . . 0.85 109.922 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 216' ' ' VAL . . . . . 0.803 HG21 HG21 ' C' ' 183' ' ' THR . 58.6 t -114.8 136.78 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -1.076 . . . . 0.92 108.8 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.87 135.77 45.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.438 -0.789 . . . . 1.42 109.836 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 218' ' ' ALA . . . . . . . . . . . . . . . -110.17 131.37 55.12 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.315 -0.994 . . . . 0.64 108.315 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -120.97 153.51 37.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.401 -0.812 . . . . 0.72 109.808 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 54.8 t -126.35 117.83 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.624 0.726 . . . . 0.6 109.07 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 31.7 m -141.01 165.14 19.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.412 -0.805 . . . . 0.57 109.622 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 222' ' ' ASP . . . . . 0.709 ' OD1' ' N ' ' C' ' 225' ' ' LYS . 6.8 p30 -94.18 167.23 11.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.479 -0.763 . . . . 1.34 109.305 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.46 -44.82 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.151 -0.968 . . . . 0.54 110.455 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 224' ' ' ALA . . . . . 0.852 ' O ' HG22 ' C' ' 227' ' ' ILE . . . -62.72 -44.73 95.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.934 -1.104 . . . . 0.67 109.398 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 225' ' ' LYS . . . . . 0.709 ' N ' ' OD1' ' C' ' 222' ' ' ASP . 45.7 tttm -68.14 -35.35 77.95 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.775 -1.203 . . . . 2.11 109.674 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 226' ' ' MET . . . . . . . . . . . . . 10.3 tpt -62.08 -40.4 95.71 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.934 -1.104 . . . . 1.54 111.191 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 227' ' ' ILE . . . . . 0.852 HG22 ' O ' ' C' ' 224' ' ' ALA . 17.4 tt -60.9 -34.56 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.611 -0.885 . . . . 0.69 108.611 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.47 -38.86 62.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.722 -0.611 . . . . 4.01 110.948 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 70.3 t -62.18 -41.73 92.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.864 -1.162 . . . . 0.63 107.864 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 230' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' C' ' 230' ' ' TYR . 36.7 t80 -67.04 -32.13 73.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.102 -0.999 . . . . 0.64 109.927 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 231' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.76 6.73 2.34 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.119 -0.988 . . . . 0.95 110.104 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 232' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -110.18 117.78 50.87 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.246 -0.909 . . . . 0.93 109.435 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 233' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -65.73 1.51 2.19 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.646 1.564 . . . . 0.99 111.98 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 234' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.36 -24.76 65.33 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 1.59 108.807 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 235' ' ' TYR . . . . . 0.501 ' O ' ' HB2' ' C' ' 238' ' ' GLU . 81.1 m-85 -105.49 15.71 26.66 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.594 -0.842 . . . . 1.19 109.003 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.81 135.62 47.44 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.076 -1.64 . . . . 0.67 109.65 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.78 -33.41 1.9 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.288 -1.525 . . . . 0.64 109.288 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 238' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' C' ' 235' ' ' TYR . 4.0 mm-40 -54.25 138.93 37.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.805 -1.409 . . . . 2.48 109.437 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 239' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -99.1 116.33 31.08 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.463 -0.939 . . . . 2.96 108.463 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 240' ' ' VAL . . . . . 0.594 HG21 ' SD ' ' C' ' 162' ' ' MET . 26.3 t -121.85 148.78 25.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.876 0.846 . . . . 0.66 110.448 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 241' ' ' MET . . . . . . . . . . . . . 13.8 ttm -102.9 134.95 45.47 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.925 -1.139 . . . . 1.63 107.925 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 242' ' ' LEU . . . . . 0.402 ' HB3' ' CE2' ' C' ' 244' ' ' PHE . 61.2 mt -102.04 127.28 49.0 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.689 -0.804 . . . . 0.35 109.877 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 243' ' ' LEU . . . . . . . . . . . . . 97.6 mt -109.5 126.08 53.15 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.981 0.896 . . . . 0.68 109.045 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 244' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' C' ' 242' ' ' LEU . 77.7 m-85 -127.0 162.03 26.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.771 0.796 . . . . 0.3 109.275 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 245' ' ' THR . . . . . . . . . . . . . 70.2 p -109.48 -19.47 13.23 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.958 -0.756 . . . . 0.43 108.958 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 246' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' C' ' 246' ' ' ASN . 17.3 p30 -151.08 141.85 14.91 Favored Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 120.003 -0.679 . . . . 1.0 109.872 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 247' ' ' PRO . . . . . 0.451 ' HG3' ' CE2' ' C' ' 291' ' ' PHE . 7.3 Cg_endo -60.85 -14.63 33.4 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.683 2.255 . . . . 0.59 112.1 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 248' ' ' THR . . . . . . . . . . . . . 95.7 m -64.99 -42.66 94.31 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.151 0.976 . . . . 0.64 108.624 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 249' ' ' ASP . . . . . 0.42 ' O ' HD12 ' C' ' 253' ' ' LEU . 97.8 m-20 -67.48 -23.4 65.48 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.54 -0.725 . . . . 0.53 109.801 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 250' ' ' VAL . . . . . . . . . . . . . 98.3 t -73.62 -43.77 54.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.672 -1.267 . . . . 0.4 109.848 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 251' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.41 -35.02 77.92 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.426 -0.953 . . . . 1.51 108.426 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 252' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -62.48 -44.09 97.23 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.723 -0.791 . . . . 3.24 110.156 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 253' ' ' LEU . . . . . 0.42 HD12 ' O ' ' C' ' 249' ' ' ASP . 1.2 mp -64.07 -40.42 96.22 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 117.999 -1.48 . . . . 1.06 108.876 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 254' ' ' VAL . . . . . 0.57 ' CG2' HD12 ' C' ' 260' ' ' ILE . 70.6 t -60.7 -44.61 97.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 120.835 -1.165 . . . . 0.48 108.948 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 255' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.23 -30.97 69.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.018 -1.052 . . . . 2.47 109.917 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 256' ' ' GLY . . . . . . . . . . . . . . . -74.28 2.8 43.16 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.498 -1.441 . . . . 0.55 109.498 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 257' ' ' GLY . . . . . . . . . . . . . . . 94.37 15.79 45.94 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.627 -1.389 . . . . 0.51 109.627 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 258' ' ' VAL . . . . . . . . . . . . . 96.7 t -77.66 139.72 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.034 -1.469 . . . . 0.45 107.034 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 259' ' ' LYS . . . . . 0.709 ' NZ ' ' ND2' ' C' ' 159' ' ' ASN . 17.9 tttt -99.01 123.93 43.64 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.089 -1.007 . . . . 3.12 110.811 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 260' ' ' ILE . . . . . 0.57 HD12 ' CG2' ' C' ' 254' ' ' VAL . 98.1 mt -129.99 125.67 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.43 -0.794 . . . . 0.41 109.147 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 65.9 p -89.51 -31.44 17.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.776 -1.202 . . . . 0.57 110.238 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 262' ' ' SER . . . . . . . . . . . . . 15.8 m -159.06 153.51 24.15 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.176 -0.953 . . . . 0.46 110.092 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 263' ' ' VAL . . . . . . . . . . . . . 50.9 t -122.74 134.61 65.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.538 -0.912 . . . . 0.37 108.538 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 264' ' ' ASN . . . . . 0.468 ' ND2' ' CH2' ' C' ' 182' ' ' TRP . 33.7 t30 -108.57 128.08 54.51 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.517 0.675 . . . . 1.17 110.607 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 265' ' ' VAL . . . . . 0.451 HG21 ' SD ' ' C' ' 314' ' ' MET . 3.2 t -90.64 108.43 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 120.058 -0.657 . . . . 0.4 109.68 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 266' ' ' GLY . . . . . . . . . . . . . . . -80.75 -53.94 3.84 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.153 -1.179 . . . . 0.41 110.153 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . -172.57 152.93 17.73 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.646 -1.74 . . . . 0.41 111.476 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 268' ' ' MET . . . . . 0.44 ' HB2' ' H ' ' C' ' 282' ' ' SER . 97.0 mtp -143.1 118.08 10.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.481 -1.011 . . . . 0.5 110.443 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.34 128.21 21.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.371 -0.831 . . . . 0.57 109.523 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 270' ' ' PHE . . . . . 0.536 ' CG ' ' N ' ' C' ' 271' ' ' ARG . 13.3 t80 -69.5 161.8 28.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.92 109.618 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 271' ' ' ARG . . . . . 0.536 ' N ' ' CG ' ' C' ' 270' ' ' PHE . 32.7 ttm180 -160.66 158.67 29.24 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.27 -0.972 . . . . 3.23 109.676 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 272' ' ' GLN . . . . . 0.4 ' N ' ' HG2' ' C' ' 271' ' ' ARG . 73.9 mt-30 -66.48 138.25 57.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.081 -1.012 . . . . 2.98 110.459 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 273' ' ' GLY . . . . . . . . . . . . . . . 95.52 -12.32 67.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.818 -1.713 . . . . 0.87 108.818 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 274' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -101.81 163.37 12.29 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.484 -1.01 . . . . 1.66 109.388 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 275' ' ' THR . . . . . 0.561 HG21 HG21 ' C' ' 321' ' ' ILE . 20.8 m -109.95 135.83 50.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.674 -0.862 . . . . 0.84 108.674 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 276' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -82.02 119.21 23.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.246 -0.909 . . . . 2.77 110.176 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 277' ' ' VAL . . . . . 0.519 HG12 ' CD1' ' C' ' 321' ' ' ILE . 27.5 m -99.22 -28.18 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.81 -0.756 . . . . 0.74 109.612 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 278' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' C' ' 279' ' ' ASN . 10.2 t-20 -135.99 -177.16 4.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.658 0.742 . . . . 1.52 109.761 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' C' ' 278' ' ' ASN . 39.5 m-20 -56.93 -29.88 63.5 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.791 -0.568 . . . . 2.29 110.787 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . -148.06 27.01 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.829 -1.169 . . . . 0.6 109.538 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 281' ' ' VAL . . . . . 0.498 ' O ' HG22 ' C' ' 277' ' ' VAL . 60.8 t -118.99 121.98 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.825 0.822 . . . . 0.61 109.678 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 282' ' ' SER . . . . . 0.44 ' H ' ' HB2' ' C' ' 268' ' ' MET . 29.0 m -118.64 147.61 43.58 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.447 0.642 . . . . 0.75 110.02 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 283' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.26 142.84 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.446 1.117 . . . . 0.7 110.539 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 284' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' C' ' 287' ' ' ASP . 44.1 p-10 -110.61 171.67 7.33 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 106.923 -1.51 . . . . 0.77 106.923 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 285' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.18 -24.21 40.12 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.833 -1.167 . . . . 2.34 109.587 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 286' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -79.59 -43.46 22.89 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.233 -0.917 . . . . 2.0 110.026 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 287' ' ' ASP . . . . . 0.57 ' N ' ' OD1' ' C' ' 284' ' ' ASP . 93.3 m-20 -64.25 -42.08 96.67 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.237 -0.915 . . . . 0.62 109.096 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 288' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.48 -45.77 97.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.387 -0.821 . . . . 0.73 109.518 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 289' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -57.44 -39.6 76.6 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.216 -0.928 . . . . 2.52 110.262 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.37 -41.01 85.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.82 -1.175 . . . . 0.6 109.9 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 291' ' ' PHE . . . . . 0.451 ' CE2' ' HG3' ' C' ' 247' ' ' PRO . 40.0 m-85 -63.93 -39.02 93.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.57 109.73 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 292' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -64.08 -39.5 94.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.149 -0.969 . . . . 2.05 110.226 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 293' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -65.78 -41.54 91.86 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.943 -1.098 . . . . 1.8 109.635 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 294' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.18 -43.22 99.32 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.871 -1.143 . . . . 0.53 108.867 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 295' ' ' ASN . . . . . 0.58 HD22 ' HG3' ' C' ' 315' ' ' MET . 40.3 t-20 -64.01 -40.01 95.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 1.45 109.953 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.66 -21.38 65.67 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.815 -1.178 . . . . 0.69 109.242 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 297' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -90.13 8.85 30.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.769 -1.207 . . . . 2.49 109.91 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.44 11.43 82.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.903 -1.279 . . . . 0.6 109.903 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 299' ' ' ILE . . . . . . . . . . . . . 97.8 mt -84.71 134.56 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.974 -1.309 . . . . 0.53 109.151 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 300' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -82.0 141.66 33.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.869 . . . . 2.3 110.615 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 301' ' ' LEU . . . . . . . . . . . . . 66.9 mt -123.08 111.27 16.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.269 -0.641 . . . . 0.54 109.269 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 302' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.57 139.87 49.69 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.9 . . . . 2.26 110.289 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 303' ' ' VAL . . . . . 0.611 ' CG2' ' SD ' ' C' ' 314' ' ' MET . 51.8 t -111.99 124.77 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.673 -0.862 . . . . 0.55 108.673 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 304' ' ' ARG . . . . . 0.459 ' HE ' ' CG ' ' C' ' 264' ' ' ASN . 33.4 ptt180 -164.93 137.87 4.64 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.505 -0.878 . . . . 2.7 110.343 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 305' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -80.82 -45.42 16.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 3.19 109.817 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 306' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.33 154.01 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.106 -0.996 . . . . 0.65 108.737 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 307' ' ' SER . . . . . . . . . . . . . 83.5 p -64.55 -16.29 62.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.983 -1.073 . . . . 1.36 109.516 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 308' ' ' THR . . . . . 0.539 ' CG2' ' NH2' ' C' ' 181' ' ' ARG . 44.5 p -86.14 -9.07 57.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.047 -1.033 . . . . 0.85 110.005 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 309' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -92.49 152.69 42.35 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.025 -1.047 . . . . 0.81 109.936 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 310' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -55.37 139.15 81.42 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.968 1.779 . . . . 0.93 111.755 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 311' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -84.24 132.82 34.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 3.09 109.823 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 312' ' ' LEU . . . . . . . . . . . . . 80.2 mt -117.51 154.74 30.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.103 -0.998 . . . . 0.73 108.309 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 313' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -91.26 130.49 37.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.076 -1.015 . . . . 2.24 109.827 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 314' ' ' MET . . . . . 0.611 ' SD ' ' CG2' ' C' ' 303' ' ' VAL . 8.2 tpt -56.39 -44.17 79.97 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.67 -0.644 . . . . 1.03 109.63 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 315' ' ' MET . . . . . 0.58 ' HG3' HD22 ' C' ' 295' ' ' ASN . 95.9 mmm -61.18 -40.39 93.73 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.299 -0.876 . . . . 1.71 110.22 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 316' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.9 -44.0 97.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.319 -0.863 . . . . 0.82 109.81 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 317' ' ' LEU . . . . . . . . . . . . . 92.8 mt -66.49 -41.98 88.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.877 . . . . 0.8 110.036 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 318' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.26 -24.49 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.311 -0.868 . . . . 0.86 109.957 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 319' ' ' SER . . . . . 0.475 ' O ' ' C ' ' C' ' 323' ' ' LYS . 0.9 OUTLIER -72.72 -31.56 65.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.084 -1.01 . . . . 1.52 109.518 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 320' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -84.19 -2.45 56.9 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.78 -1.168 . . . . 2.04 109.167 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 321' ' ' ILE . . . . . 0.561 HG21 HG21 ' C' ' 275' ' ' THR . 93.2 mt -113.76 -58.74 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.914 -1.143 . . . . 1.17 107.914 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 322' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' C' ' 323' ' ' LYS . 12.3 t0 -95.01 85.11 4.26 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.16 -1.792 . . . . 2.26 106.16 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 323' ' ' LYS . . . . . 1.262 ' HA ' ' NZ ' ' C' ' 323' ' ' LYS . 0.0 OUTLIER . . . . . 1 C--O 1.524 15.537 0 CA-C-O 126.309 2.957 . . . . 5.92 109.465 -177.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.548 ' HB ' ' HG2' ' A' ' 105' ' ' ARG . 76.6 p . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 121.106 0.479 . . . . 0.44 111.038 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.614 ' O ' ' HD2' ' A' ' 105' ' ' ARG . 47.0 mt -71.24 136.2 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.736 -1.95 . . . . 0.38 105.736 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.98 144.42 36.76 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 115.292 -0.867 . . . . 0.35 110.744 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.3 mt -126.27 130.14 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.825 0.85 . . . . 0.31 109.053 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.29 129.28 74.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.035 -1.839 . . . . 0.32 106.035 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 mt -109.11 132.24 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.445 -0.576 . . . . 0.26 109.445 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.55 133.01 6.17 Favored Glycine 0 N--CA 1.463 0.476 0 C-N-CA 120.271 -0.966 . . . . 0.24 111.849 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.68 HG21 ' HB3' ' A' ' 13' ' ' ALA . 14.4 t -141.61 163.83 31.87 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 107.422 -1.325 . . . . 0.26 107.422 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' NEP . . . . . 0.586 ' ND1' ' OD2' ' A' ' 67' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 73.28 -147.27 38.96 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 116.57 -2.728 . . . . 0.31 114.981 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -121.95 25.66 9.01 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 114.486 1.291 . . . . 0.78 114.486 -174.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.68 ' HB3' HG21 ' A' ' 9' ' ' THR . . . -78.92 -27.27 43.73 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 115.277 1.584 . . . . 0.25 115.277 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.7 -46.48 74.15 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.827 0.74 . . . . 0.26 112.799 -176.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -59.79 -40.39 88.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.593 -0.443 . . . . 0.44 111.224 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.31 -35.22 73.53 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.105 1.15 . . . . 0.38 114.105 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.05 -39.99 95.3 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.139 -1.43 . . . . 0.27 107.139 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.13 -43.47 91.81 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.149 -0.685 . . . . 0.34 109.149 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -61.56 -39.18 90.2 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.242 0.544 . . . . 0.44 111.234 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.96 -47.64 79.64 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 115.048 -0.978 . . . . 0.37 108.609 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.71 86.11 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 119.754 -0.778 . . . . 0.39 111.465 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.96 -23.34 65.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.103 -0.499 . . . . 2.5 110.692 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.47 -32.01 69.39 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 105.703 -1.962 . . . . 2.59 105.703 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.8 mt -84.74 -38.38 19.74 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 113.817 1.043 . . . . 0.49 113.817 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -109.6 -12.03 14.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 119.025 2.972 . . . . 0.5 119.025 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.98 165.07 31.38 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 105.457 -3.057 . . . . 0.51 105.457 -175.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -58.82 138.97 56.96 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 122.41 1.1 . . . . 0.58 112.611 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -105.91 146.75 29.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.264 -1.789 . . . . 0.45 113.038 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -106.46 157.34 17.72 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.497 -1.229 . . . . 0.54 107.816 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.25 41.22 20.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.096 1.147 . . . . 0.42 114.096 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.8 t -131.09 134.53 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.381 -0.97 . . . . 0.38 108.381 177.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.66 18.93 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 109.899 -1.28 . . . . 0.35 109.899 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.22 157.76 36.4 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 118.203 1.001 . . . . 0.41 108.921 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.84 159.15 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.453 -0.794 . . . . 0.36 110.29 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -113.46 162.85 15.63 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.757 -0.656 . . . . 0.42 109.592 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 36' ' ' PHE . 1.9 t80 -134.19 117.5 16.57 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.886 -1.524 . . . . 0.41 106.886 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.6 t -108.11 145.44 31.45 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 113.92 -1.491 . . . . 0.49 110.848 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -57.06 136.08 74.54 Favored 'Trans proline' 0 C--N 1.352 0.752 0 N-CA-C 107.929 -1.604 . . . . 0.53 107.929 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.55 -25.75 16.55 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.065 -1.214 . . . . 0.58 110.065 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.34 157.66 21.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.373 0.606 . . . . 0.52 110.009 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -125.08 179.29 5.11 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.343 -0.984 . . . . 2.23 108.343 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.19 72.97 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 113.003 0.742 . . . . 0.49 113.003 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.86 -36.45 84.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.84 0.828 . . . . 2.83 112.164 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.5 m -63.92 -47.58 79.99 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 106.01 -1.848 . . . . 0.56 106.01 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.71 -37.48 86.7 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.108 0.781 . . . . 0.47 113.108 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.1 mt -58.59 -43.15 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.587 -0.894 . . . . 0.5 108.587 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -62.58 -42.73 99.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.966 -0.694 . . . . 0.59 110.875 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -61.58 -44.34 97.21 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 119.347 -0.941 . . . . 0.48 111.34 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -61.02 -45.65 93.96 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 120.015 -0.674 . . . . 0.42 109.595 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -60.15 -40.04 88.44 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 113.158 0.799 . . . . 0.51 113.158 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.58 -35.64 81.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.449 0.643 . . . . 0.52 110.135 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.17 -43.61 70.47 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 119.578 -0.849 . . . . 0.45 110.205 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.73 -37.92 80.28 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.281 -0.418 . . . . 0.45 112.041 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.31 -26.36 29.07 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.699 0.629 . . . . 0.53 112.699 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -95.49 -4.75 44.35 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.224 0.824 . . . . 0.53 113.224 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 69.8 mt -105.85 157.54 17.4 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 113.313 0.857 . . . . 0.46 113.313 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -89.34 107.94 19.35 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 102.541 -3.133 . . . . 0.47 102.541 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.9 p -106.98 15.38 25.39 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 124.097 0.873 . . . . 0.44 111.05 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.3 p -64.03 -34.27 77.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 115.553 1.686 . . . . 0.49 115.553 -177.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.77 -9.39 43.79 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.274 0.559 . . . . 0.49 112.271 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.71 172.22 13.03 Favored Glycine 0 C--O 1.242 0.598 0 C-N-CA 119.486 -1.34 . . . . 0.4 113.406 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.3 t -139.47 130.17 32.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 N-CA-C 109.273 -0.639 . . . . 0.36 109.273 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.8 tp -115.86 113.37 23.26 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.549 1.781 . . . . 0.3 108.446 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.68 122.19 33.23 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 106.507 -1.664 . . . . 0.34 106.507 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.0 mt -109.55 115.25 29.56 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 104.519 -2.4 . . . . 0.22 104.519 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.4 m -119.93 163.31 17.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 113.221 0.823 . . . . 0.23 113.221 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.586 ' OD2' ' ND1' ' A' ' 10' ' ' NEP . 14.3 p-10 -64.94 -54.05 36.8 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 118.031 2.604 . . . . 0.27 118.031 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -142.23 151.41 42.09 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 122.541 1.163 . . . . 0.26 112.693 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -66.32 134.47 52.67 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.178 -1.374 . . . . 0.45 107.857 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.72 -8.14 70.59 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 121.281 3.272 . . . . 0.38 121.281 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.23 174.9 55.24 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 119.341 -1.409 . . . . 0.34 110.065 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.18 -47.77 98.5 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 122.089 -0.653 . . . . 1.24 112.057 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -53.5 -41.56 72.46 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 118.293 -0.671 . . . . 0.32 110.604 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -67.28 -48.26 68.2 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 123.506 0.504 . . . . 0.37 109.865 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -60.1 -42.71 95.24 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.945 1.091 . . . . 1.99 113.945 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.6 85.57 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.388 -0.925 . . . . 0.41 111.675 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.83 89.97 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.7 -0.852 . . . . 0.38 108.7 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.685 ' O ' HG13 ' A' ' 82' ' ' VAL . 70.3 m -58.72 -39.82 81.96 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.423 0.527 . . . . 1.38 112.423 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.611 ' O ' HG22 ' A' ' 82' ' ' VAL . 33.8 mtt180 -67.31 -29.55 69.15 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 112.957 0.725 . . . . 3.38 112.957 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.408 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 76.5 mt -77.15 -42.18 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.755 0.65 . . . . 0.45 112.755 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 87' ' ' TYR . 2.6 m -80.15 -16.72 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 115.456 1.65 . . . . 0.45 115.456 -175.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 78' ' ' SER . 2.9 m -29.31 -55.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 1 N-CA-C 122.123 4.12 . . . . 0.62 122.123 -177.007 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.55 39.4 3.97 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 116.387 -2.125 . . . . 0.59 109.525 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -112.33 133.55 54.37 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 114.505 -1.225 . . . . 0.49 109.745 -179.401 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.23 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 106.732 -1.581 . . . . 0.52 106.732 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.67 15.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 115.395 1.628 . . . . 0.47 115.395 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.477 ' HB3' ' HB ' ' A' ' 81' ' ' VAL . 6.1 m-85 -127.47 130.92 50.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.538 -2.023 . . . . 0.42 105.538 175.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.59 154.67 41.76 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.29 -0.564 . . . . 0.39 110.311 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 t -121.69 128.48 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 106.315 -1.735 . . . . 0.33 106.315 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.3 mt -124.16 119.51 56.87 Favored 'Isoleucine or valine' 0 C--O 1.256 1.405 0 N-CA-C 108.258 -1.016 . . . . 0.29 108.258 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.4 163.29 19.6 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 114.674 -1.148 . . . . 0.25 112.388 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.71 24.62 55.53 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 114.821 0.688 . . . . 0.19 114.821 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.82 132.73 6.61 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 N-CA-C 113.483 0.92 . . . . 0.16 113.483 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' B' ' 94' ' ' ASN . 50.9 p30 -141.88 169.61 17.28 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.65 -1.241 . . . . 0.24 107.65 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 95' ' ' ILE . 50.4 mm -60.22 -43.37 93.47 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 114.522 1.304 . . . . 0.29 114.522 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.55 -42.94 55.52 Favored 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 117.584 -1.144 . . . . 0.31 110.343 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 39.8 ttm -61.56 -48.93 78.75 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 120.348 -0.541 . . . . 0.28 109.704 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.44 -48.05 83.43 Favored 'General case' 0 C--O 1.201 -1.487 0 N-CA-C 112.784 0.661 . . . . 0.3 112.784 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.642 HG11 ' CG ' ' C' ' 177' ' ' GLN . 84.7 t -61.51 -49.8 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 112.729 0.641 . . . . 0.42 112.729 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -63.67 -40.51 97.01 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.253 -0.579 . . . . 2.04 111.671 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.3 m -66.24 -46.09 78.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.35 110.89 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.5 -37.84 88.93 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 123.537 0.523 . . . . 0.4 110.571 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 69.8 mtp -66.12 -45.74 80.0 Favored 'General case' 0 C--O 1.243 0.717 0 O-C-N 121.353 -0.842 . . . . 1.7 112.099 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.86 75.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.179 0.807 . . . . 0.44 113.179 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.614 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 15.7 ttp180 -52.6 -32.63 42.43 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 113.4 0.889 . . . . 0.43 113.4 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -73.6 -19.6 60.83 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 114.001 1.111 . . . . 2.19 114.001 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -90.67 18.24 6.64 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.204 1.002 . . . . 2.2 109.49 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.6 t70 46.69 58.55 16.73 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 117.248 2.314 . . . . 0.51 117.248 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.413 ' HG3' HD13 ' A' ' 114' ' ' LEU . 44.8 Cg_endo -74.13 168.5 24.66 Favored 'Trans proline' 0 C--O 1.206 -1.1 0 C-N-CA 120.455 0.77 . . . . 0.47 110.659 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.4 p -77.05 162.74 27.27 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.613 -1.625 . . . . 0.49 106.613 175.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -55.95 -51.55 67.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 112.373 0.509 . . . . 0.43 112.373 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.51 -37.73 76.21 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 112.924 0.712 . . . . 0.51 112.924 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -62.8 -46.87 85.94 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.416 -0.356 . . . . 0.54 110.156 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.413 HD13 ' HG3' ' A' ' 109' ' ' PRO . 15.0 tp -64.26 -45.97 85.78 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 121.087 -0.245 . . . . 0.41 111.235 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.91 -48.3 81.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.583 -0.447 . . . . 0.37 110.478 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.83 -44.31 94.1 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.202 0.525 . . . . 0.45 112.338 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.34 -42.93 99.79 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 122.071 -0.393 . . . . 0.44 111.009 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.06 94.48 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 119.748 -0.781 . . . . 0.35 112.096 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.65 -46.26 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.83 -0.433 . . . . 0.38 109.83 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -63.65 -45.29 90.84 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.678 0.992 . . . . 0.52 113.678 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.2 p -71.42 -32.35 68.29 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 120.607 -0.437 . . . . 0.41 111.867 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.41 -45.58 95.63 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.362 -1.495 . . . . 0.32 109.362 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.43 -42.01 65.53 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 112.588 0.588 . . . . 0.46 112.588 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.52 -20.32 62.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 119.609 -0.836 . . . . 2.4 111.899 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.61 -16.69 76.03 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 124.203 0.939 . . . . 0.37 113.559 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.6 t -88.97 112.98 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 106.193 -1.78 . . . . 0.4 106.193 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -156.43 136.92 13.11 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.387 -0.968 . . . . 2.88 108.387 -173.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.65 146.67 23.98 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 122.043 0.925 . . . . 0.5 109.996 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.497 HD11 ' CE ' ' A' ' 132' ' ' LYS . 42.3 tp -66.84 -56.86 8.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.314 -0.857 . . . . 0.57 111.407 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.5 mttt 62.97 178.54 0.15 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.655 0.741 . . . . 2.8 110.518 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.13 146.74 53.15 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.345 -0.983 . . . . 1.16 108.345 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.71 ' HD3' HD11 ' C' ' 207' ' ' LEU . 0.2 OUTLIER -113.53 147.66 38.02 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.484 -0.76 . . . . 4.81 109.529 -179.148 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.442 ' HG2' HG21 ' C' ' 206' ' ' THR . 19.1 Cg_endo -64.66 148.64 90.36 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.305 2.003 . . . . 2.95 112.415 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.633 HG12 HG22 ' C' ' 203' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.014 -0.993 . . . . 3.74 109.17 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . 0.531 ' HB ' ' HG2' ' B' ' 105' ' ' ARG . 77.3 p . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.166 0.508 . . . . 0.37 111.01 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.633 ' O ' ' HD2' ' B' ' 105' ' ' ARG . 47.1 mt -71.25 136.18 26.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 105.791 -1.929 . . . . 0.39 105.791 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.99 144.43 36.73 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.387 -0.824 . . . . 0.34 110.795 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 44.6 mt -126.23 130.25 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.764 0.826 . . . . 0.28 108.981 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 86.4 t -124.42 129.27 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.004 -1.85 . . . . 0.33 106.004 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 35.7 mt -109.06 132.27 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 109.548 -0.538 . . . . 0.29 109.548 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.52 133.04 6.19 Favored Glycine 0 N--CA 1.462 0.384 0 C-N-CA 120.326 -0.94 . . . . 0.31 111.885 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.739 HG21 ' HB3' ' B' ' 13' ' ' ALA . 15.0 t -145.94 160.12 42.28 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.363 -1.347 . . . . 0.36 107.363 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' NEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.48 -141.86 26.25 Favored Glycine 0 C--N 1.315 -0.623 0 C-N-CA 116.756 -2.64 . . . . 0.4 114.863 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -123.57 25.67 8.1 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 114.44 1.274 . . . . 0.78 114.44 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.739 ' HB3' HG21 ' B' ' 9' ' ' THR . . . -79.03 -27.17 43.15 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 115.216 1.562 . . . . 0.3 115.216 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.74 -46.44 74.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.887 0.767 . . . . 0.27 112.834 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.79 -40.35 88.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.958 -0.464 . . . . 0.39 111.265 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.19 -35.46 73.97 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.056 1.132 . . . . 0.35 114.056 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.02 -39.95 95.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.09 -1.448 . . . . 0.2 107.09 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 18.6 tp -65.21 -43.39 91.68 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 109.192 -0.67 . . . . 0.25 109.192 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -61.62 -39.11 90.1 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 121.242 0.544 . . . . 0.36 111.266 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.9 -47.64 79.77 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-N 115.056 -0.975 . . . . 0.23 108.59 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.7 86.26 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.681 -0.808 . . . . 0.24 111.49 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.98 -23.21 65.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.014 -0.539 . . . . 2.54 110.755 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.66 -31.87 68.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.689 -1.967 . . . . 2.59 105.689 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 45.6 mt -84.75 -38.3 19.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.837 1.051 . . . . 0.34 113.837 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 91.3 mt -109.66 -11.98 14.69 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 119.046 2.98 . . . . 0.35 119.046 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.83 165.08 31.57 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 105.521 -3.032 . . . . 0.34 105.521 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.69 138.99 56.72 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.338 1.066 . . . . 0.42 112.687 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -106.06 146.7 29.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.272 -1.785 . . . . 0.3 112.963 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -106.37 157.34 17.69 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 114.434 -1.257 . . . . 0.39 107.794 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.13 41.3 20.68 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.085 1.142 . . . . 0.34 114.085 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 93.7 t -131.08 134.62 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.31 -0.996 . . . . 0.3 108.31 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.73 18.91 Favored Glycine 0 N--CA 1.469 0.886 0 N-CA-C 109.82 -1.312 . . . . 0.31 109.82 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.26 157.69 36.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.167 0.983 . . . . 0.39 108.953 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.79 159.1 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.577 -0.738 . . . . 0.41 110.306 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.36 162.78 15.66 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.713 -0.676 . . . . 0.47 109.617 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' B' ' 36' ' ' PHE . 2.3 t80 -134.16 117.56 16.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.888 -1.523 . . . . 0.53 106.888 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 95.0 t -108.1 145.42 31.42 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.943 -1.481 . . . . 0.58 110.855 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -57.01 136.14 74.96 Favored 'Trans proline' 0 C--N 1.352 0.719 0 N-CA-C 107.949 -1.597 . . . . 0.64 107.949 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.48 -25.78 16.61 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.126 -1.19 . . . . 0.69 110.126 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.27 157.66 21.48 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.336 0.588 . . . . 0.64 110.031 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' B' ' 41' ' ' ASN . 29.5 p-10 -125.06 179.31 5.1 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.372 -0.973 . . . . 2.32 108.372 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.13 73.0 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 112.972 0.73 . . . . 0.61 112.972 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.77 -36.58 84.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.934 0.873 . . . . 2.82 112.163 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 89.4 m -63.9 -47.53 80.25 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 105.987 -1.857 . . . . 0.65 105.987 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.74 -37.68 87.52 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 112.979 0.733 . . . . 0.56 112.979 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.47 -43.14 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.635 -0.876 . . . . 0.61 108.635 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -62.66 -42.72 99.77 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 119.984 -0.686 . . . . 0.65 110.825 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.52 -44.42 97.1 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 119.346 -0.942 . . . . 0.53 111.47 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -60.89 -45.72 93.5 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 119.986 -0.686 . . . . 0.47 109.637 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -60.09 -40.14 88.55 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 113.131 0.789 . . . . 0.57 113.131 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.5 -35.61 81.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.434 0.635 . . . . 0.52 110.17 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.11 -43.83 70.23 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 119.572 -0.851 . . . . 0.45 110.141 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.55 -38.0 79.92 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.261 -0.427 . . . . 0.45 112.048 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.27 -26.32 28.39 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.744 0.646 . . . . 0.51 112.744 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -95.57 -4.73 44.13 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 113.126 0.787 . . . . 0.48 113.126 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 69.4 mt -105.77 157.43 17.45 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.396 0.888 . . . . 0.41 113.396 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -89.34 107.99 19.38 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 102.557 -3.127 . . . . 0.42 102.557 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 72.9 p -107.09 15.4 25.26 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 124.153 0.908 . . . . 0.45 111.064 -177.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 73.0 p -63.95 -34.29 77.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 115.595 1.702 . . . . 0.48 115.595 -177.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.87 -9.35 43.61 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.267 0.556 . . . . 0.47 112.202 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.74 172.19 13.02 Favored Glycine 0 C--O 1.242 0.642 0 C-N-CA 119.484 -1.341 . . . . 0.43 113.383 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.41 130.25 32.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 109.259 -0.645 . . . . 0.4 109.259 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp -115.84 113.42 23.34 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.497 1.748 . . . . 0.35 108.411 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.78 122.17 33.29 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.491 -1.67 . . . . 0.41 106.491 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 83.2 mt -109.52 115.27 29.61 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 104.531 -2.396 . . . . 0.28 104.531 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 26.0 m -120.01 163.4 17.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 113.186 0.81 . . . . 0.34 113.186 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' B' ' 67' ' ' ASP . 14.8 p-10 -64.9 -54.07 36.53 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 118.069 2.618 . . . . 0.39 118.069 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 45.3 p -142.23 151.4 42.06 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.533 1.158 . . . . 0.39 112.692 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' TRP . . . . . 0.58 ' HE1' HG11 ' C' ' 211' ' ' VAL . 32.8 t-105 -66.27 134.45 52.67 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.153 -1.385 . . . . 0.6 107.818 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.73 -8.14 70.6 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 121.218 3.247 . . . . 0.52 121.218 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.2 174.92 55.25 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 119.282 -1.437 . . . . 0.48 110.109 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.15 -47.84 98.4 Favored Pre-proline 0 C--N 1.329 -0.291 0 O-C-N 122.017 -0.696 . . . . 1.31 112.01 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -53.44 -41.6 71.92 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 118.391 -0.606 . . . . 0.45 110.619 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -67.2 -48.37 68.1 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 123.458 0.474 . . . . 0.5 109.845 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -60.05 -42.71 95.08 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.972 1.101 . . . . 2.04 113.972 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.46 85.71 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.242 -0.983 . . . . 0.52 111.721 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.05 -38.83 90.25 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 108.618 -0.882 . . . . 0.49 108.618 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.684 ' O ' HG13 ' B' ' 82' ' ' VAL . 70.5 m -58.65 -39.89 81.88 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.416 0.524 . . . . 1.4 112.416 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.619 ' O ' HG22 ' B' ' 82' ' ' VAL . 34.0 mtt180 -67.2 -29.58 69.28 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 113.042 0.756 . . . . 3.47 113.042 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 76.1 mt -77.2 -42.15 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.697 0.629 . . . . 0.55 112.697 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' B' ' 87' ' ' TYR . 2.6 m -80.03 -16.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.901 0 N-CA-C 115.465 1.654 . . . . 0.56 115.465 -175.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . 0.684 HG13 ' O ' ' B' ' 78' ' ' SER . 2.9 m -29.4 -55.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.352 1 N-CA-C 122.096 4.11 . . . . 0.74 122.096 -176.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.49 39.3 3.99 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 116.394 -2.122 . . . . 0.72 109.601 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.37 133.55 54.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.442 -1.254 . . . . 0.61 109.748 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.25 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 106.707 -1.59 . . . . 0.63 106.707 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.68 15.24 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 115.406 1.632 . . . . 0.55 115.406 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' TYR . . . . . 0.479 ' HB3' ' HB ' ' B' ' 81' ' ' VAL . 6.1 m-85 -127.45 130.89 50.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 105.506 -2.035 . . . . 0.49 105.506 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.6 154.66 41.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.228 -0.589 . . . . 0.49 110.357 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.77 128.47 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 106.235 -1.765 . . . . 0.44 106.235 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 34.2 mt -124.14 119.52 56.93 Favored 'Isoleucine or valine' 0 C--O 1.255 1.378 0 N-CA-C 108.245 -1.02 . . . . 0.36 108.245 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.46 163.21 19.59 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 114.738 -1.119 . . . . 0.36 112.314 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.89 24.49 55.33 Favored Glycine 0 CA--C 1.499 -0.911 0 N-CA-C 114.817 0.687 . . . . 0.29 114.817 176.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.85 132.85 6.69 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 N-CA-C 113.461 0.911 . . . . 0.22 113.461 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' A' ' 94' ' ' ASN . 51.2 p30 -141.98 169.48 17.52 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.688 -1.227 . . . . 0.2 107.688 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 51.3 mm -60.2 -43.37 93.54 Favored Pre-proline 0 C--O 1.24 0.588 0 N-CA-C 114.491 1.293 . . . . 0.17 114.491 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.55 -42.85 56.53 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 117.575 -1.15 . . . . 0.23 110.34 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 39.9 ttm -61.72 -48.85 78.86 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 120.377 -0.529 . . . . 0.26 109.633 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.46 -48.01 83.62 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 112.822 0.675 . . . . 0.2 112.822 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.52 -49.9 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 112.715 0.635 . . . . 0.26 112.715 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -63.52 -40.59 97.43 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 120.235 -0.586 . . . . 2.01 111.696 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' THR . . . . . . . . . . . . . 53.5 m -66.23 -46.12 78.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.731 -0.668 . . . . 0.28 110.892 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.47 -37.79 88.76 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 123.607 0.567 . . . . 0.29 110.563 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' MET . . . . . . . . . . . . . 72.6 mtp -66.1 -45.81 79.84 Favored 'General case' 0 C--O 1.242 0.695 0 O-C-N 121.264 -0.897 . . . . 1.76 112.132 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' B' ' 109' ' ' PRO . . . -67.72 -33.81 75.62 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.3 0.852 . . . . 0.38 113.3 -178.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.633 ' HD2' ' O ' ' B' ' 3' ' ' ILE . 15.8 ttp180 -52.56 -32.69 42.16 Favored 'General case' 0 C--O 1.21 -1.013 0 N-CA-C 113.4 0.889 . . . . 0.37 113.4 -178.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.57 -19.59 60.85 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 114.1 1.148 . . . . 2.13 114.1 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -90.62 18.15 6.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 122.159 0.981 . . . . 2.27 109.476 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 12.7 t70 46.79 58.47 16.88 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 117.269 2.322 . . . . 0.48 117.269 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.42 ' HG3' HD13 ' B' ' 114' ' ' LEU . 44.9 Cg_endo -74.09 168.43 24.82 Favored 'Trans proline' 0 C--O 1.206 -1.109 0 C-N-CA 120.55 0.833 . . . . 0.47 110.604 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 54.3 p -77.0 162.78 27.28 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.706 -1.59 . . . . 0.53 106.706 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -55.94 -51.48 67.5 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 112.445 0.535 . . . . 0.48 112.445 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -58.67 -37.67 76.51 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 112.897 0.703 . . . . 0.6 112.897 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -62.84 -46.77 86.37 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 116.417 -0.356 . . . . 0.57 110.141 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.42 HD13 ' HG3' ' B' ' 109' ' ' PRO . 15.1 tp -64.41 -45.86 85.77 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 121.019 -0.272 . . . . 0.43 111.191 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 63.5 t -56.88 -48.32 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 O-C-N 121.891 -0.506 . . . . 0.44 110.52 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.25 94.3 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.133 0.492 . . . . 0.49 112.326 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 tp -62.4 -42.8 99.71 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 122.125 -0.359 . . . . 0.42 110.989 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.29 -45.1 94.51 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 119.798 -0.761 . . . . 0.35 112.059 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.61 -46.26 89.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.803 -0.443 . . . . 0.42 109.803 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -63.71 -45.22 90.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 113.717 1.006 . . . . 0.52 113.717 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 34.6 p -71.44 -32.28 68.16 Favored 'General case' 0 C--O 1.216 -0.681 0 C-N-CA 120.585 -0.446 . . . . 0.36 111.987 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.38 -45.74 95.31 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.332 -1.507 . . . . 0.3 109.332 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.21 -42.15 66.11 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 112.622 0.601 . . . . 0.48 112.622 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.43 -20.27 62.92 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 119.578 -0.849 . . . . 2.42 111.964 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.78 -16.6 76.3 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 124.246 0.966 . . . . 0.31 113.511 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 93.7 t -88.99 113.07 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 106.171 -1.789 . . . . 0.34 106.171 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -156.45 136.84 13.03 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.409 -0.96 . . . . 2.95 108.409 -173.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.6 146.71 23.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.031 0.92 . . . . 0.4 109.986 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . 0.5 HD11 ' CE ' ' B' ' 132' ' ' LYS . 42.3 tp -66.94 -57.09 7.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.337 -0.847 . . . . 0.45 111.37 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 63.01 178.65 0.15 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.646 0.736 . . . . 2.83 110.595 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.03 146.61 53.36 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.353 -0.98 . . . . 1.34 108.353 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.5 ' CE ' HD11 ' B' ' 129' ' ' LEU . 0.2 OUTLIER -113.33 147.94 38.5 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.444 -0.785 . . . . 4.96 109.476 -179.224 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -64.76 148.7 90.21 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.415 2.076 . . . . 3.1 112.368 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.011 -0.995 . . . . 3.89 109.12 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 159' ' ' ASN . . . . . 0.709 ' ND2' ' NZ ' ' C' ' 259' ' ' LYS . 1.8 t-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 108.992 -0.744 . . . . 6.34 108.992 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 160' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -85.87 25.5 1.1 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.59 -0.893 . . . . 3.89 108.59 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 161' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -118.63 -141.88 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.583 -0.895 . . . . 1.72 108.583 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 162' ' ' MET . . . . . 0.594 ' SD ' HG21 ' C' ' 240' ' ' VAL . 0.3 OUTLIER -61.63 156.19 20.55 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.764 -1.21 . . . . 2.0 110.562 -178.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 163' ' ' VAL . . . . . . . . . . . . . 94.9 t -113.11 117.68 56.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.06 -0.719 . . . . 0.63 109.06 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 164' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.73 103.39 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.49 -0.929 . . . . 0.46 108.49 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.59 -35.33 80.7 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.211 -1.555 . . . . 0.44 109.211 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 tp -172.04 147.97 2.18 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.771 -1.172 . . . . 0.47 111.209 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 167' ' ' ALA . . . . . . . . . . . . . . . -117.69 104.39 10.96 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.048 -0.723 . . . . 0.29 109.048 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 168' ' ' ARG . . . . . 0.941 ' NH1' HG12 ' C' ' 178' ' ' VAL . 44.4 ttp180 -106.37 126.09 51.81 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.972 0.891 . . . . 3.14 110.835 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 169' ' ' ILE . . . . . . . . . . . . . 82.3 mt -95.5 129.21 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 109.222 -0.659 . . . . 0.34 109.222 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 170' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -165.95 117.04 1.04 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.812 -0.755 . . . . 0.49 110.327 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 171' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.97 -9.94 11.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.429 -0.794 . . . . 2.33 109.759 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 172' ' ' ARG . . . . . . . . . . . . . 12.4 mtt180 -101.71 -5.16 25.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 2.95 110.47 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 173' ' ' LEU . . . . . . . . . . . . . 14.5 mt 59.0 -100.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.141 -0.974 . . . . 1.39 109.917 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 174' ' ' ILE . . . . . 0.438 HG23 ' CB ' ' C' ' 179' ' ' ALA . 77.7 mt -97.71 121.3 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.026 -1.046 . . . . 0.53 108.285 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 175' ' ' HIS . . . . . 0.672 ' CE1' HG21 ' C' ' 178' ' ' VAL . 2.6 p80 -143.19 127.57 17.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.131 -0.98 . . . . 0.65 109.426 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 176' ' ' GLY . . . . . . . . . . . . . . . 60.33 -152.63 37.16 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.833 -1.307 . . . . 0.57 109.833 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 177' ' ' GLN . . . . . 0.799 ' H ' ' NE2' ' C' ' 177' ' ' GLN . 0.1 OUTLIER -89.36 12.21 16.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.573 -0.957 . . . . 3.26 109.332 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . 0.941 HG12 ' NH1' ' C' ' 168' ' ' ARG . 48.1 t -61.54 -42.83 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 0.51 108.953 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 179' ' ' ALA . . . . . 0.448 ' O ' ' OG1' ' C' ' 183' ' ' THR . . . -73.16 -36.38 66.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.929 -1.107 . . . . 0.53 110.187 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 180' ' ' THR . . . . . . . . . . . . . 21.5 m -66.34 -54.42 24.82 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.697 -0.801 . . . . 0.68 109.79 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 181' ' ' ARG . . . . . 0.539 ' NH2' ' CG2' ' C' ' 308' ' ' THR . 55.1 ttt-85 -64.7 -43.62 92.88 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.013 -0.675 . . . . 3.12 110.608 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 182' ' ' TRP . . . . . 0.533 ' O ' HG23 ' C' ' 186' ' ' THR . 19.5 m95 -65.82 -32.2 73.6 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.034 -1.041 . . . . 0.9 109.591 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 183' ' ' THR . . . . . 0.803 HG21 HG21 ' C' ' 216' ' ' VAL . 71.9 m -65.29 -47.1 77.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.946 -1.096 . . . . 0.59 110.252 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -69.66 -42.93 73.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 2.2 110.806 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 185' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -68.32 -39.61 81.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.95 -1.094 . . . . 2.52 109.569 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 186' ' ' THR . . . . . 0.533 HG23 ' O ' ' C' ' 182' ' ' TRP . 72.6 p -81.42 -1.26 45.03 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.282 -0.886 . . . . 0.59 109.685 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 187' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 52.14 48.42 22.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.055 -1.028 . . . . 2.1 108.604 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 188' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.05 133.46 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.164 -0.96 . . . . 1.37 110.122 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 189' ' ' SER . . . . . . . . . . . . . 27.8 p -109.75 -6.33 15.32 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.761 -0.829 . . . . 1.4 108.761 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 190' ' ' ARG . . . . . . . . . . . . . 29.4 mtt-85 -135.92 142.83 44.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.555 -0.716 . . . . 3.52 110.441 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 191' ' ' ILE . . . . . . . . . . . . . 87.6 mt -133.38 127.61 54.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.173 -1.047 . . . . 0.51 108.173 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 192' ' ' ILE . . . . . 0.455 HD12 HG11 ' C' ' 240' ' ' VAL . 97.1 mt -115.66 128.68 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.257 -0.902 . . . . 0.46 109.665 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 193' ' ' VAL . . . . . . . . . . . . . 53.3 t -99.7 128.88 51.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.825 -0.806 . . . . 0.71 108.825 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 194' ' ' VAL . . . . . . . . . . . . . 43.0 t -112.51 103.57 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.535 -0.728 . . . . 0.43 109.479 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 195' ' ' SER . . . . . . . . . . . . . 38.0 t -167.25 125.61 1.31 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.342 -0.943 . . . . 1.38 109.31 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 196' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.01 -34.88 66.65 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.574 -0.704 . . . . 0.98 109.984 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 197' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -65.55 -45.49 83.21 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.147 -0.971 . . . . 2.32 109.959 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 198' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.11 -43.21 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.102 -0.998 . . . . 0.71 109.028 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.6 -26.5 55.72 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.79 -0.764 . . . . 0.74 109.168 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 200' ' ' ALA . . . . . . . . . . . . . . . -84.9 -5.38 59.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.028 -1.045 . . . . 0.89 109.882 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 201' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -102.75 95.38 6.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.9 -1.125 . . . . 1.15 109.554 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 202' ' ' THR . . . . . . . . . . . . . 24.7 p -66.22 -33.21 75.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.407 -0.808 . . . . 1.61 110.631 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 203' ' ' VAL . . . . . 0.633 HG22 HG12 ' A' ' 134' ' ' VAL . 55.8 t -66.33 -47.49 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.851 -1.156 . . . . 0.9 109.598 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 204' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -63.69 -42.24 98.04 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.349 -0.94 . . . . 3.07 109.576 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 205' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -58.01 -42.42 85.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 1.72 109.482 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 206' ' ' THR . . . . . 0.442 HG21 ' HG2' ' A' ' 133' ' ' PRO . 73.2 m -60.63 -48.71 80.55 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.088 -1.045 . . . . 0.92 109.564 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 207' ' ' LEU . . . . . 0.71 HD11 ' HD3' ' A' ' 132' ' ' LYS . 30.6 mt -62.62 -44.45 96.26 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.934 -1.107 . . . . 0.82 110.736 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' C' ' 208' ' ' LEU . 81.6 mt -62.5 -41.45 98.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.718 -1.239 . . . . 0.73 110.055 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 209' ' ' THR . . . . . . . . . . . . . 35.8 p -67.89 -31.83 71.89 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.371 -0.831 . . . . 0.84 110.28 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 210' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -80.37 -17.54 51.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.782 -1.199 . . . . 2.32 110.857 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . 0.58 HG11 ' HE1' ' B' ' 69' ' ' TRP . 17.5 m -107.69 17.65 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.952 -1.092 . . . . 0.93 108.639 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.29 123.42 82.48 Favored Pre-proline 0 N--CA 1.483 1.221 0 N-CA-C 107.82 -1.178 . . . . 0.76 107.82 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 213' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -44.31 144.48 2.95 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.037 1.825 . . . . 0.93 112.731 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 214' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -56.52 134.85 66.98 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.196 1.931 . . . . 1.14 112.028 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 215' ' ' GLY . . . . . . . . . . . . . . . 79.91 -8.52 50.03 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.922 -1.271 . . . . 0.85 109.922 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 216' ' ' VAL . . . . . 0.803 HG21 HG21 ' C' ' 183' ' ' THR . 58.6 t -114.8 136.78 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -1.076 . . . . 0.92 108.8 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.87 135.77 45.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.438 -0.789 . . . . 1.42 109.836 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 218' ' ' ALA . . . . . . . . . . . . . . . -110.17 131.37 55.12 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.315 -0.994 . . . . 0.64 108.315 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -120.97 153.51 37.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.401 -0.812 . . . . 0.72 109.808 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 54.8 t -126.35 117.83 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.624 0.726 . . . . 0.6 109.07 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 31.7 m -141.01 165.14 19.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.412 -0.805 . . . . 0.57 109.622 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 222' ' ' ASP . . . . . 0.709 ' OD1' ' N ' ' C' ' 225' ' ' LYS . 6.8 p30 -94.18 167.23 11.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.479 -0.763 . . . . 1.34 109.305 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.46 -44.82 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.151 -0.968 . . . . 0.54 110.455 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 224' ' ' ALA . . . . . 0.852 ' O ' HG22 ' C' ' 227' ' ' ILE . . . -62.72 -44.73 95.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.934 -1.104 . . . . 0.67 109.398 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 225' ' ' LYS . . . . . 0.709 ' N ' ' OD1' ' C' ' 222' ' ' ASP . 45.7 tttm -68.14 -35.35 77.95 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.775 -1.203 . . . . 2.11 109.674 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 226' ' ' MET . . . . . . . . . . . . . 10.3 tpt -62.08 -40.4 95.71 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.934 -1.104 . . . . 1.54 111.191 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . 0.852 HG22 ' O ' ' C' ' 224' ' ' ALA . 17.4 tt -60.9 -34.56 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.611 -0.885 . . . . 0.69 108.611 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.47 -38.86 62.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.722 -0.611 . . . . 4.01 110.948 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 70.3 t -62.18 -41.73 92.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.864 -1.162 . . . . 0.63 107.864 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 230' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' C' ' 230' ' ' TYR . 36.7 t80 -67.04 -32.13 73.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.102 -0.999 . . . . 0.64 109.927 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 231' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.76 6.73 2.34 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.119 -0.988 . . . . 0.95 110.104 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 232' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -110.18 117.78 50.87 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.246 -0.909 . . . . 0.93 109.435 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 233' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -65.73 1.51 2.19 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.646 1.564 . . . . 0.99 111.98 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 234' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.36 -24.76 65.33 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 1.59 108.807 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 235' ' ' TYR . . . . . 0.501 ' O ' ' HB2' ' C' ' 238' ' ' GLU . 81.1 m-85 -105.49 15.71 26.66 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.594 -0.842 . . . . 1.19 109.003 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.81 135.62 47.44 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.076 -1.64 . . . . 0.67 109.65 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.78 -33.41 1.9 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.288 -1.525 . . . . 0.64 109.288 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 238' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' C' ' 235' ' ' TYR . 4.0 mm-40 -54.25 138.93 37.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.805 -1.409 . . . . 2.48 109.437 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 239' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -99.1 116.33 31.08 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.463 -0.939 . . . . 2.96 108.463 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . 0.594 HG21 ' SD ' ' C' ' 162' ' ' MET . 26.3 t -121.85 148.78 25.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.876 0.846 . . . . 0.66 110.448 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 241' ' ' MET . . . . . . . . . . . . . 13.8 ttm -102.9 134.95 45.47 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.925 -1.139 . . . . 1.63 107.925 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 242' ' ' LEU . . . . . 0.402 ' HB3' ' CE2' ' C' ' 244' ' ' PHE . 61.2 mt -102.04 127.28 49.0 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.689 -0.804 . . . . 0.35 109.877 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 243' ' ' LEU . . . . . . . . . . . . . 97.6 mt -109.5 126.08 53.15 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.981 0.896 . . . . 0.68 109.045 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 244' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' C' ' 242' ' ' LEU . 77.7 m-85 -127.0 162.03 26.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.771 0.796 . . . . 0.3 109.275 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 245' ' ' THR . . . . . . . . . . . . . 70.2 p -109.48 -19.47 13.23 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.958 -0.756 . . . . 0.43 108.958 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 246' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' C' ' 246' ' ' ASN . 17.3 p30 -151.08 141.85 14.91 Favored Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 120.003 -0.679 . . . . 1.0 109.872 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 247' ' ' PRO . . . . . 0.451 ' HG3' ' CE2' ' C' ' 291' ' ' PHE . 7.3 Cg_endo -60.85 -14.63 33.4 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.683 2.255 . . . . 0.59 112.1 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 248' ' ' THR . . . . . . . . . . . . . 95.7 m -64.99 -42.66 94.31 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.151 0.976 . . . . 0.64 108.624 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 249' ' ' ASP . . . . . 0.42 ' O ' HD12 ' C' ' 253' ' ' LEU . 97.8 m-20 -67.48 -23.4 65.48 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.54 -0.725 . . . . 0.53 109.801 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 250' ' ' VAL . . . . . . . . . . . . . 98.3 t -73.62 -43.77 54.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.672 -1.267 . . . . 0.4 109.848 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 251' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.41 -35.02 77.92 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.426 -0.953 . . . . 1.51 108.426 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 252' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -62.48 -44.09 97.23 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.723 -0.791 . . . . 3.24 110.156 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 253' ' ' LEU . . . . . 0.42 HD12 ' O ' ' C' ' 249' ' ' ASP . 1.2 mp -64.07 -40.42 96.22 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 117.999 -1.48 . . . . 1.06 108.876 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 254' ' ' VAL . . . . . 0.57 ' CG2' HD12 ' C' ' 260' ' ' ILE . 70.6 t -60.7 -44.61 97.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 120.835 -1.165 . . . . 0.48 108.948 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 255' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.23 -30.97 69.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.018 -1.052 . . . . 2.47 109.917 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 256' ' ' GLY . . . . . . . . . . . . . . . -74.28 2.8 43.16 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.498 -1.441 . . . . 0.55 109.498 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 257' ' ' GLY . . . . . . . . . . . . . . . 94.37 15.79 45.94 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.627 -1.389 . . . . 0.51 109.627 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 258' ' ' VAL . . . . . . . . . . . . . 96.7 t -77.66 139.72 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.034 -1.469 . . . . 0.45 107.034 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 259' ' ' LYS . . . . . 0.709 ' NZ ' ' ND2' ' C' ' 159' ' ' ASN . 17.9 tttt -99.01 123.93 43.64 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.089 -1.007 . . . . 3.12 110.811 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 260' ' ' ILE . . . . . 0.57 HD12 ' CG2' ' C' ' 254' ' ' VAL . 98.1 mt -129.99 125.67 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.43 -0.794 . . . . 0.41 109.147 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 65.9 p -89.51 -31.44 17.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.776 -1.202 . . . . 0.57 110.238 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 262' ' ' SER . . . . . . . . . . . . . 15.8 m -159.06 153.51 24.15 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.176 -0.953 . . . . 0.46 110.092 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 263' ' ' VAL . . . . . . . . . . . . . 50.9 t -122.74 134.61 65.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.538 -0.912 . . . . 0.37 108.538 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 264' ' ' ASN . . . . . 0.468 ' ND2' ' CH2' ' C' ' 182' ' ' TRP . 33.7 t30 -108.57 128.08 54.51 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.517 0.675 . . . . 1.17 110.607 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 265' ' ' VAL . . . . . 0.451 HG21 ' SD ' ' C' ' 314' ' ' MET . 3.2 t -90.64 108.43 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 120.058 -0.657 . . . . 0.4 109.68 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 266' ' ' GLY . . . . . . . . . . . . . . . -80.75 -53.94 3.84 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.153 -1.179 . . . . 0.41 110.153 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . -172.57 152.93 17.73 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.646 -1.74 . . . . 0.41 111.476 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 268' ' ' MET . . . . . 0.44 ' HB2' ' H ' ' C' ' 282' ' ' SER . 97.0 mtp -143.1 118.08 10.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.481 -1.011 . . . . 0.5 110.443 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.34 128.21 21.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.371 -0.831 . . . . 0.57 109.523 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 270' ' ' PHE . . . . . 0.536 ' CG ' ' N ' ' C' ' 271' ' ' ARG . 13.3 t80 -69.5 161.8 28.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.92 109.618 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 271' ' ' ARG . . . . . 0.536 ' N ' ' CG ' ' C' ' 270' ' ' PHE . 32.7 ttm180 -160.66 158.67 29.24 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.27 -0.972 . . . . 3.23 109.676 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 272' ' ' GLN . . . . . 0.4 ' N ' ' HG2' ' C' ' 271' ' ' ARG . 73.9 mt-30 -66.48 138.25 57.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.081 -1.012 . . . . 2.98 110.459 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 273' ' ' GLY . . . . . . . . . . . . . . . 95.52 -12.32 67.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.818 -1.713 . . . . 0.87 108.818 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 274' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -101.81 163.37 12.29 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.484 -1.01 . . . . 1.66 109.388 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 275' ' ' THR . . . . . 0.561 HG21 HG21 ' C' ' 321' ' ' ILE . 20.8 m -109.95 135.83 50.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.674 -0.862 . . . . 0.84 108.674 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 276' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -82.02 119.21 23.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.246 -0.909 . . . . 2.77 110.176 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 277' ' ' VAL . . . . . 0.519 HG12 ' CD1' ' C' ' 321' ' ' ILE . 27.5 m -99.22 -28.18 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.81 -0.756 . . . . 0.74 109.612 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 278' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' C' ' 279' ' ' ASN . 10.2 t-20 -135.99 -177.16 4.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.658 0.742 . . . . 1.52 109.761 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' C' ' 278' ' ' ASN . 39.5 m-20 -56.93 -29.88 63.5 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.791 -0.568 . . . . 2.29 110.787 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . -148.06 27.01 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.829 -1.169 . . . . 0.6 109.538 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 281' ' ' VAL . . . . . 0.498 ' O ' HG22 ' C' ' 277' ' ' VAL . 60.8 t -118.99 121.98 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.825 0.822 . . . . 0.61 109.678 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 282' ' ' SER . . . . . 0.44 ' H ' ' HB2' ' C' ' 268' ' ' MET . 29.0 m -118.64 147.61 43.58 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.447 0.642 . . . . 0.75 110.02 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 283' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.26 142.84 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.446 1.117 . . . . 0.7 110.539 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 284' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' C' ' 287' ' ' ASP . 44.1 p-10 -110.61 171.67 7.33 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 106.923 -1.51 . . . . 0.77 106.923 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 285' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.18 -24.21 40.12 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.833 -1.167 . . . . 2.34 109.587 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 286' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -79.59 -43.46 22.89 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.233 -0.917 . . . . 2.0 110.026 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 287' ' ' ASP . . . . . 0.57 ' N ' ' OD1' ' C' ' 284' ' ' ASP . 93.3 m-20 -64.25 -42.08 96.67 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.237 -0.915 . . . . 0.62 109.096 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 288' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.48 -45.77 97.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.387 -0.821 . . . . 0.73 109.518 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 289' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -57.44 -39.6 76.6 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.216 -0.928 . . . . 2.52 110.262 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.37 -41.01 85.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.82 -1.175 . . . . 0.6 109.9 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 291' ' ' PHE . . . . . 0.451 ' CE2' ' HG3' ' C' ' 247' ' ' PRO . 40.0 m-85 -63.93 -39.02 93.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.57 109.73 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 292' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -64.08 -39.5 94.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.149 -0.969 . . . . 2.05 110.226 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 293' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -65.78 -41.54 91.86 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.943 -1.098 . . . . 1.8 109.635 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 294' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.18 -43.22 99.32 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.871 -1.143 . . . . 0.53 108.867 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 295' ' ' ASN . . . . . 0.58 HD22 ' HG3' ' C' ' 315' ' ' MET . 40.3 t-20 -64.01 -40.01 95.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 1.45 109.953 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.66 -21.38 65.67 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.815 -1.178 . . . . 0.69 109.242 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 297' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -90.13 8.85 30.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.769 -1.207 . . . . 2.49 109.91 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.44 11.43 82.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.903 -1.279 . . . . 0.6 109.903 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 299' ' ' ILE . . . . . . . . . . . . . 97.8 mt -84.71 134.56 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.974 -1.309 . . . . 0.53 109.151 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 300' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -82.0 141.66 33.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.869 . . . . 2.3 110.615 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 301' ' ' LEU . . . . . . . . . . . . . 66.9 mt -123.08 111.27 16.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.269 -0.641 . . . . 0.54 109.269 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 302' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.57 139.87 49.69 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.9 . . . . 2.26 110.289 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 303' ' ' VAL . . . . . 0.611 ' CG2' ' SD ' ' C' ' 314' ' ' MET . 51.8 t -111.99 124.77 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.673 -0.862 . . . . 0.55 108.673 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 304' ' ' ARG . . . . . 0.459 ' HE ' ' CG ' ' C' ' 264' ' ' ASN . 33.4 ptt180 -164.93 137.87 4.64 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.505 -0.878 . . . . 2.7 110.343 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 305' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -80.82 -45.42 16.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 3.19 109.817 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 306' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.33 154.01 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.106 -0.996 . . . . 0.65 108.737 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 307' ' ' SER . . . . . . . . . . . . . 83.5 p -64.55 -16.29 62.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.983 -1.073 . . . . 1.36 109.516 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 308' ' ' THR . . . . . 0.539 ' CG2' ' NH2' ' C' ' 181' ' ' ARG . 44.5 p -86.14 -9.07 57.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.047 -1.033 . . . . 0.85 110.005 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 309' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -92.49 152.69 42.35 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.025 -1.047 . . . . 0.81 109.936 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 310' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -55.37 139.15 81.42 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.968 1.779 . . . . 0.93 111.755 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 311' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -84.24 132.82 34.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 3.09 109.823 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 312' ' ' LEU . . . . . . . . . . . . . 80.2 mt -117.51 154.74 30.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.103 -0.998 . . . . 0.73 108.309 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 313' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -91.26 130.49 37.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.076 -1.015 . . . . 2.24 109.827 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . 0.611 ' SD ' ' CG2' ' C' ' 303' ' ' VAL . 8.2 tpt -56.39 -44.17 79.97 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.67 -0.644 . . . . 1.03 109.63 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 315' ' ' MET . . . . . 0.58 ' HG3' HD22 ' C' ' 295' ' ' ASN . 95.9 mmm -61.18 -40.39 93.73 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.299 -0.876 . . . . 1.71 110.22 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 316' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.9 -44.0 97.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.319 -0.863 . . . . 0.82 109.81 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 317' ' ' LEU . . . . . . . . . . . . . 92.8 mt -66.49 -41.98 88.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.877 . . . . 0.8 110.036 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 318' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.26 -24.49 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.311 -0.868 . . . . 0.86 109.957 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . 0.475 ' O ' ' C ' ' C' ' 323' ' ' LYS . 0.9 OUTLIER -72.72 -31.56 65.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.084 -1.01 . . . . 1.52 109.518 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 320' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -84.19 -2.45 56.9 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.78 -1.168 . . . . 2.04 109.167 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 321' ' ' ILE . . . . . 0.561 HG21 HG21 ' C' ' 275' ' ' THR . 93.2 mt -113.76 -58.74 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.914 -1.143 . . . . 1.17 107.914 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 322' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' C' ' 323' ' ' LYS . 12.3 t0 -95.01 85.11 4.26 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.16 -1.792 . . . . 2.26 106.16 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 323' ' ' LYS . . . . . 1.262 ' HA ' ' NZ ' ' C' ' 323' ' ' LYS . 0.0 OUTLIER . . . . . 1 C--O 1.524 15.537 0 CA-C-O 126.309 2.957 . . . . 5.92 109.465 -177.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.548 ' HB ' ' HG2' ' A' ' 105' ' ' ARG . 76.6 p . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 121.106 0.479 . . . . 0.44 111.038 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.614 ' O ' ' HD2' ' A' ' 105' ' ' ARG . 47.0 mt -71.24 136.2 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.736 -1.95 . . . . 0.38 105.736 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.98 144.42 36.76 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 115.292 -0.867 . . . . 0.35 110.744 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.3 mt -126.27 130.14 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.825 0.85 . . . . 0.31 109.053 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.29 129.28 74.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.035 -1.839 . . . . 0.32 106.035 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 mt -109.11 131.73 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.445 -0.576 . . . . 0.26 109.445 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.75 135.83 7.43 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.791 -1.324 . . . . 0.24 109.791 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 13' ' ' ALA . 8.2 t -151.78 164.71 36.44 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.025 -1.28 . . . . 0.26 109.592 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' NEP . . . . . 0.568 ' ND1' ' OD2' ' A' ' 67' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.89 -140.3 15.77 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.02 -1.232 . . . . 0.31 110.02 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -130.69 32.1 4.43 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.233 -1.157 . . . . 0.78 110.447 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.521 ' HB3' HG21 ' A' ' 9' ' ' THR . . . -75.51 -27.27 58.68 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 115.277 1.584 . . . . 0.25 115.277 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.7 -46.48 74.15 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.827 0.74 . . . . 0.26 112.799 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -59.79 -40.39 88.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.593 -0.443 . . . . 0.44 111.224 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.31 -35.22 73.53 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.105 1.15 . . . . 0.38 114.105 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.05 -39.99 95.3 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.139 -1.43 . . . . 0.27 107.139 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.13 -43.47 91.81 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.149 -0.685 . . . . 0.34 109.149 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -61.56 -39.18 90.2 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.242 0.544 . . . . 0.44 111.234 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.432 HG23 ' HB3' ' B' ' 10' ' ' NEP . 17.4 m -63.96 -47.64 79.64 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 115.048 -0.978 . . . . 0.37 108.609 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.71 86.11 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 119.754 -0.778 . . . . 0.39 111.465 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.96 -23.34 65.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.103 -0.499 . . . . 2.5 110.692 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.47 -32.01 69.39 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 105.703 -1.962 . . . . 2.59 105.703 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.8 mt -84.74 -38.38 19.74 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 113.817 1.043 . . . . 0.49 113.817 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -109.6 -12.03 14.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 119.025 2.972 . . . . 0.5 119.025 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.98 165.07 31.38 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 105.457 -3.057 . . . . 0.51 105.457 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -58.82 138.97 56.96 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 122.41 1.1 . . . . 0.58 112.611 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -105.91 146.75 29.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.264 -1.789 . . . . 0.45 113.038 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -106.46 157.34 17.72 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.497 -1.229 . . . . 0.54 107.816 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.25 41.22 20.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.096 1.147 . . . . 0.42 114.096 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.8 t -131.09 134.53 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.381 -0.97 . . . . 0.38 108.381 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.66 18.93 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 109.899 -1.28 . . . . 0.35 109.899 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.22 157.76 36.4 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 118.203 1.001 . . . . 0.41 108.921 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.84 159.15 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.453 -0.794 . . . . 0.36 110.29 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -113.46 162.85 15.63 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.757 -0.656 . . . . 0.42 109.592 173.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 36' ' ' PHE . 1.9 t80 -134.19 117.5 16.57 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.886 -1.524 . . . . 0.41 106.886 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.6 t -108.11 145.44 31.45 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 113.92 -1.491 . . . . 0.49 110.848 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -57.06 136.08 74.54 Favored 'Trans proline' 0 C--N 1.352 0.752 0 N-CA-C 107.929 -1.604 . . . . 0.53 107.929 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.55 -25.75 16.55 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.065 -1.214 . . . . 0.58 110.065 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.34 157.66 21.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.373 0.606 . . . . 0.52 110.009 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -125.08 179.29 5.11 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.343 -0.984 . . . . 2.23 108.343 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.19 72.97 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 113.003 0.742 . . . . 0.49 113.003 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.86 -36.45 84.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.84 0.828 . . . . 2.83 112.164 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.5 m -63.92 -47.58 79.99 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 106.01 -1.848 . . . . 0.56 106.01 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.71 -37.48 86.7 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.108 0.781 . . . . 0.47 113.108 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.1 mt -58.59 -43.15 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.587 -0.894 . . . . 0.5 108.587 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -62.58 -42.73 99.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.966 -0.694 . . . . 0.59 110.875 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -61.58 -44.34 97.21 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 119.347 -0.941 . . . . 0.48 111.34 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -61.02 -45.65 93.96 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 120.015 -0.674 . . . . 0.42 109.595 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -60.15 -40.04 88.44 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 113.158 0.799 . . . . 0.51 113.158 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.58 -35.64 81.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.449 0.643 . . . . 0.52 110.135 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.17 -43.61 70.47 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 119.578 -0.849 . . . . 0.45 110.205 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.73 -37.92 80.28 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.281 -0.418 . . . . 0.45 112.041 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.31 -26.36 29.07 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.699 0.629 . . . . 0.53 112.699 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -95.49 -4.75 44.35 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.224 0.824 . . . . 0.53 113.224 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 69.8 mt -105.85 157.54 17.4 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 113.313 0.857 . . . . 0.46 113.313 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -89.34 107.94 19.35 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 102.541 -3.133 . . . . 0.47 102.541 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.9 p -106.98 15.38 25.39 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 124.097 0.873 . . . . 0.44 111.05 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.3 p -64.03 -34.27 77.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 115.553 1.686 . . . . 0.49 115.553 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.77 -9.39 43.79 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.274 0.559 . . . . 0.49 112.271 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.71 172.22 13.03 Favored Glycine 0 C--O 1.242 0.598 0 C-N-CA 119.486 -1.34 . . . . 0.4 113.406 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.3 t -139.47 130.17 32.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 N-CA-C 109.273 -0.639 . . . . 0.36 109.273 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.8 tp -115.86 113.37 23.26 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.549 1.781 . . . . 0.3 108.446 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.68 122.19 33.23 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 106.507 -1.664 . . . . 0.34 106.507 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.0 mt -109.55 115.25 29.56 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 104.519 -2.4 . . . . 0.22 104.519 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.4 m -119.93 163.31 17.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 113.221 0.823 . . . . 0.23 113.221 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.568 ' OD2' ' ND1' ' A' ' 10' ' ' NEP . 14.3 p-10 -64.94 -54.05 36.8 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 118.031 2.604 . . . . 0.27 118.031 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -142.23 151.41 42.09 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 122.541 1.163 . . . . 0.26 112.693 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -66.32 134.47 52.67 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.178 -1.374 . . . . 0.45 107.857 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.72 -8.14 70.59 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 121.281 3.272 . . . . 0.38 121.281 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.23 174.9 55.24 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 119.341 -1.409 . . . . 0.34 110.065 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.18 -47.77 98.5 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 122.089 -0.653 . . . . 1.24 112.057 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.434 ' HD2' ' NE2' ' A' ' 10' ' ' NEP . 83.3 Cg_exo -53.5 -41.56 72.46 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 118.293 -0.671 . . . . 0.32 110.604 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -67.28 -48.26 68.2 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 123.506 0.504 . . . . 0.37 109.865 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -60.1 -42.71 95.24 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.945 1.091 . . . . 1.99 113.945 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.6 85.57 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.388 -0.925 . . . . 0.41 111.675 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.83 89.97 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.7 -0.852 . . . . 0.38 108.7 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.685 ' O ' HG13 ' A' ' 82' ' ' VAL . 70.3 m -58.72 -39.82 81.96 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.423 0.527 . . . . 1.38 112.423 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.611 ' O ' HG22 ' A' ' 82' ' ' VAL . 33.8 mtt180 -67.31 -29.55 69.15 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 112.957 0.725 . . . . 3.38 112.957 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.408 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 76.5 mt -77.15 -42.18 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.755 0.65 . . . . 0.45 112.755 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 87' ' ' TYR . 2.6 m -80.15 -16.72 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 115.456 1.65 . . . . 0.45 115.456 -175.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 78' ' ' SER . 2.9 m -29.31 -55.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 1 N-CA-C 122.123 4.12 . . . . 0.62 122.123 -177.007 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.55 39.4 3.97 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 116.387 -2.125 . . . . 0.59 109.525 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -112.33 133.55 54.37 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 114.505 -1.225 . . . . 0.49 109.745 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.23 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 106.732 -1.581 . . . . 0.52 106.732 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.67 15.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 115.395 1.628 . . . . 0.47 115.395 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.477 ' HB3' ' HB ' ' A' ' 81' ' ' VAL . 6.1 m-85 -127.47 130.92 50.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.538 -2.023 . . . . 0.42 105.538 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.59 154.67 41.76 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.29 -0.564 . . . . 0.39 110.311 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 t -121.69 128.48 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 106.315 -1.735 . . . . 0.33 106.315 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.3 mt -124.16 119.51 56.87 Favored 'Isoleucine or valine' 0 C--O 1.256 1.405 0 N-CA-C 108.258 -1.016 . . . . 0.29 108.258 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.4 163.29 19.6 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 114.674 -1.148 . . . . 0.25 112.388 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.71 24.62 55.53 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 114.821 0.688 . . . . 0.19 114.821 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.82 132.73 6.61 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 N-CA-C 113.483 0.92 . . . . 0.16 113.483 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' B' ' 94' ' ' ASN . 50.9 p30 -141.88 169.61 17.28 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.65 -1.241 . . . . 0.24 107.65 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 95' ' ' ILE . 50.4 mm -60.22 -43.37 93.47 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 114.522 1.304 . . . . 0.29 114.522 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.55 -42.94 55.52 Favored 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 117.584 -1.144 . . . . 0.31 110.343 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 39.8 ttm -61.56 -48.93 78.75 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 120.348 -0.541 . . . . 0.28 109.704 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.44 -48.05 83.43 Favored 'General case' 0 C--O 1.201 -1.487 0 N-CA-C 112.784 0.661 . . . . 0.3 112.784 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.642 HG11 ' CG ' ' C' ' 177' ' ' GLN . 84.7 t -61.51 -49.8 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 112.729 0.641 . . . . 0.42 112.729 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -63.67 -40.51 97.01 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.253 -0.579 . . . . 2.04 111.671 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.3 m -66.24 -46.09 78.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.35 110.89 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.5 -37.84 88.93 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 123.537 0.523 . . . . 0.4 110.571 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 69.8 mtp -66.12 -45.74 80.0 Favored 'General case' 0 C--O 1.243 0.717 0 O-C-N 121.353 -0.842 . . . . 1.7 112.099 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.86 75.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.179 0.807 . . . . 0.44 113.179 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.614 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 15.7 ttp180 -52.6 -32.63 42.43 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 113.4 0.889 . . . . 0.43 113.4 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -73.6 -19.6 60.83 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 114.001 1.111 . . . . 2.19 114.001 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -90.67 18.24 6.64 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.204 1.002 . . . . 2.2 109.49 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.6 t70 46.69 58.55 16.73 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 117.248 2.314 . . . . 0.51 117.248 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.413 ' HG3' HD13 ' A' ' 114' ' ' LEU . 44.8 Cg_endo -74.13 168.5 24.66 Favored 'Trans proline' 0 C--O 1.206 -1.1 0 C-N-CA 120.455 0.77 . . . . 0.47 110.659 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.4 p -77.05 162.74 27.27 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.613 -1.625 . . . . 0.49 106.613 175.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -55.95 -51.55 67.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 112.373 0.509 . . . . 0.43 112.373 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.51 -37.73 76.21 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 112.924 0.712 . . . . 0.51 112.924 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -62.8 -46.87 85.94 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.416 -0.356 . . . . 0.54 110.156 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.413 HD13 ' HG3' ' A' ' 109' ' ' PRO . 15.0 tp -64.26 -45.97 85.78 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 121.087 -0.245 . . . . 0.41 111.235 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.91 -48.3 81.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.583 -0.447 . . . . 0.37 110.478 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.83 -44.31 94.1 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.202 0.525 . . . . 0.45 112.338 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.34 -42.93 99.79 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 122.071 -0.393 . . . . 0.44 111.009 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.06 94.48 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 119.748 -0.781 . . . . 0.35 112.096 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.65 -46.26 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.83 -0.433 . . . . 0.38 109.83 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -63.65 -45.29 90.84 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.678 0.992 . . . . 0.52 113.678 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.2 p -71.42 -32.35 68.29 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 120.607 -0.437 . . . . 0.41 111.867 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.41 -45.58 95.63 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.362 -1.495 . . . . 0.32 109.362 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.43 -42.01 65.53 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 112.588 0.588 . . . . 0.46 112.588 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.52 -20.32 62.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 119.609 -0.836 . . . . 2.4 111.899 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.61 -16.69 76.03 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 124.203 0.939 . . . . 0.37 113.559 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.6 t -88.97 112.98 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 106.193 -1.78 . . . . 0.4 106.193 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -156.43 136.92 13.11 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.387 -0.968 . . . . 2.88 108.387 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.65 146.67 23.98 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 122.043 0.925 . . . . 0.5 109.996 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 tp -66.84 -56.53 9.97 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.314 -0.857 . . . . 0.57 111.407 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 62.48 178.69 0.14 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.653 0.739 . . . . 2.8 110.403 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.18 146.25 53.57 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.691 -0.855 . . . . 1.16 108.691 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.716 ' HD3' HD11 ' C' ' 207' ' ' LEU . 0.8 OUTLIER -113.01 145.21 32.61 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.581 -0.699 . . . . 4.81 109.317 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.437 ' HG2' HG21 ' C' ' 206' ' ' THR . 21.8 Cg_endo -64.24 146.97 91.09 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.513 2.142 . . . . 2.95 112.472 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.615 HG12 HG22 ' C' ' 203' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 118.043 -0.979 . . . . 3.74 109.095 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . 0.531 ' HB ' ' HG2' ' B' ' 105' ' ' ARG . 77.3 p . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.166 0.508 . . . . 0.37 111.01 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.633 ' O ' ' HD2' ' B' ' 105' ' ' ARG . 47.1 mt -71.25 136.18 26.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 105.791 -1.929 . . . . 0.39 105.791 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.99 144.43 36.73 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.387 -0.824 . . . . 0.34 110.795 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 44.6 mt -126.23 130.25 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.764 0.826 . . . . 0.28 108.981 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 86.4 t -124.42 129.27 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.004 -1.85 . . . . 0.33 106.004 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 35.7 mt -109.06 131.71 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 109.548 -0.538 . . . . 0.29 109.548 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.79 135.71 7.35 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.817 -1.313 . . . . 0.31 109.817 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.496 HG21 ' HB3' ' B' ' 13' ' ' ALA . 7.9 t -152.13 165.63 34.16 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.083 -1.245 . . . . 0.36 109.77 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' NEP . . . . . 0.749 ' NE2' ' P ' ' B' ' 10' ' ' NEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.53 -138.94 19.03 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.327 -1.416 . . . . 0.4 110.93 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -131.25 32.04 4.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.469 -1.018 . . . . 0.78 110.628 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.496 ' HB3' HG21 ' B' ' 9' ' ' THR . . . -75.5 -27.17 58.66 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 115.216 1.562 . . . . 0.3 115.216 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' B' ' 9' ' ' THR . . . -54.74 -46.44 74.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.887 0.767 . . . . 0.27 112.834 -176.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.79 -40.35 88.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.958 -0.464 . . . . 0.39 111.265 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -70.19 -35.46 73.97 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.056 1.132 . . . . 0.35 114.056 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.02 -39.95 95.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.09 -1.448 . . . . 0.2 107.09 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 18.6 tp -65.21 -43.39 91.68 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 109.192 -0.67 . . . . 0.25 109.192 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -61.62 -39.11 90.1 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 121.242 0.544 . . . . 0.36 111.266 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -63.9 -47.64 79.77 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-N 115.056 -0.975 . . . . 0.23 108.59 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.7 86.26 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.681 -0.808 . . . . 0.24 111.49 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.98 -23.21 65.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.014 -0.539 . . . . 2.54 110.755 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.66 -31.87 68.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.689 -1.967 . . . . 2.59 105.689 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 45.6 mt -84.75 -38.3 19.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.837 1.051 . . . . 0.34 113.837 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 91.3 mt -109.66 -11.98 14.69 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 119.046 2.98 . . . . 0.35 119.046 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.83 165.08 31.57 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 105.521 -3.032 . . . . 0.34 105.521 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.69 138.99 56.72 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.338 1.066 . . . . 0.42 112.687 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -106.06 146.7 29.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.272 -1.785 . . . . 0.3 112.963 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -106.37 157.34 17.69 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 114.434 -1.257 . . . . 0.39 107.794 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 26.8 t30 59.13 41.3 20.68 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.085 1.142 . . . . 0.34 114.085 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 93.7 t -131.08 134.62 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.31 -0.996 . . . . 0.3 108.31 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.57 167.73 18.91 Favored Glycine 0 N--CA 1.469 0.886 0 N-CA-C 109.82 -1.312 . . . . 0.31 109.82 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -156.26 157.69 36.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.167 0.983 . . . . 0.39 108.953 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 pt -136.79 159.1 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.577 -0.738 . . . . 0.41 110.306 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.36 162.78 15.66 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.713 -0.676 . . . . 0.47 109.617 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' B' ' 36' ' ' PHE . 2.3 t80 -134.16 117.56 16.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.888 -1.523 . . . . 0.53 106.888 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 95.0 t -108.1 145.42 31.42 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.943 -1.481 . . . . 0.58 110.855 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -57.01 136.14 74.96 Favored 'Trans proline' 0 C--N 1.352 0.719 0 N-CA-C 107.949 -1.597 . . . . 0.64 107.949 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.48 -25.78 16.61 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.126 -1.19 . . . . 0.69 110.126 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -84.27 157.66 21.48 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.336 0.588 . . . . 0.64 110.031 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' B' ' 41' ' ' ASN . 29.5 p-10 -125.06 179.31 5.1 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.372 -0.973 . . . . 2.32 108.372 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.13 73.0 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 112.972 0.73 . . . . 0.61 112.972 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.77 -36.58 84.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.934 0.873 . . . . 2.82 112.163 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 89.4 m -63.9 -47.53 80.25 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 105.987 -1.857 . . . . 0.65 105.987 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.74 -37.68 87.52 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 112.979 0.733 . . . . 0.56 112.979 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.47 -43.14 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.635 -0.876 . . . . 0.61 108.635 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -62.66 -42.72 99.77 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 119.984 -0.686 . . . . 0.65 110.825 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.52 -44.42 97.1 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 119.346 -0.942 . . . . 0.53 111.47 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -60.89 -45.72 93.5 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 119.986 -0.686 . . . . 0.47 109.637 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -60.09 -40.14 88.55 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 113.131 0.789 . . . . 0.57 113.131 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.5 -35.61 81.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.434 0.635 . . . . 0.52 110.17 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.11 -43.83 70.23 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 119.572 -0.851 . . . . 0.45 110.141 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.55 -38.0 79.92 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.261 -0.427 . . . . 0.45 112.048 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.27 -26.32 28.39 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.744 0.646 . . . . 0.51 112.744 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -95.57 -4.73 44.13 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 113.126 0.787 . . . . 0.48 113.126 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 69.4 mt -105.77 157.43 17.45 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.396 0.888 . . . . 0.41 113.396 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -89.34 107.99 19.38 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 102.557 -3.127 . . . . 0.42 102.557 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 72.9 p -107.09 15.4 25.26 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 124.153 0.908 . . . . 0.45 111.064 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 73.0 p -63.95 -34.29 77.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 115.595 1.702 . . . . 0.48 115.595 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.87 -9.35 43.61 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.267 0.556 . . . . 0.47 112.202 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.74 172.19 13.02 Favored Glycine 0 C--O 1.242 0.642 0 C-N-CA 119.484 -1.341 . . . . 0.43 113.383 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.41 130.25 32.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 109.259 -0.645 . . . . 0.4 109.259 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp -115.84 113.42 23.34 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 125.497 1.748 . . . . 0.35 108.411 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.78 122.17 33.29 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.491 -1.67 . . . . 0.41 106.491 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 83.2 mt -109.52 115.27 29.61 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 104.531 -2.396 . . . . 0.28 104.531 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 26.0 m -120.01 163.4 17.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 113.186 0.81 . . . . 0.34 113.186 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' B' ' 67' ' ' ASP . 14.8 p-10 -64.9 -54.07 36.53 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 118.069 2.618 . . . . 0.39 118.069 -177.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 45.3 p -142.23 151.4 42.06 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.533 1.158 . . . . 0.39 112.692 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' TRP . . . . . 0.58 ' HE1' HG11 ' C' ' 211' ' ' VAL . 32.8 t-105 -66.27 134.45 52.67 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.153 -1.385 . . . . 0.6 107.818 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.73 -8.14 70.6 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 121.218 3.247 . . . . 0.52 121.218 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.2 174.92 55.25 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 119.282 -1.437 . . . . 0.48 110.109 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.15 -47.84 98.4 Favored Pre-proline 0 C--N 1.329 -0.291 0 O-C-N 122.017 -0.696 . . . . 1.31 112.01 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -53.44 -41.6 71.92 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 118.391 -0.606 . . . . 0.45 110.619 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -67.2 -48.37 68.1 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 123.458 0.474 . . . . 0.5 109.845 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -60.05 -42.71 95.08 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.972 1.101 . . . . 2.04 113.972 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.46 85.71 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.242 -0.983 . . . . 0.52 111.721 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.05 -38.83 90.25 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 108.618 -0.882 . . . . 0.49 108.618 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.684 ' O ' HG13 ' B' ' 82' ' ' VAL . 70.5 m -58.65 -39.89 81.88 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.416 0.524 . . . . 1.4 112.416 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.619 ' O ' HG22 ' B' ' 82' ' ' VAL . 34.0 mtt180 -67.2 -29.58 69.28 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 113.042 0.756 . . . . 3.47 113.042 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 76.1 mt -77.2 -42.15 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.697 0.629 . . . . 0.55 112.697 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' B' ' 87' ' ' TYR . 2.6 m -80.03 -16.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.901 0 N-CA-C 115.465 1.654 . . . . 0.56 115.465 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . 0.684 HG13 ' O ' ' B' ' 78' ' ' SER . 2.9 m -29.4 -55.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.352 1 N-CA-C 122.096 4.11 . . . . 0.74 122.096 -176.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.49 39.3 3.99 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 116.394 -2.122 . . . . 0.72 109.601 178.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.37 133.55 54.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.442 -1.254 . . . . 0.61 109.748 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -78.44 141.5 38.25 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 106.707 -1.59 . . . . 0.63 106.707 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 60.5 m170 62.75 33.68 15.24 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 115.406 1.632 . . . . 0.55 115.406 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' TYR . . . . . 0.479 ' HB3' ' HB ' ' B' ' 81' ' ' VAL . 6.1 m-85 -127.45 130.89 50.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 105.506 -2.035 . . . . 0.49 105.506 175.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.6 154.66 41.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.228 -0.589 . . . . 0.49 110.357 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.77 128.47 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 106.235 -1.765 . . . . 0.44 106.235 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 34.2 mt -124.14 119.52 56.93 Favored 'Isoleucine or valine' 0 C--O 1.255 1.378 0 N-CA-C 108.245 -1.02 . . . . 0.36 108.245 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.46 163.21 19.59 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 114.738 -1.119 . . . . 0.36 112.314 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.89 24.49 55.33 Favored Glycine 0 CA--C 1.499 -0.911 0 N-CA-C 114.817 0.687 . . . . 0.29 114.817 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -48.85 132.85 6.69 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 N-CA-C 113.461 0.911 . . . . 0.22 113.461 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' A' ' 94' ' ' ASN . 51.2 p30 -141.98 169.48 17.52 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.688 -1.227 . . . . 0.2 107.688 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 51.3 mm -60.2 -43.37 93.54 Favored Pre-proline 0 C--O 1.24 0.588 0 N-CA-C 114.491 1.293 . . . . 0.17 114.491 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.55 -42.85 56.53 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 117.575 -1.15 . . . . 0.23 110.34 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 39.9 ttm -61.72 -48.85 78.86 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 120.377 -0.529 . . . . 0.26 109.633 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.46 -48.01 83.62 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 112.822 0.675 . . . . 0.2 112.822 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.52 -49.9 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 112.715 0.635 . . . . 0.26 112.715 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -63.52 -40.59 97.43 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 120.235 -0.586 . . . . 2.01 111.696 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' THR . . . . . . . . . . . . . 53.5 m -66.23 -46.12 78.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.731 -0.668 . . . . 0.28 110.892 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.47 -37.79 88.76 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 123.607 0.567 . . . . 0.29 110.563 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' MET . . . . . . . . . . . . . 72.6 mtp -66.1 -45.81 79.84 Favored 'General case' 0 C--O 1.242 0.695 0 O-C-N 121.264 -0.897 . . . . 1.76 112.132 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' B' ' 109' ' ' PRO . . . -67.72 -33.81 75.62 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.3 0.852 . . . . 0.38 113.3 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.633 ' HD2' ' O ' ' B' ' 3' ' ' ILE . 15.8 ttp180 -52.56 -32.69 42.16 Favored 'General case' 0 C--O 1.21 -1.013 0 N-CA-C 113.4 0.889 . . . . 0.37 113.4 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.57 -19.59 60.85 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 114.1 1.148 . . . . 2.13 114.1 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -90.62 18.15 6.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 122.159 0.981 . . . . 2.27 109.476 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 12.7 t70 46.79 58.47 16.88 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 117.269 2.322 . . . . 0.48 117.269 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.42 ' HG3' HD13 ' B' ' 114' ' ' LEU . 44.9 Cg_endo -74.09 168.43 24.82 Favored 'Trans proline' 0 C--O 1.206 -1.109 0 C-N-CA 120.55 0.833 . . . . 0.47 110.604 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 54.3 p -77.0 162.78 27.28 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 106.706 -1.59 . . . . 0.53 106.706 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -55.94 -51.48 67.5 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 112.445 0.535 . . . . 0.48 112.445 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -58.67 -37.67 76.51 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 112.897 0.703 . . . . 0.6 112.897 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -62.84 -46.77 86.37 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 116.417 -0.356 . . . . 0.57 110.141 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.42 HD13 ' HG3' ' B' ' 109' ' ' PRO . 15.1 tp -64.41 -45.86 85.77 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 121.019 -0.272 . . . . 0.43 111.191 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 63.5 t -56.88 -48.32 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 O-C-N 121.891 -0.506 . . . . 0.44 110.52 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.25 94.3 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.133 0.492 . . . . 0.49 112.326 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 tp -62.4 -42.8 99.71 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 122.125 -0.359 . . . . 0.42 110.989 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.29 -45.1 94.51 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 119.798 -0.761 . . . . 0.35 112.059 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.61 -46.26 89.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.803 -0.443 . . . . 0.42 109.803 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -63.71 -45.22 90.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 113.717 1.006 . . . . 0.52 113.717 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 34.6 p -71.44 -32.28 68.16 Favored 'General case' 0 C--O 1.216 -0.681 0 C-N-CA 120.585 -0.446 . . . . 0.36 111.987 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.38 -45.74 95.31 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.332 -1.507 . . . . 0.3 109.332 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 8.7 mtp-105 -72.21 -42.15 66.11 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 112.622 0.601 . . . . 0.48 112.622 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.43 -20.27 62.92 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 119.578 -0.849 . . . . 2.42 111.964 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.78 -16.6 76.3 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 124.246 0.966 . . . . 0.31 113.511 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 93.7 t -88.99 113.07 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 106.171 -1.789 . . . . 0.34 106.171 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -156.45 136.84 13.03 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.409 -0.96 . . . . 2.95 108.409 -173.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.6 146.71 23.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.031 0.92 . . . . 0.4 109.986 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 tp -66.94 -56.78 8.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.337 -0.847 . . . . 0.45 111.37 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 62.63 178.8 0.14 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.612 0.72 . . . . 2.83 110.401 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.97 146.22 53.78 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.719 -0.845 . . . . 1.34 108.719 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.413 ' H ' ' HG2' ' B' ' 132' ' ' LYS . 0.8 OUTLIER -112.87 145.23 32.61 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.513 -0.742 . . . . 4.96 109.219 -179.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -64.41 146.97 90.57 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.474 2.116 . . . . 3.1 112.42 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.988 -1.006 . . . . 3.89 109.133 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 159' ' ' ASN . . . . . 0.709 ' ND2' ' NZ ' ' C' ' 259' ' ' LYS . 1.8 t-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 108.992 -0.744 . . . . 6.34 108.992 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 160' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -85.87 25.5 1.1 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.59 -0.893 . . . . 3.89 108.59 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 161' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -118.63 -141.88 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.583 -0.895 . . . . 1.72 108.583 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 162' ' ' MET . . . . . 0.594 ' SD ' HG21 ' C' ' 240' ' ' VAL . 0.3 OUTLIER -61.63 156.19 20.55 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.764 -1.21 . . . . 2.0 110.562 -178.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 163' ' ' VAL . . . . . . . . . . . . . 94.9 t -113.11 117.68 56.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.06 -0.719 . . . . 0.63 109.06 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 164' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.73 103.39 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.49 -0.929 . . . . 0.46 108.49 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.59 -35.33 80.7 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.211 -1.555 . . . . 0.44 109.211 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 tp -172.04 147.97 2.18 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.771 -1.172 . . . . 0.47 111.209 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 167' ' ' ALA . . . . . . . . . . . . . . . -117.69 104.39 10.96 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.048 -0.723 . . . . 0.29 109.048 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 168' ' ' ARG . . . . . 0.941 ' NH1' HG12 ' C' ' 178' ' ' VAL . 44.4 ttp180 -106.37 126.09 51.81 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.972 0.891 . . . . 3.14 110.835 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 169' ' ' ILE . . . . . . . . . . . . . 82.3 mt -95.5 129.21 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 109.222 -0.659 . . . . 0.34 109.222 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 170' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -165.95 117.04 1.04 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.812 -0.755 . . . . 0.49 110.327 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 171' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.97 -9.94 11.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.429 -0.794 . . . . 2.33 109.759 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 172' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' C' ' 174' ' ' ILE . 12.4 mtt180 -101.71 -6.49 23.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 2.95 110.47 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 173' ' ' LEU . . . . . . . . . . . . . 13.7 mt 59.1 -89.16 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.44 -0.948 . . . . 1.39 108.44 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 174' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' C' ' 172' ' ' ARG . 70.8 mt -109.98 116.77 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.069 -1.02 . . . . 0.53 110.227 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 175' ' ' HIS . . . . . 0.742 ' ND1' ' P ' ' B' ' 10' ' ' NEP . 10.0 p80 -139.35 117.61 11.95 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.947 -1.095 . . . . 0.65 109.033 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.55 -152.74 45.05 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 110.066 -1.214 . . . . 0.57 110.066 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 177' ' ' GLN . . . . . 0.785 ' H ' ' NE2' ' C' ' 177' ' ' GLN . 0.1 OUTLIER -91.15 12.21 20.76 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.744 -0.856 . . . . 3.26 109.332 -178.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . 0.941 HG12 ' NH1' ' C' ' 168' ' ' ARG . 48.1 t -61.54 -42.83 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 0.51 108.953 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 179' ' ' ALA . . . . . 0.448 ' O ' ' OG1' ' C' ' 183' ' ' THR . . . -73.16 -36.38 66.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.929 -1.107 . . . . 0.53 110.187 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 180' ' ' THR . . . . . . . . . . . . . 21.5 m -66.34 -54.42 24.82 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.697 -0.801 . . . . 0.68 109.79 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 181' ' ' ARG . . . . . 0.539 ' NH2' ' CG2' ' C' ' 308' ' ' THR . 55.1 ttt-85 -64.7 -43.62 92.88 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.013 -0.675 . . . . 3.12 110.608 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 182' ' ' TRP . . . . . 0.533 ' O ' HG23 ' C' ' 186' ' ' THR . 19.5 m95 -65.82 -32.2 73.6 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.034 -1.041 . . . . 0.9 109.591 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 183' ' ' THR . . . . . 0.803 HG21 HG21 ' C' ' 216' ' ' VAL . 71.9 m -65.29 -47.1 77.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.946 -1.096 . . . . 0.59 110.252 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 184' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -69.66 -42.93 73.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 2.2 110.806 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 185' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -68.32 -39.61 81.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.95 -1.094 . . . . 2.52 109.569 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 186' ' ' THR . . . . . 0.533 HG23 ' O ' ' C' ' 182' ' ' TRP . 72.6 p -81.42 -1.26 45.03 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.282 -0.886 . . . . 0.59 109.685 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 187' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 52.14 48.42 22.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.055 -1.028 . . . . 2.1 108.604 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 188' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.05 133.46 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.164 -0.96 . . . . 1.37 110.122 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 189' ' ' SER . . . . . . . . . . . . . 27.8 p -109.75 -6.33 15.32 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.761 -0.829 . . . . 1.4 108.761 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 190' ' ' ARG . . . . . . . . . . . . . 29.4 mtt-85 -135.92 142.83 44.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.555 -0.716 . . . . 3.52 110.441 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 191' ' ' ILE . . . . . . . . . . . . . 87.6 mt -133.38 127.61 54.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.173 -1.047 . . . . 0.51 108.173 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 192' ' ' ILE . . . . . 0.455 HD12 HG11 ' C' ' 240' ' ' VAL . 97.1 mt -115.66 128.68 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.257 -0.902 . . . . 0.46 109.665 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 193' ' ' VAL . . . . . . . . . . . . . 53.3 t -99.7 128.88 51.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.825 -0.806 . . . . 0.71 108.825 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 194' ' ' VAL . . . . . . . . . . . . . 43.0 t -112.51 103.57 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.535 -0.728 . . . . 0.43 109.479 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 195' ' ' SER . . . . . . . . . . . . . 38.0 t -167.25 125.61 1.31 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.342 -0.943 . . . . 1.38 109.31 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 196' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.01 -34.88 66.65 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.574 -0.704 . . . . 0.98 109.984 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 197' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -65.55 -45.49 83.21 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.147 -0.971 . . . . 2.32 109.959 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 198' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.11 -43.21 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.102 -0.998 . . . . 0.71 109.028 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.6 -26.5 55.72 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.79 -0.764 . . . . 0.74 109.168 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 200' ' ' ALA . . . . . . . . . . . . . . . -84.9 -5.38 59.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.028 -1.045 . . . . 0.89 109.882 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 201' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -102.75 95.38 6.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.9 -1.125 . . . . 1.15 109.554 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 202' ' ' THR . . . . . . . . . . . . . 24.7 p -66.22 -33.21 75.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.407 -0.808 . . . . 1.61 110.631 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 203' ' ' VAL . . . . . 0.615 HG22 HG12 ' A' ' 134' ' ' VAL . 55.8 t -66.33 -47.49 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.851 -1.156 . . . . 0.9 109.598 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 204' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -63.69 -42.24 98.04 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.349 -0.94 . . . . 3.07 109.576 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 205' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -58.01 -42.42 85.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 1.72 109.482 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 206' ' ' THR . . . . . 0.437 HG21 ' HG2' ' A' ' 133' ' ' PRO . 73.2 m -60.63 -48.71 80.55 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.088 -1.045 . . . . 0.92 109.564 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 207' ' ' LEU . . . . . 0.716 HD11 ' HD3' ' A' ' 132' ' ' LYS . 30.6 mt -62.62 -44.45 96.26 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.934 -1.107 . . . . 0.82 110.736 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' C' ' 208' ' ' LEU . 81.6 mt -62.5 -41.45 98.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.718 -1.239 . . . . 0.73 110.055 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 209' ' ' THR . . . . . . . . . . . . . 35.8 p -67.89 -31.83 71.89 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.371 -0.831 . . . . 0.84 110.28 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 210' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -80.37 -17.54 51.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.782 -1.199 . . . . 2.32 110.857 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . 0.58 HG11 ' HE1' ' B' ' 69' ' ' TRP . 17.5 m -107.69 17.65 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.952 -1.092 . . . . 0.93 108.639 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.29 123.42 82.48 Favored Pre-proline 0 N--CA 1.483 1.221 0 N-CA-C 107.82 -1.178 . . . . 0.76 107.82 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 213' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -44.31 144.48 2.95 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.037 1.825 . . . . 0.93 112.731 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 214' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -56.52 134.85 66.98 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.196 1.931 . . . . 1.14 112.028 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 215' ' ' GLY . . . . . . . . . . . . . . . 79.91 -8.52 50.03 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.922 -1.271 . . . . 0.85 109.922 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 216' ' ' VAL . . . . . 0.803 HG21 HG21 ' C' ' 183' ' ' THR . 58.6 t -114.8 136.78 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -1.076 . . . . 0.92 108.8 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.87 135.77 45.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.438 -0.789 . . . . 1.42 109.836 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 218' ' ' ALA . . . . . . . . . . . . . . . -110.17 131.37 55.12 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.315 -0.994 . . . . 0.64 108.315 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -120.97 153.51 37.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.401 -0.812 . . . . 0.72 109.808 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 54.8 t -126.35 117.83 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.624 0.726 . . . . 0.6 109.07 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 31.7 m -141.01 165.14 19.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.412 -0.805 . . . . 0.57 109.622 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 222' ' ' ASP . . . . . 0.709 ' OD1' ' N ' ' C' ' 225' ' ' LYS . 6.8 p30 -94.18 167.23 11.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.479 -0.763 . . . . 1.34 109.305 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.46 -44.82 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.151 -0.968 . . . . 0.54 110.455 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 224' ' ' ALA . . . . . 0.852 ' O ' HG22 ' C' ' 227' ' ' ILE . . . -62.72 -44.73 95.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.934 -1.104 . . . . 0.67 109.398 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 225' ' ' LYS . . . . . 0.709 ' N ' ' OD1' ' C' ' 222' ' ' ASP . 45.7 tttm -68.14 -35.35 77.95 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.775 -1.203 . . . . 2.11 109.674 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 226' ' ' MET . . . . . . . . . . . . . 10.3 tpt -62.08 -40.4 95.71 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.934 -1.104 . . . . 1.54 111.191 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . 0.852 HG22 ' O ' ' C' ' 224' ' ' ALA . 17.4 tt -60.9 -34.56 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.611 -0.885 . . . . 0.69 108.611 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.47 -38.86 62.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.722 -0.611 . . . . 4.01 110.948 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 70.3 t -62.18 -41.73 92.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.864 -1.162 . . . . 0.63 107.864 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 230' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' C' ' 230' ' ' TYR . 36.7 t80 -67.04 -32.13 73.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.102 -0.999 . . . . 0.64 109.927 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 231' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.76 6.73 2.34 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.119 -0.988 . . . . 0.95 110.104 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 232' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -110.18 117.78 50.87 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.246 -0.909 . . . . 0.93 109.435 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 233' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -65.73 1.51 2.19 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.646 1.564 . . . . 0.99 111.98 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 234' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.36 -24.76 65.33 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 1.59 108.807 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 235' ' ' TYR . . . . . 0.501 ' O ' ' HB2' ' C' ' 238' ' ' GLU . 81.1 m-85 -105.49 15.71 26.66 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.594 -0.842 . . . . 1.19 109.003 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.81 135.62 47.44 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.076 -1.64 . . . . 0.67 109.65 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.78 -33.41 1.9 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.288 -1.525 . . . . 0.64 109.288 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 238' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' C' ' 235' ' ' TYR . 4.0 mm-40 -54.25 138.93 37.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.805 -1.409 . . . . 2.48 109.437 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 239' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -99.1 116.33 31.08 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.463 -0.939 . . . . 2.96 108.463 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . 0.594 HG21 ' SD ' ' C' ' 162' ' ' MET . 26.3 t -121.85 148.78 25.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.876 0.846 . . . . 0.66 110.448 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 241' ' ' MET . . . . . . . . . . . . . 13.8 ttm -102.9 134.95 45.47 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.925 -1.139 . . . . 1.63 107.925 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 242' ' ' LEU . . . . . 0.402 ' HB3' ' CE2' ' C' ' 244' ' ' PHE . 61.2 mt -102.04 127.28 49.0 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.689 -0.804 . . . . 0.35 109.877 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 243' ' ' LEU . . . . . . . . . . . . . 97.6 mt -109.5 126.08 53.15 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.981 0.896 . . . . 0.68 109.045 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 244' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' C' ' 242' ' ' LEU . 77.7 m-85 -127.0 162.03 26.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.771 0.796 . . . . 0.3 109.275 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 245' ' ' THR . . . . . . . . . . . . . 70.2 p -109.48 -19.47 13.23 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.958 -0.756 . . . . 0.43 108.958 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 246' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' C' ' 246' ' ' ASN . 17.3 p30 -151.08 141.85 14.91 Favored Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 120.003 -0.679 . . . . 1.0 109.872 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 247' ' ' PRO . . . . . 0.451 ' HG3' ' CE2' ' C' ' 291' ' ' PHE . 7.3 Cg_endo -60.85 -14.63 33.4 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.683 2.255 . . . . 0.59 112.1 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 248' ' ' THR . . . . . . . . . . . . . 95.7 m -64.99 -42.66 94.31 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.151 0.976 . . . . 0.64 108.624 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 249' ' ' ASP . . . . . 0.42 ' O ' HD12 ' C' ' 253' ' ' LEU . 97.8 m-20 -67.48 -23.4 65.48 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.54 -0.725 . . . . 0.53 109.801 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 250' ' ' VAL . . . . . . . . . . . . . 98.3 t -73.62 -43.77 54.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.672 -1.267 . . . . 0.4 109.848 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 251' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.41 -35.02 77.92 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.426 -0.953 . . . . 1.51 108.426 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 252' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -62.48 -44.09 97.23 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.723 -0.791 . . . . 3.24 110.156 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 253' ' ' LEU . . . . . 0.42 HD12 ' O ' ' C' ' 249' ' ' ASP . 1.2 mp -64.07 -40.42 96.22 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 117.999 -1.48 . . . . 1.06 108.876 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 254' ' ' VAL . . . . . 0.57 ' CG2' HD12 ' C' ' 260' ' ' ILE . 70.6 t -60.7 -44.61 97.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 120.835 -1.165 . . . . 0.48 108.948 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 255' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.23 -30.97 69.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.018 -1.052 . . . . 2.47 109.917 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 256' ' ' GLY . . . . . . . . . . . . . . . -74.28 2.8 43.16 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.498 -1.441 . . . . 0.55 109.498 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 257' ' ' GLY . . . . . . . . . . . . . . . 94.37 15.79 45.94 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.627 -1.389 . . . . 0.51 109.627 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 258' ' ' VAL . . . . . . . . . . . . . 96.7 t -77.66 139.72 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.034 -1.469 . . . . 0.45 107.034 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 259' ' ' LYS . . . . . 0.709 ' NZ ' ' ND2' ' C' ' 159' ' ' ASN . 17.9 tttt -99.01 123.93 43.64 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.089 -1.007 . . . . 3.12 110.811 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 260' ' ' ILE . . . . . 0.57 HD12 ' CG2' ' C' ' 254' ' ' VAL . 98.1 mt -129.99 125.67 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.43 -0.794 . . . . 0.41 109.147 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 65.9 p -89.51 -31.44 17.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.776 -1.202 . . . . 0.57 110.238 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 262' ' ' SER . . . . . . . . . . . . . 15.8 m -159.06 153.51 24.15 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.176 -0.953 . . . . 0.46 110.092 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 263' ' ' VAL . . . . . . . . . . . . . 50.9 t -122.74 134.61 65.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.538 -0.912 . . . . 0.37 108.538 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 264' ' ' ASN . . . . . 0.468 ' ND2' ' CH2' ' C' ' 182' ' ' TRP . 33.7 t30 -108.57 128.08 54.51 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.517 0.675 . . . . 1.17 110.607 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 265' ' ' VAL . . . . . 0.451 HG21 ' SD ' ' C' ' 314' ' ' MET . 3.2 t -90.64 108.43 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 120.058 -0.657 . . . . 0.4 109.68 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 266' ' ' GLY . . . . . . . . . . . . . . . -80.75 -53.94 3.84 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.153 -1.179 . . . . 0.41 110.153 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . -172.57 152.93 17.73 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.646 -1.74 . . . . 0.41 111.476 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 268' ' ' MET . . . . . 0.44 ' HB2' ' H ' ' C' ' 282' ' ' SER . 97.0 mtp -143.1 118.08 10.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.481 -1.011 . . . . 0.5 110.443 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.34 128.21 21.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.371 -0.831 . . . . 0.57 109.523 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 270' ' ' PHE . . . . . 0.536 ' CG ' ' N ' ' C' ' 271' ' ' ARG . 13.3 t80 -69.5 161.8 28.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.92 109.618 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 271' ' ' ARG . . . . . 0.536 ' N ' ' CG ' ' C' ' 270' ' ' PHE . 32.7 ttm180 -160.66 158.67 29.24 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.27 -0.972 . . . . 3.23 109.676 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 272' ' ' GLN . . . . . 0.4 ' N ' ' HG2' ' C' ' 271' ' ' ARG . 73.9 mt-30 -66.48 138.25 57.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.081 -1.012 . . . . 2.98 110.459 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 273' ' ' GLY . . . . . . . . . . . . . . . 95.52 -12.32 67.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.818 -1.713 . . . . 0.87 108.818 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 274' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -101.81 163.37 12.29 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.484 -1.01 . . . . 1.66 109.388 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 275' ' ' THR . . . . . 0.561 HG21 HG21 ' C' ' 321' ' ' ILE . 20.8 m -109.95 135.83 50.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.674 -0.862 . . . . 0.84 108.674 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 276' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -82.02 119.21 23.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.246 -0.909 . . . . 2.77 110.176 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 277' ' ' VAL . . . . . 0.519 HG12 ' CD1' ' C' ' 321' ' ' ILE . 27.5 m -99.22 -28.18 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.81 -0.756 . . . . 0.74 109.612 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 278' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' C' ' 279' ' ' ASN . 10.2 t-20 -135.99 -177.16 4.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.658 0.742 . . . . 1.52 109.761 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' C' ' 278' ' ' ASN . 39.5 m-20 -56.93 -29.88 63.5 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.791 -0.568 . . . . 2.29 110.787 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . -148.06 27.01 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.829 -1.169 . . . . 0.6 109.538 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 281' ' ' VAL . . . . . 0.498 ' O ' HG22 ' C' ' 277' ' ' VAL . 60.8 t -118.99 121.98 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.825 0.822 . . . . 0.61 109.678 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 282' ' ' SER . . . . . 0.44 ' H ' ' HB2' ' C' ' 268' ' ' MET . 29.0 m -118.64 147.61 43.58 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.447 0.642 . . . . 0.75 110.02 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 283' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.26 142.84 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.446 1.117 . . . . 0.7 110.539 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 284' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' C' ' 287' ' ' ASP . 44.1 p-10 -110.61 171.67 7.33 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 106.923 -1.51 . . . . 0.77 106.923 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 285' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.18 -24.21 40.12 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.833 -1.167 . . . . 2.34 109.587 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 286' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -79.59 -43.46 22.89 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.233 -0.917 . . . . 2.0 110.026 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 287' ' ' ASP . . . . . 0.57 ' N ' ' OD1' ' C' ' 284' ' ' ASP . 93.3 m-20 -64.25 -42.08 96.67 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.237 -0.915 . . . . 0.62 109.096 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 288' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.48 -45.77 97.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.387 -0.821 . . . . 0.73 109.518 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 289' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -57.44 -39.6 76.6 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.216 -0.928 . . . . 2.52 110.262 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.37 -41.01 85.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.82 -1.175 . . . . 0.6 109.9 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 291' ' ' PHE . . . . . 0.451 ' CE2' ' HG3' ' C' ' 247' ' ' PRO . 40.0 m-85 -63.93 -39.02 93.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.57 109.73 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 292' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -64.08 -39.5 94.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.149 -0.969 . . . . 2.05 110.226 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 293' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -65.78 -41.54 91.86 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.943 -1.098 . . . . 1.8 109.635 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 294' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.18 -43.22 99.32 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.871 -1.143 . . . . 0.53 108.867 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 295' ' ' ASN . . . . . 0.58 HD22 ' HG3' ' C' ' 315' ' ' MET . 40.3 t-20 -64.01 -40.01 95.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 1.45 109.953 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.66 -21.38 65.67 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.815 -1.178 . . . . 0.69 109.242 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 297' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -90.13 8.85 30.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.769 -1.207 . . . . 2.49 109.91 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.44 11.43 82.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.903 -1.279 . . . . 0.6 109.903 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 299' ' ' ILE . . . . . . . . . . . . . 97.8 mt -84.71 134.56 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.974 -1.309 . . . . 0.53 109.151 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 300' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -82.0 141.66 33.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.869 . . . . 2.3 110.615 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 301' ' ' LEU . . . . . . . . . . . . . 66.9 mt -123.08 111.27 16.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.269 -0.641 . . . . 0.54 109.269 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 302' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.57 139.87 49.69 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.9 . . . . 2.26 110.289 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 303' ' ' VAL . . . . . 0.611 ' CG2' ' SD ' ' C' ' 314' ' ' MET . 51.8 t -111.99 124.77 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.673 -0.862 . . . . 0.55 108.673 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 304' ' ' ARG . . . . . 0.459 ' HE ' ' CG ' ' C' ' 264' ' ' ASN . 33.4 ptt180 -164.93 137.87 4.64 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.505 -0.878 . . . . 2.7 110.343 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 305' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -80.82 -45.42 16.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 3.19 109.817 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 306' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.33 154.01 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.106 -0.996 . . . . 0.65 108.737 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 307' ' ' SER . . . . . . . . . . . . . 83.5 p -64.55 -16.29 62.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.983 -1.073 . . . . 1.36 109.516 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 308' ' ' THR . . . . . 0.539 ' CG2' ' NH2' ' C' ' 181' ' ' ARG . 44.5 p -86.14 -9.07 57.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.047 -1.033 . . . . 0.85 110.005 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 309' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -92.49 152.69 42.35 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.025 -1.047 . . . . 0.81 109.936 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 310' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -55.37 139.15 81.42 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.968 1.779 . . . . 0.93 111.755 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 311' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -84.24 132.82 34.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 3.09 109.823 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 312' ' ' LEU . . . . . . . . . . . . . 80.2 mt -117.51 154.74 30.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.103 -0.998 . . . . 0.73 108.309 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 313' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -91.26 130.49 37.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.076 -1.015 . . . . 2.24 109.827 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . 0.611 ' SD ' ' CG2' ' C' ' 303' ' ' VAL . 8.2 tpt -56.39 -44.17 79.97 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.67 -0.644 . . . . 1.03 109.63 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 315' ' ' MET . . . . . 0.58 ' HG3' HD22 ' C' ' 295' ' ' ASN . 95.9 mmm -61.18 -40.39 93.73 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.299 -0.876 . . . . 1.71 110.22 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 316' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.9 -44.0 97.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.319 -0.863 . . . . 0.82 109.81 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 317' ' ' LEU . . . . . . . . . . . . . 92.8 mt -66.49 -41.98 88.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.877 . . . . 0.8 110.036 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 318' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.26 -24.49 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.311 -0.868 . . . . 0.86 109.957 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . 0.475 ' O ' ' C ' ' C' ' 323' ' ' LYS . 0.9 OUTLIER -72.72 -31.56 65.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.084 -1.01 . . . . 1.52 109.518 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 320' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -84.19 -2.45 56.9 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.78 -1.168 . . . . 2.04 109.167 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 321' ' ' ILE . . . . . 0.561 HG21 HG21 ' C' ' 275' ' ' THR . 93.2 mt -113.76 -58.74 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.914 -1.143 . . . . 1.17 107.914 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 322' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' C' ' 323' ' ' LYS . 12.3 t0 -95.01 85.11 4.26 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.16 -1.792 . . . . 2.26 106.16 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 323' ' ' LYS . . . . . 1.262 ' HA ' ' NZ ' ' C' ' 323' ' ' LYS . 0.0 OUTLIER . . . . . 1 C--O 1.524 15.537 0 CA-C-O 126.309 2.957 . . . . 5.92 109.465 -177.693 . . . . . . . . 3 3 . 1 stop_ save_